anthroposophic pharmaceutical codex apc · ˜e anthroposophic pharmaceutical codex, apc is now...

�e International Association of Anthroposophic PharmacistsIAAP

ANTHROPOSOPHICPHARMACEUTICAL CODEXAPC

3rd EDITION2013

International Association of Anthroposophic PharmacistsGoetheanumMedical Section4143 DornachSwitzerland

www.iaap.org.ukemail: [email protected]

ANTHROPOSOPHIC PHARMACEUTICAL CODEX APC 3.0

Introductory Note APC 3rd edition 2013

International Association of Anthroposophic Pharmacists, IAAP

�e IAAP is the international umbrella organization of the national associations of Anthroposophic Pharma-cists.

Its purpose, objective and tasks are, in detail:

• To represent anthroposophic pharmacists in the anthroposophic-medical movement and in public life on an international level: Anthroposophic pharmacy is understood as an extension of conventional phar-macy.

• To establish standards regarding education, further training and practice in anthroposophic pharmacy (including but not limited to retail pharmacists).

• To promote research in anthroposophic pharmacy.• To achieve international recognition by specialised

publications as well as training material for anthro-posophic pharmacists.

• To establish a cooperative network between anthro-posophic pharmacists to exchange information and best practice throughout the world.

• To initiate / coordinate international activities.

It is in respect of this last aim that the Board is pleased to publish the 3rd edition 2013 of the Anthroposophic Pharmaceutical Codex (APC).

Several de�nitions have been harmonised with the de�nitions in the Swiss and German Law, as well as in the monograph on anthroposophic preparations “Anthropo- sophische Zubereitungen” in the Swiss Pharmacopoeia.

Several manufacturing procedures have been worded more precisely and new manufacturing methods have been included. Where appropriate, the European Pharmacopoeia has been referred to. Also the lists of starting materials used have been updated to include new substances, nomenclature, references to o�cial pharmacopoeias as well as a literature reference which demonstrates that the substance is generally known in anthroposophic pharmacy / medicine.

�e most relevant change however is the inclusion of �ve monographs:• Cydonia oblonga, fruit• Cydonia oblonga, fruit, heat treated aqueous tincture

1:2.1• Cydonia oblonga, fruit, glycerol extract with heat

treatment 1:2.1• Cydonia oblonga, fruit, mother tincture obtained

by rhythmic application of heat and cold: Cydonia oblonga e fructibus ferm 33b

• Levico Water

�e APC is reviewed and updated by an anthropo-sophic pharmaceutical committee responsible to the IAAP board.

�e changes in summary:new texts Manufacturing methods3.3.1, 3.3.2, 3.9.3, 3.12.25.2.2, 5.2.37.2, 7.58.2 with 8.2.1 and 8.2.2

MonographsCydonia oblonga, fruitCydonia oblonga, fruit, heat treated aqueous tincture 1:2.1Cydonia oblonga, fruit, glycerol extract with heat treat-ment 1:2.1Cydonia oblonga, fruit, mother tincture obtained by rhythmic application of heat and cold: Cydonia oblonga e fructibus ferm 33bLevico Water

revised texts General chaptersAll textsManufacturing methodsAll methodsChanged numbers: 7.2 into 7.4AppendicesAll appendices

deleted textsManufacturing methods3.9.2

Members of the APC committee

Gabriele Jones, pharmacist, Germany

Herwig Judex, chemist, Germany

Judith Klahre Parker, pharmacist, United Kingdom, Chairperson of the British Association, BAAP, (British Association of Anthroposophic Pharmacists)

Andrea Kühn, pharmacist, Germany

Jakob Maier, pharmacist, Switzerland, Board Member of VAEPS and Member of the Committee on Comple-mentary Medicinal Products of the Swiss Pharmaco-poeia

Mónica Mennet-von Ei�, pharmacist, Switzerland, Presi-dent of the Swiss association VAEPS, Board Member of the IAAP; Member of the Working Group HOM on Homoeopathic Raw Materials and Stocks of the Euro-pean Pharmacopoeia

• Introductory N

ote

2


Christiaan Mol, pharmacist, Germany, Chairman of the APC committee, Board Member of the IAAP; Member of the Committee on Manufacturing Methods of the German Homoeopathic Pharmacopoeia

Peter Pedersen, pharmacist, Denmark; Member of the Committee on Manufacturing Methods of the German Homoeopathic Pharmacopoeia

Nelly Segur, pharmacist, France

Marion Zeeck, pharmacist, Germany

�e APC is recognised by the following national anthro-posophic pharmaceutical associations:

the French Association AFERPA (Association Française d'étude et de recherche sur la pharmacie anthroposo-phique – French Association for Studies and Research on Anthroposophic Pharmacy);the British Association, BAAP (British Association of Anthroposophic Pharmacists) and its Associate, New Zealand;the Belgian/Dutch Association BNVAA (Belgisch – Ned-erlandse Vereniging van Antroposo�sch georiënteerde Apothekers – Belgian Dutch Association of Anthropo-sophic Pharmacists);the Brazilian Association Farmantropo (Associação Brasileira de Farmácia Antroposó�ca – Brazilian An-throposophic Pharmacy Association);the German Association GAPiD (Gesellscha� Anthro-posophischer Apotheker in Deutschland – Society of Anthroposophic Pharmacists in Germany);the Austrian Association ÖGAPh (Österreichische Ge-sellscha� anthroposophischer Pharmazeuten – Austrian Society of Anthroposophic Pharmacists);the Italian Association SOFAI (Società di farmacisti antroposo� in Italia – Society of Anthroposophic Phar-macists in Italy);the Swiss association VAEPS (Verband für Anthroposo-phisch Erweiterte Pharmazie in der Schweiz – Associa-tion for Anthroposophically Extended Pharmacy in Switzerland).

Dr. Manfred Kohlhase, President IAAP, 30.06.2013For full details of the IAAP Guidelines, see website www.iaap.org.uk

• In

trod

ucto

ry N

ote

3

• Introductory N

ote

4


Endorsement Universität Witten/Herdecke

As a professor for Anthroposophic Medicine I warmly welcome the third edition of the Anthroposphic Pharmaceutical Codex. Anthroposophic Medicine is an integrative system of medicine involving conventional medicine and a set of di�erentiated thera-peutic tools. A very important tool is its array of medicinal products. Anthroposophic Medicine claims a substance related e�ect as well as a dynamic or process related e�ect for its medicines, both of which are meant to activate self healing processes. �e task of the APC is to develop appropriate quality principles as well as quality standards in line with the characteristics and requirements of anthroposophic medicines. Substance related standards are well documented as well as manufacturing methods, which relate to the process characteristics of anthroposophic medicinal products.

Prof. Peter Heusser

Endorsement IVAA

�e International Federation of Anthroposophic Medical Associations (IVAA) is the international umbrella organisation representing 31 anthroposophic medical associa-tions worldwide in political and legal matters. As well as services provided to member organisations, the IVAA provides similar assistance to doctors in more than 30 ad-ditional countries throughout the world.

�e IVAA´s mission includes political e�orts to ensure legal and regulatory safeguards for the availability of Anthroposophic Medicinal Products (AMPs) in any country in the world where doctors practise the anthroposophic medical approach.

�e Anthroposophic Pharmaceutical Codex (APC) is an indispensable document for de�ning the anthroposophic medical system, and provides detailed insight into the di�erent types of medicinal products used in Anthroposophic Medicine, including source materials, pharmaceutical processes and standards.

�e APC makes it possible to relate knowledge of substances and pharmaceutical pro-cesses to insight into human health and illness. From a pharmaceutical point of view it o�ers a full description of Anthroposophic Medicine as a complex medical system founded on the interrelationship between these processes and insights.

On behalf of the IVAA I wish to acknowledge and endorse this achievement by the community of anthroposophic pharmacists a�liated within the IAAP. Successful compilation of the codex now gives Anthroposophic Pharmacy a �rm position within general medical culture.

Peter Zimmermann MD, PhDPresident IVAA

• In

trod

ucto

ry N

ote

5

IVAA International Federation of Anthroposophic Medical AssociationsRue du Trône 194B-1050 BruxellesPhone: +32 2 644 00 20email: [email protected]


Endorsement Escamp

With pleasure I have taken notice of the recently �nalised new version of the APC. �e development of the APC is very important for ESCAMP. �e aim of ESCAMP is to develop the scienti�c basis for a permanent regulatory framework for Anthroposophic Medicinal Products (AMPs) in Europe. �e ESCAMP strategy includes a description of Anthroposophic Medicine as a whole system and an evaluation of single AMP’s and AMP groups (see www.escamp.org). For this work the APC provides essential pharma-ceutical source material, including de�nitions of AMPs as well as descriptions of their starting materials, manufacturing processes and dosage forms. On behalf of ESCAMP I herewith endorse the relevant steps that have been under-taken to revise and expand the APC, in particular the inclusion of speci�c substance monographs with relevant quality standards.

Dr. Harald Johan HamreFreiburg im Breisgau

• Introductory N

ote

6

Harald Johan HamreScienti�c Director and President of the European Scienti�c Cooperative of Anthroposophic Medicinal Products (ESCAMP)


Dear Sir or Madam,

�e Anthroposophic Pharmaceutical Codex, APC is now available in its revised 3rd edition. ECHAMP is the international industrial association that has given itself a number of tasks with regard to the further development of anthroposophic and homoeopathic medicinal products. Article 2 of the Articles of Association quotes as follows:

“Active promotion of the harmonisation, legalisation, research and the respective in-tegration of homeopathic and anthroposophic medicinal products into o�cial phar-macopoeias, primarily in the European Union, with the purpose of further enabling e�ective access by representatives of the professional groups and the general public to these medicinal products.” (Italics by the author)

�e APC is an important document from this perspective, since it provides the pool of pharmaceutical information in pharmacopoiea language which makes such an objec-tive possible for the stakeholders active in the area.

We wish to express our congratulations to the International Association of Anthropo-sophic Pharmacists, IAAP, for this new step. As an association also representing the anthroposophic medicinal product industries, we fully endorse the APC and wish that it will provide guidance in any concerned regulation process.

Nand de Herdt, President of ECHAMP

• In

trod

ucto

ry N

ote

7

European Coalition on Homeopathic and Anthroposophic Medicinal Products E.E.I.G.Rue Gray 100, 1040 Brussels ,Belgium, Tel: +32-2-649.94.40, Fax: +32-2-649.41.77o�[email protected] , www.echamp.eu , VAT BE 0467 826 644 RPR Brussels


Endorsement ECHAMP


• Introductory N

ote

8

Endorsement Hogeschool Leiden

�e International Association of Anthroposophic Pharmacists, IAAP, is publishing the 3rd edition of the Anthroposophic Pharmaceutical Codex, APC. For me as an aca-demic in the �eld of Anthroposophic Medicine it is of paramount importance to rely on the e�orts of the joint disciplines making Anthroposophic Medicine a constantly developing reality, in this case the precious work of my colleague pharmacists. With enthusiasm therefore I have taken notice of the further developments, in particular of the inclusion of monographs of starting materials and preparations. �e APC gives the framework of what belongs to the pharmaceutical identity of Anthroposophic Medi-cine. With this edition this identity is further validated and applied to single important preparations. With anthroposophic preparations derived from the quince, Cydonia oblongata, now monographed in the APC I have had the pleasure to carry out clinical research1. I wish the IAAP further successful steps in further developing the APC.

Erik BaarsHogeschool Leiden Lectoraat Antroposo�sche Gezondheitszorg

1 Erik W. Baars, Miek Jong, Andreas F. M. Nierop, Inge Boers, and Huub F. J. Savelkoul, “Citrus/Cydonia Compositum Subcutaneous Injections versus Nasal Spray for Seasonal Allergic Rhinitis: A Randomized Controlled Trial on E�cacy and Safety,” ISRN Allergy, vol. 2011, Article ID 836051, 11 pages, 2011. doi:10.5402/2011/836051


• In

trod

ucto

ry N

ote

9

Endorsement Eberhard Karls University, Tübingen

The quality of medicinal products is - besides their safety and efficacy - definitely an im-portant aspect of public health. Usually the required quality is defined by the relevant phar-macopeias and the proper drug quality is guaranteed by respective analytical procedures. However, the quality of an anthroposophic medicinal product represents usually much more than the sum of its analytical characteristics. Its unique quality is strictly related to the entire process chain involved, including the source material, pharmaceutical processes and standards. In this context, I am very pleased to hold in my hand the 3rd Edition of the Anthroposo-phic Pharmaceutical Codex. It looks and defines quality in its entirety and represents thus a huge step forward for anthroposophic medicinal products in the direction of an up to date quality understanding. The APC successfully helps to close the gap which exists between those medicinal products described in official pharmacopeias, e.g. the European Pharma-copeia and the German Homeopathic Pharmacopeia, and the traditional anthroposophic codices. It was a real challenge to develop the quality related tools in line with the special needs of anthroposophic medicinal products.

Congratulations to the IAAP for showing the courage to venture to do this and congratula-tions for having done it so successfully.

Prof. Rolf DanielsChair of Pharmaceutical Technology, Pharmaceutical Institute Eberhard Karls University, Tübingen


Endorsement Faculty of Pharmacy, Philipps-Universität Marburg

Anthroposophic medicinal products do have a long tradition in Germany and its neigh-bouring countries. �e pharmaceutical pro�le of these products is comparable to that of homoeopathic medicinal products and their quality is usually de�ned by the quality of the starting materials as well as the manufacturing processes, as required by regula-tion. Consequently, the quality and testing procedures of raw materials and stocks - like for example mother tinctures - used for the production of anthroposophic medicinal products should be de�ned by monographs in the relating pharmacopeias (e.g., German Homoeopathic Pharmacopoeia and also more and more the European Pharmacopoeia).

�erefore, I am very pleased that the 3rd Edition of the Anthroposophic Pharmaceutical Codex now includes four monographs on starting materials and the relating preparations. �is represents a huge step towards a state of the art quality understanding of anthro-posophic medicinal products. �e APC successfully helps to close the gap, which exists between those medicinal products and starting materials described in o�cial phar-macopeias as mentioned above, and those which have not been covered by any o�cial monograph so far. It is a real challenge to develop the quality related tools in line with the special needs of anthroposophic medicinal products.

Congratulations to the IAAP for e�ectively closing this quality gap for anthroposophic starting materials.

Prof. Michael KeusgenDean of the Faculty of Pharmacy, Philipps-Universität Marburg, Germany

• Introductory N

ote

10


• Fo

rew

ord

11

Foreword

Pharmacy extended by the principles of anthroposophy began to be developed at the beginning of the 20th century by Rudolf Steiner (founder of anthroposophy, 1861 – 1925) and Oskar Schmiedel (Austrian chemist, 1887 – 1959), in collaboration with a number of physi-cians. �eir aim was to reinterpret and complement the results of pharmaceutical and medical research with insights gained from anthroposophic research of the human being and nature.�e basis of the anthroposophic approach to pharmacy is the “holistic” knowledge of mankind and nature, which recognizes the notion that human beings and the kingdoms of nature are related through a common evolution1.�is perception leads to a comprehensive view of substances in their relationship to health, illness and to a speci�c approach to pharmacy.

�erefore anthroposophic pharmacy uses substances from the mineral, plant and animal kingdoms2,3.

Anthroposophic medicinal products have been on the market world-wide and prescribed by quali�ed medical practitioners since 1921.

�e range of anthroposophic medicinal products is partially determined by the physical characteristics of substances, whereby allopathic, phytotherapeutic and homoeopathic criteria are taken into considera-tion. Most particularly, anthroposophic medicinal products are characterised by their manufacturing processes involving speci�c anthroposophic and typi-cal homoeopathic pharmaceutical procedures. �e range of anthroposophic medicinal products includes potentised medicinal products, manufactured by using the methods of the o�cial homoeopathic pharma-copoeias, as well as concentrated mineral, herbal or animal substances or preparations and compounded medicinal products. Considering this diversity, anthroposophic medicinal products, cannot be de�ned under a single substance classi�cation.

1 Jos Verhulst: „Der Erstgeborene“ (�e �rst-born), publisher Verlag Freies Geistesleben, Stuttgart, D 2001.2 Rudolf Steiner/Ita Wegman: „Grundlegendes für eine Erweiter-ung der Heilkunst nach geisteswissenscha�lichen Erkenntnis-sen.“ GA 27, publisher Rudolf Steiner Verlag, Dornach, CH, 1992.In English: „Extending Practical Medicine – Fundamental Prin-ciples based on the Science of the Spirit“. Rudolf Steiner Press , London, GB, 19963 Rudolf Steiner: „Geisteswissenscha� und Medizin“, 20 Vorträge für Ärzte (1920), Rudolf Steiner Verlag, Dornach, CH 1985.In English: „Introducing Anthroposophical Medicine“ (previ-ously published as: Spiritual Science and Medicine). Twenty lectures to doctors. Dornach 21 March – 9 April 1920, GA 312. Anthroposophic Press, Hudson, NY, USA, 1999.

�e Anthroposophic Pharmaceutical Codex APC gives an overview of substances and methods used in the manufacture of anthroposophic medicinal products as well as of the related quality parameters.

Legal SituationToday the European Union Directive 2001/83/EEC and amendments contain the main legislation concerning medicinal products. �e legal status of anthroposophic medicinal products in the EU is closely related to that of homoeopathic medicinal products (see below).

Preamble of Directive 2001/83/EEC n° (22) refers to anthroposophic medicinal products as follows:“Anthroposophic medicinal products, which are described in an o�cial pharmacopoeia and prepared by a homoeo-pathic method are to be considered, as regards to regis-tration and marketing authorization, as homeopathic medicinal products.”

From a regulatory point of view anthroposophic medicinal products can be devided into two categories:• anthroposophic medicinal products manufactured

according to a homoeopathic manufacturing method within the meaning of Directive 2001/83/EEC, article 1, 5.: “Any medicinal product prepared from substances called homoeopathic stocks in accordance with a homoeopathic manufacturing procedure described by the European Pharmacopoeia or, in absence thereof, by the pharmacopoeias currently used o�cially in the Member States. (...)”

• anthroposophic medicinal products other than those manufactured by a homoeopathic manufacturing method.

�ese are equally important and have never been included in any pharmacopoeia.

�e de�nitions of anthroposophic medicinal products given in the Swiss and German Drug Laws take both cat-egories into account (translations by APC Committee):

Switzerland: Regulation of Swissmedic concerning the simpli�ed Authorisation of Complementary and Herbal Medicinal Products (Verordnung des Schweizerischen Heilmittelinstituts über die vereinfachte Zulassung von Komplementär- und Phytoarzneimitteln) Art. 4, 2 f: Anthroposophic medicinal product: Medicinal product, whose active substances are manu-factured by a homoeopathic manufacturing procedure, or according to an anthroposophic manufacturing procedure described in the German Homoeopathic

• Forew

ord

Pharmacopoeia or in the British Homoeopathic Pharmacopoeia or according to a special anthroposophic manufacturing procedure and that is formulated and developed according to the anthroposophic knowledge of man, animal, substance and nature and is meant to be used according to these principles.

Germany: Medicinal Products Act (Gesetz über den Verkehr mit Arzneimitteln) Art. 4, (33) An anthroposophic medicinal product is a medicinal product that has been developed according to the anthroposophic knowledge of man and nature and that is manufactured according to a homoeopathic manufacturing procedure described in the European Pharmacopoeia or in absence thereof in a pharma-copoeia o�cially used in the Member States or according to a special anthroposophic manufacturing procedure and that is meant to be used according to the anthro-posophic principles concerning man and nature.

In many EU countries, and also world-wide, medicinal products used for the anthroposophic therapeutics are thus partially integrated in legislation.

In Brazil as well as in Australia the APC has been of-�cially recognised as quality standard and reference for anthroposophic medicinal products (RESOLUÇÃO RDC No – 26, DE 30 DE MARÇO DE 2007; amend-ments to the Australian �erapeutic Goods Act, 2009).

In summary anthroposophic medicinal products as a whole are step by step gaining legal recognition in the EU as well as world-wide, and among other things this requires comprehensive publication of their pharma-ceutical quality.

�e publication of the Anthroposophic Pharmaceutical Codex is to provide transparency of anthroposophic pharmaceutical quality for pharmacists and bodies requiring an appreciation of anthroposophic medicinal products and pharmacy. Furthermore it provides a basis for the maintenance of existing and development of new anthroposophic medicinal products.

�e relationship of the APC to the European Pharmacopoeia, to other existing o�cial Pharma-copoeias and non o�cial pharmacopoeias

�e APC is published by the IAAP, an independent association of professional pharmacists, within the context of o�cial existing pharmacopoeias. It is the intention of the APC to refer where possible to existing pharmacopoeias. In fact anthroposophic medicinal products are o�en manufactured and controlled

12

according to existing speci�cations and standards.A part of the reference pharmacopoeias for the APC are published by o�cial Authorities, in particular�e European Pharmacopoeia�e French Pharmacopoeia�e German Homoeopathic Pharmacopoeia (which is a part of the German Pharmacopoeia);�e Swiss Pharmacopoiea has implemented two texts concerning anthroposophic pharmacy in the last four years:• in 2009 (Suppl. 10.1) with the general Ph.Helv.-mono-

graph “Praeparationes anthroposophicae (Anthropo-sophic Preparations)” (Ph.Helv. CH 306); it was the �rst time that anthroposophic preparations appeared as a monograph in an o�cial pharmacopeia. �is monograph includes the paragraphs de�nitions, starting materials, methods of preparation and dosage forms, by analogy with the Ph.Eur.-monograph Homoeopathic preparations Ph.Eur. 1038.

• in September 2013 (Suppl. 11.1) the new Ph.Helv.-chapter “17.7 Manufacturing methods for anthropo-sophic preparations” came into force. �is chapter gives an overview on the general manufacturing processes and describes in more detail some manu-facturing methods which are more frequently used in anthroposophic pharmacy and had not been described in an o�cial pharmacopoeia before.

�e APC served as important basis to establish both of these Ph.Helv.-texts. �erefore it can be concluded, that the continuing work of the APC supports the establish-ment of the pharmaceutical quality standards and the regulation of anthroposophic medicinal products in Switzerland.

Further o�cial pharmacopoeias of reference:�e Austrian Pharmacopoeia�e British Pharmacopoeia

In particular the European Pharmacopoeia today represents and for the future will represent a reference of paramount importance for the APC.

�erefore in part IV of the APC containing the lists of the various substances used in anthroposophic phar-macy reference is made where possible to the European Pharmacopoeia and other o�cial pharmacopoeias.

Particularly important Ph.Eur. monographs are:Herbal drugs for homoeopathic preparations (2045)Homoeopathic preparations (1038)Methods of preparation of homoeopathic stocks and potentisation (2371)Minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (50208)


• Fo

rew

ord

13


Mother tinctures for homoeopathic preparations (2029)Tinctures (chapter in 0765 Extracts)Viral safety (50107)Other pharmacopoeias referred to in the APC are not o�cially recognised. Nevertheless they provide reliable standards accepted e.g. by regulatory authorities, in particular the British Homoeopathic Pharmacopoeia.

�e IAAP understands its task to sustain anthro-posophic pharmaceutical activities at any level (e.g. manufacturing, quality control, regulatory a�airs), worldwide, that is, beyond the countries of the European Pharmacopoeia Convention. �erefore during the evolution of the APC other o�cial pharmacopoeias (or reliable private pharmacopoeias) will possibly be referred to, e.g. the Brazilian Pharmacopoeia.

• Table of C

ontent

Table of ContentStructure of the Anthroposophic Pharma ceutical Codex, APC .....................................................................................16List of Abbreviations and Symbols ......................................................................................................................................17Glossary .......................................................................................................................................................................18

PART I De�nitions ......................................................................................................................................................191. Anthroposophic medicinal product ...............................................................................................................................202. Starting materials, general information .........................................................................................................................20 2.1. Minerals, rocks, including natural waters ..............................................................................................................21 2.2. Starting material of botanical origin ......................................................................................................................21 2.3. Starting materials of zoological origin ...................................................................................................................21 2.4. Starting materials that can be described chemically ............................................................................................22 2.5. Starting materials that have undergone special treatment ..................................................................................22 2.6. Compositions (for further information see “Glossary”) ......................................................................................223. Vehicles and excipients ....................................................................................................................................................224. Active substances ..............................................................................................................................................................22 4.1. Starting materials ......................................................................................................................................................22 4.2. Preparations ...............................................................................................................................................................22

PART IIa General monographs of preparations and speci�c production methods (Pharmaceutical processes) ........... 231. SPECIAL TREATMENTS OF RAW MATERIALS .....................................................................................................28 1.1. Vegetabilisation methods (“vegetabilised metals“) ...............................................................................................282. METAL PREPARATIONS ...............................................................................................................................................29 2.1. Metal mirrors .............................................................................................................................................................293. TINCTURES, MOTHER TINCTURES, GLYCEROL MACERATES AND VISCOUS EXTRACTS ...................30 3.1. Cold treated mother tinctures and liquid preparations thereof ..........................................................................30 3.2. Tinctures and mother tinctures made by macerations with water or ethanol/water .......................................31 3.3. Glycerol macerates ....................................................................................................................................................32 3.4. Liquid preparations made by maceration with oil ................................................................................................33 3.5. Mother tinctures made by percolation ...................................................................................................................34 3.6. Bu�ered aqueous mother tinctures manufactured under exclusion of oxidative in�uence ............................35 3.7. Fermented mother tinctures ....................................................................................................................................35 3.8. Tinctures and mother tinctures made by digestion (Digestio) ...........................................................................36 3.9. Tinctures and mother tinctures made by infusion (Infusum) .............................................................................37 3.10. Tinctures and mother tinctures made by decoction (Decoction) ....................................................................39 3.11. Viscous extracts with heat treatment ....................................................................................................................40 3.12. Preparations made by distillation (Distillates) ....................................................................................................40 3.13. Mother tinctures obtained by rhythmic application of heat and cold .............................................................414. SOLID STARTING MATERIALS OBTAINED BY HEAT ..........................................................................................43 4.1. Toasted preparations – Tosta ....................................................................................................................................43 4.2. Carbons – Carbo .......................................................................................................................................................43 4.3. Ashes – Cinis .............................................................................................................................................................445. SOLID PREPARATIONS FROM PLANTS (DRYING ONTO A VEHICLE) ..........................................................44 5.1. Solid preparations from fresh plants ......................................................................................................................44 5.2. Solid preparations from liquids, plant juices or aqueous extracts ......................................................................456. LIQUID DILUTIONS ......................................................................................................................................................46

14


• Ta

ble

of C

onte

nt

15


7. COMPOSITIONS .............................................................................................................................................................46 7.1. Compositions made by treating two or more starting materials by one or more pharmaceutical processes ....................................................................................................................46 7.2. Compositions made by treating two or more extracts or mother tinctures of one plant by one or more pharmaceutical processes ...................................................................................................47 7.3. Compositions made by treating one or more starting materials with one or more mother tinctures which undergo one or more pharmaceutical processes together ................................................49 7.4. Compositions made by treating two or more extracts or mother tinctures and/or dilutions by one or more pharmaceutical processes ......................................................................49 7.5. Compositions made by co-potentising ..................................................................................................................498. POTENTISED PREPARATIONS ...................................................................................................................................49 8.1. Co-potentised preparations......................................................................................................................................50 8.2. Potentising in an ointment base ..............................................................................................................................51 8.3. Triturations .................................................................................................................................................................529. MIXTURES .......................................................................................................................................................................52

PART IIb Individual monographs of starting materials and preparations .......................................................................53CYDONIA OBLONGA, FRUIT .........................................................................................................................................54CYDONIA OBLONGA, FRUIT, HEAT TREATED AQUEOUS TINCTURE 1:2.1 ...................................................54CYDONIA OBLONGA, FRUIT, GLYCEROL EXTRACT WITH HEAT TREATMENT 1:2.1 ................................................................................................................55CYDONIA OBLONGA, FRUIT, MOTHER TINCTURE OBTAINED BY RHYTHMIC APPLICATION OF HEAT AND COLD CYDONIA OBLONGA E FRUCTIBUS FERM 33B ..............................56LEVICO WATER ..................................................................................................................................................................57

PART III Dosage forms ......................................................................................................................................................59

INDEX LIST OF TERMS OF PART I, II AND III ..........................................................................................................63

PART IV Appendices ......................................................................................................................................................66Note concerning appendix 2.3. ..........................................................................................................................................67References concerning nomenclature in appendices 2.1. to 2.6. ..................................................................................67Note concerning the references for usage in anthroposophic medicine in appendices 2.1. to 2.6. ..........................67References concerning the use in anthroposophic medicine in appendices 2.1. to 2.6. ............................................68IVAA statement concerning starting materials of animal origin not yet mentioned in published anthroposophic medical literature or in published o�cial regulatory documents concerning anthroposophic medicinal products ...................................................................................................................................69

Appendix 2.1. List of minerals, rocks and natural waters ...............................................................................................75Appendix 2.2. List of starting materials of botanical origin ...........................................................................................85Appendix 2.3. List of starting materials of zoological origin ...................................................................................... 127 Appendix 2.4 List of starting materials that can be described chemically ............................................................... 153Appendix 2.5. List of starting materials that have undergone special treatment ..................................................... 165Appendix 2.6. List of compositions ................................................................................................................................ 169Appendix II .................................................................................................................................................................... 181Correlation table: Ph.Eur. / HAB manufacturing methods used in anthroposophic pharmacy and corresponding manufacturing methods in the HPUS ........................................................................................... 181

• Structure of A

PC

Structure of the Anthroposophic Pharma ceutical Codex, APC

Part I “De�nitions” provides de�nitions and describes quality aspects as well as parameters related to an-throposophic medicinal products. �e di�erent stages incurred in the obtaining of a medicinal product, from the starting material to the dosage form, are described in this part.

Part IIa “General Monographs of speci�c production methods (Pharmaceutical processes)” contains general monographs concerning the types of preparations/ active substances that are prepared by speci�ed pro-cedures. Beneath the relevant general monograph(s), di�erent speci�c production methods by which a particular type of a starting material can be prepared are either quoted from other pharmacopoeias or an APC production method is set out.

In this way, the relationship between the APC and other pharmacopoeias, as well as the option to de�ne substances through their production methods are outlined.

Schematically the following order is applied:

General monographs

De�nition, Identi�cation, Tests, Assay, Storage, Recommended Designation

Speci�c production methods related to the particular general monograph

Ph.Eur. Methods

HAB Methods

Ph.fr. Methods

B.Hom.P. Methods 1, 2, 3, 4, 5a, 5b, 6,

8a, 12

APC Methods

16

Part IIb “Monographs of starting materials and prepa-rations” sets standards for speci�c starting materials and preparations. In their last section the monographs of the starting materials list a) Some existing anthroposophic preparations that utilise the starting material and/ or b) Manufacturing methods, described in the Ph.Eur., the HAB or the APC commonly used for the processing of the particular starting material. �at list is not meant to be exhaustive.

Part III, information about dosage forms in anthro-posophic pharmacy as well as production methods of speci�c dosage forms for anthroposophic medicinal products.

Part IV “Appendices”

In appendix I starting materials for the preparation of anthroposophic medicinal products are listed (not excipients and vehicles). �e appendices are numbered according to the related chapter in part I: 2.1., 2.2., 2.3., 2.4., 2.5., 2.6.

In appendix II a link to the HPUS is given:• Correlation table: Ph.Eur./HAB manufacturing

methods used in anthroposophic pharmacy and corresponding manufacturing in the HPUS.


• St

rucr

ure

of A

PC

17


List of Abbreviations and Symbols

* see p. 67

1 CH Symbol for the �rst centesimal potency, see also C1 and 1C

1 DH Symbol for the �rst decimal potency, see also D1 and 1X

1C Symbol for the �rst centesimal potency, see also 1 CH and C1

1X Symbol for the �rst decimal potency, see also 1 DH and D1

ABMA-Vademe-cum

Gardin NE, Schleier R: Medicamentos Antropo-só�cos: Vademecum. Associação Brasileira de Medicina Antroposó�ca. São Paolo:Editor João de Barro; 2009

aph ad preparationes homoeopathicae

APC Anthroposophic Pharmaceutical Codex

B.Hom.P. British Homoeopathic Pharmacopoeia

B.P. British Pharmacopoeia

Br1 Numbering of the production methods of the B.Hom.P.

C1 Symbol for the �rst centesimal potency, see also 1 CH and 1C

CVD Chemical Vapour Decomposition

D1 Symbol for the �rst decimal potency, see also 1 DH and 1X

DAB Deutsches Arzneibuch(German Pharmacopoeia)

DAC Deutscher Arzneimittel-Codex(German Codex of Medicinal Products)

EU European Union

�p for homoeopathic preparations

GHP German Homoeopathic Pharmacopoeia. Un-authorized translation of the HAB. In case of di�erences between the GHP and the HAB the latter is decisive

Gl Symbol for mother tinctures prepared by HAB method 41 using glycerol

H 2.2.6 Analytical method speci�ed in the HAB

HAB Deutsches Homöopathisches Arzneibuch(German Homoeopathic Pharmacopoeia)

HPUS �e Homœopathic Pharmacopœia of the United States

IAAP International Association of Anthroposophic Pharmacists

IVAAstatement 2013

see p. 69

KC Mono-graph

Monograph of the “Kommission C” (Commis-sion of the German Ministry of Health for the an-throposophic therapeutic system and substances), published in the o�cial Gazette of the German government (in German: “Bundesanzeiger”)

Liste HAS

Liste der Homöopathischen und Anthropo- sophischen Sto�e (Anhang 4 zurVerordnung des Schweizerischen Heilmittelinstituts über die vereinfachte Zulassung von Komplementär- und Phytoarzneimitteln (List of Homoeopathic and Anthroposophic Subtances (Appendix 4 in the Regulation of the Swissmedic concerning the simpli�ed Authorisation of Complementary and Herbal Medicinal Products in Switzerland))

LM Symbol for potencies prepared according to Ph.Eur. (2371) 5.2 dra�

MT Mother tincture

Ph.Eur. European Pharmacopoeia

Ph.Eur. (2371)

Ph.Eur. Monograph 2371 “Methods of prepara-tion of homoeopathic stocks and potentisation”

Ph.fr. Pharmacopée Française (french Pharma copoeia), including monographies de souches pour pré-parations homéopathiques (monographs of the stocks for homoeopathic preparations)

Ph.Helv. Pharmacopoea Helvetica(Swiss Pharmacopoeia)

Q Symbol for potencies dilutedby the ratio 1: 50 000

Rh Symbol for mother tinctures prepared by HAB methods 21 and 22 (rhythmic procedure)

• Structure of A

PC

Glossary

In this glossary only those terms are referred to, that need extra clari�cation prior to the de�nitions given in part I.

Composition De�nition given in the monograph “Anthroposophische Zubereitungen”, (Anthroposophic preparations), Swiss Pharmacopoeia, Supplement 10.2, (translation by Swissmedic): “Compositions are active substances which are obtained, when two or more starting materials or preparations, with or without excipients, are processed together in a pharmaceutical process of anthroposophic pharmacy (e.g. Ferrum-Quarz).”

Excipient Excipients are auxiliary substances, which may be used for the production of pharmaceutical dosage forms. Excipients may beused in the production of mixtures.

Pharmaceutical process General term for substance transformations at di�erent stages to obtain starting materials for medicinal products or a medicinal product.

Preparation/active substance

A class of processed starting material speci�ed in the monographs of part II.

Production method A general manufacturing procedure speci�ed in a pharmacopoeia (see e.g. HAB).

Raw material Substance which has not undergone any pharmaceutical process and meets a general quality characterisation, e.g. an optical identi�cation.

Starting material A substance or a composition that meets a speci�cation and can be used as active substance or can be further processed.

Vehicle Vehicles are auxiliary substances which may be used to produce an active substance. Vehicles may be used in the production of mixtures.

18


• A

PC P

art I

19



PART IDe�nitions

Table of ContentPart I1. Anthroposophic medicinal product .................. 202. Starting materials, general information ............ 20 2.1. Minerals, rocks, including natural waters . 21 2.2. Starting material of botanical origin .......... 21 2.3. Starting materials of zoological origin ....... 21 2.4. Starting materials that can be described chemically ........................................... 22 2.5. Starting materials that have undergone special treatment .............................. 22

2.6. Compositions (for further information see “Glossary”) .......... 223. Vehicles and excipients........................................ 224. Active substances ................................................. 22 4.1. Starting materials .......................................... 22 4.2. Preparations................................................... 22

• A

PC Part I

1. Anthroposophic medicinal product

definitionAn anthroposophic medicinal product is conceived, developed and produced in accordance with the anthroposophic knowledge of man, nature, substance and pharmaceutical processing1. �e application within anthroposophic medicine results from that knowledge2.

According to anthroposophic principles, active sub-stances may be starting materials which are used as such or starting materials which have been transformed into active substances by a process of anthroposophic pharmacy, including compositions.

An anthroposophic medicinal product can contain one or more active substances (see also part I, chapter 4).

An anthroposophic medicinal product can fundamen-tally be employed in every dosage form, including external (topical), internal and parenteral dosage forms (see also part III).

production�e active substances or dosage forms of anthroposophic medicinal products are produced:

• in accordance with classical homoeopathic or anthro-posophic-homoeopathic manufacturing methods as described in the Ph.Eur., HAB, Ph.fr., and B.Hom.P. (Methods 1, 2, 3, 4, 5a, 5b, 6, 8a, 12)

• in accordance with anthroposophic pharmaceutical codex production methods, i.e. “APC Methods”

1 See IAAP brochure: “Basic Information on the Working Prin-ciples of Anthroposophic Pharmacy”, 2005, http://www.iaap.org.uk/downloads/principles.pdf2 For clari�cation it has to be mentioned here, that anthroposo-phic medicine from the beginning includes “Over the Counter” products (OTC). A part of its medicinal products had been con-ceived right from the start for broad use for typical health disor-ders; see Chapter XX, “Typical Remedies”, in Rudolf Steiner/Ita Wegman: “Grundlegendes für eine Erweiterung der Heilkunst nach geisteswissenscha�lichen Erkenntnissen.” GA 27, publisher Rudolf Steiner Verlag, Dornach, CH, 1992.In English: “Extending Practical Medicine – Fundamental Prin-ciples based on the Science of the Spirit”. Rudolf Steiner Press , London, GB, 1996

20

and/or• in accordance with anthroposophic manufacturing

methods described in the individual monograph.

An anthroposophic medicinal product complies with the relevant speci�cations/ monographs set out in parts I and II.

recommended designation Concerning the designation of anthroposophic medici-nal products a reference to the APC is recommended.

2. Starting materials, general information

Starting materials for the production of anthroposophic medicinal products are:

2.1. Minerals, rocks, including natural waters

2.2. Starting materials of botanical origin Dried or fresh plants or parts of plants, including algae, fungi and lichens; Plant secretions, juices, extracts, oleoresins, essential oils or distillation products.

2.3. Starting materials of zoological origin Whole animals, organs, parts of organs dried or fresh; Animal secretions, extracts, blood products, calcareous products.

2.4. Starting materials that can be described chemically

2.5. Starting materials that have undergone special treatment

2.6. Compositions (for further information see “Glossary”)

Starting materials for the production of anthropo-sophic medicinal products comply with any relevant monograph in the European Pharmacopoeia or in the absence thereof, with the relevant monographs in national pharmacopoeias used in the Member States, or in absence thereof with the individual monograph.

Starting materials can be active substances themselves or can be processed into preparations (see also Part I, chapter 4).


• A

PC P

art I

21


2.1. Minerals, rocks, including natural watersMinerals are solid, crystalline components of natural origin belonging to the earth’s crust and other celestial bodies. A mineral has a de�ned crystal system and crystal class. Minerals are chemically and physically homogeneous to a signi�cant extent. In reality, how-ever, there are always deviations from the theoretical mineral formula. Many minerals may show di�erences in their colours. Form and habitus may be signi�cantly di�erent within the same type.

Rocks are composed of one or more minerals having a geological de�nition and distribution in their natural deposit with a certain statistical homogeneity.

Pieces that will be used for production should be big enough to allow mineralogical identi�cation. If a powdered mineral is used, adequate documentation should ensure the quality and natural origin. In fact pieces used for production must be free from visible foreign matter. �ey have not undergone any unwanted mechanical or chemical treatment: in particular any chemical reaction, colouring, varnishing, heating and arti�cial radiation must be excluded. �e amount of foreign matter accepted a�er chemical analysis is speci�ed in the respective monograph.

Natural waters can come from a natural source (e.g. Levico), from the sea (e.g. aqua maris) or from mineral cavities (e.g. agate water).

List of minerals, rocks, including natural waters: see part IV, appendix 2.1.

2.2. Starting materials of botanical originStarting materials of botanical origin are:• Dried or fresh plants or parts of plants,

including algae, fungi and lichens;• Plant secretions, juices, extracts, oleoresins,

essential oils or distillation products.

Fresh plants should be used shortly a�er harvest. If this is not possible, the quality is guaranteed by appropriate measures, e.g. freezing.

If material from cultivated plants is used preference should be given to materials from plants cultivated by biodynamic cultivation (“Demeter” certi�ed) or by other certi�ed organic cultivation methods in accord-ance to the relevant European regulations ruling organic agricultural products (see also Council Directive (EEC) n° 2092/91).If wild plants are harvested protection of species according to relevant regulations is granted and special care is taken of the eco-system concerned.

Plants or parts of plants are, as far as possible, free from impurities such as soil, dust, dirt and other contami-nants such as fungal, insect and other animal contami-nations. �ey are not decayed.

Harvested plants or the mother tinctures made thereof are analysed for content of heavy metals and pesticides.�e range and frequency of this testing can occur ac-cording to a monitoring plan based on risk assessment.

Unless otherwise stated, the collecting or harvesting times are generally:

Whole plants with underground partsand plants without underground parts

at �owering time

Leaves and shoots when fully developed

Flowers shortly a�er opening

Bark throughout the year

Underground parts of annual plants

at seed ripening time

Underground parts of biennial and perennial plants

in spring

Fruits and seeds at the time of ripening

Fungi when the fruiting bod-ies are fully developed

Starting materials of botanical origin see part IV, appendix 2.2.

2.3. Starting materials of zoological originStarting materials of zoological origin are:• Whole animals, organs, parts of organs

dried or fresh;• Animal secretions, extracts, blood products,

calcareous products. Lower animals as well as warm-blooded animals are used.

Animal husbandry and keeping must be adequate for the animal species (see also Council Directive (EEC) n° 2092/91). In particular in the case of warm-blooded

• A

PC Part I

species animals from well-monitored “Demeter” or biodynamic herds are preferentially used.

�e starting materials of zoological origin must meet the requirements of the European and/ or relevant national pharmacopoeias regarding the preparation of medicinal products from materials of animal origin and with EU directives and/or national guidelines of the appropriate regulatory authorities.In particular the Ph.Eur. monographs on TSE safety (Ph.Eur. 50208), and viral safety (Ph.Eur. 50107) apply.

Animals must be healthy and in good hygienic condition. �e intervals given in legislation a�er the administration of drugs to animals must be observed before the animals are used.

Health requirements, animal keeping, protection of species and processing of animals must comply with the relevant guidelines of responsible national authorities and those of the European Union, where applicable.

List of starting materials of zoological origin see part IV, appendix 2.3.

2.4. Starting materials that can be described chemicallyStarting materials that can be described chemically are inorganic and organic substances.Organic substances are generally of natural origin, e.g. puri�ed fractions.

Preference should be given to clearly traceable sub-stances, that comply with the quality standards in 2.1, 2.2, 2.3.

List of starting materials that can be described chemically see part IV, appendix 2.4.

2.5. Starting materials that have undergone special treatmentStarting materials that have undergone a special treatment are: e.g. plants, parts of plants cultivated by special treatment (see part IIa, chapter 1.1. Vegetabilisation methods of substances used for mother tinctures).

List of starting materials that have undergone special treatment see part IV appendix 2.5.

22

2.6. CompositionsDi�erent starting materials described in 2.1, 2.2, 2.3, 2.4, 2.5 undergo one or more pharmaceutical processes that will lead to a substance that cannot be described as an addition of its ingredients. �e rationale for the synthesis is an anthroposophic formula, in accordance with the anthroposophic understanding of man and nature1.

List of compositions see part IV, appendix 2.6.

3. Vehicles and excipients

Vehicles are auxiliary substances, which may be used for the production of active substances (e.g. ethanol to obtain an extract or lactose monohydrate to obtain a potentised preparation). Vehicles are also used in the production of mixtures (see part IIa, chapter 9).

Excipients are auxiliary substances, which may be used for the production of the pharmaceutical dosage forms (e.g. NaCl to obtain an isotonic solution for parenteral preparations). Excipients are also used in the production of mixtures (see part IIa, chapter 9).

Vehicles and excipients used in the manufacture of anthroposophic medicinal products comply with the relevant requirements of the European Pharmacopoeia or of the national pharmacopoeias used in the EU Member States.

4. Active substances

4.1. Starting materialsActive substances can be starting materials themselves or preparations.Starting material used directly as active substances may be the �nal dosage form, e.g. a herbal tea.

4.2. PreparationsPreparations are obtained from one or more starting materials.

Preparations comply with the speci�cations described in part II or in the individual monograph.

Preparations can be the �nal dosage form or can be processed further, e.g. to obtain mixtures.

1 As an example see: “Biodoron/Kephalodoron” , in Persephone N° 12, M. Kohlhase editor; publisher Verlag am Goetheanum, Dornach, CH, 1998.


• A

PC P

art I

Ia

23



PART IIaGeneral monographs of preparations and speci�c production methods (Pharmaceutical processes)

Table of Content Part IIa1. SPECIAL TREATMENTS OF RAW MATERIALS .........................................................28 1.1. Vegetabilisation methods ............................282. METAL PREPARATIONS ..................................29 2.1. Metal mirrors ................................................293. TINCTURES, MOTHER TINCTURES, GLYC- . EROL MACERATES, VISCOUS EXTRACTS .30 3.1. Cold treated mother tinctures and liquid preparations thereof .................................30 3.2. Tinctures and mother tinctures made by macerations with water or ethanol/water ....31 3.3. Glycerol macerates .......................................32 3.4. Liquid preparations made by maceration with oil ..............................................33 3.5. Mother tinctures made by percolation ......34 3.6. Bu�ered aqueous mother tinctures manufactured under exclusion of oxidative in�uence ...............................................35 3.7. Fermented mother tinctures .......................35 3.8. Tinctures and mother tinctures made by digestion (Digestio) .............................36 3.9. Tinctures and mother tinctures made by infusion (Infusum) .........................................37 3.10. Tinctures and mother tinctures made by decoction (Decoction) ........................39 3.11. Viscous extracts with heat treatment .......40 3.12. Preparations made by distillation .............40 3.13. Mother tinctures obtained by rhythmic application of heat and cold .........41

4. SOLID STARTING MATERIALS OBTAINED BY HEAT ........................................43 4.1. Toasted preparations – Tosta .......................43 4.2. Carbons – Carbo ...........................................43 4.3. Ashes – Cinis .................................................445. SOLID PREPARATIONS FROM PLANTS .....44 5.1. Solid preparations from fresh plants ..........44 5.2. Solid preparations from liquids, plant juices or aqueous extracts .........................456. LIQUID DILUTIONS .........................................467. COMPOSITIONS ................................................46 7.1. Compositions made by treating two or more starting materials by one or more pharmaceutical processes ...................................46 7.2. Compositions made by treating two or more extracts or mother tinctures of one plant by one or more pharmaceutical processes ........47 7.3. Compositions made by treating one or more starting materials with one or more mother tinctures which undergo one or more pharmaceutical processes together ..........49 7.4. Compositions made by treating two or more extracts or mother tinctures and/or dilutions by one or more pharmaceutical processes ........49 7.5. Compositions made by co-potentising ......498. POTENTISED PREPARATIONS ......................49 8.1. Co-potentised preparations9. MIXTURES ..........................................................52

• A

PC Part IIa

24

Introduction: Brief description of the main pharmaceutical processes applied in anthroposophic pharmacySeveral pharmaceutical processes are described in existing homoeopathic pharmacopoeias as “production methods”. �ese homoeopathic pharmacopoeial pro-duction methods can be seen as examples of the general anthroposophic pharmaceutical principle described in the general APC monographs of part IIa.

In anthroposophic pharmacy the treatment of the raw or starting materials can already be part of the pharma-ceutical processing, e.g. a plant can be cultivated under treatment with a metal or mineral preparation.

Metals can either be used as a concentrated starting material or undergo a pharmaceutical process depending on the rationale of the anthroposophic therapeutics.

Preparations can be di�erentiated according to the thermal condition or treatment in the pharmaceutical process. Hereby follows a scheme concerning the related pharmaceutical processes applied to plant material and the main sphere of action.

Preparations may be the �nal dosage form, be incor-porated into the �nal dosage form or be processed further, e.g. by potentisation.

Pharmaceutical process

Heat/cold degree

Starting material Main sphere of therapeutic action 1, 2

Cold maceration 2 – 8 °C fresh or dried plants, all parts System of nerves and senses throughout the whole organism

Maceration 15 – 25 °C fresh plants, all parts system of nerves and senses throughout the whole organism

Rhythmic processing

4/37 °C fresh plants, all parts rhythmic system

Digestion 37 °C fresh plants, leaves, �owers rhythmic system, circulation

Infusion 60 – 90 °C dried leaves, �owers metabolic system, any type of gland

Decoction ca 100 °C dried roots, barks, seeds metabolic system, digestive tract(stomach, intestine)

Distillation steam,ca 100 °C

fresh or dried plants, all parts metabolic system, digestion

Treatments in liquid phase

Pharmaceutical process

Heat degree Starting material Main sphere of therapeutic action 1, 2

Toasting 170 – 250 °C dried plants, all parts, dried zoological starting material

metabolic system, digestion (liver)

Carbonisation above 200 °C dried plants, all parts, zoo-logical starting material

metabolic system, kidney organisation

Ash process above 500 °C dried plants, all parts, zoo-logical starting material

region of the lungs (respiration)

Treatments in dry phase


A crucially important pharmaceutical process is potentisation:• Potentised preparations are gradually diluted sub-

stances, whereby at each diluting step a rhythmic succussion (liquid potencies) or trituration (solid potencies) has been carried out.

• During this process the surface of the vehicle and the substance to be potentised are expanded and the mixing is thorough. �e potentising time di�ers for solid and liquid potentised preparations. Astrono-mical aspects may be considered (e.g. solar or lunar eclipse). Anthroposophic pharmacy mainly uses decimal attenuations. For co-potentised preparations the ratio between active substances to vehicle may vary, di�ering from 1:10 for homoeopathic co-potentising methods (see also Part IIa, 8 ”Potentised Preparations“).

• A

PC P

art I

Ia

25

1General scheme for the correlation between spheres of therapeutic action/ degree of potentisation:

Mother tincture – D10 Metabolic system

D11-D20 Rhythmic system

>D20 System of nerves and senses

See also:International Federation of Anthroposophic Medical Associa-tions, “�e System of Anthroposophic Medicine”, pp. 26-28 at http://www.ivaa.info/user�les/�le/SystemAnthroposMedicine2011_Interaktiv.pdf

2 See IAAP brochure: “Basic Information on the Working Prin-ciples of Anthroposophic Pharmacy”, 2005, http://www.iaap.org.uk/downloads/principles.pdf


• A

PC Part IIa

26

General method of the APC Related speci�c production method

Ph.Eur. (2371)

HAB Ph.Helv. B.Hom.P. APC

1. Special treatment of raw materials

1.1. Vegetabilisation methods of substances used for mother tinctures

17.7.1.1, 17.7.1.2

Br1 1.1.1, 1.1.2

2. Metal preparations

2.1. Metal mirrors 17.7.2.1 – 4

2.1.1, 2.1.2, 2.1.3, 2.1.4

3. Tinctures and viscous extracts

3.1. Cold treated mother tinctures and liquid preparations thereof

38 17.7.6

3.2. Tinctures made by maceration with water or ethanol/water

1.1.1 – 1.1.11

12b, c, m, n, o, p, q; 49

17.7.7.1 3.2.1, 3.2.2

3.3. Glycerol macerates 2.1.1 – 2.1.3 2.2.1 – 2.2.4

3.3.1, 3.3.2

3.4. Liquid preparations made by maceration with oil

3.4.1

3.5. Tinctures made by percolation 1.1.8 – 1.1.9 17.7.7.2 3.5.1

3.6. Bu�ered aqueous mother tinctures under exclusion of oxidative in�uence

32

3.7. Fermented tinctures 53 17.7.7.3 3.7.1

3.8. Tinctures made by digestion (Digestio) 18, 24b 17.7.8.1 3.8.1

3.9. Tinctures made by infusion (Infusum) 20, 24a; 17.7.8.3 3.9.1, 3.9.2, 3.9.3

3.10. Tinctures made by decoction (Decoction) 12k, l, 19, 23

17.7.8.4 3.10.1

3.11. Oil extracts with heat treatment 12d – g, 57

3.12. Preparations made by distillation 52 17.7.8.5 3.12.1, 3.12.2

Correlation table of general methods for the manufacturing of anthroposophic medicinal products – related speci�c production methods


• A

PC P

art I

Ia

27

General method of the APC Related speci�c production method

Ph.Eur. (2371)

HAB Ph.Helv. B.Hom.P. APC

3.13. Tinctures obtained with rhythmic application of heat and cold

21 – 22, 33 – 37, 51

17.7.9 3.13.1, 3.13.2.

4. Solid starting materials obtained by heat

4.1. Toasted preparations (Tosta) 17.7.4.1

4.2. Carbons (Carbo) 17.7.4.2 Br4

4.3. Ashes (Cinis) 17.7.4.3 Br3

5. Solid preparations from plants (drying onto a vehicle)

5.1. Solid preparations from fresh plants 17.7.5.1 5.1.1

5.2. Solid preparations from liquids, plant juices or aqueous extracts

17.7.5.2 5.2.1, 5.2.2, 5.2.3

6. Liquid dilutions 3.1.1 – 3.1.3

7. Compositions 17.7.3 7.2.1 – 7.2.4

8. Potentised preparations

Potentising speci�cations in: 1 – 5

12j, 17

11, 15, 18, 19, 20 – 24, 32 – 38, 39a, 39b, 45, 51, 53

Br5 – 6 8.1.1, 8.1.2, 8.2.1, 8.2.2Other APC Methods8.3

9. Mixtures 12, 16

Note: anthroposophic medicinal products may also be manufactured in accordance with individual speci�cations or monographs, see also Part I, chapter 1.


• A

PC Part IIa

28

monograph; the �owers or/and the leaves with petioles, possibly with stalks, but no woody parts are included. �e plant material is mixed together with neutral plant-compost which activates the �rst composting processes. �is metal plant-compost mixture is stored in terracotta pots which are buried almost completely in the soil in the same �eld used in that growing sea-son. �e composting process is continued during the whole winter until the next spring.In spring the compost is completed and ready to be used to treat the plants of the next growing season, the second life cycle.

2nd life cycle:Seeds of the same species are sown in cultivation substrate or soil, which was treated with the compost, made from the plant of the 1st growing season. �ese plants (of the second life cycle) are also grown to their speci�c plant development stage (i.e. �owering). Compost is made from these plants, which is prepared in a way similar to the compost of the plants of the �rst life cycle. �is compost is stored in terracotta pots, buried in the soil, in the �eld of the plants of the second life cycle.

3rd life cycle:Seeds of the same species are sown in cultivation substrate or soil which was treated with compost made from the plants of the second vegetation period. �e plants of the third growing season (third vegetation period) are cultivated to their speci�ed harvest stage.

further processing�e harvested plants are processed into a mother tincture according to a manufacturing method of the Ph.Eur., HAB or the APC or are otherwise processed.

identification, tests, assayAccording to the relevant tincture monograph (See Part IIa, chapters in section 3) or dried herbal drug.

recommended designation �e designation states:• the fertilised plant,• the substance used,• the designation “cultum”, “culta”,• the reference pharmacopoeia/codex.

Examples: Tabacum Cupro cultum APC, Equisetum arvense Silicea cultum APC

Speci�c pharmacopoeia/APC production methods to produce vegetabilised substancesAPC Method 1.1.1 Vegetabilisation of substances of metallic origin (“vegetabilised metals”)

1. SPECIAL TREATMENTS OF RAW MATERIALS

In anthroposophic pharmacy treatment of the raw materials can be part of the pharmaceutically relevant processing, e.g. a plant can be cultivated under treatment with a preparation of a mineral, normally containing a speci�c metal.

1.1. Vegetabilisation methods (“vegetabilised metals“)

definitionVegetabilisation of substances can be considered as a particular kind of potentising process of metals or minerals taking place through nature. �e potentising process is carried out with plants and normally goes through three life cycles. �e life cycle means one vegetation period (growing season) for annual, and two growing seasons for biennial plants. �e substance and appropriate plant are chosen in accordance with the rationale of anthroposophic understanding of man and nature.

preparation of mineral substancesSee APC Method 1.1.1 and 1.1.2.

cultivation�e cultivation of vegetabilised metals is a three years process (for biennial plants 6 years), meaning three generations of plants are grown until the �nal plant can be further processed, for example to a mother tincture. �is process is basically the same for each speci�c metal (mineral)-plant combination. Important for the cultivation process is, that each plant grows in the cultivation substrate and �eld soil speci�-cally prepared for each vegetation period. �e following is a cultivation description for each of the three growing seasons or life cycles.Exemptions have to be prescribed in individual monographs (e.g. Bryophyllum, Equisetum arvense and �uja occidentalis).

1st life cycle: �e seeds are sown in soil, which has been treated with a diluted preparation of the concerned inorganic substance (approximately 50 – 200 g/m2). Alternatively, jars with cultivation substrate, mixed with 5 – 20 g di-luted preparation/L can be used. In this case, the young growing plants are transferred to soil, which has been treated as mentioned above.When the plants reach their full development, i.e. in the �owering stage, compost is made from these plants. For preparing that compost, the upper aerial parts of the speci�c plant are used as prescribed in the individual


• A

PC P

art I

Ia

29

through di�erent states of aggregation.�e metals or metal salts can be brought through a liquid state (melted or as solution), gas state or plasmatic state to be subsequently (obtained again) condensed in solid state as the pure metal.Metal mirrors are deposits of metals in reduced state onto a surface by a speci�c method of production.

Metal mirrors, produced according to APC methods 2.1.1, 2.1.2 and 2.1.3 can be removed from the surface and may be potentised according to Ph.Eur. method 4.1.1 and 4.1.2 and HAB method 48.

tests�e following analytical tests are always carried out for the metal which is used as starting material to produce the mirror. �e metal mirror itself is only tested when it is produced by the method of reduction of metal salts (2.1.3), the method of chemical vapour decomposition (2.1.2) or the method of sputtering (2.1.4). �e metal mirror produced by the method of distillation (2.1.1) is tested a�er further processing as the �rst or second produced dilution.

identificationAt least one suitable identi�cation test is carried out.

testssee the individual monograph.

assayContent according to the individual monograph.

storageStore in a well-closed container.

recommended designation �e designation states:• the metal used,• the designation ”metallicum praeparatum” or in the

case of metal mirror foil the name of the metal follo-wed of the word “foil”,

• the reference pharmacopoeia/codex,Examples: Argentum metallicum praeparatum APC Cuprum mirror foil APC.

Speci�c pharmacopoeial/APC production methods to prepare metal mirrors

APC Method 2.1.1 Metal mirrors obtained by distillationMetal mirrors prepared by distillation are obtained from the pure metal.�e pure metal is heated in appropriate equipment under vacuum until it evaporates. �e temperature and

For the vegetabilisation of substances of metallic origin plants are treated with a diluted substance, prepared from either a naturally occurring metal or a metal containing mineral (ore).

preparation of metallic substance�e raw material for the manufacturing of the mineral substance is a naturally occurring metal or a metal containing mineral (ore). �is is treated during several steps with mineral acids and other substances, contain-ing the chemical elements C, H, N, O and S, to a com-plex composition containing the metal in a form whose chemical structure is not clearly de�ned. It is triturated with lactose monohydrate, the result being the metal substance D1: the content of the metal is 8 – 12 %. �e metal substance D1 is diluted with a neutral material, e.g. cellulose or sucrose, to form the diluted metal substance that is ready for use. �e calculated metal content of this diluted metal substance di�ers, according to the toxicity and natural abundance of the metal in the soil:Au, Ag, Pb, Sn, Hg: max. 100 ppmFe, Cu: max. 1000 ppm

APC Method 1.1.2 Vegetabilisation of silicatesFor the vegetabilisation of silicates plants are treated with appropriate mineral containing silica.

preparation of mineral substance�e raw material for the manufacturing of the mineral substance is a pulverised mineral silicate. �is is treated during several steps with mineral acids and other sub-stances, containing the chemical elements C, H, N, O and S, to a complex composition containing silicium in a form whose chemical structure is not clearly de�ned. It is triturated with lactose monohydrate; the result is the silica, particularly quartz substance D1: the content of silicium is 8 – 12 %, calculated as silicium dioxide .�e silica, particularly quartz substance D1 is diluted with a neutral material, e.g. cellulose or sucrose, to form the diluted silica, particularly quartz substance that is ready for use. �e calculated content is max. 1 % silicium dioxide.

2. METAL PREPARATIONS

Metals can either be used as a concentrated starting material or undergo a pharmaceutical process depend-ing on the rationale of the anthroposophic therapeutics.

2.1. Metal mirrors

definitionBy producing metal mirrors the metal is transformed


• A

PC Part IIa

30

molecules. Ions of the inert gas impact then the surface of the metal and the result is an ejection of metal atoms from the surface. �e electric �eld leads to an ionisa-tion of the metal which goes into a plasma aggregation state (at 30 – 45 °C) and condensates as a metal mirror on the substrate, in this case a plastic foil (e.g. PET). A�er this process the metal mirror foil is stitched to a special cotton tissue directly over the metal mirror.�e metal mirror foils must not be further processed.

tests�ickness of the mirror.

recommended designation the reference pharmacopoeia/codex,for external use only.

3. TINCTURES, MOTHER TINCTURES, GLYCEROL MACERATES AND VISCOUS EXTRACTS

Tinctures, mother tinctures, glycerol macerates and viscous extracts are obtained from starting materials from botanical or zoological origin by pharmaceutical processes under cold condition (2 – 8 °C), at ambient temperature (15 – 25 °C), with heat treatment at dif-ferent temperatures, by rhythmic application of heat and cold, by fermentation as well as by destillation. If applicable, vehicles e.g. water, ethanol, water/ethanol mixtures, glycerol, oils may be used. �ey may be processed further.

3.1. Cold treated mother tinctures and liquid preparations thereof

definitionCold treated mother tinctures are prepared from fresh (frozen) or dried herbal drugs. �e maceration is carried out at a temperature of 2 – 8 °C using puri�ed water, water for injections or isotonic solution.

productionIf necessary, comminute the matter to be extracted. �e prescribed quantity of extraction solvent according to the individual monograph is added to the starting material. Mix thoroughly and allow to stand in a closed container, where applicable protected from light, for an appropriate time (at least 7 days). Shake or stir occa-sionally. Express and �lter.

identificationAt least one chromatographic identi�cation test is carried out.

the vacuum are to be chosen in such a way, that the metal is distilled. �e metal vapour condenses onto the surface of the cooler parts of the distillation equipment, producing a metal mirror. �e metal mirror is removed a�er cooling from the surface.�e exact conditions of the distillation are described in the individual monograph.

APC Method 2.1.2. Metal mirrors obtained by Chemical Vapour Decomposition, CVDMetal mirrors prepared by chemical vapour decompo-sition are obtained from a volatile metal compound.A volatile metal compound is distilled under vacuum in appropriate equipment. �e temperature and the vacuum are to be chosen in such a way, that the metal compound is distilled. �e vapour is further heated until decomposition of the metal compound. As a result, the pure metal condenses onto the surface of the distillation equipment, producing a metal mirror. A�er cooling the metal mirror is removed from the surface.

APC Method 2.1.3. Metal mirrors obtained by reductionMetal mirrors prepared by reduction are obtained from an appropriate metal salt.To a solution of a metal salt an appropriate reducing agent and reagents are added. �e pure metal precipi-tates onto the surface of the reaction vessel producing the metal mirror. �e metal mirror is removed from the surface, �ltered from the solution, washed with puri�ed water and ethanol (the concentration of ethanol depending of the nature of the used reagents), until foreign matters are no longer detectable in the rinsing water and then dried.

APC Method 2.1.4. Metal mirror foilMetal mirror foils are prepared by a process which transforms the processed metal into a plasma aggre-gation and �nally condenses as an approximate 55 – 65 nm thick metal mirror on to the substrate.To produce a metal mirror foil a process known as sputtering is used. In this vapour phase technique there is no melting of the metal. �e sputtering process is most commonly used for thin-�lm deposition of many di�erent metals. High energy ions impacting on the target can liberate sputtered atoms of the metal as well as positive ions and electrons. A metal target is put under the e�ect of a magnetrom. A magnetrom is comprised of a cathode (electron source) an anode (electron collector) and a combined electric and magnetic �eld. Vacuum conditions (0.5 – 5 x 10-3 mbar) are generated and an inert gas (e.g. Argon Ph.Eur.) is used as medium. �e process begins as a result of a collision and momentum transfer from an incoming particle which impacts the inert gas


• A

PC P

art I

Ia

31

from light for an appropriate time. If necessary shake or stir occasionally. Express and �lter, if necessary.Adjustment of the content of constituents may be car-ried out, if necessary, either by adding the extraction solvent of suitable concentration or by adding another macerate of the herbal or animal starting material used. If prescribed in the individual monograph, the tincture can be adjusted to the speci�ed content by concentra-tion, carried out generally under vacuum.


testsDry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e pre-paration complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Ethanol content (Ph.Eur. 2.9.10). Where applicable, the ethanol content complies with that prescribed in the individual monograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial Pharmacopoeia, or another limit is justi�ed and authorised.

assayAn assay with quantitative limits is performed when starting materials with toxicologically or therapeuti-cally relevant substances are used.

storageStore in a well-closed container, protected from light.

recommended designation �e designation states:• the herbal or animal matter used,• where applicable, the fresh herbal or animal matter

used,• where applicable, the ethanol content in the pre-

paration,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to preparation,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce tinctures and mother tinctures made by macerations with water or ethanol/water

Ph.Eur. (2371) Methods1.1.1 – 11

testspH (Ph.Eur. 2.2.3). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e pre-paration complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial Pharmacopoeia, or another limit is justi�ed and authorised.


recommended designation �e designation states:• the herbal drug used,• where applicable, the fresh herbal drug used,• where applicable, the ethanol content in the

preparation,• where applicable, the ratio of starting material to ex-


Speci�c pharmacopoeial/APC production methods to produce mother tinctures obtained under cold conditions (2 – 8 °C)HAB Method 38

3.2. Tinctures and mother tinctures made by macerations with water or ethanol/water

definitionTinctures and mother tinctures made by maceration with water or ethanol/water are liquids and are ob-tained from fresh (frozen) or dried matter of botanical or zoological origin. �e maceration is carried out at a temperature not above 25 °C by using ethanol of a suitable concentration or puri�ed water.

productionIf necessary, comminute the matter to be extracted; animals are processed immediately a�er killing. �e pre-scribed quantity of extraction solvent according to the individual monograph is added to the starting material. Mix thoroughly and allow to stand in a closed container at the required temperature, where applicable protected


• A

PC Part IIa

32

productionLower animals are killed immediately before process-ing; the parts of warm-blooded animals are processed immediately a�er being killed. Killing is carried out with respect for the animal su�ering.Comminute the matter to be extracted. Add the prescribed quantity of extraction solvent according to the individual monograph to the raw material. Mix thoroughly and allow to stand in a closed container at a temperature not above 25 °C, protected from light for an appropriate time. If necessary shake or stir occasionally. Express and �lter, if necessary.Adjustment of the content of constituents may be carried out, if necessary, either by adding the extraction solvent of suitable concentration or by adding another macera-te of the starting material of botanical or animal origin used.

identificationAt least one chromatographic or electrophoretic (animal matter) identi�cation test is carried out.

testsConductivity (Ph.Eur. 2.2.38). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). �e preparation com-plies with the limits prescribed in the individual mono-graph. Alternatively, the refractive index can be used.Refractive index (Ph.Eur. 2.2.6). Where applicable (preparations according to APC Methods 3.3.1 and 3.3.2), the refractive index of the preparation is mea-sured in appropriate equipment, this measure indicates the water content in the glycerol1, and this value is called ηm indicating the refractive index of the macerate. �is measure is used to calculate the proportion of glycerol of the macerate. �is calculation is made based on the following equation:

(eq.1)1

Electrophoresis (Ph.Eur. 2.2.31). Where applicable, the preparation complies with the characteristics prescribed in the individual monograph.Microbiological examination (Ph.Eur. 2.6.12, 2.6.13). Where applicable, the macerate complies with the limits prescribed.


HAB Methods1 – 412b, c, m, n, o49

APC Method 3.2.1 (related to Ph.Eur. (2371) Method 1.1.8)Mother tinctures according to APC Method 3.2.1 are prepared using the maceration methods given in the Ph.Eur. monograph “Extracts” (0765). Use 1 part of dried plant or parts of plants to 20 parts of ethanol in suitable concentration (see HAB H 5.3), unless other-wise prescribed in the individual monograph.If adjustment to a given concentration is necessary, calculate the amount of ethanol required to obtain the concentration speci�ed or used for production from the equation given in Ph.Eur. (2371) Method 1.1.1. Mix the calculated amount of ethanol with the �ltrate. Allow to stand for not less than 5 days at a temperature not exceeding 20 °C, then �lter if necessary.

potentisation�e 2nd decimal dilution (D2) is made from2 parts of the mother tincture and8 parts of ethanol of the same concentration.

�e 3rd decimal dilution (D3) is made from1 part of 2nd decimal dilution and9 parts of ethanol of the same concentration.

Unless a di�erent ethanol concentration is speci�ed, use ethanol 30 per cent (m/m) for D4 and then 15 per cent (m/m) for subsequent dilutions from D5 onwards and proceed accordingly.

APC Method 3.2.2 (related to HAB Method 12a)Preparations according to APC Method 3.2.2 are tinc-tures for external use. �ey are prepared as follows:Use 1 part of dried plant or parts of plants to 10 parts of ethanol in suitable concentration (see HAB H 5.3), un-less otherwise prescribed in the individual monograph.Glycerol may be added up to 10 per cent.

3.3. Glycerol macerates

definitionGlycerol macerates comply with the de�nition in Ph.Eur. monograph 1038. �ey are prepared from fresh (frozen) or dried matter of botanical or zoologi-cal origin. �e maceration is carried out at the required temperature (not above 25 °C) using glycerol of a suitable concentration or a glycerol solution containing sodium chloride. 1 Miner, Carl S.& Dalton, N.N: (ed.). Glycerol, American Che-

mical Society, Monograph Series, n0 117. Reinhold Publishing Corp., New York 1953.

% Glycerol m⁄m = ηm – 1.3195

0.0016


• A

PC P

art I

Ia

33

of the total mass, calculated based on the equation above (refractive index). Adjustment of the �nal content of glycerol to 85 % is carried out using measurement of refractive index, and adding glycerol.Adjustment of the content of constituents may be carried out, if necessary by adding another macerate of the herbal or animal starting material used.

3.4. Liquid preparations made by maceration with oil

definitionLiquid preparations prepared by maceration with oil are prepared from fresh (frozen) or dried matter of botanical or zoological origin. �e maceration is carried out at the required temperature (not above 25° C) mostly by using arachis oil or olive oil.

productionIf necessary, comminute the matter to be extracted. When animal matter is used, lower animals are killed immediately before processing, the parts of warm-blooded animals being processed immediately a�er killing. Killing is carried out with respect for the animal su�ering, e.g. according to HAB H 5.2.4.�e prescribed quantity of extraction solvent according to the individ-ual monograph is added to the starting material. Mix thoroughly and allow to stand in a closed container at the required temperature, protected from light for an appropriate time. If necessary shake or stir occasionally. Express and �lter, if necessary.Adjustment of the content of constituents may be car-ried out, if necessary, either by adding the extraction solvent of suitable concentration or by adding another macerate of the herbal or animal starting material used.


tests Relative density (Ph.Eur. 2.2.5). �e preparation complies with the limits prescribed in the individual monograph.Refractive index (Ph.Eur. 2.2.6). �e preparation complies with the limits prescribed in the individual monograph.Peroxide value (Ph.Eur. 2.5.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.



recommended designation �e designation states:• the dried herbal drug or animal matter used,• where applicable, the fresh herbal drug or animal

matter used,• the glycerol content of the solvent used for the prepa-

ration,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to macerate,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce glycerol maceratesPh.Eur. (2371) Methods2.1.1 – 2.1.3 (HAB Methods 42)2.2.1 – 2.2.4 (HAB Methods 41)

APC Method 3.3.1Glycerol macerates according to APC Method 3.3.1 are prepared from 3 parts of fresh (frozen) matter of botanical or zoological origin and 7 parts of glycerol by maceration.�e prescribed quantity of glycerol is added to the starting material. Mix thoroughly and allow to stand in a closed container for an appropriate time according to the individual monograph. If necessary, shake or stir occasionally. Express and �lter, if necessary.�e content of glycerol is determined using measure-ment of refractive index and should be 70–85 % (m/m) of the total mass, calculated based on the equation above (refractive index). Adjustment of the �nal content of glycerol to 85 % is carried out using measurement of refractive index, and adding glycerol.Adjustment of the content of constituents may be carried out, if necessary by adding another macerate of the herbal or animal starting material used.

APC Method 3.3.2Glycerol macerates according to APC Method 3.3.2 are prepared from 1 part of dried plants or parts of plants, 2 parts of puri�ed water and 7 parts of glycerol by maceration.�e prescribed quantity of puri�ed water is added to the starting material. Allow standing in a closed con-tainer for 6 hours. A�er that, the prescribed quantity of glycerol is added to the mixture. Mix thoroughly and allow to stand in a closed container for an appro-priate time according to the individual monograph. If necessary, shake or stir occasionally. Express and �lter, if necessary.�e content of glycerol is determined using measure-ment of refractive index and should be 75–85 % (m/m)


• A

PC Part IIa

34


testsRelative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e pre-paration complies with the limits prescribed in the individual monograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial Pharmacopoeia, or another limit is justi�ed and authorised.

assayAn assay with quantitative limits is performed when starting materials with toxicologically or therapeutically relevant substances are used.


recommended designation �e designation states:• the fresh herbal drug used,• where applicable, the dried herbal drug used,• where applicable, the ethanol content in the

preparation,• where applicable, the ratio of starting material

to extraction liquid or of starting material to preparation,

• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce mother tinctures made by percolation

Ph.Eur. (2371), Methods 1.1.8, 1.1.9

HAB Methods 4

APC Method 3.5.1 (related to Ph.Eur. (2371) Method 1.1.8)

Mother tinctures according to APC Method 3.5.1 are prepared using the percolation methods given in the Ph.Eur. monograph “Extracts” (0765). Use 1 part of dried plant or parts of plants to 20 parts of ethanol in suitable concentration (see HAB H 5.3), unless other-wise prescribed in the individual monograph.If adjustment to a given concentration is necessary, calculate the amount of ethanol required to obtain the concentration speci�ed or used for production from


recommended designation �e designation states:• the dried herbal drug or animal matter used,• where applicable, the fresh herbal drug or animal

matter used,• where applicable, the solvent used for the preparation,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to preparation,


Speci�c pharmacopoeial/APC production methods to produce liquid preparations made by maceration with oil

APC Method 3.4.1Preparations made according to APC Method 3.4.1 are oil extracts for external use prepared from 1 part of lower animals and 10 parts of arachis oil, re�ned (Ph.Eur.) as follows:

A�er having killed the animals with CO2, the animals are minced and mixed thoroughly with 10 parts of arachis oil, re�ned (Ph.Eur.). Protect the mixture from light. �e extraction time should not exceed 8 hours. �en �lter.

3.5. Mother tinctures made by percolation

definitionMother tinctures made by percolation are prepared from fresh (frozen) or dried herbal drugs. �e percolation is carried out at room temperature using ethanol of suitable concentration or puri�ed water.

productionIf necessary, comminute the herbal drug to be extracted to pieces of suitable size. Mix thoroughly with a potion of the prescribed extraction solvent and allow to stand for an appropriate time. Transfer to a percolator and allow the percolate to �ow slowly making sure that the matter to be extracted is always covered with the remaining extraction solvent. �e residue may be pressed out and the expressed liquid combined with the percolate.

Adjustment of the content of constituents may be carried out, if necessary, either by adding the extraction solvent of suitable concentration or by adding another percolate of the herbal drug used for the preparation.


• A

PC P

art I

Ia

35

Potentisation is generally carried out according to HAB Method 32.

Bu�ered aqueous mother tinctures and their liquid dilutions are exclusively intended for parenteral dosage forms. Before they are processed to �nished products, the mother tincture (D2) and the liquid dilution D3 must be stored for between 6 weeks and 1 year. Any eventual sediment must be excluded from the further processing.


testsLoss on drying (H 2.8.1). Loss on drying of the residue a�er �ltration.Sterility (Ph.Eur. 2.6.1). If bu�ered aqueous mother tinctures and their liquid dilutions are stored before further processing, they must comply with the test. Proportion of original extracts: Where applicable, the proportion of both extracts in the composition is determined e.g. by HPLC or by other suitable methods.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial Pharmacopoeia or another limit is justi�ed and authorised.


storageStore in a well-closed, airtight container.

recommended designation �e designation states:• the herbal drug used,• the amount of herbal drug used,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce bu�ered aqueous mother tinctures manufactured under exclusion of oxidative in�uence

HAB Method 32

3.7. Fermented mother tinctures

definitionFermented mother tinctures are aqueous preparations

the equation given in Ph.Eur. (2371) Method 1.1.1. Mix the calculated amount of ethanol with the �ltrate. Allow to stand for not less than 5 days at a temperature not exceeding 20 °C, then �lter if necessary.

�e 2nd decimal dilution (D2) is made from2 parts of the mother tincture and8 parts of ethanol of the same concentration.

�e 3rd decimal dilution (D3) is made from1 part of 2nd decimal dilution and9 parts of ethanol of the same concentration.

Unless a di�erent ethanol concentration is speci�ed, use ethanol 43 per cent (m/m) for subsequent dilutions from D4 onwards and proceed accordingly.

3.6. Bu�ered aqueous mother tinctures manufactured under exclusion of oxidative in�uence

definitionBu�ered aqueous mother tinctures manufactured under exclusion of oxidative in�uence are produced by exhaustive extraction of fresh (frozen) plants or parts of plants under the exclusion of atmospheric oxygen with a bu�er.

If the fresh plant material is not processed immediately, it must be stored in liquid nitrogen. �e loss on drying (H 2.8.1) must be determined before it is placed in liquid nitrogen.From 1 part of the plant material an amount of mother tincture, prescribed in the individual monograph, is produced according to HAB Method 32. �is amount is determined in a validation and depends on the loss on drying of the harvested plant material.�e mother tincture corresponds to the 2nd decimal dilution (mother tincture = D2).At �rst add a de�ned amount of ascorbate phosphate bu�er solution to the plant material and then �nely reduce this mixture to a slurry. Under further size reduction, add a quantity of ascorbate phosphate bu�er solution, su�cient for achieving the required amount of extract. Express, �lter and adjust to the required volume with ascorbate phosphate bu�er solution.

According to the individual monograph the production of the mother tincture may require the addition of a second extract from material of the same plant species harvested at a di�erent season. In this case mix the extracts in an appropriate apparatus to a composition (see Chapter 7) and then dilute in a de�ned proportion with ascorbate phosphate bu�er solution. �is compo-sition is the mother tincture (=D2).


• A

PC Part IIa

36

HAB Method 53APC Methods 7.2.1, 7.2.3, 7.2.4

APC Method 3.7.1 (see also Compositions 7.2.1)Mother tinctures according to APC Method 3.7.1 are prepared from fresh plants or parts of plants following the procedure given below.Finely comminute the plants or parts of plants and mix 1 part of the plant mass with 1 part of puri�ed water. Leave to ferment at 20 to 24°C with the exclusion of air, ending the fermentation when the pH of the fermentation liquid has fallen to between 4 and 5. �en express and weigh the expressed liquid. �e weight of the expressed liquid is equal to 2 parts and is mixed with 1 part of a mixture of 0.95 parts of ethanol 94 per cent (m/m) and 0.05 parts of puri�ed water.�is tincture can together with another tincture of the same plant undergo a special pharmaceutical process leading to a composition according to method 7.2.1.

�is procedure is followed for plants harvested in the summer and for plants of the same species, harvested in the winter. �e mother tincture is produced by composing equal parts of the two tinctures.

potentisation�e 1st decimal dilution (D1) is made from3 parts of the mother tincture and7 parts of ethanol 30 per cent (m/m).

�e 2nd decimal dilution (D2) is made from1 part of the 1st decimal dilution and9 parts of ethanol 15 per cent (m/m).

Subsequent dilutions are produced as stated for D2.

recommended designation Preparations according to APC Method 3.7.1 carry the designation „ferm APC 3.7.1“.

3.8. Tinctures and mother tinctures made by digestion (Digestio)

definitionTinctures and mother tinctures made by digestion are liquids prepared from fresh (frozen) or dried plants or parts of plants with an additional heat treatment usually at 37 °C. �e digestion is carried out using ethanol of a suitable concentration or puri�ed water.

productionIf necessary, comminute the plant or parts of plants to be extracted. �e quantity of extraction liquid is

from fresh (frozen) or dried herbal drugs prepared by fermentation at room temperature.

productionIf necessary, comminute the herbal drug. Add puri�ed water according to the individual monograph and mix thoroughly. If stated in the individual monograph, add the prescribed fermenting agent. Allow to stand at room temperature for the time prescribed in the individual monograph protected from air, from light and, if necessary, from oxidation. Herea�er express and �lter, if necessary.

Adjustment of the content of constituents may be carried out with puri�ed water or by adding puri�ed water to the residue and expressing again.


testspH (Ph.Eur. 2.2.3). �e preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). �e preparation complies with the limits prescribed in the individual monograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial Pharmacopoeia, or another limit is justi�ed and authorised.



recommended designation �e designation states:• the fresh herbal drug used,• where applicable, the dried herbal drug used,• where applicable, the ratio of starting material to ex-


Speci�c pharmacopoeial/APC production methods to produce fermented mother tinctures


• A

PC P

art I

Ia

37

• the designation “Digestio” or “ethanol. Digestio” if ethanol is used,


Speci�c pharmacopoeial/APC production methods to produce tinctures and mother tinctures made by digestion

HAB Methods 18HAB Method 24b

APC Method 3.8.1Tinctures according to APC Method 3.8.1 are prepared from fresh plants with puri�ed water as follows:Comminute the plants or parts of plants unless other-wise prescribed in the monograph. �e amount of plants or parts of plants and puri�ed water are de�ned by the monograph. Introduce the amount of puri�ed water into a round-bottomed �ask, place in a water bath and heat up to 48 – 52 °C. Add the plants or parts of plants whereby the �ask should be a half to three quarters full, mix thoroughly. Close the �ask hermeti-cally. Keep the mixture at 48 – 52 °C for 6 hours. Allow to cool to 35 – 39 °C in the course of 20 – 24 hours and maintain this temperature for 64 – 72 hours with occasional stirring. Allow to cool. If prescribed in the individual monograph add the amount of ethanol 94 per cent (m/m) prescribed then express and �lter.Tinctures according to APC Method 3.8.1 which are prepared with puri�ed water only, are generally processed immediately to solid preparations (see method 5.2 “Solid preparations from liquids, plant juices or aqueous extracts”).

recommended designation Preparations made according to APC Method 3.8.1 carry the designation “Digestio APC 3.8.1”. �e same applies to preparations made from them. Preparations made according to APC Method 3.8.1 with addition of ethanol carry the designation “ethanol. stab. digestio APC 3.8.1”.

3.9. Tinctures and mother tinctures made by infusion (Infusum)

definitionTinctures and mother tinctures made by infusion are prepared from adequately prepared dried plant material by adding boiling puri�ed water. If ethanol (of the prescribed concentration) is used, the quantities of ethanol and puri�ed water are added separately.

productionIf necessary, comminute the plant material. Boiling

added according to the individual monograph. Mix thoroughly and warm to 35 – 39°C. �en keep at 35 – 39°C in a covered container. Allow to stand at this temperature for the time prescribed in the individual monograph, stirring occasionally. A�er cooling, allow to stand at room temperature in a well-closed container, protected from light for the time described in the individual monograph. Add ethanol of appropriate concentration if prescribed. If necessary shake or stir occasionally. Express and �lter, if necessary.Adjustment of the content of constituents may be carried out by diluting, either with the same liquid used for the digestion or with another digestion of the same raw material.If prescribed in the individual monograph, the tincture can be adjusted to the speci�ed content by concentration, carried out carefully and generally under vacuum.


testspH (Ph.Eur. 2.2.3). Where applicable the preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). �e preparation complies with the limits prescribed in the individualmonograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial pharmacopoeia, or another limit is justi�ed and authorised.



recommended designation �e designation states:• the dried herbal drug used,• where applicable, the fresh herbal drug used,• where applicable, the ethanol content in the

preparation,• where applicable, the ratio of starting material

to extraction liquid or of starting material to preparation,


• A

PC Part IIa

38

HAB Method 20HAB Method 24a

APC Method 3.9.1 (related to HAB Method 20)Mother tinctures according to APC Method 3.9.1 are prepared from dried plants or parts of plants, using 1 part of the plant material and 10 parts of ethanol of the concentration, prescribed in the individual monograph as follows:Add the amounts of ethanol and puri�ed water required to obtain the prescribed ethanol concentration separately.Unless a degree of comminution is speci�ed in the monograph, comminute the herbal drug appropriately, add the total amount of boiling puri�ed water, cover and allow to stand until room temperature is reached, for not more than 12 h. Compensate any water loss by evaporation and add the required amount of ethanol. Allow to stand in a well-closed container for 24 – 36 h, stirring occasionally. Express and �lter.

potentisation�e mother tincture corresponds to the 1st decimal dilution (Ø = D1).�e 2nd decimal dilution (D2) is made from1 part of the mother tincture and9 parts of ethanol of the same concentration as calculated for the mother tincture.

Subsequent decimal dilutions are produced accordingly; in this process the ethanol concentration is reduced with each step in the succession – 43 – 30 – 15 per cent (m/m) until the 15 per cent level is reached.

recommended designation Preparations made according to APC Method 3.9.1 carry the designation “ethanol. stab. infusum”. �e same applies to preparations made from them.

APC Method 3.9.2 (related to HAB Method 20) deleted

APC Method 3.9.3Mother tinctures according to APC Method 3.9.3 are prepared from fresh or dried plants or parts of plants, using 1 part of the plant material and 10 parts of water (m/m) or according to the individual monograph.Comminute the starting material and add the total amount of boiling puri�ed water, cover and allow to stand until room temperature is reached, for not more than 12 h. Compensate any water loss. Allow to stand in a well-closed container for 24 – 36 h, stirring occasionally. Express and �lter.

puri�ed water is used for extraction. If ethanol of suitable concentration is used, the quantity of ethanol is either used prior to extraction for moistening the dried plant material for the time prescribed or added to the mixture a�er cooling. Allow to stand in a well-closed container for the time prescribed. If only puri�ed water is used as solvent, it is also used for moistening and to make up the �nal mass if prescribed. Express and �lter, if necessary. If only puri�ed water is used as solvent the preparation is processed further immediately.


testsDry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e preparation complies with the limits prescribed in the individual monograph. Relative density (Ph.Eur. 2.2.5). �e preparation complies with the limits prescribed in the individual monograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial Pharmacopoeia , or another limit is justi�ed and authorised.Sterility (Ph.Eur. 2.6.1). Applicable only if the infusion is a stored aqueous preparation.


storageStore in a well-closed container, protected from light, if the tincture contains ethanol.If aqueous tinctures made by infusion are stored they must meet the requirements of sterility (Ph.Eur. 2.6.1).

recommended designation �e designation states:• the herbal drug used,• where applicable, the ethanol content in the


traction liquid or of starting material to preparation,• the designation “Infusum” or “ethanol. Infusum”, if

ethanol is used,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce tinctures and mother tinctures made by infusion


• A

PC P

art I

Ia

39

cent V/V of 2-propanol, unless otherwise authorised by a national o�cial pharmacopoeia, or another limit is justi�ed and authorised.



recommended designation �e designation states:• the herbal substance used,• where applicable, the fresh or dried herbal drug used,• where applicable, the ethanol content in the


traction liquid or of starting material to preparation,• the designation “Decoctum” or “ethanol. Decoctum”,

if ethanol is used,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce tinctures and mother tinctures made by decoction

HAB Methods 12k, 12l, 12qHAB Methods 19HAB Methods 23

APC Method 3.10.1 (related to HAB Method 19f)APC Method 3.10.1. is used for dried herbal drugs.Mother tinctures according to APC Method 3.10.1 are prepared by maceration with ethanol of an appropriate concentration as speci�ed in the individual monograph with additional heat treatment (decoction) as described below.1 part of dried herbal drug is macerated with 20 parts of ethanol of the appropriate concentration (anhydrous, 94 per cent m/m – 96 per cent V/V, 86 per cent m/m – 90 per cent V/V, 73 per cent m/m – 80 per cent V/V, 62 per cent m/m – 70 per cent V/V, 43 per cent m/m – 50 per cent V/V, 30 per cent m/m – 36 per cent V/V, 15 per cent m/m – 18 per cent V/V), unless otherwise prescribed in the individual monograph.

Unless otherwise prescribed, comminute the herbal drug, mix thoroughly with the total amount of ethanol of the appropriate concentration and heat to boiling under re�ux, maintaining at boiling temperature for 30 min unless otherwise speci�ed in the individual monograph.

potentisation�e mother tincture corresponds to the 1st decimal dilution (Ø= D1).�e 2nd decimal dilution (D2) is made from1 part of the mother tincture and9 parts of glycerol 85 % (m/m).

Subsequent dilutions are produced as stated for D2.

3.10. Tinctures and mother tinctures made by decoction (Decoction)

definitionTinctures and mother tinctures made by decoction are prepared from fresh or dried plants or parts of plants that have been allowed to boil with ethanol of a suitable concentration or puri�ed water or extracted with glycerol 85 % at 1000C.

productionIf necessary, comminute the plants or parts of plants, add the prescribed quantity of extraction solvent according to the individual monograph and mix thoroughly. Heat the mixture to boiling (in the case of glycerol 85 % to 1000C), if necessary under re�ux, maintaining at boiling temperature (in the case of glycerol 85 % at 1000C) for the time prescribed, usually 30 min. A�er cooling allow to stand in a well-closed container protected from light at room temperature for the time described in the individual monograph. If necessary, shake or stir occasionally. Express and �lter, if necessary.

Adjustment of the content of constituents may be carried out by diluting, either with the same liquid used for the decoction or with another decoction of the same raw material.If prescribed in the individual monograph, the tincture can be adjusted to the speci�ed content by concentration, carried out carefully and generally under vacuum.


testsDry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e pre-paration complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). �e preparation complies with the limits prescribed in the individual monograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per


• A

PC Part IIa

40

Peroxide value (Ph.Eur. 2.5.5). Where applicable, the preparation made with a vegetable oil complies with the limits prescribed in the individual monograph.


storageStore in a well-�lled, airtight container, protected from light and heat. If necessary, the empty space in the container of oil extracts is �lled with an inert gas.

recommended designation �e designation states:• the fresh herbal drug used,• where applicable, the dried herbal drug used,• the extraction liquid used,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to preparation,• an indication of the extraction temperature,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce viscous extracts with heat treatment

HAB Methods 12 d-gHAB Method 57

Individual Monographs:Cydonia oblonga, fruit, glycerol extract with heat treatment 1:2.1.

3.12. Preparations made by distillation (Distillates)

definitionDistillates are prepared from fresh plants or parts of plants or dried plants, organic or inorganic substances by steam distillation or water-and-steam distillation.�e distillation can be done in the presence of other substances that will not interfere with the �nal com-position of the distillate. �is process can be repeated several times in a rhythmic sequence of evaporation/condensation. Distillated preparations can be part of a more complex formulation that is composed by several fractions. Distillated preparations can be used as starting materials or �nished products and can be potentised.

productionAccording to the speci�c methods or the individual monograph.

Cool or allow to cool and leave the mixture to stand in a closed container for 12 – 36 h. Separate the residue from the ethanol and, if necessary, press out. In the latter case, combine the 2 liquids obtained.Adjust to the concentrations required in the individual monograph in accordance with Ph.Eur. (2371) Method 1.1.8.

potentisation�e 2nd decimal dilution (D2) is made from2 parts of the mother tincture and8 parts of ethanol of the same concentration.

�e 3rd decimal dilution (D3) is made from1 part of the 2nd decimal dilution and9 parts of ethanol of a reduced concentration as given below.

Subsequent decimal dilutions are produced accordingly; in this process the alcohol concentration is reduced with each step in the succession 94 – 86 – 73 – 62 – 43 – 30 – 15 per cent (m/m) until the 15 per cent level is reached.

3.11. Viscous extracts with heat treatment

definitionViscous extracts with heat treatment are prepared from fresh or dried herbal drugs using a fatty or mineral oil or glycerol 85 % as extraction liquid with heat.

productionIf necessary, comminute the herbal drug. Ethanol 94 per cent (m/m) may be added to moisten the plant material. �e prescribed quantity of the extraction liquid (mostly peanut, olive, sesame or sun�ower oil, liquid para�n, or glycerol 85 %) is added and mixed thoroughly with the herbal drug. �e mixture is heated at the prescribed temperature and allowed to stand in a closed container for an appropriate time. Extraction temperature and time are prescribed in the individual monograph. Finally express and �lter. If necessary, the empty space of the container is �lled with a protecting gas.


testsRelative density (Ph.Eur. 2.2.5). �e preparation complies with the limits prescribed in the individual monograph.Refractive index (Ph.Eur. 2.2.6). �e preparation complies with the limits prescribed in the individual monograph.


• A

PC P

art I

Ia

41

heat with �ame source, ending the distillation when 50 parts of distillated have been collected or according to the individual monograph.

�e aqueous distillation can be done in the presence of other substances that will not interfere with the �nal composition of the �nal distillate.

3.13. Mother tinctures obtained by rhythmic application of heat and cold

definitionMother tinctures obtained by rhythmic application of heat and cold are aqueous preparations from fresh or dried herbal drugs or saps from fresh herbal drugs, obtained by fermentation under cold and heat appli-cation.

productionComminute the herbal drug if necessary. Add puri�ed water. If stated in the individual monograph, add the prescribed fermenting agent.It is also possible to ferment the expressed plant sap or the �nely minced fresh plant without addition of puri�ed water. Treat rhythmically with application of heat (generally 37°C) and cold (generally 4°C). Where required, express and �lter a�er the time prescribed in the individual monograph. Salts, speci�c plant ashes, metals or minerals may be added according to the individual monograph.


testspH (Ph.Eur. 2.2.3). �e preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial pharmacopoeia, or another limit is justi�ed and authorised.



testsDry residue (Ph.Eur. 2.8.16 or H 2.2.6). �e preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national o�cial pharmacopoeia or another limit is justi�ed and authorised.

recommended designation Distillates and derived dosage forms carry the designation „destillata“.

Speci�c pharmacopoeial/APC production methods to produce preparations made by distillation

APC Method 3.12.1 Preparations made by ethanolic distillation (related to HAB Method 52)

Distillates according to APC method 3.12.1 are prepared from fresh plants or parts of plants following the proce-dure given below.Comminute the plant material. Pour 8 parts of ethanol 86 per cent (m/m) over 100 parts of plant mass. Leave to stand in a closed container for at least 24 h, then steam distil, ending the steam distillation when 50 parts of distillate have been collected.

�e mother tincture is made from1 part of distillate and1 part of ethanol 15 per cent (m/m).

potentisation�e 1st decimal dilution (D1) is made from1 part of the mother tincture and9 parts of alcohol 15 per cent (m/m).Subsequent dilutions are produced as stated for D1.

APC Method 3.12.2 Preparations made by aqueous distillation

Distillates according to APC Method 3.12.2 are preparations of fresh or dried starting materials from mineral, vegetal and animal source, obtained by aqueous distillation.Comminute the material. To 1 part of material add water according to the individual monograph, then


• A

PC Part IIa

42

�e 1st decimal dilution (D1) is made from1 part of Rh mother tincture and9 parts of water for injections.

Subsequent decimal dilutions are produced as stated for D1.

Ethanolic Dilutions �e 1st decimal dilution (D1) is made from1 part of Rh mother tincture and9 parts of ethanol 15 per cent (m/m).


recommended designation Preparations made according to APC Method 3.13.1 carry the designation “Rh”; the same applies to prepa-rations made from them. If ethanol 15 per cent (m/m) is used from the 1st decimal dilution onwards, state this on the label.

APC Method 3.13.2 (related to HAB Method 22)Rh mother tinctures according to APC Method 3.13.2 are prepared from fresh plants, generally yielding distinctly less than 50 per cent of expressed liquid, as follows:

Comminute the plants immediately a�er harvesting. Subject the plant material to the diurnal hot-cold rhythm (“Rh”) for 7 – 10 days. Each morning, warm the plant material to approximately 35 – 39°C and maintain at this temperature. Each evening, cool the plant mate-rial to 2 – 6°C and maintain at this temperature.�en express. Transfer the expressed juice to containers and subject to the diurnal hot-cold rhythm (“Rh”) as described under method 3.13.1.

potentisationAqueous dilutions�e 1st decimal dilution (D1) is made from1 part of Rh mother tincture and9 parts of water for injections.


Ethanolic dilutions�e 1st decimal dilution (D1) is made from1 part of Rh mother tincture and9 parts of ethanol 15 per cent (m/m).

storageStore in a well-closed container, protected from light, at 8 – 15°C.

recommended designation �e designation states:• the herbal drug used,• where applicable, the fresh herbal drug used,• where applicable, the name of the salt, metal or

mineral added,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to preparation,• the designation „ferm“ (with water and fermenting

agents) or „Rh“ (fermented plant sap without fermenting agents),


Speci�c pharmacopoeial/APC production methods to produce mother tinctures obtained with rhythmic application of heat and cold

HAB Method 21HAB Method 22HAB Methods 33HAB Methods 34HAB Methods 35HAB Method 36HAB Methods 37HAB Methods 51

APC Method 3.13.1 (related to HAB Method 21)Rh mother tinctures according to APC Method 3.13.1 are prepared from fresh plants generally yielding more than 50 per cent of expressed liquid, as follows:

Comminute the plants immediately a�er harvesting and express. Transfer the expressed juice to containers and subject to the diurnal hot-cold rhythm (“Rh”) described below until fermentation is complete.Each morning, warm the expressed liquid to 35 – 39°C over a period of 30 – 90 min and maintain at this temperature. Each evening, cool the expressed liquid to 2 – 6°C over a period of 30 – 90 min and maintain at this temperature.Stir the liquid for 60 – 200 min during both temperature phases at the beginning, gradually decreasing to 10 min at the end of the fermentation process. Filter as soon as fermentation has ceased.

potentisationAqueous dilutions


• A

PC P

art I

Ia

43


recommended designation �e designation states:• the name of herbal or animal matter used,• the designation “tostus/a/um/”, example: Spongia

tosta,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce toasted preparations.

According to the individual monograph.

4.2. Carbons – Carbo

definitionCarbons are obtained from dried plants or parts of plants or dried animal matter. �ey are dry, brittle, and generally black substances.�e plant or animal matter is heated to a temperature usually above 200 °C under reduced presence of oxygen to produce the carbonised deposit. �e carbonised substance is powdered.Carbons may be potentised according to Ph.Eur 4.1.1.

identification�e identi�cation is carried out according to the individual monograph.

tests�e tests are carried out according to the individual monograph, where applicable:• Acidity or Alkalinity,• Acid-soluble substances,• Adsorption power,• Alkali-soluble coloured matter,• Cyanide,• Ethanol-soluble substances,• Fluorescent substances,• Heavy metals (e.g. Ph.Eur. 2.4.8),• Loss on drying (Ph.Eur. 2.2.32),• Sulfated ash (Ph.Eur. 2.4.14),• Sul�de,• Total ash (Ph.Eur. 2.4.16),• Zinc.

assayAn assay is carried out according to the individual monograph, where applicable.



recommended designation Mother tinctures made according to APC Method 3.13.2 carry the designation “Rh”; the same applies to preparations made from them. If ethanol 15 per cent (m/m) is used from the 1st decimal dilution onwards, state this on the label.

4. SOLID STARTING MATERIALS OBTAINED BY HEAT

Heat treatment can be applied directly to solid starting materials from botanical or zoological origin without addition of a vehicle. �e heat treatment may be per-formed under presence or reduced presence of oxygen. Solid starting materials obtained by heat include toasted preparations (Tosta), carbons (Carbo) and ashes (Cinis).

4.1. Toasted preparations – Tosta

definitionToasted preparations are obtained from dried plants or parts of plants or solid, dried animal matter by toasting. Toasted preparations are dry, usually brownish and have an intense and characteristic odour.

�e substances to be toasted are crushed, if necessary, and are exposed to a heat source for the prescribed time. During the process water evaporates and the matter becomes brown or brownish. �is is achieved through control of the heat supply, usually 170 – 250 °C and by tossing the material during this procedure. �e toasted substance is powdered.Particle size of the raw material, temperature and heat-ing time are prescribed in the individual monograph.

Toasted substances may be potentised according to Ph.Eur. 4.1.1.

identificationAccording to the individual monograph.

tests�e tests are carried out according to the individual monograph, where applicable.

assayAn assay is carried out according to the individual monograph, where applicable.


• A

PC Part IIa

44

5. SOLID PREPARATIONS FROM PLANTS (DRYING ONTO A VEHICLE)

Solid preparations from plants are obtained either by drying fresh plants, plant juices or aqueous extracts onto a vehicle.

5.1. Solid preparations from fresh plants

definitionSolid preparations of fresh plants are prepared by drying fresh plant material onto suitable vehicles e.g. lactose monohydrate.

productionComminute the fresh plant material, and mix thoroughly with the vehicle in order to adsorb its liquid part. Dry the mixture gently and mill if necessary.�e preparation can be potentised according to Ph.Eur. (2371) Methods 4.1.1 and 4.1.2.

identificationAt least one chromatographic test is carried out.

testsLoss on drying (Ph.Eur. 2.2.32): �e solid preparation complies with the limits prescribed in the individual monograph.Microbiological quality (Ph.Eur. 5.1.4): (Non-aqueous preparations for oral use).

assayAn assay with quantitative limits is performed when raw materials with toxicologically or therapeutically relevant substances are used.


recommended designation �e designation states:• the name of the plant material used,• the quantity used,• the vehicle used,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce solid preparations from fresh plants

Ph.Eur. (2371) Method4.1.1

APC Method 5.1.1Preparations according to APC Method 5.1.1 are solid preparations of fresh plants prepared by drying fresh

recommended designation �e designation states:• the name of the herbal or animal matter used,• the designation ”Carbo”, example: Carbo Gentianae,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce carbons

B.Hom.P. Method Br4

4.3. Ashes – Cinis

definitionAshes are obtained from dried plants or parts of plants or dried animal matter. �ey are generally �ne, amorphous, white, grey, beige or brown powders.

�e herbal or animal matter is incinerated generally at a temperature above 500 °C.

Ashes may be potentised according to Ph.Eur. 4.1.1.

identification�e identi�cation is carried out according to the individual monograph.

tests�e tests are carried out according to the individual monograph, where applicable:• Acid insoluble substances,• Arsenic (e.g. Ph.Eur. 2.4.2),• Heavy metals (e.g. Ph.Eur. 2.4.8),• Loss on drying (Ph.Eur. 2.2.32).

assayWhere applicable the Cinis complies with the individual monograph.

storageStore in a well-closed container with a desiccant if necessary.

recommended designation �e designation states:• the name of the herbal or animal substance used,• the designation ”Cinis”, example: Cinis Tabaci,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce ashes

B.Hom.P. Method Br3


• A

PC P

art I

Ia

45

• the name of the plant material used,• the quantity used,• the vehicle used,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce solid preparations from liquid extracts/ plant juicesPh.Eur. (2371) Methods (refer to potentisation)4.1.14.1.2

APC Method 5.2.1Preparations according to APC Method 5.2.1 are solid preparations from fresh plant juices prepared by drying the fresh plant juice onto lactose monohydrate or another excipient.Add 1 part of the expressed plant juice or aqueous extract to 1.9 parts of lactose monohydrate unless otherwise prescribed in the individual monograph to obtain a wet granulate. Dry the wet granulate gently until it reaches the dryness required. Mill, if necessary, then sieve as speci�ed in the individual monograph and remix thoroughly. For granulation it may be necessary to concentrate the plant juice under reduced pressure.

APC Method 5.2.2Preparations according to APC Method 5.2.2 are solid preparations from fresh plant juices prepared by drying the fresh plant juice onto lactose monohydrate or another excipient.�e expressed plant juice of 1 part of the fresh plant is added to 3 parts of lactose monohydrate unless other-wise prescribed in the individual monograph to obtain a wet granulate. Dry the wet granulate gently until it reaches the dryness required. Mill, if necessary, then sieve as speci�ed in the individual monograph and re-mix thoroughly. Before granulation it may be necessary to concentrate the plant juice under reduced pressure.

APC Method 5.2.3Preparations according to APC Method 5.2.3 are solid preparations from aqueous extracts prepared by drying aqueous extracts of fresh plants onto lactose monohydrate or another excipient.Mix 1 part of the comminuted fresh plants with 0.15 parts of puri�ed water. �en express the mixture. �e expressed aqueous extract is added to 4 parts of lactose monohydrate unless otherwise prescribed in the individual monograph to obtain a wet granulate. Dry the wet granulate gently until it reaches the dry-ness required. Mill, if necessary, then sieve as speci�ed in the individual monograph and remix thoroughly. Before granulation it may be necessary to concentrate the aqueous extract under reduced pressure.

herbal drugs onto lactose monohydrate.Comminute the plants or parts of plants. To 1 part of the plant material add the required amount of lactose mono hydrate, usually 2.9 parts unless otherwise pre-scribed in the individual monograph. Mix thoroughly. Dry the moist mixture gently until it reaches the dryness required. Mill, if necessary, then sieve as speci�ed in the individual monograph and remix thoroughly.

potentisation�e preparation can be potentised according to Ph.Eur. (2371) Methods 4.1.1 and 4.1.2.�e 1st decimal dilution (D1) is made from 3 parts of the solid preparation and7 parts of lactose monohydrate

5.2. Solid preparations from liquids, plant juices or aqueous extracts

definitionSolid preparations of liquids are prepared by drying plant juices, tinctures, aqueous extracts or solutions or their dilutions onto suitable vehicles e.g. lactose monohydrate. �e expressed juice or the tincture from the fresh plant material or the solution is mixed thoroughly with the vehicle. �e mixture is dried gently and milled if necessary.�e preparation can be potentised according to Ph.Eur. (2371) Methods 4.1.1 and 4.1.2.


identificationAt least one chromatographic test is carried out.

testsLoss on drying (Ph.Eur. 2.2.32). �e solid preparation complies with the limits prescribed in the individual monograph.Microbiological quality (Ph.Eur. 5.1.4). (Non-aqueous preparations for oral use)

assayAn assay with quantitative limits is performed when raw or starting materials with toxicologically or therapeutically relevant substances are used.


recommended designation �e designation states:


• A

PC Part IIa

46

7. COMPOSITIONS

Compositions are active substances which are obtained when two or more starting materials and/or prepara-tions with or without excipients and/or vehicles are processed together in a pharmaceutical process that will lead to a new substance (unit). �e rationale for composing is the anthroposophic understanding of man, nature, substance and processing. Compositions may be directly used as an active substance or can be potentised or diluted for any dosage form.

7.1. Compositions made by treating two or more starting materials by one or more pharmaceutical processes

definitionCompositions made by treating two or more starting materials or preparations by one or more pharma-ceutical processes are prepared by combining starting materials in a de�ned ratio according to the individual monograph using a speci�ed process (e.g. speci�ed mixing, heat treatment, chemical process).


identification/testsAccording to the nature of the composition. �e components of the composition comply with the requirements of the relevant monographs.

recommended designation �e designation states:• the name of the composition,• the composition of the product

(quantity of the ingredients),• reference pharmacopoeia/codex.

Speci�c APC production methods to produce compositions according to 7.1

Examples (see appendix 2.6): Anis-Pyrit, Ferrum-Quarz, Hepar-Magnesium, Hepar sulfuris, Kalium aceticum comp., Plumbum mellitum, Solutio Sacchari comp. (mineral compositions according to the model of a plant).

6. LIQUID DILUTIONS

definitionLiquid dilutions are prepared by dissolving one or more starting materials in an appropriate vehicle. �e liquid obtained may be directly potentised.

production�e starting material is dissolved in the appropriate vehicle. Dissolution may require heating or stirring. �e separation of a residue may be necessary.

Where necessary, immediately a�er the dissolution the �rst potentisation step is carried out in accordance with the individual monograph.

identificationLiquid dilutions are identi�ed using a suitable method.

testsAppearance (Ph.Eur. 2.2.1, 2.2.2). Where applicable, the preparation complies with the limits described in the individual monograph.pH (Ph.Eur. 2.2.3). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). Where applicable, the liquid solution complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). �e preparation complies with the limits prescribed in the individual monograph.

assayWhere applicable, liquid solutions of chemically de�ned starting materials are assayed.


recommended designation �e designation states:• the name of the substance dissolved,• the quantity dissolved,• where applicable, the degree of potentisation,• the reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce liquid dilutions

Ph.Eur. (2371) Methods3.1.13.1.2

HAB Methods 5


• A

PC P

art I

Ia

47

�is procedure is followed for plants harvested in summer and for plants of the same species, harvested in winter.�e mother tincture is a composition, produced by unifying equal parts of the two tinctures.

�e mother tincture can be potentised as follows:

�e 1st decimal dilution (D1) is made from3 parts of the mother tincture and7 parts of alcohol 30 per cent (m/m).

�e 2nd decimal dilution (D2) is made from1 part of the 1st decimal dilution and9 parts of alcohol 15 per cent (m/m).Subsequent dilutions are produced as stated for D2.

recommended designation Preparations according to APC Method 7.2.1 carry the designation „ferm APC 7.2.1“.

APC Method 7.2.2 Compositions of aqueous extracts and liquid preparations thereofCompositions according to APC Method 7.2.2 are mother tinctures produced from fresh (frozen) plants or parts of plants by the following procedure.�e plants or parts of plants are comminuted in a grinder, pressed in appropriate boxes and frozen at – 10°C to – 30°C. �e plants or parts of plants are combined to a speci�c formulation: Plants and parts of plants from winter harvest with plants from spring harvest to give the so called winter formulation. Plants from summer harvest with plants from autumn harvest to give the so called summer formulation. 5 parts of frozen plants are extracted for 1 – 4 h at 10 – 20°C with 95 parts of 0.09 % sodium chloride solution in a container with stirring. �e coarse plants or plant parts are separated by centrifugation. �e centrifugate is �lled up to 100 parts with 0.09 percent sodium chloride solution and �ltered. �e winter formulation produces the so called winter extract, the summer formulation the so called summer extract. If the extract is to be stored, sterile �ltration must take place.�e composition is produced by composing three parts of winter extract and one part of summer extract as described below.�e winter extract is stirred in a specially constructed gilded mixing vessel. �e summer extract is allowed to drop from the top of the vessel into the vortex of the winter extract. �e osmolality is adjusted by adding sodium chloride and the pH is adjusted to 6.1 – 6.3 by adding sodium hydroxide solution. If the composition is to be stored, sterile �ltration must take place. �e composition (mother tincture) can be used directly or

7.2. Compositions made by treating two or more extracts or mother tinctures of one plant by one or more pharmaceutical processes

definitionCompositions made by treating two or more mother tinctures of one plant by pharmaceutical processes are prepared from extracts (mother tinctures) of the same plant species harvested at di�erent seasons, i.e. at di�erent stages of development. According to the individual monograph the extracts are combined in a de�ned ratio by a speci�c pharmaceutical process possibly using speci�c equipment. Adjustment of concentration, of pH, and of osmolality may be carried out.





Speci�c pharmacopoeial APC production methods to produce compositions according to 7.2

HAB Method 32HAB Method 38See appendix 2.6, for example Viscum album compositions.

APC Method 7.2.1 (see also APC Method 3.7.1)Compositions according to APC Method 7.2.1 are produced from fresh plants or parts of plants by the following procedure:Finely comminute the plants or parts of plants and mix 1 part of the plant mass with 1 part of puri�ed water. Leave to ferment at 20 to 24°C with the exclusion of air, ending the fermentation when the pH of the fermenta-tion liquid has fallen to between 4 and 5. �en express and weigh the expressed liquid. �e weight of the expressed liquid is equal to 2 parts and is mixed with 1 part of a mixture of 0.95 parts of ethanol 94 per cent (m/m) and 0.05 parts of puri�ed water. �is tincture is stored until it will undergo another pharmaceutical process with a second tincture of the same plant.


• A

PC Part IIa

48

Method 7.2.3Mix two parts of summer extract with 3 parts of water for injections.Mix one part of winter extract of plant material and one part of extract of berries with 3 parts of water for injections.

Method 7.2.4Mix two parts of summer extract with 3 parts of water for injections. Mix one part of winter extract of plant material and one part of extract of berries with a mixture of 0.002 parts of a metal salt trituration from the D4 potentisation step and 2.998 parts of water for injections.

Methods 7.2.3 and 7.2.4Feed the mixture of the winter extracts continuously onto the centre of a rotating disk. At the same time, feed the summer extracts continuously onto the slightly raised edge of the disk. �e blended mixture �ows con-tinually o� over the edge of the disk. Filter the mixture; the �ltrate is the mother tincture. If the mother tincture is stored for further processing, it must comply with the test for sterility (Ph.Eur. 2.6.1).�e dilution series is (composition or dilution + water for injections): 1+9 (20 mg), 1+19 (10 mg, correspond-ing to a 1:20 dilution); 1+39 (5 mg); 1 + 99 (2 mg); 1 part 1:20 dilution + 9 parts water for injections (1:200 or 1 mg); 1 part 1:200 dilution + 9 parts water for injections (1:2,000 or 0.1 mg); 1 part 1:2,000 dilution + 9 parts water for injections (1:20,000 or 0.01 mg); 1 part 1:20,000 dilution + 9 parts water for injections (1:200,000 or 0.001 mg); 1 part 1:200,000 dilution + 9 parts water for injections (0.0001 mg). To prepare the �nal preparation, add sodium chloride to the water for injections to obtain an isotonic solution.

Compositions produced according to methods 7.2.3 and 7.2.4 may be potentised according to chapter 8.

recommended designation �e amount of herbal drug (fresh plant) which was extracted to achieve 1 mL of the �nal preparation.

storageStore the mother tincture in a well-closed container at 2 – 8°C.

can be used for further dilutions. �e addition of anti oxidants or substances for pH adjustment is allowed.

Dilutions are obtained by diluting the composition. At a temperature between 10°C and 25°C the necessary amount of 0.9 percent sodium chloride solution is stirred in a vessel; the composition is dropped from the top into the vortex. �e dilution series is: (Composition + sodium chloride solution) e.g. 3+2 (30 mg), 2+3 (20 mg), 1+4 (10 mg), 1+9 (5 mg), 1+49 (1mg), 1+499 (0.1 mg); 1+4999 (0.01 mg). If the dilution is to be stored, sterile �ltration must take place.

recommended designation �e amount of herbal drug (fresh plant) which was extracted to achieve 1 mL/2 mL of the �nal preparation.

APC Method 7.2.3 and 7.2.4 Compositions of fermented aqueous extracts and liquid preparations thereofCompositions according to APC Method 7.2.3 and 7.2.4 are mother tinctures produced from fresh plants or parts of plants by the following procedure.Finely comminute the plants or parts of plants and mix 1 part of the plant mass with 1.318 parts of water for injections, 0.03 parts of sucrose, and 0.002 parts of a Lactobacillus plantarum suspension, 109 – 1010 cfu/mL and mix thoroughly. Leave to ferment for 3 days at 20 to 27°C with the exclusion of air. �en express and weigh the expressed liquid. If (except for the berries) gentle pressure applied to the plant residue does not achieve a �nal mass of extract equal to 2 parts, pour a su�cient amount of water for injections over the plant residue and express gently. Use the resulting extract to make the extract up to 2 parts. If prescribed in the indi-vidual monograph, adjust the pH to 5.0 – 6.5 by adding sodium hydroxide.Follow the same procedure for plant material harvested in the summer and for plant material of the same species, harvested in the winter. However, for the winter harvest, process the berries and the other plant parts separately according to the method described above and use 1.328 parts of water for injections and 0.02 parts of sucrose. Also, leave the berry mixture to ferment for 4 days.If the extracts are stored for further processing, they must comply with the test for sterility (Ph.Eur. 2.6.1).

�e composition is produced by composing equal parts of the summer and the combined winter extracts as described below.


• A

PC P

art I

Ia

49

recommended designation �e designation states:• the name of the preparation,• the composition of the product


Speci�c pharmacopoeial/APC production methods to produce compositions according to 7.4

Examples (see appendix 2.6): Onopordum acanthium, Folium rec., ethanol. Digestio (1:3.1) with 1 – 2 % Hyoscyamus niger, Herba rec. Ø, see also Plantago lanceolata and Primula.

7.5. Compositions made by co-potentising

definitionCompositions made by co-potentising are prepared from two or more starting materials and/or prepara-tions (e.g. mother tinctures, potencies) by co-poten-tising over one or more steps.

productionAccording to APC Method 8.1 or the individual monograph.


recommended designation �e designation states:• the name, quantity and potency degree of each

ingredient,• how many potentising steps were carried out on the

mixture as a whole,• reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce compositions according to 7.5Ph.Eur. (2371) Methods5.1.15.1.25.1.5

8. POTENTISED PREPARATIONS

Potentised preparations are gradually diluted substances, whereby at each diluting step a rhythmic succussion (liquid potencies) or trituration (solid or semi-solid potencies) has been carried out for a de�ned time. �e

7.3. Compositions made by treating one or more starting materials with one or more mother tinctures which undergo one or more pharmaceutical processes together

definitionCompositions made by treating one or more starting materials with one or more mother tinctures are obtained by combining one or more starting materials with one or more stocks in a de�ned ratio according to the individual monograph.





Speci�c pharmacopoeial/APC production methods to produce compositions according to 7.3

Examples (see appendix 2.6): Cinis e fructibus Avenae sativae cum Magnesio phosphorico (1:1), Cissus-Ossa.

7.4. Compositions made by treating two or more extracts or mother tinctures and/or dilutions by one or more pharmaceutical processes

definitionComposition made by treating two or more extracts or mother tinctures and/or dilutions by pharmaceutical processes are prepared according to an individual monograph prescribing the combination of the ingre-dients in a de�ned ratio by a speci�c pharmaceutical process using speci�c equipment.

productionAccording to the individual monograph.



• A

PC Part IIa

50

B.Hom.P. Method Br5B.Hom.P. Method Br6

�e potentising speci�cations in Ph.Eur. monograph 2371 of Methods 1.1.1 – 1.1.11, 2.1.1, 2.1.2, 2.2.1 – 2.2.4 and 5.1.1 – 5.1.5.

�e potentising speci�cations in HAB methods5, 11, 15, 18, 19, 20, 21, 22, 23, 24, 32, 33, 34, 35, 36, 37, 38, 39a, 39b, 45, 51, 53.

�e potentising speci�cations in APC Methods.

8.1. Co-potentised preparations

definitionMethod 8.1 is used for preparing dilutions by co- potentising two or more stocks and/or dilutions thereof, where co-potentisation consists of mixing several stocks or dilutions of stocks then potentising them together in one or more potentisation steps.

productionCo-potentised compositions according to APC Method 8.1 may be prepared from starting materials and/or solutions, potentised preparations and mother tinctures whose method of production is speci�ed by a ratio of 1 part of starting material and 10 parts of extraction solvent.When a solid potency D4 shall be potentised with liquids, it can be potentised one step according to Ph.Eur. (2371) Methods 3.2, and then be used as D5 for co-potentisation or dilution to a �nal concentration of 1 ppm.

Co-potentised compositions may be used to produce all types of dosage forms. Co-potentisation of mixtures according to APC Method 8.1 to produce parenteral preparations or eye drops is carried out with water for injections or an isotonic solution as diluting agent.

identification, test, assayare carried out according to the individual monograph.


recommended designation �e designation states:• the name of the potentised substance(s),• where applicable, the ethanol content,• the potentising ratio; decimal potencies may be

designated as D or DH or X,• the potency degree, example: D3 or 3 DH or 3X,• the reference pharmacopoeia/codex.

potentising time di�ers for solid and liquid potentised preparations. Astronomical aspects may be considered (e.g. solar or lunar eclipse ).�e preparations are de�ned by the number of liquid potentising or trituration steps respectively and by the ratio between the vehicle (diluting agent) and the substance to be potentised.

�e potentising ratio is usually:1 part of substance9 parts of vehicle.

�e potentising ratio for co-potentised preparations is usually:1 part of a mixture of equal parts of active substances9 parts of vehicle.

liquid potencies:�e substance or mixture to be potentised is dissolved in the vehicle in the chosen ratio. Usual vehicles for liquid potencies are water (puri�ed or water for injections), ethanol of various concentrations, glycerol or vegetable oils. Excipients might be necessary, for example to emulsify an aqueous substance into oil. A�er dissolution, rhythmic succussion is carried out. For the next poten-tising step one part of the �rst potency and the prescribed amount of vehicle are brought together and succussed. Further potentising is carried out in likewise manner.

solid potencies (triturations):Potencies of solid substances are prepared by trituration of the substance to be potentised usually with lactose monohydrate in the prescribed ratio in a mortar with a pestle or in an adequate trituration machine.Solid potencies can be further potentised in liquid phase, if they are soluble in a vehicle.

semi-solid potencies:Semi-solid potencies are prepared by trituration of a liquid or a solid substance to be potentised with an ointment base in the prescribed ratio in a mortar with a pestle or in an adequate trituration machine.

Speci�c pharmacopoeial/APC production methods to produce potentised preparationsPh.Eur. (2371) Methods3.2.1 – 34.1.1 – 24.2.1 – 25.1.1 – 5

HAB Method 12jHAB Method 17


• A

PC P

art I

Ia

51

identification, tests, assayare carried out according to the individual monograph.


recommended designation �e designation states:• the name of the potentised substance(s),• the potentising ratio; decimal potencies may be

designated as D or DH or X,• the potency degree in the ointment,• the reference pharmacopoeia/codex.

APC Method 8.2.1 (Ointments containing powdered solid starting materials, related to HAB Method 48)Ointments containing powdered solid starting materials are produced with 1 part of a powdered metal, powdered mineral or a composition containing minerals and 9 parts of an ointment base leading to a homogeneous ointment. �is potentising step in an ointment base results in the �rst decimal dilution (D1). �e particle size of the powdered solid starting material must be smaller than 100 mm.Ointments according to APC Method 8.2.1 must meet the requirements of the Ph.Eur. monograph "Semi-solid preparations for cutaneous application" (0132).Ointments according to APC Method 8.2.1 can be used further to produce ointments according to HAB Method 13.

recommended designation Ointments according to APC Method 8.2.1 carry the desigation “APC M” and the resulting decimal dilution “D1”.

APC-Method 8.2.2 Ointments containing solid or liquid dilutionsOintments containing solid or liquid dilutions are produced with 1 part of a decimal solid or liquid dilution (Dn) and 9 parts of an ointment base leading to a homogeneous ointment. �e resulting decimal dilution degree is (Dn+1).Ointments according to APC Method 8.2.2. must meet the requirements of the Ph.Eur. monograph “Semi-solid preparations for cutaneous application” (0132).

recommended designation Ointments according to APC Method 8.2.2 carry the designation of the resulting degree of decimal dilution. Example: D3 or 3 DH or 3X APC 8.2.2.

APC Method 8.1.1 (Ph.Eur. (2371) Method 5.1.5)Co-potentised preparations according to APC Method 8.1.1 are liquid dilutions potentised with a suitable vehicle from two or more (n) preparations, each making up 1 part of the �nal 10 parts. Consequently the vehicle is 10 minus n parts.

potentisationFor the �rst co-potentisation step combine and succuss 1 part of each of the n preparations with 10 minus n parts of water or ethanol of the appropriate concen-tration speci�ed under HAB H 5.3. For each further co-potentisation step the ratio is 1 part of the given composed potency and 9 parts of vehicle.

recommended designation �e designation of co-potentised compositions according to APC Method 8.1.1 and derived dosage forms states how many potentising steps were carried out on the mixture as a whole adding the expressions “rhythmically diluted”.

APC Method 8.1.2 (related to Ph.Eur. (2371) Methods 5.1.1 and 5.1.2)

Co-potentised preparations according to APC Method 8.1.2. are liquid dilutions potentised with a suitable vehicle from two or more (n) preparations, each making up 1/n part of the �nal 10 parts. Consequently the vehicle is 9 parts.

potentisationFor the �rst co-potentisation step combine and succuss 1/n part of each of the n preparations with 9 parts of water or ethanol of the appropriate concentration speci�ed under HAB H 5.3. For each further co-poten-tisation step the ratio is 1 part of the given composed potency and 9 parts of vehicle.

recommended designation �e designation of co-potentised compositions according to APC Method 8.1.2. and derived dosage forms states how many potentising steps were carried out on the mixture as a whole.

8.2. Potentising in an ointment base

definitionLiquid and solid starting materials can be potentised within an ointment base.



• A

PC Part IIa

52

9.2. Mixtures of preparations with a vehicle9.2a. Liquid preparations produced according to Ph.Eur., HAB or APC Methods in which the vehicle is added in a ratio other than 1 to 10 or 1 to 100.9.2b. Solid preparations produced according to Ph.Eur., HAB or APC Methods in which the vehicle is added in a ratio other than 1 to 10 or 1 to 100.9.2c. Liquid and solid preparations, produced according to Ph.Eur., HAB or APC Methods, resulting in a liquid preparation, in which the vehicle is added in a ratio other than 1 to 10 or 1 to 100.9.3. Mixtures of preparations with excipients and vehicles.9.3a. Liquid preparations produced according to Ph.Eur., HAB or APC Methods with an excipient(s).Vehicles may be added.9.3b. Liquid and solid preparations, produced according to Ph.Eur., HAB or APC Methods, resulting in a liquid preparation with an excipient(s). Vehicles may be added.9.4. Mixtures of starting materials used as active substances and mother tinctures or preparations with or without vehicles and/or excipients.

recommended labelling• the ingredients mixed and their quantity,• reference pharmacopoeia/codex.

Speci�c pharmacopoeial/APC production methods to produce mixturesHAB Method 12HAB Method 16

8.3. Triturations

definitionPreparations according to APC Method 8.3 are tritura-tions of solid substances with lactose monohydrate as potentising vehicle unless otherwise speci�ed in a ratio of 1:10.

productionTriturate using a machine that ensures even trituration. Suitable machines include mixers with rhythmic, pul sating spatial inversion (e.g. “Turbula”), in combination with a sealable mixing vessel and appropriate grinding balls as well as other machines with rotating movements such as the ball mill.Triturate the whole amount of vehicle with the substance to be potentised.�e trituration time depends on the machine and the chosen parameters. Trituration must be between 15 and 60 minutes. It has to be ensured, that the trituration is homogeneous and that particle size reduction is achieved.

testsare carried out according to the individual monograph.

recommended designation Preparations according to APC Method 8.3 carry the designation of the resulting degree of decimal dilution. Example: D3 or 3 DH or 3X APC 8.3.

9. MIXTURES

definitionMixtures are produced from usually two or more active substances.Vehicles and/or excipients may be added. Mixtures contain the sum of the active substances mixed together. Mixtures can also be produced from one active substance and a vehicle. A special manufacturing method is not needed (cf. compositions). Mixtures are used to facilitate the administration of more than one active substance in one single �nished product. �e mixture itself may be the �nal dosage form.

Mixtures can be classi�ed into four categories:9.1. Mixtures of preparations without a vehicle9.1a. Mixtures of liquid preparations produced according to Ph.Eur., HAB or APC Methods.9.1b. Mixtures of solid preparations produced according to Ph.Eur., HAB or APC Methods.9.1c. Liquid and solid preparations, produced according to Ph.Eur., HAB or APC Methods, resulting in a liquid preparation.


• A

PC P

art I

Ib

53



PART IIbIndividual monographs of starting materials and preparations

Table of ContentPart IIbCYDONIA OBLONGA, FRUIT ............................ 54CYDONIA OBLONGA, FRUIT, HEAT TREATED AQUEOUS TINCTURE 1:2.1 ............ 54CYDONIA OBLONGA, FRUIT, GLYCEROL EXTRACT WITH HEAT TREATMENT 1:2.1 ..................................... 55

CYDONIA OBLONGA, FRUIT, MOTHER TINCTURE OBTAINED BY RHYTHMIC APPLICATION OF HEAT AND COLD CYDONIA OBLONGA E FRUCTIBUS FERM 33B ..................................... 56LEVICO WATER ..................................................... 57

• A

PC Part IIb

54

production�e heat treated aqueous tincture is prepared in a ratio of fresh fruits to puri�ed water 1:2.1 and by heat treatment at 65 – 70°C as follows:

�e whole fresh ripe fruit are cut into pieces (2 – 4 cm). To 1 part of the cut fruit add 2.1 parts of puri�ed water and mix thoroughly. Heat to 65 – 70°C in a closed container and keep at this temperature for one hour swirling repeatedly. A�er cooling to 40 – 45°C separate by straining the mixture through gauze, �lter the resulting liquid and process immediately.

charactersAppearance: light yellow, slightly turbid liquid.Odour: fruity.

identification�in-layer chromatography (Ph.Eur. 2.2.27).

Test solution. Apply 10 mL onto a cartridge �lled with octadecylsilylated silica gel RH (particle size 55 – 110 µm, 360 mg), preconditioned sequentially with 10 mL of methanol R and 10 mL of water R. Wash the cartridge with 10 mL of water R. Elute with 10 mL of methanol R. Evaporate the eluate to dryness under reduced pressure. Dissolve the residue in 1 mL of methanol R.

Reference solution. Dissolve 5 mg of rutin R, 5 mg of hyperoside R and 5 mg of scopoletin R in 10 mL of methanol R.

Plate: TLC silica gel plate R.

Mobile phase: anhydrous formic acid R, water R, ethyl acetate R (15:15:70 V/V/V).

Application: 20 µL as bands.

Development: over a path of 10 cm.

Drying: at 105 °C for 5 min.

Detection: spray the plate while still warm with a 10 g/L solution of diphenylboric acid aminoethyl ester R in methanol R. Subsequently spray with a 50 mL/L solu-tion of macrogol 400 R. Examine in ultraviolet light at 365 nm within 30 min.

Results: see below the sequence of the zones present in the chromatograms obtained with the reference solution and the test solution. Other faint zones may be present in the chromatogram obtained with the test solution.

CYDONIA OBLONGA, FRUITCydonia oblonga, FructusCydonia

definitionFresh, ripe fruit of Cydonia oblonga Mill. collected during late summer and autumn.

characters�e odour is characterised by a typical �owery scent.

identification�e pear-shaped variety (var. pyriformis) is yellow, fragrant, fuzzy, 7 – 15 cm in diameter. �e gentle so� pulp is golden yellow.�e apple-shaped variety (var. maliformis) is yellow to greenish yellow, fuzzy, 7-15 cm in diameter and less fragrant. �e pulp is characterised by stone cells.Both varieties obtain �ve oblong-ovate sepals with serrate margins which are located in a depression. �ey are completely adnate with the 5 carpels. �e 5 loculi of the core generally each contain 5 to 15 or sometimes more brown, cuneate seeds arranged in 2 vertical rows and stuck together with a mucilaginous coat.

testsForeign matter (Ph.Eur. 2.8.2).As low as possible. �e whole batch is checked during manufacture. Foreign matter is sorted out.

Adulteration.Fruits from Japanese quince [Choenomeles japonica (�unb.) Lindl. ex Spach, syn. Cydonia japonica Pers., Rosaceae] and Chinese quince [Choenomeles speciosa (Sweet) Nakai, Rosaceae] are 4 to 5 cm in diameter with a smooth peel and being devoid of stone cells.

preparations1. Heat treated aqueous preparation according to the individual monograph,2. Heat treated preparation with glycerol according to the individual monograph,3. Tincture obtained by rhythmic application of heat and cold according to APC method 3.13 and method HAB 33b.

CYDONIA OBLONGA, FRUIT, HEAT TREATED AQUEOUS TINCTURE 1:2.1

definition�e heat treated aqueous tincture is prepared from the fresh cut fruit of Cydonia oblonga Mill., see Cydonia oblonga, Fruit (Cydonia oblonga, Fructus; Cydonia) APC


• A

PC P

art I

Ib

55


charactersAppearance: light yellow, slightly turbid, viscous liquid.Odour: fruity.

identification�in-layer chromatography (Ph.Eur. 2.2.27).

Test solution. To 5 mL add 15 mL of water R. Apply the mixture onto a cartridge �lled with octadecylsi-lylated silica gel RH (particle size 55 – 110 µm, 360 mg), preconditioned sequentially with 10 mL of methanol R and 10 mL of water R. Wash the cartridge with 10 mL of water R. Elute with 10 mL of methanol R. Evaporate the eluate to dryness under reduced pressure. Dissolve the residue in 0.5 mL of methanol R.

Reference solution. Dissolve 10 mg of rutin R, 10 mg of hyperoside R and 2 mg of scopoletin R in 10 mL of methanol R.


Mobile phase: anhydrous formic acid R, water R, ethylacetate R (15:15:70 V/V/V).

Application: 20 µL as bands.


Drying: at 105 °C for 5 min.

Detection: spray the plate while still warm with a 10 g/L solution of diphenylboric acid aminoethyl ester R in methanol R. Subsequently spray with a 50 mL/L solution of macrogol 400 R. Examine in ultraviolet light at 365 nm within 30 min.

Results: see below the sequence of the zones present in the chromatograms obtained with the reference solution and the test solution. Other faint zones may be present in the chromatogram obtained with the test solution.

Top of the plate

Scopoletin: a blue zone A blue zone

A blue zone

__________________ __________________

Hyperoside: an orange zone

A strong light blue zone

Rutin: an orange zone An orange zone

__________________ __________________

Reference solution Test solution

testsRelative density (Ph.Eur. 2.2.5): 1.002 to 1.022.pH (Ph.Eur. 2.2.3): 3.0 to 4.0.Dry residue (Ph.Eur. 2.8.16): min. 2.5 % (3 g initial weight and dry at 105 °C for 2 hours).

storageIf stored it must meet the requirements of sterility, store in well closed containers, protected from light.

CYDONIA OBLONGA, FRUIT, GLYCEROL EXTRACT WITH HEAT TREATMENT 1:2.1

definition�e glycerol extract with heat treatment is prepared from the fresh cut fruit of Cydonia oblonga Mill., see Cydonia oblonga, Fruit (Cydonia oblonga, Fructus; Cydonia) APC.

production�e glycerol extract with heat treatment is prepared in a ratio of fresh fruits to glycerol (85 per cent) 1:2.1 and by heat treatment at 65 – 70 C as follows:

�e whole fresh ripe fruit are cut into pieces (2 – 4 cm). To 1 part of the cut fruit add 2.1 parts of glycerol (85 per cent) and mix thoroughly. Heat to 60 – 70°C in a closed container and keep at this temperature for one hour swirling repeatedly. A�er cooling to 40 – 45°C separate the mixture by straining through gauze, then �lter if necessary.

• A

PC Part IIb

56

Test solution. Apply 2 mL of the tincture onto a cartridge �lled with octadecylsilylated silica gel RH (sorbens mass 500 mg, 3 mL reservoir) preconditioned sequen-tially with 2 mL of methanol R and 2 mL of water R. Wash the cartridge with 10 mL of water R. Elute with 10 mL of ether R. �e eluate is evaporated to dryness. Dissolve the residue in 0.5 mL of methanol R.

Reference solution. Dissolve 10 mg of ca�eic acid R and 10 mg of hyperoside R in 10 mL of methanol R.


Mobile phase: anhydrous formic acid R, water R, ethyl acetate R (10:10:80 V/V/V).

Application: 60 µL of test solution and 10 µL of reference solution, as bands.


Drying: in air.

Detection: spray with a 10 g/L solution of diphenylboric acid aminoethyl ester R in methanol R. Subsequently spray with a 50 g/L solution of macrogol 400 R in methanol R. Examine in ultraviolet light at 365 nm a�er 30 min.

Results: See below the sequence of the zones present in the chromatograms obtained with the reference solution and the test solution. Other faint zones may be present in the chromatogram obtained with the test solution.

Top of the plate

Scopoletin: a blue zone A blue zone

A blue zone

__________________ __________________

Hyperoside: an orange zone

A strong light blue zone

Rutin: an orange zone An orange zone

__________________ __________________


testsRelative density (Ph.Eur. 2.2.5): 1.170 to 1.185.pH (Ph.Eur. 2.2.3): 3.5 to 5.0.

storageProtected from light.

CYDONIA OBLONGA, FRUIT, MOTHER TINCTURE OBTAINED BY RHYTHMIC APPLICATION OF HEAT AND COLD CYDONIA OBLONGA E FRUCTIBUS FERM 33B

definition�e tincture obtained by rhythmic application of heat and cold is prepared from the fresh minced fruit of Cydonia oblonga Mill., see Cydonia oblonga, Fruit (Cydonia oblonga, Fructus; Cydonia) APC.

production�e tincture obtained by rhythmic application of heat and cold is prepared according to HAB method 33b (APC method 3.13).

charactersAppearance: slightly yellow liquid.Odour: sour, fruity.

identification�in-layer chromatography (Ph.Eur. 2.2.27)


• A

PC P

art I

Ib

57


LEVICO WATER

Aqua LeviciLevico

definitionNaturally occurring spring water from the source Levico (Italy).Content:• Arsenic: 4 – 8 ppm• Iron: 1000 – 2500 ppm

charactersAppearance: colourless to yellowish-brown liquid, usually clear, a slight sediment may occur.Odour: almost odourless.

identificationA. Identi�cation of arsenic by atomic absorption spectrometry (Ph.Eur. 2.2.23), see Assay.Results: the absorbance obtained with the test solution is not below the absorbance obtained with the reference solution with the lowest concentration.B. Identi�cation of iron by atomic absorption spectrometry (Ph.Eur. 2.2.23), see Assay.Results: the absorbance obtained with the test solution is not below the absorbance obtained with the reference solution with the lowest concentration.C. Identi�cation of copper by atomic absorption spectrometry (Ph.Eur. 2.2.23, Method I).Test solution. To 1.0 mL add 0.200 mL nitric acid R and dilute to 10.0 mL with water R.Reference solution. Prepare the reference solutions (0.5, 1.0, 2.0 and 4.0 ppm Cu) using copper standard solution R, diluted as necessary with a 5 per cent (V/V) solution of nitric acid R. Alternatively, commercially available copper standard solutions for atomic absorption spectrometry can be used.Source: copper hollow-cathode lamp using a transmis-sion band preferably of 0.5 nm.Wavelength: 324.8 nm.Flame: air-acetylene.Results: the absorbance obtained with the test solution is not below the absorbance obtained with the reference solution with the lowest concentration.D. To 0.5 mL add 4.5 mL of water R. �e solution gives reaction a on sulfates (Ph.Eur. 2.3.1).

testsRelative density (Ph.Eur. 2.2.5): 1.004 to 1.015.pH (Ph.Eur. 2.2.3): 1.5 to 2.5.

assayArsenic: 4 ppm to 8 ppm.

Top of the plate

Ca�eic acid: a light blue zone A light blue zone

__________________ __________________

Hyperoside: an orange yellow zone A light blue zone

__________________ __________________


testsRelative density (Ph.Eur. 2.2.5): 1.001 to 1.013.Dry residue (based on Ph.Eur. 2.2.32 d): minimum 1.0 per cent, determined on 1.000 g of mother tincture by drying for 4 to 5 hours at 105 °C.Calculate the dry residue (per cent m/m) from the expression:

∙ 100(m3 - m1)m2∙

m1 = mass of the crucible used, in grams;m2 = mass of the mother tincture used, in grams;m3 = mass of the crucible containing the mother tincture a�er drying, in grams.pH (Ph.Eur. 2.2.3): 3.0 to 4.2.

storageIn a well closed container at a temperature of max 15 °C.

• A

PC Part IIb

58

preparationsAccording to Ph.Eur., monograph 2371 Methods3.1.1, 3.1.2.

Atomic absorption spectrometry (Ph.Eur. 2.2.23, Method I).Test solution. To 0.200 mL add 2.00 mL nitric acid R and dilute to 100 mL with water R.Reference solutions. Prepare the reference solutions (5.0, 10.0, 15.0 and 20.0 ppb As) using arsenic standard solution R, diluted as necessary with a 5 per cent (V/V) solution of nitric acid R. Alternatively, commercially available arsenic standard solutions for atomic absorp-tion spectrometry can be used.Source: arsenic hollow-cathode lamp using a trans-mission band preferably of 0.5 nm.Wavelength: 193.7 nm.Atomisation device: graphite furnace.Calculate the content of arsenic in mg/kg from the expression:

X [ppm] = ( ) /1000A1 ∙ F1

F2∙

A1: measured concentration of arsenic in µg/LF1: 100 mL (dilution factor) F2: 0.200 mL

Iron: 1000 ppm to 2500 ppm.Atomic absorption spectrometry (Ph.Eur. 2.2.23, Method I).Test solution. To 0.500 mL add 2.00 mL nitric acid R and dilute to 100 mL with water R.Reference solutions. Prepare the reference solutions (5.0, 10.0, 15.0 and 20.0 ppm Fe) using iron standard solution R, diluted as necessary with a 5 per cent (V/V) solution of nitric acid R. Alternatively, commercially available iron standard solutions for atomic absorption spectrometry can be used.Source: iron hollow-cathode lamp using a transmission band preferably of 0.2 nm.Wavelength: 372.0 nm. Flame: air-acetylene.Calculate the content of iron in mg/kg from the expression:

X [ppm] = A2 ∙ F1

F2∙

A2: measured concentration of iron in mg/LF1: 100 mL (dilution factor) F2: 0.500 mL



• A

PC P

art I

II

59



PART IIIDosage forms

Table of ContentPart IIIDosage forms ............................................................ 60 Index list of terms of part I, II and III .................... 63

• A

PC Part III

60

Dosage formsPrincipally an anthroposophic medicinal product can be administered in every dosage form, including ex-ternal (topical), internal and parenteral dosage forms, with or without excipients.A dosage form of an anthroposophic medicinal product complies with any relevant dosage form monograph

Main dosage forms for oral use Relevant monograph(s) in (Monograph number):

Standard term Traditional name

Capsules Capsules Ph.Eur. (0016)

Granules Granules Ph.Eur. (0499)

Homoeopathic Pillules, coated

Globuli velati Ph.Eur. (1038, 2786 Dra�), HAB Method 39

Homoeopathic Pillules, impregnated

Pillules Ph.Eur. (1038, 2079), HAB Method 10

Tablets Tablets Ph.Eur. (1038, 0478), HAB Method 9

Powders, oral Trituration Ph.Eur. (1165)

Oral drops Oral drops Ph.Eur. (0672)

Syrups Syrups Ph.Eur. (0672)

Oral solution Mother tincture, Dilution

Ph.Eur. (0672)

Main dosage forms for cutaneous use Relevant monograph(s) in (Monograph number):


Creams Creams Ph.Eur. (0132)

Ointments Ointments Ph.Eur. (0132), HAB Methods 13 and 48

Gels Gels Ph.Eur. (0132), HAB Method 13

Lotions Lotions B.P., Ph.Eur. (0927)

Oils Oils HAB Methods 12, Ph.Eur. (0927)

and any relevant test for that dosage form as described in the European Pharmacopoeia or in pharmacopoeias currently used o�cially in the EU Member States.

Main dosage forms for anthroposophic medicinal products and concerning references to o�cial pharmacopoeias:


• A

PC P

art I

II

61


Main dosage forms for cutaneous use Relevant monograph(s) in (Monograph number):

Liquid preparations (other)

Tinctures for external use, external emulsions, suspensions

Ph.Eur. (0927), HAB Methods 12

Powders Powders Ph.Eur. (1166)

Main dosage forms for auricular use Relevant monograph(s) in (Monograph number):


Ear drops Ear drops Ph.Eur. (0652)

Main dosage forms for ophthalmic use Relevant monograph(s) in (Monograph number):


Eye drops Eye drops Ph.Eur. (1163), HAB Method 15

Semi-solid eye preparations

Eye ointments Ph.Eur. (1163)

Main dosage forms for nasal use Relevant monograph(s) in (Monograph number):


Nasal drops, solution Nasal drops Ph.Eur. (0676), HAB Method 45

Nasal spray, solution Nasal spray Ph.Eur. (0676)

Main dosage forms for oromucosal use Relevant monograph(s) in (Monograph number):


Gels Gels Ph.Eur. (1807)

Solutions Solutions Ph.Eur. (1807)

Sprays Sprays Ph.Eur. (1807)

Pillules Pillules Ph.Eur. (1038, 2079, 2786 Dra�), HAB Methods 10 and 39

• A

PC Part III

62

Main dosage forms for vaginal use Relevant monograph(s) in (Monograph number):


Gels Gels Ph.Eur. (1164)

Semi-solid vaginal preparations

Globules Ph.Eur. (1164)

Vaginal tablets Vagitories Ph.Eur. (1164)

Main dosage forms for rectal use Relevant monograph(s) in (Monograph number):


Suppositories Suppositories Ph.Eur. (1145), HAB Method 14

Main dosage forms for parenteral use Relevant monograph(s) in (Monograph number):


Injections Liquid dilutions for injection, ampoules, Solutions for injection

Ph.Eur. (0520), HAB Method 11

APC Pillules containing lactose (related to HAB Method 10)APC Pillules containing lactose are pillules made by applying one or more potentised liquid preparations to saccharose pillules, which may contain up to 5 per cent of lactose. �e potentising ratio usually is 1:100 (v/m or m/m). �e ethanol concentration of the potentised liquid preparation(s) is at least 60 per cent (m/m). If this is not the case and interactions are excluded, the last potentisation step for decimal potentised prepa-rations must be carried out with ethanol of at least 62 per cent (m/m). In case incompatibilities are expected, use ethanol of lower concentration.Preformed pillule sizes Ph.Eur. 3 and 6:Ph.Eur. size 3: 110 to 130 pillules weigh 1 gPh.Eur. size 6: 20 to 28 pillules weigh 1 g.Dry the pillules a�er impregnation in air.

recommended designation the designation states:the amount of potentised preparation(s),the potency degree,the potentising ratio in case other than 1:100.


• In

dex

63


Cissus-Ossa 49Cold maceration 24Compositions 18, 20, 22, 27, 36, 46, 47, 48, 49, 50, 51, 52Composting process 28Contaminants 21Co-potentisation 50, 51Co-potentising 25, 49, 50Council Directive (EEC) 21Creams 60Crystal 21Cuprum mirror foil 29Cutaneous application 51Cydonia oblonga 2, 8, 40, 54, 55, 56

DDAB 17DAC 17Demeter 21, 22Digestion 24, 26, 36, 37Directive 2001/83/EEC 11Distillate 40, 41 Distillation 20, 21, 24, 26, 29, 30, 40, 41Distillation products 20, 21Dornach 11, 20, 22Dosage forms 6, 12, 16, 18, 20, 22, 35, 41, 50, 51, 60, 61, 62

EEar drops 61ECHAMP 7Equisetum arvense Silicea cultum 28ESCAMP 6Essential oils 20, 21European Pharmacopoeia 2, 11, 12, 13, 17, 20, 22, 60Excipient 16, 18, 22, 45, 46, 50, 52, 60Extracts

13, 20, 21, 26, 27, 30, 32, 34, 35, 37, 40, 44, 45, 47, 48, 49Eye drops 50, 61

FFarmantropo 3Ferm 2, 36, 42, 47, 56Fermentation 30, 36, 41, 42, 47Fermented tinctures 26Ferrum-Quarz 18, 46Flowers 21, 24, 28French Pharmacopoeia 12, 17Fungi 20, 21

GGAPiD 3Gels 60, 61, 62German Homoeopathic Pharmacopoeia 11, 12, 17German Pharmacopoeia 12, 17GHP 17Glossary 18Glycerol macerates 26, 30, 32, 33Granules 60Growing season 28

INDEX LIST OF TERMS OF PART I, II AND III

AAbbreviations, list of 17Active substances 11, 16, 18, 20, 22, 25, 46, 50, 52AFERPA 3Agate water 21Algae 20, 21Animal matter 31, 32, 33, 34, 43, 44Animal origin 22, 32Anis-Pyrit 46Anode 30Anthroposophic medicinal products

11, 12, 16, 20, 22, 26, 27, 60Anthroposophic Pharmaceutical Codex

2, 11, 12, 16, 17, 20Anthroposophic pharmacy

2, 3, 11, 12, 16, 18, 20, 24, 25, 28Anthroposophic preparations 2, 12, 16, 18APC 17APC committee 2, 3, 11Aqua maris 21Argentum metallicum praeparatum 29Argon 30Ascorbate phosphate bu�er solution 35Ash process 24Astronomical aspects 25, 50Austrian Pharmacopoeia 12

BBAAP 3Bark 21, 24Biennial 21, 28Biodoron 22Biodynamic cultivation 21Blood products 20, 21BNVAA 3Botanical origin, starting materials of 20, 21Brazilian Pharmacopoeia 13British Homoeopathic Pharmacopoeia 12, 13, 17British Pharmacopoeia 12, 17

CCalcareous products 20, 21Capsules 60Carbo 27, 43, 44Carbo Gentianae 44Carbonisation 24Carbons 27, 43, 44Cathode 30, 57, 58Chemical vapour decomposition 17, 29, 30Cinis 27, 43, 44, 49Cinis e fructibus Avenae sativae

cum Magnesio phosphorico 49Cinis Tabaci 44

• Index

64


HHeat treatment 2, 26, 30, 36, 39, 40, 43, 46, 53, 55Hepar-Magnesium 46Hepar sulfuris 46Herbal Medicinal Products 11, 17Homoeopathic stocks 11, 12, 17Homoeopathic manufacturing method 11Homoeopathic manufacturing procedure 11, 12Homoeopathic preparations 12, 13, 17HPUS 16, 17

IIAAP 2, 12, 13, 17, 20, 25Infusion 24, 26, 37, 38Infusum 26, 37, 38Injections 8, 30, 42, 48, 50, 62Isotonic solution 22, 30, 48, 50IVAA 5, 17, 25

JJuices 20, 21, 27, 37, 44, 45

KKalium aceticum comp. 46KC Monograph 17Kohlhase, Manfred 3, 22Kommission C 17

LLactobacillus plantarum suspension 48Leaves and shoots 21Levico 2, 21, 57Lichens 20, 21Life cycle 28Liquid dilutions 27, 35, 46, 51, 62Liquid potencies 25, 49, 50Liquid preparations 26, 30, 33, 34, 47, 48, 52, 61, 62Liquid solutions 46Lotions 60Lunar eclipse 25, 50

MMaceration 24, 26, 30, 31, 32, 33, 34, 39Magnetrom 30Medicinal Products Act 12Metabolic system 24, 25Metallicum praeparatum 29Metal mirrors 26, 29, 30Metal plant-compost 28Metal preparations 26, 29Metal salts 29Metal vapour 30Minerals 20, 21, 28, 41, 51Mineral substances 28Miner, Carl S. 32Mixtures 18, 22, 27, 30, 50, 52Mother tinctures 13, 17, 21, 22, 26, 30, 31,

32, 34, 35, 36, 37, 38, 39, 41, 42, 43, 47, 48, 49, 50, 52

NNasal drops 61Nasal spray 8, 61Nitrogen 35

OÖGAPh 3Oils 30, 50, 60

see also Vegetable oilsOintments 51, 60Oleoresins 20, 21Oral drops 60Oral solution 60Organs 20, 21

PParenteral preparations 22, 50Percolate 34Percolation 26, 34Perennial plants 26, 34Petioles 28Pharmaceutical process

16, 18, 20, 22, 24, 25, 29, 30, 36, 46, 47, 49Pharmaceutical quality 12Pharmacopoea Helvetica 17Pharmacopoeia 2, 11, 12, 13, 16, 17, 18, 20, 22, 24, 28, 29,

30, 31, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 49, 50, 51, 52, 60 see also Austrian Pharmacopoeia see also British Pharmacopoeia see also British Homoeopathic Pharmacopoeia see also Brazilian Pharmacopoeia see also European Pharmacopoeia see also French Pharmacopoeia see also German Pharmacopoeia see also German Homoeopathic Pharmacopoeia see also Swiss Pharmacopoeia

Ph.Helv. 12, 17, 26, 27Pillules 60, 61, 62Plant secretions 20, 21Plumbum mellitum 46Potentised preparation 22, 25, 27, 49, 50, 51, 62Powders 44, 60, 61Preparations 18, 22, 24

QQuartz 29

RRaw materials 18, 26, 28, 44Rh 17, 42, 43Rhythmically diluted 51Rhythmic application 2, 27, 30, 41, 42, 54, 56Rhythmic procedure 17Rhythmic processing 24Rhythmic succussion 25, 49, 50Rhythmic system 24, 25Rocks 20, 21Rotating disk 48

• In

dex

65


SSchmiedel, Oskar 11Semi-solid vaginal preparations 62Silica 29, 54, 55, 56Silicium 29SOFAI 3Solar or lunar eclipse 25, 50Solid or semi-solid potencies 25, 49, 50Solid preparations from plants 27, 44Solid starting materials obtained by heat 27, 43Solutions 45, 50, 57, 58, 61, 62Solutio Sacchari comp. 46Sprays 61Sputtering 29, 30Starting materials 2, 12, 16, 18, 20, 21, 22, 24, 27, 30, 31, 32,

33, 34, 35, 36, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 51, 52Steiner, Rudolf 11, 20Summer extract 47, 48Suppositories 62Swissmedic 11, 17, 18Swiss Pharmacopoeia 2, 3, 17, 18Syrups 60

TTabacum Cupro cultum 28Tablets 60, 62�uja 28Tincture 2, 13, 17, 25, 26, 28, 30, 31, 32, 36, 37, 38,

39, 45, 47, 54, 56, 61 see also Fermented tincture see also Mother tincture

Toasted preparations 27, 43Toasting 24, 43Tosta 27, 43Trituration 25, 48, 49, 50, 52, 60

VVAEPS 3Vaginal tablets 62Vapour decomposition 29, 30Vegetabilisation 22, 26, 28, 29Vegetabilised metals 28Vegetable oils 50 Vegetation period 28Vehicle 16, 18, 22, 25, 27, 30, 43, 44, 45, 46, 50, 51, 52 Viscous extracts 26, 30, 40

WWaters, natural 20, 21Wegman, Ita 11, 20

ZZoological origin, starting materials of

20, 21, 22, 30, 31, 32, 33, 43



PART IVAppendices

• Appendix

66

Table of ContentPart IVNote concerning appendix 2.3. ......................................67References concerning nomenclature in appendices 2.1. to 2.6. .................................................67Note concerning the references for usage in anthro-posophic medicine in appendices 2.1. to 2.6. ...............67References concerning usage in anthroposophic medicine in appendices 2.1. to 2.6. ...............................68IVAA statement concerning starting materials of animal origin not yet mentioned in published anthroposophic medical literature or in published o�cial regulatory documents concerning anthroposophic medicinal products .............................69

Appendix 2.1. List of minerals, rocks and natural waters ....................75Appendix 2.2. List of starting materials of botanical origin ................85

Appendix 2.3. List of starting materials of zoological origin ............127Appendix 2.4. List of starting materials that can be described chemically .....................................................153Appendix 2.5. List of starting materials that have undergone special treatment ............................................................165Appendix 2.6. List of compositions ......................................................169

Appendix II .....................................................................181

Correlation table: Ph.Eur. / HAB manufacturing meth-ods used in anthroposophic pharmacy and correspond-ing manufacturing methods in the HPUS ..................181


• Ap

pend

ix

67

Jäger EJ (Hrsg.).In: Rothmaler W. Exkursions�ora von Deutschland. Heidelberg: Springer Spektrum; 2011.

Schindler H, Helma F. Tiere in der Pharmazie und Medizin. Stuttgart: Hippokrates-Verlag; 1961.

Schmeil O, Fitschen J. Flora von Deutschland und angrenzender Länder. Heidelberg: Quelle & Meyer Verlag; 2006.

Schweingruber FH. Anatomie europäischer Hölzer. Bern/ Stuttgart: Haupt; 1990

Bresinsky A, Körner C, Kadereit JW, Neuhaus G, Sonnewald U. Strasburger Lehrbuch der Botanik. Heidelberg: Springer Spektrum; 2008.

Teuscher E. Biogene Arzneimittel.Stuttgart: Wissenscha�liche Verlagsgesellscha� mbH; 1997.

Note concerning the references for usage in anthro-posophic medicine in appendices 2.1. to 2.6.�e references given in the columns to the right in the appendices 2.1 to 2.6 aim to provide evidence, that the particular starting material is known and has been part of the medicinal tradition in anthroposophic medicine.

Where available, the monographs of the Commission C for medicinal products for human use dealing with the anthroposophic therapeutic direction (accord-ing to §25 of the German Drug Law) published in the German Federal Gazette (Bundesanzeiger) have been referred to. Where more than one monograph could be referred to, only one has been included. Not all starting materials are mentioned in the Commission C mono-graphs, because on the one hand its work stopped in 1994 a�er the 5th amendment of the German Drug law prior to completion work. On the other hand a number of starting materials in the lists are only known in the anthroposophic medicine tradition in countries other than Germany. �e Commission C monographs also refer to speci�c and composed active substances as well as existing pharmaceutical products. A number of references from other sources may refer generically to particular raw or starting materials, sometimes without linking to speci�c active substances. �e latter refer-ences show that the raw or starting material has been considered in therapeutic and pharmaceutical grounds in anthroposophic medicine. �ey may however also refer to speci�c active substances.

Note concerning appendix 2.3.Animal substances marked with “*” belong to cat-egory A materials according to “Note for guidance on minimising the risk of transmitting animal spongi-form encephalopathy agents via human and veteri-nary medicinal products” if sourced e.g. from cattle Bos taurus L. �ough sourcing from animals below 6 months of age from herds not fed with meat bone meal has been practice up to now in the �eld of concerning anthroposophic quality management, pharmaceutical manufacturers must continuously adapt their sourcing to the requirements of the Note for guidance, such as changing the donor animal. �e APC Committee needs to re�ect the existing practice and will adapt to imple-mented changes.

References concerning nomenclature in appendices 2.1. to 2.6.Bertsch K. Flora von Südwest-Deutschland. Stuttgart: Wissenscha�liche Verlagsgesellscha� mbH; 1962.

Chmelar J, Meusel W. Die Weiden Europas. Wittenberg Lutherstadt: Ziemsen-Verlag; 2004.

Erhardt W, Götz E, Bödeker N, Seybold S. Zander: Handwörterbuch der P�anzennamen. Stuttgart: Eugen Ulmer; 2008.

HagerROM 2006. Hagers Handbuch der Drogen und Arzneisto�e. Heidelberg: Springer Medizin Verlag; 2006.

Harms H. Die Mistel und ihre Verbreitung in Ostwestfalen. Mitt. Dt. Dendrologischen Gesellscha�; 1973.

Hartmann �. Anatomische und morphologische Untersuchungen zum Wechselverhältnis von Mistelp�anzen und ihren Wirtsgehölzen am Beispiel der Tannenmistel und der Kiefermistel. [Dissertation]. Technische Universität Berlin; 1994.

Moberg R, Holmasen I. Flechten von Nord- und Mitteleuropa. Ein Bestimmungsbuch. Stuttgart: Gustav Fischer; 1992.

Roberts WL, Rapp GR Jr, Weber J. Encyclopedia of Minerals. New York: Van Nostrand; 1974.


• Appendix

68

International Federation of Anthroposophic Medical Associations, IVAA. Statement concerning starting materials of animal origin not yet mentioned in published anthroposophic medical literature or in published o�cial regulatory documents concerning anthroposophic medicinal products. Brussels: printed in APC Appendix I; 2013.

Monographs of the Commission C for medicinal prod-ucts for human use dealing with the anthroposophic therapeutic direction (according to §25 of the German Drug Law) published in the German Federal Gazette (Bundesanzeiger). Publication as compilation: An-throposophische Arzneimittel, Au�ereitungsmonog-raphien der Kommission C, published by Gesellscha� Anthroposophischer Ärzte in Deutschland e.V. (Soci-ety of anthroposophic doctors in Germany registered association) on behalf of the Medical Section at the Goetheanum, Dornach/ Switzerland; 1999.

Gesellscha� Anthroposophischer Ärzte in Deutschland e.V. and Medizinische Sektion der Freien Hochschule für Geisteswissenscha� Dornach. Vademecum An-throposophische Arzneimittel. Filderstadt (Germany); 2011; 3rd edition 2013.

Where there is no reference, the particular starting material has not yet been presented or discussed in publications. However anthroposophic pharmaceutical manufacturers place medicinal products on the market obtained from those starting materials. �e IAAP sees it as its task to promote the writing of publications, to support the relevance of the starting material in anthro-posophic medicine. Much work still needs to be done.

References concerning the use in anthroposophic medicine in appendices 2.1. to 2.6.Der Merkurstab (Zeitschri� für anthroposophische Medizin – Journal of Anthroposophic Medicine). Filderstadt: Gesellscha� Anthroposophischer Ärzte in Deutschland (Society of anthroposophic doctors in Germany).

Gardin N Schleier R. Vademecum, medicamentos antroposo�cos. São Paulo-SP: João de Barra Editora Ltda; 2009. Portugese.

Glöckler M. Anthroposophische Arzneitherapie (Anthroposophic �erapy with Medicinal Products). Stuttgart: Publisher Wissenscha�liche Verlagsgesell-scha�; 2010.


• Ap

pend

ix

69

Statement concerning starting materials of animal origin not yet mentioned in published anthroposophic medical literature or in published o�cial regulatory documents concerning anthroposophic medicinal products

Anthroposophic medicinal products containing preparations from starting materials of animal origin belong to the range of anthroposophic therapeutics.1

Most of these starting materials and/or the anthroposophic medicinal products concerned are mentioned in anthroposophic medical literature or in o�cial regulatory documents. A certain number of these however are not mentioned in such references, although belonging to the range of anthroposophically used starting materials of animal origin. �e anthroposophic medicinal products concerned are available to doctors.2

�is statement con�rms the anthroposophic therapeutic usage and relevance of these starting ma-terials.3

�e starting materials of animal origin are listed on the following papers.4

For the IVAA

Dr. Peter ZimmermannDr. Andreas Arendt

15.02.2013

1 Girke M. Innere Medizin. 2. edition. Berlin: Salumed Verlag; 2012.2 Jütte R. Organpräparate in der Geschichte der „Schulmedizin“, der Homöopathie und der Anthroposophischen Medizin. Der Merkurstab 2009; 1: 49–60.3 Roemer F. Sommer M. Zur Bedeutung der potenzierten Organpräparate in der anthroposophischen �erapierichtung. Der Merkurstab 1998; Sonderhe� Organpräparate.4 Gesellscha� Anthroposophischer Ärzte in Deutschland e.V. and Medizinische Sektion der Freien Hochschule für Geistes-wissenscha� Dornach. Vademecum Anthroposophische Arzneimittel. 2. edition. Filderstadt (Germany); 2011.


• Appendix

70

Scientific name Scientific name of the animal

Abbreviated definition

Aorta Oryctolagus cuniculus L.

Aorta from the rabbit

Aranea avicularis Avicularia avicularia L Whole bird spiderArteria basilaris Bos taurus L. Arteria basilaris from the calfArteria brachialis Bos taurus L. Arteria brachialis from the calfArteria coeliaca see Truncus coeliacusArteria pulmonalis Bos taurus L. Arteria pulmonalis from the calfArteria renalis Bos taurus L. Arteria renalis from the calfArticulatio cubiti Bos taurus L. Elbow joint with parts from the bones that form the joint, joint

cartilage, parts of joint capsule, synovia and parts of the liga-ments from the calf

Articulatio radio-carpea

Bos taurus L. Radiocarpal joint with parts of the bones, cartilage, ligaments and joint capsule that form the proximal carpal joint from the calf

Articulatio tem-poromandibularis

Bos taurus L. Parts of the os mandibulare and of the os temporale in the joint area, of the joint capsule, of the ligaments, of cartilage, as well as synovia from the calf

Articulationes inter-carpeae

Bos taurus L. Parts of the bones forming the joint, of the cartilage like surface of the articulation, as well as synovia from the calf

Articulationes intervertebrales cervicales

Bos taurus L. Region of the cervix: Parts of the bone process that participate to the intervertebral joints, cartilage and joint capsules, as well as synovia from the calf

Articulationes inter-vertebrales lumbales

Bos taurus L. Region of the loin: Parts of the bone process that participate to the intervertebral joints, cartilage and joint capsules, as well as synovia from the calf

Asterias rubens Asterias rubens L. �e whole star�sh Atlas Bos taurus L. Parts of the Atlas (1. cervical) from the calfAxis Bos taurus L. Parts of the Axis (2. cervical) from the calfBlatta orientalis Blatta orientalis L �e whole fresh or dried animalCartilago articularis coxae

Bos taurus L. Cartilage of the hip joint from the calf

Cervix uteri Bos taurus L. Parts of the neck of the womb from the cowCirculus arteriosus cerebri

Bos taurus L. Circulus arteriosus cerebri of the pituitary sha� from the calf

Coccus cacti Dactylopius coccus Costa

�e dried, fertilized, female of Dactylopius coccus Costa

Columna anterior Bos taurus L. Parts of the columna anterior of the spinal chord from the calf

Columna posterior Bos taurus L. Parts of the columna posterior of di�erent parts of the spinal chord from the calf

Cornu Caprae ibecis Capra ibex L. Horn from the ibex




Dactylopius coccus see Coccus cactiDens Bos taurus L. Teeth from the calfDiencephalon Bos taurus L. Diencephalon from the calfDuctus deferens Bos taurus L. Ductus deferens from the calfDura mater en-cephali

Bos taurus L. Dura mater encephali from the calf

Elaps Micrurus corallinus Merrem

Poison from Micrurus corallinus Merrem

Endocardium Bos taurus L. Endocardium from the calfEpididymis Bos taurus L. Le� epididymis from the bullErytrocytes Equus przewalskii f.

caballus PoliakovErythrocytes from the blood of the horse

Favus Apis mellifera L. Honey combs with pollenFolliculi lymphatici aggregati

Sus scrofa domestica L. Parts of Peyers’s patch of the small intestine from the pig

Galea aponeurotica Bos taurus L. Parts of the super�cial fascia of the forehead from the calf Glandula parotis Bos taurus L. Glandular tissue of the body of the parotid gland

from the calfGlandula suprarena-lis (Cortex)

Bos taurus L. Glandula suprarenalis (cortex) from the calf

Glandula suprarena-lis (Medulla)

Bos taurus L. Medulla glandulae suprarenalis of both adrenal glands from the calf

Glucogenum Oryctolagus cuniculus L.

Glycogen from the rabbit liver

Gyrus cinguli Bos taurus L. Gyrus cinguli from the calfHepar Oryctolagus cuniculus

L.Liver from the rabbit

Jejunum Sus scrofa domestica L. Jejunum from the pigKeratinum Equi Equus przewalskii f.

caballus PoliakovHoof from the horse

Lac vaccae Bos taurus L. Fresh cow’s milkLigamentum longi-tudinale anterius

Bos taurus L. Parts of the ligamentum longitudinale anterius of thoracic and lumbar regions of the spine from the calf

Lingua Bos taurus L. Parts of the tongue muscles, mucous membrane and papillae from the calf

Liquor cerebrospi-nalis

Bos taurus L. Liquor cerebrospinalis from the calf

Mephitis putorius Mephitis mephitis Schreb.

Liquid secretion of anal glands from Mephitis mephitis Schreb.

Moschus Moschus moschiferus L. Secretion of bursa from male Moschus moschiferus L.

• Ap

pend

ix

71


72



Musculi glutaei Bos taurus L. Gluteal muscles from the calf Musculus soleus-Komplex

Bos taurus L. Parts of the musculus soleus-complex, musculus soleus, musculus �bularis (peronaeus) longus, musculus gastrocnemius from the calf

Mygale avicularis see Aranea avicularisNaja tripudians Naja naja L. Carefully dried poison from Naja naja L.Nervus abducens Bos taurus L. Nervus abducens from the calfNervus accessorius Bos taurus L. Nervus accessorius from the calfNervus femoralis Bos taurus L. Nervus femoralis from the calfNervus hypoglossus Bos taurus L. Nervus hypoglossus from the calfNervus pudendus Bos taurus L. Nervus pudendus from the calfNervus radialis Bos taurus L. Nervus radialis from the calfNervus tibialis Bos taurus L. Nervus tibialis from the calfNervus ulnaris Bos taurus L. Nervus ulnaris from the calfOesophagus Sus scrofa domestica L. Oesophagus from the pigOssa longa Bos taurus L. Ossa longa from the calfOssicula auditus Bos taurus L. Auditory bones from the calfPapillae duodeni Sus scrofa domestica L. Papilla duodeni region of the small intestine

from the pigPars pallida Bos taurus L. Parts of the base of the brain from the calfPatella Bos taurus L. Patella from the calfPelvis renalis (et Ureter)

Bos taurus L. Parts of the pelvis renalis and ureter from the calf

Penis Bos taurus L. Penis from the bullPia mater encephali Bos taurus L. Pia mater encephali from the calfPlexus lumbalis Bos taurus L. Plexus lumbalis from the calfPlexus rectalis see Plexus haemorr-

hoidalisPortio vaginalis Bos taurus L. Portio vaginalis from the cowRenes, regio pyelo-renalis

Bos taurus L. Parts of tissue from the pelvis renalis and medulla renalis from the calf

Sclera Bos taurus L. Sclera from the calfSinus cavernosus-Komplex

Bos taurus L. Parts of the sinus cavernosus-complex; sinus cavernosus, nervus opticus, nervus oculomotorius, nervus trochlearis, nervus trigeminus and nervus abducens from the calf

Tarantula hispanica Lycosa hispanica �e whole spider Lycosa tarantula L., Allocosa fasciiventris Duf., or Hogna hispanica Walck.

�rombocytes Equus przewalskii f. caballus Poliakov

�rombocytes from the blood of the horse

Tonsilla pharyngea Bos taurus L. Tonsilla pharyngea from the calf

• Appendix


• Ap

pend

ix

73



Trachea Bos taurus L. Trachea from the calfTruncus coeliacus Bos taurus L. Arteria coeliaca (Truncus coeliacus) from the calfTruncus encephali Bos taurus L. Brain stem from the calfTruncus encephali Bos taurus L. Hypothalamus, thalamus, corpora quadrigemina, pons,

medulla oblongata from the calfTunica mucosa intestini tenuis

Sus scrofa domestica L. Mucosa from the di�erent regions of the small intestine from the pig

Tunica mucosa recti Sus scrofa domestica L. Tunica mucosa recti from the pigTunica mucosa ventriculi

Sus scrofa domestica L. Mucosa from the di�erent regions of the stomach from the pig

Ureter Bos taurus L. Ureter from the calfVagina Bos taurus L. Vagina from the cowValva trunci pulmo-nalis

Bos taurus L. Valva trunci pulmonalis from the calf

Valvula aortae Bos taurus L. Valva aortae from the calfValvula mitralis Bos taurus L. Valva mitralis from the calfVena cava Bos taurus L. Parts of the vena cava cranialis and vena cava caudalis

from the calfVena portae Bos taurus L. Vena portae from the calfVena tibialis Bos taurus L. Vena tibialis from the calfVertebra cervicalis Bos taurus L. Vertebra cervicalis from the calfVertebra coccygea Bos taurus L. Vertebra coccygea from the calfVertebra lumbalis Bos taurus L. Vertebra lumbalis from the calf


74

• Appendix 2.1


75

• Ap

pend

ix 2

.1

APPENDIX 2.1

List of minerals, rocks and natural waters Additional Information, see p. 21


• Appendix 2.1

76

Engl

ish n

ame:

Ph

.Eur

. or s

cien

ti�c

Germ

an n

ame:

H

AB (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

de�n

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Am

ber

Succ

inum

(Ber

nste

in)

Foss

ilize

d tr

ee re

sin

HA

BSu

ccin

um(0

7.04

.198

8)A

met

hyst

(Am

ethy

st)

A v

iole

t var

iety

of q

uart

z (S

iO2)

Trop

aeol

um co

mp.

(0

2.03

.199

1)A

ntim

onite

See

Stib

nite

Ant

imon

it (0

2.09

.198

7)

Apat

iteAp

atit

Apat

ite�

e na

tura

l min

eral

H

AB

Apat

it (0

5.12

.198

9)A

gate

wat

er

(Ach

atw

asse

r)W

ater

exi

stin

g in

side

an u

ndam

aged

A

gate

geo

deD

er M

erku

rsta

b 20

09;

62(6

): 60

5-61

9A

qua

mar

is(M

eerw

asse

r)Se

e Se

awat

erA

rago

nite

(Ara

goni

t)A

rago

nite

�e

natu

ral m

iner

al

(cal

cium

car

bona

te; c

hem

.: C

aCO

3)A

rand

isite

(Ara

ndisi

t)A

rand

isite

�e

natu

ral m

iner

al

(com

plex

tin

silic

ate)

Ara

ndist

(02.

03.1

991)

Arg

entit

eA

rgen

titA

rgen

tite

�e

natu

ral m

iner

al

HA

BA

rgen

tit (0

5.12

.198

9)A

rgen

tum

(Silb

er)

Arg

ent n

atif

�e

natu

ral m

iner

al (n

atur

ally

oc

curr

ing

silve

r with

trac

es o

f oth

er

elem

ents

)

Arg

entu

m m

etal

licum

(04.

06.1

986)

Arg

illac

eous

Sha

leLa

pis s

ectil

is,

(Ton

schi

efer

)La

pis s

ectil

is�

e na

tura

l ver

y �n

e-gr

aine

d cl

ayey

ro

ck (c

onsis

ting

of cl

ay m

iner

als,

quar

tz, f

elds

par,

mic

a, co

mm

only

ch

lorit

e, gr

aphi

te a

nd o

ther

s)A

rsen

opyr

iteA

rsen

opyr

itA

rsen

opyr

ite�

e na

tura

l min

eral

(ars

enic

-iron

su

l�de

)Va

dem

ecum

: A

rsen

opyr

itAu

rum

(Gol

d)O

r nat

if�

e na

tura

l min

eral

(n

atur

ally

occ

urrin

g go

ld w

ith tr

aces

of

oth

er el

emen

ts)

Auru

m m

etal

licum

(04.

06.1

986)

Bary

silite

Bary

silit

�e

natu

ral m

iner

al (L

ead

man

gane

se

silic

ate)

Bary

silit

(DA

Z N

r. 29

vom

21

.07.

1994

)Ba

salt

(Bas

alt)

�e

natu

rally

occ

urrin

g,

�ne-

grai

ned

dark

gra

y to

bla

ck

volc

anic

rock

(con

sistin

g of

pl

agio

clas

e, py

roxe

ne an

d ot

hers

)


• Ap

pend

ix 2

.1

77

Engl

ish n

ame:

Ph

.Eur

. or s

cien

ti�c

Germ

an n

ame:

H

AB (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

de�n

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Bert

hier

iteBe

rthi

erit

Bert

hier

ite�

e na

tura

l min

eral

(a

ntim

ony-

iron

sul�

de; c

hem

.: Fe

Sb2S

4)Bo

lus a

lba

(Bol

us)

See

Kao

linite

Cal

cite

(Kal

zit)

Cal

cite

�e

natu

ral m

iner

al

(cal

cium

car

bona

te; c

hem

.: C

aCO

3)(C

alx

jura

ssic

a)(J

urak

alk)

�e

natu

ral r

ock

Lim

esto

ne fr

om Ju

ra

perio

d (m

ainl

y co

nsist

ing

of c

alci

te)

Car

nelia

n(K

arne

ol)

�e

natu

ral m

iner

al (a

red

varie

ty o

f sil

icic

aci

d w

ith tr

aces

of i

ron

oxid

e)C

assit

erite

(Kas

siter

it, Z

inns

tein

)C

assit

érite

�e

natu

ral m

iner

al

(tin

oxi

de; c

hem

.: Sn

O2)

Kas

siter

it(0

7.04

.198

8)C

hlor

argy

rite

(Chl

orar

gyrit

)�

e na

tura

l min

eral

(s

ilver

chlo

ride;

chem

.: A

gCl)

Car

tilag

o/H

orne

rz

com

p. (0

5.12

.198

9)C

erite

(Cer

it)�

e na

tura

l min

eral

(com

plex

silic

ate

of

rare

ear

th el

emen

ts (c

eriu

m, l

anth

anum

an

d ot

hers

) and

cal

cium

, mag

nesiu

m

and

iron)

Cor

/Cra

taeg

us co

mp.

(0

2.03

.199

1)

Cer

ussit

eC

erus

sit

Cér

usite

�e

natu

ral m

iner

alH

AB

Cer

ussit

(07.

04.1

988)

Cha

lced

ony

(Cha

lced

on)

(Cha

lzed

on)

�e

natu

ral m

iner

al

(sili

cic a

cid;

chem

.: Si

O2)

Cha

lcoc

ite(C

halk

osin

)C

halc

osin

e�

e na

tura

l min

eral

H

AB

�yr

eoid

ea co

mp.

(0

3.07

.199

2)C

halc

opyr

ite(C

halk

opyr

it)C

halc

opyr

ite�

e na

tura

l min

eral

(c

oppe

r-iro

n su

l�de

; che

m.:

CuFe

S 2)

Chr

ysol

ite(C

hrys

olith

)C

hrys

olith

e�

e na

tura

l min

eral

H

AB

Chr

ysol

ith co

mp.

(25.

10.1

994)

Chr

ysop

rase

(Chr

ysop

ras)

�e

natu

ral m

iner

al (s

ilici

c aci

d

with

smal

l am

ount

s of n

icke

l)C

inna

bar

(Zin

nobe

r)

Cin

naba

ritC

inna

baris

nat

ural

e�

e na

tura

l min

eral

H

AB

Zinn

ober

(02.

09.1

987)

Cupr

iteCu

prit

Cupr

ite�

e na

tura

l min

eral

H

AB

Cupr

it (0

2.03

.199

1)


• Appendix 2.1

78

Engl

ish n

ame:

Ph

.Eur

. or s

cien

ti�c

Germ

an n

ame:

H

AB (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

de�n

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Dia

mon

d(D

iam

ant)

�e

natu

ral m

iner

al

(Car

bon;

chem

.: C

, mos

t with

trac

es o

f iro

n an

d ot

her e

lem

ents

)D

iasp

ore

(Dia

spor

)�

e na

tura

l min

eral

(alu

min

ium

oxi

de

hydr

oxid

e; ch

em.:

AlO

OH

)D

iopt

ase

Dio

ptas

Dio

ptas

e�

e na

tura

l min

eral

(cop

per s

ilica

te;

chem

.: Cu

6Si 6O

18·6

H2O

)H

AB

Dio

ptas

(1

2.09

.199

2)D

yscr

asite

Dys

kras

itD

yscr

asite

�e

natu

ral m

iner

al

HA

BD

ykra

sit (D

AZ

Nr.

29

vom

21.

07.1

994)

Emer

ald

(Sm

arag

d)A

gre

en v

arie

ty o

f ber

yl

(alu

min

ium

-ber

ylliu

m si

licat

e;

chem

.: A

l 2Be 3

(Si 6O

18),

colo

ured

by

trac

e am

ount

s of c

hrom

ium

and

so

met

imes

van

adiu

mFe

rrum

side

reum

(Met

eore

isen)

Ferr

um si

dere

umSe

e Ir

on m

eteo

rite

= m

eteo

ric ir

onFe

rrum

silic

icum

See

Non

tron

iteFl

int

(Flin

t, Fe

uers

tein

)Si

lex

�e

natu

ral m

iner

al

(che

m.:

silic

ic a

cid

SiO

2)

Lapi

s Can

cri/F

lints

tein

(07.

04.1

988)

Fluo

rite

Fluo

rit (F

luss

spat

)Fl

uorit

e�

e na

tura

l min

eral

H

AB

Fluo

rit (0

2.09

.198

7)G

alen

aG

alen

it (B

leig

lanz

)G

alèn

e�

e na

tura

l min

eral

H

AB

Blei

glan

z/Se

cale

com

p.

(12.

09.1

992)

Gar

net

(Gra

nat)

�e

natu

ral m

iner

al: A

lman

dine

(ir

on-a

lum

iniu

m si

licat

e; ch

em.:

Fe3A

l 2(Si

O4)

3 ) o

r oth

er v

arie

ties

Der

Mer

kurs

tab

2004

; 57

(1):

57-5

8

(Gla

cies

Mar

iae)

See

sele

nite

Gne

iss(G

neis)

�e

natu

ral p

ale

rock

(Gne

iss fr

om

Gas

tein

(A);

cons

istin

g of

qua

rtz,

feld

-sp

ar, m

ica

and

othe

rs);

syn.

: Lap

is al

bus

Gra

nite

(Gra

nit)

Gra

nit

�e

natu

ral r

ock

(con

sistin

g of

qua

rtz,

feld

spar

and

mic

a an

d ot

hers

)D

isci/R

hus t

oxi-

code

ndro

n co

mp.

(0

5.12

.198

9)G

raph

iteG

raph

ites (

Gra

phit)

Gra

phite

s�

e na

tura

l min

eral

H

AB

Gra

phite

s (07

.04.

1988

)


• Ap

pend

ix 2

.1

79

Engl

ish n

ame:

Ph

.Eur

. or s

cien

ti�c

Germ

an n

ame:

H

AB (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

de�n

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Hem

atite

Häm

atit

Hém

atite

�e

natu

ral m

iner

al

HA

BFe

rrum

rosa

tum

/G

raph

ites (

03.0

7.19

92)

Hal

iteH

alit

�e

natu

ral m

iner

al

HA

BH

alit

(07.

04.1

988)

Hek

la L

ava

See

Lava

Hel

iotr

ope

(Hel

iotr

op)

A g

reen

var

iety

of c

halc

edon

y w

ith re

d in

clus

ions

(sili

cic a

cid;

chem

.: Si

O2

with

iron

oxi

de)

Hya

cint

h(H

yazi

nth)

See

Zirc

onH

ydra

rgyr

um(Q

ueck

silbe

r)Se

e M

ercu

rius v

ivus

nat

ural

isIr

on m

eteo

rite

Ferr

um si

dere

um

(Met

eore

isen)

Ferr

um si

dere

um�

e na

tura

l met

eoric

iron

HA

BFe

rrum

side

reum

(0

4.06

.198

6)Ja

sper

(Jas

pis)

A re

d va

riety

of c

halc

edon

y (s

ilici

c ac

id; c

hem

.: Si

O2 w

ith ir

on o

xide

)K

aolin

ite(K

aolin

, wei

ßer T

on)

�e

natu

ral m

iner

al (a

lum

iniu

m

silic

ate;

chem

.: A

l 4[(O

H) 8

/Si 4O

10];

syn.

: Chi

na cl

ay, K

aolin

um p

onde

rosu

m

Ph. E

ur.

Bolu

s alb

a co

mp.

(0

2.03

.199

1)

Kas

siter

iteSe

e C

assit

erite

Kat

optr

ite(K

atop

trit)

�e

natu

ral m

iner

al (c

ompl

ex

man

gane

se-a

ntim

ony-

iron

silic

ate)

Kie

serit

e(K

iese

rit)

Kie

sérit

e�

e na

tura

l min

eral

H

AB

Kie

serit

(12.

09.1

992)

Lapi

s alb

us(G

neiss

)Se

e G

neiss

Lapi

s sec

tilis

(Ton

schi

efer

)Se

e A

rgill

aceo

us S

hale

Lava

Hek

la L

ava

(Lav

a)H

ekla

lava

�e

natu

ral r

ock

from

vol

cano

Hek

la

(Ice

land

) (co

nsist

ing

of d

i�er

ent

silic

ates

of c

alci

um, m

agne

sium

, al

umin

ium

and

sodi

um)

Levi

co w

ater

Levi

coLe

vico

Min

eral

wat

er fr

om th

e so

urce

Lev

ico,

Ita

lyA

PCLe

vico

(04.

06.1

986)

Mag

nesit

eM

agne

sitM

agné

site

�e

natu

ral m

iner

al

HA

BM

agne

sit/M

amm

a co

mp.

(12.

09.1

992)

Mal

achi

teM

alac

hit

Mal

achi

te�

e na

tura

l min

eral

H

AB

Mal

achi

t (12

.09.

1992

)


• Appendix 2.1

80

Engl

ish n

ame:

Ph

.Eur

. or s

cien

ti�c

Germ

an n

ame:

H

AB (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

de�n

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Mar

ble

(Mar

mor

)M

arbr

e�

e na

tura

l gra

ined

, whi

te ro

ck

(mai

nly

cons

istin

g of

cal

cite

)M

arm

or/S

tibiu

m(0

3.07

.199

2)M

ercu

rius v

ivus

na

tura

lis(Q

ueck

silbe

r,

gedi

egen

)M

ercu

rius v

ivus

Nat

ural

ly o

ccur

ring

mer

cury

with

tr

aces

of o

ther

elem

ents

Ph.fr

.M

ercu

rius v

ivus

(02.

09.1

987)

(Met

eore

isen)

See

Ferr

um si

dere

umN

ontr

onite

Non

tron

itN

ontr

onite

�e

natu

ral m

iner

al; s

yn.:

Fe

rrum

silic

icum

nat

ural

eH

AB

Ferr

um u

stum

com

p.

(04.

06.1

986)

Oliv

enite

Oliv

enit

Oliv

énite

�e

natu

ral m

iner

al

HA

BO

liven

it (0

2.09

.198

7)O

livin

eSe

e C

hrys

olite

O

nyx

Ony

xO

nyx

�e

natu

ral m

iner

al

HA

BO

nyx

(05.

12.1

989)

Opa

l(O

pal)

�e

natu

ral m

iner

al

(sili

cic a

cid,

cont

aini

ng w

ater

)D

er M

erku

rsta

b 20

09;

62(6

): 60

5-61

9O

rtho

clas

e(O

rtho

klas

)�

e na

tura

l min

eral

(pot

assiu

m-

alum

iniu

m si

licat

e; ch

em.:

KA

lSi 3O

8)O

rtho

klas

(07.

04.1

988)

Palla

site

(Pal

lasit

)St

one-

Iron

-Met

eorit

e (o

livin

e cr

ysta

ls in

an

iron-

nick

el m

atrix

)Ph

arm

acol

itePh

arm

akol

ithPh

arm

acol

ithe

�e

natu

ral m

iner

al

HA

BPh

arm

akol

ith (D

AZ

Nr.

29 v

om 2

5.10

.199

4)Ph

osph

oroc

alci

te(P

hosp

horo

chal

cit,

Pseu

dom

alac

hit)

Phos

phor

ocha

lcite

�e

natu

ral m

iner

al

(alk

alin

e co

pper

pho

spha

te;

chem

.: Cu

5[(O

H) 4

/(PO

4)2]

)Pl

atin

um(P

latin

) Pl

atin

a�

e na

tura

l min

eral

(nat

ural

ly

occu

rrin

g pl

atin

um w

ith tr

aces

of o

ther

el

emen

ts)

Pyra

rgyr

ite(P

yrar

gyrit

)Py

rarg

yrite

�e

natu

ral m

iner

al (s

ilver

-ant

imon

y su

l�de

; che

m.:

Ag 3

SbS 3

)Py

rite

Pyrit

Pyrit

e�

e na

tura

l min

eral

H

AB

Pyrit

(04.

06.1

986)

Pyro

lusit

ePy

rolu

sitPy

rolu

site

�e

natu

ral m

iner

al (m

anga

nese

di-

oxyd

e; ch

em.:

MnO

2)Py

rom

orph

itePy

rom

orph

itPy

rom

orph

ite�

e na

tura

l min

eral

H

AB

Pyro

mor

phit

(21.

07.1

994)

Qua

rtz

Qua

rzQ

uart

z�

e na

tura

l min

eral

H

AB

Qua

rz (0

4.06

.198

6)


• Ap

pend

ix 2

.1

81

Engl

ish n

ame:

Ph

.Eur

. or s

cien

ti�c

Germ

an n

ame:

H

AB (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

de�n

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Real

gar

(Rea

lgar

)Ré

alga

r�

e na

tura

l min

eral

(a

rsen

ic su

l�de

; che

m.:

As 4

S 4)

Real

gar

(05.

12.1

989)

Rose

qua

rtz

(Ros

enqu

arz)

�e

natu

ral m

iner

al (s

ilici

c aci

d;

chem

.: Si

O2)

; syn

.: Q

uarz

rosa

eRu

belli

te(R

ubel

lit)

Pink

to re

d to

urm

alin

e (c

ompl

ex

silic

ate

with

alu

min

ium

, bor

on,

�uor

ine,

lithi

um, i

ron,

sodi

um a

nd

othe

r ele

men

ts)

Vade

mec

um:

Rube

llit

Ruby

(Rub

in)

�e

natu

ral r

ed co

rund

um

(alu

min

ium

oxi

de; c

hem

.: A

l 2O3

with

trac

es o

f Chr

omiu

m)

Sal M

aris

See

Sea

salt

Sapp

hire

(Sap

hir)

�e

natu

ral b

lue

(alu

min

ium

oxi

de;

chem

.: A

l 2O3 w

ith tr

aces

of i

ron

and/

or

tita

nium

)Sc

orod

iteSk

orod

itSc

orod

ite�

e na

tura

l min

eral

H

AB

Skor

odit

(04.

06.1

986)

Sea

salt

(Mee

rsal

z)N

atru

m m

uria

ticum

Sea

salt

(che

m.:

com

plex

mix

ture

w

ith ch

lorid

es a

nd su

lfate

s of m

ainl

y so

dium

, mag

nesiu

m, c

alci

um a

nd

pota

ssiu

m b

esid

e m

inor

com

pone

nts)

; sy

n.: S

al M

aris

Ph.fr

.

Seaw

ater

Aqu

a m

aris

Aqu

a m

aris

Oce

anic

wat

er (c

hem

.: di

ssol

ved

mix

-tu

re o

f chl

orid

es a

nd su

lfate

s of m

ainl

y so

dium

, mag

nesiu

m, c

alci

um a

nd

pota

ssiu

m b

esid

e m

inor

com

pone

nts)

Aqu

a m

aris/

Prun

ussp

inos

a, S

umm

itate

s(0

5.12

.198

9)

Der

Mer

kurs

tab

2009

; 62

(6):

605-

619

Sele

nite

(Gla

cies

mar

ias,

Gip

s, M

arie

ngla

s)�

e na

tura

l min

eral

: Tra

nspa

rent

, co

lour

less

, var

iety

of G

ypsu

m (c

alci

um

sulfa

te; c

hem

.: C

aSO

4·2H

2O);

sy

n.: G

laci

es M

aria

eSi

derit

eSi

derit

Sidé

rite

�e

natu

ral m

iner

al

HA

BSi

derit

(21.

07.1

994)

Sile

xSi

lex

See

Flin

t Si

licea

nat

ural

eSe

e Q

uart

zSm

arag

dSe

e Em

eral

d


• Appendix 2.1

82

Engl

ish n

ame:

Ph

.Eur

. or s

cien

ti�c

Germ

an n

ame:

H

AB (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

de�n

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Stib

nite

Ant

imon

it (G

raus

-pi

eßgl

anz)

Stib

ine

�e

natu

ral m

iner

al

HA

BA

ntim

onit

(02.

09.1

987)

Succ

inum

See

Am

ber

Sulfu

rSu

lfur

Sulfu

r�

e na

tura

l min

eral

Su

lfur (

17.0

2.19

86)

Sulfu

r sel

enos

um(S

ulfu

r sel

enos

um)

Sulfu

r sel

enos

um�

e na

tura

l min

eral

cont

aini

ng a

co

lloid

al so

lutio

n of

sele

nium

Vade

mec

um:

Sulfu

r sel

enos

umSy

lvite

(Syl

vin)

�e

natu

ral m

iner

al

(pot

assiu

m ch

lorid

e; ch

em.:

KCl)

(Ter

ra m

edic

inal

is)(H

eile

rde)

Drie

d, �

nely

-div

ided

, nat

ural

ly o

ccur

-rin

g cl

ay a

nd si

lt w

ith a

var

ied

com

po-

sitio

n of

alu

min

ium

oxi

de, s

ilica

, iro

n ox

ide

and

limes

tone

; Ter

ra m

edic

inal

is

Plac

enta

/Tro

paeo

lum

(0

2.03

.199

1)

(Ter

ra ru

bra)

(Ter

ra ru

bra)

�e

natu

ral r

ed to

bro

wni

sh ro

ck fr

om

perio

d Ro

tlieg

end

(con

sistin

g of

dif-

fere

nt �

ne-g

rain

ed a

lum

iniu

m si

licat

es

and

iron

oxid

e)

�en

ardi

te(�

enar

dit)

�én

ardi

te�

e na

tura

l min

eral

(s

odiu

m su

lfate

; che

m.:

Na 2

SO4)

Topa

z(T

opas

)�

e na

tura

l min

eral

(alu

min

ium

-�uo

-rin

silic

ate;

chem

.: sil

icat

e of

alu

min

i-um

and

�uo

rine,

Al 2[

(F,O

H) 2

/SiO

4.)]

Tron

a(T

rona

)�

e na

tura

l min

eral

(sod

ium

car

-bo

nate

-hyd

roge

n ca

rbon

ate;

chem

.: N

a 3(C

O3)

(HC

O3)

·2H

2O

Solu

tio F

erri

com

p.(2

5.10

.199

4)

Tour

mal

ine

(Tur

mal

in)

�e

natu

ral m

iner

al T

ourm

alin

e (c

om-

plex

silic

ate

with

alu

min

ium

, bor

on,

�uor

ine

and

othe

r ele

men

ts).

Rube

llite

or

oth

er v

arie

ties.

See

Rub

ellit

eVa

nadi

nite

(Van

adin

it)�

e na

tura

l min

eral

(lea

d va

nada

te;

chem

.: Pb

5[C

l/(V

O4)

3]V

ivia

nite

Viv

iani

tV

ivia

nite

�e

natu

ral m

iner

al

HA

BV

ivia

nit (

DA

Z N

r. 29

vo

m 2

1.07

.199

4)


• Ap

pend

ix 2

.1

83

Engl

ish n

ame:

Ph

.Eur

. or s

cien

ti�c

Germ

an n

ame:

H

AB (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

de�n

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

With

erite

With

erit

With

érite

�e

natu

ral m

iner

al

HA

BFo

rmul

aire

de

med

.an-

thr.

(201

2): N

ontr

onit

D20

, Sco

rodi

t D12

, W

ither

it D

6Zi

nnob

erSe

e C

inna

bar

Zirc

on(H

yazi

nth)

�e

natu

ral m

iner

al (z

ircon

ium

oxi

de;

chem

.: Zr

[SiO

4])


84

• Appendix 2.2


85

• Ap

pend

ix 2

.2

APPENDIX 2.2

List of starting materials of botanical origin Additional Information, see p. 21


• Appendix 2.2

86

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erA

bies

alb

a M

ill.

Fres

h to

ps o

f Abi

es a

lba

Mill

.Pe

tasit

es co

mp.

(1

2.09

.199

2)A

bies

pec

tinat

a (L

am.)

DC

.Yo

ung,

fres

h, le

afy

bran

ches

of A

bies

alb

a M

ill. (

Abi

es p

ectin

ata

(Lam

.) D

C)

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)A

brot

anum

See

Art

emisi

a ab

rota

num

L.

Abs

inth

ium

See

Art

emisi

a ab

sinth

ium

L.

Ace

tum

Vin

iSe

e V

itis v

inife

ra L

.A

cetu

m V

ini d

estil

latu

mSe

e V

itis v

inife

ra L

.A

chill

ea m

illef

oliu

m L

.Fr

esh,

who

le �

ower

ing

plan

t of A

chill

ea m

illef

oliu

m L

.Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Ach

illea

mill

efol

ium

L.

Fres

h, le

aves

of A

chill

ea m

illef

oliu

m L

., co

llect

ed in

Spr

ing

Mill

efol

ium

/ H

yper

i-cu

m (0

7.04

.198

8)A

chill

ea m

illef

oliu

m L

.Fr

esh

aeria

l par

ts o

f Ach

illea

mill

efol

ium

L.,

colle

cted

at �

ower

ing

time

HA

BC

anth

aris

com

p.

(04.

06.1

986)

Ach

illea

mill

efol

ium

L.

Who

le o

r cut

, drie

d �o

wer

ing

tops

of A

chill

ea m

illef

oliu

m L

. (ya

r-ro

w).

Ph.E

ur.

Ach

illea

mill

efol

ium

L.

Drie

d �o

wer

s of A

chill

ea m

illef

oliu

m L

.Ph

.Hel

v.C

apse

lla/M

ajor

ana

com

p. (0

4.06

.198

6)A

coni

tum

nap

ellu

s L.

Fres

h, w

hole

pla

nts o

f Aco

nitu

m n

apel

lus L

. col

lect

ed at

the

end

of

�ow

erin

g tim

e

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)A

coni

tum

nap

ellu

s L.

Fres

h w

hole

pla

nts o

f Aco

nitu

m n

apel

lus L

., co

llect

ed at

the

star

t of

�ow

erin

gH

AB

Aco

nitu

m n

apel

lus

(04.

06.1

986)

Aco

nitu

m n

apel

lus L

.D

ried

tube

rs o

f Aco

nitu

m n

apel

lus L

.Ph

.Hel

v. V

IA

coni

tum

nap

ellu

s (0

4.06

.198

6)A

coni

tum

nap

ellu

s L.

Fres

h un

derg

roun

d pa

rts o

f Aco

nitu

m n

apel

lus L

.A

coni

tum

nap

ellu

s (0

2.03

.198

6)A

coru

s cal

amus

L.

Vola

tile

oil f

rom

the

unde

rgro

und

part

s of A

coru

s cal

amus

L.

Aco

rus c

alam

us L

.Pe

eled

, drie

d rh

izom

e of

Aco

rus c

alam

us L

., w

ith ro

ots a

nd le

af

resid

ues r

emov

ed.

HA

BC

alam

us, R

hizo

ma

(02.

03.1

991)

Aco

rus c

alam

us L

.Fr

esh

unde

rgro

und

part

s of A

coru

s cal

amus

L.

Berb

eris/

Juni

peru

s co

mp.

(03.

07.1

992)

Act

aea

race

mos

ase

e C

imic

ifuga

race

mos

a (L

.) N

utt.


• Ap

pend

ix 2

.2

87

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erA

ctae

a sp

icat

a L.

Fres

h, u

nder

grou

nd p

arts

of A

ctae

a sp

icat

a L.

colle

cted

a�e

r sho

ts

have

em

erge

d, b

ut b

efor

e �o

wer

ing

HA

B

Ado

nis v

erna

lis L

.Fr

esh

aeria

l par

ts o

f Ado

nis v

erna

lis L

. col

lect

ed at

�ow

erin

g tim

e

HA

BA

doni

s/Sc

illa

com

p.

(25.

10.1

994)

Aes

culu

s hip

poca

stan

um L

.Fr

esh

bark

from

you

nger

bra

nche

s of A

escu

lus h

ippo

cast

anum

L.

Cal

endu

la/T

ropa

eolu

m

com

p. (0

2.03

.199

1)A

escu

lus h

ippo

cast

anum

L.

Fres

h bu

ds o

f Aes

culu

s hip

poca

stan

um L

.Sa

l Mar

is co

mp.

(0

4.06

.198

6)A

escu

lus h

ippo

cast

anum

L.

Fres

hly

peel

ed se

eds o

f Aes

culu

s hip

poca

stan

um L

.H

AB

Aes

culu

s, Se

men

(0

2.03

.199

1)A

escu

lus h

ippo

cast

anum

L.

Fres

h un

peel

ed se

eds o

f Aes

culu

s hip

poca

stan

um L

.Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Aes

culu

s hip

poca

stan

um L

.D

ried

bark

from

bra

nche

s of A

escu

lus h

ippo

cast

anum

L.

HA

BA

escu

lus,

Cor

tex

(0

4.06

.198

6)A

escu

lus h

ippo

cast

anum

L.

Drie

d se

eds o

f Aes

culu

s hip

poca

stan

um L

.D

AB

/ USP

Aes

culu

s, Se

men

(0

2.03

.199

1)A

ethu

sa c

ynap

ium

L.

Fres

h w

hole

pla

nt o

f Aet

husa

cyn

apiu

m L

. at t

he e

nd o

f �ow

erin

g Ph

.fr.

Aga

ricus

bul

bosu

sse

e A

man

ita p

hallo

ides

(Fr.)

Lin

k.A

garic

us m

usca

rius

see

Am

anita

mus

caria

(L.)

Pers

.A

gnus

cas

tus

see

Vite

x ag

nus-

cast

us L

.A

grop

yron

repe

ns (L

.) P.

Bea

uv.

Who

le o

r cut

, was

hed

and

drie

d rh

izom

e of

Agr

opyr

on re

pens

(L.)

P. B

eauv

. (El

ymus

repe

ns [L

.] G

ould

); th

e ad

vent

itiou

s roo

ts a

re

rem

oved

(cou

ch g

rass

rhiz

ome)

Ph.E

ur.

Flor

es S

ambu

ci co

mp.

/Q

uarz

(07.

04.1

988)

Agr

opyr

on re

pens

see

Elym

us re

pens

(L.)

Gou

ldA

ilant

hus a

ltiss

ima

(Mill

.) Sw

ingl

eFr

esh

�ow

erin

g sh

oots

and

fres

h ba

rk fr

om th

e tr

unk

and

bran

ches

of

Aila

nthu

s alti

ssim

a (M

ill.)

Swin

gle

Aila

nthu

s gla

ndul

osa

see

Aila

nthu

s alti

ssim

aAj

uga

rept

ans L

.Fr

esh

who

le p

lant

s of A

juga

rept

ans L

. at �

ower

ing

time

Ph.fr

.A

lcea

rose

a L.

Drie

d, fu

lly d

evel

oped

�ow

ers w

ith c

alic

es o

f Alc

ea ro

sea

L.M

alva

com

p.

(03.

07.1

992)

Alc

hem

illa

xant

hoch

lora

Rot

hm.

Fres

h ae

rial p

arts

of A

lche

mill

a xa

ntho

chlo

ra R

othm

. at �

ower

ing

Alfa

lfase

e M

edic

ago

sativ

a L.


88

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erA

llium

cepa

L.

Fres

h bu

lbs o

f Alli

um ce

pa L

.H

AB

/ Ph.

fr.A

llium

cepa

/Mer

curia

-lis

com

p. (0

2.03

.199

1)A

llium

sativ

um L

.Fr

esh

bulb

s of A

llium

sativ

um L

. (ga

rlic f

or h

omoe

opat

hic p

repa

ra-

tions

) H

AB

/ Ph.

Eur.

/ USP

Arc

hang

elic

a co

mp.

(04.

06.1

986)

Alli

um u

rsin

um L

. Fr

esh

who

le p

lant

s of A

llium

urs

inum

L. a

t the

star

t of �

ower

ing

HA

BA

loe

fero

x M

ill. a

nd o

ther

Alo

e sp

ecie

sC

once

ntra

ted

and

drie

d ju

ice

of th

e le

aves

of v

ario

us sp

ecie

s of

Alo

e, m

ainl

y A

loe

fero

x M

iller

and

its h

ybrid

s (al

oes,

Cap

e)

Ph.fr

., H

AB

/ Ph.

Eur.

Alth

aea

o�ci

nalis

L.

Peel

ed o

r unp

eele

d, w

hole

or c

ut, d

ried

root

of A

lthae

a o�

cina

lis L

. (m

arsh

mal

low

root

)Ph

.Eur

.Si

rupu

s �ym

i com

p.

(04.

06.1

986)

Am

anita

mus

caria

(L.)

Pers

.Fr

esh

frui

ting

bodi

es o

f Am

anita

mus

caria

(L.)

Pers

.A

garic

us m

usca

rius

(12.

09.1

992)

Am

anita

pha

lloid

es (F

r.) L

ink.

Fres

h fr

uitin

g bo

dies

of A

man

ita p

hallo

ides

(Fr.

Link

)H

AB

Am

aryl

lis b

ella

-don

na L

.Fr

esh,

who

le p

lant

of A

mar

yllis

bel

la-d

onna

L. a

t �ow

erin

gA

mm

i visn

aga

(L.)

Lam

.D

ried

ripe

frui

ts o

f Am

mi v

isnag

a (L

.) La

m.

HA

BA

mm

i visn

aga

com

p.

(02.

03.1

991)

Am

ygda

lae

amar

aese

e Pr

unus

dul

cis v

ar. a

mar

a (D

C.)

Buch

heim

Ana

card

ium

see

Sem

ecar

pus a

naca

rdiu

m L

.A

naga

llis a

rven

sis L

.Fr

esh

who

le p

lant

of A

naga

llis a

rven

sis L

. at �

ower

ing

Ph.fr

.A

naga

llis c

omp.

(0

2.03

.199

1)A

naga

llis a

rven

sis L

.Fr

esh

aeria

l par

ts o

f Ana

galli

s arv

ensis

L.,

colle

cted

at �

ower

ing

Ana

galli

s / M

alac

hit

com

p. (2

5.10

.199

4)A

naga

llis a

rven

sis L

.D

ried

aeria

l par

ts o

f Ana

galli

s arv

ensis

L.,

havi

ng b

een

colle

cted

at

�ow

erin

gA

naga

llis /

Mal

achi

t co

mp.

(25.

10.1

994)

Ana

mirt

a co

ccul

us W

ight

et A

rn.

Ripe

, drie

d fr

uits

of A

nam

irta

cocc

ulus

Wig

ht e

t Arn

.H

AB

/ Ph.

fr.C

occu

lus/

Ole

um P

etra

e co

mp.

(04.

06.1

986)

Ana

nas c

omos

us (L

.) M

err.

Fres

hly

pres

sed

juic

e of

frui

t of A

nana

s com

osus

(L.)

Mer

r.Re

sina

Laric

is co

mp.

(0

4.06

.198

6)A

nana

s com

osus

(L.)

Mer

r.Fr

esh

frui

t of A

nana

s com

osus

(L.)

Mer

r.A

nana

ssa

com

p.

(02.

03.1

991)

Ang

elic

a ar

chan

gelic

a L.

Ferm

ente

d ju

ice

from

root

s of A

ngel

ica

arch

ange

lica

L. o

btai

ned

by

fres

h pr

essin

gA

rcha

ngel

ica

(05.

12.1

989)

• Appendix 2.2


89

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erA

ngel

ica

arch

ange

lica

L.Fr

esh

root

s of A

ngel

ica

arch

ange

lica

L.H

AB

Arc

hang

elic

a/Py

rit

com

p. (0

2.03

.199

1)A

ngel

ica

arch

ange

lica

L.W

hole

or c

ut, c

aref

ully

drie

d rh

izom

e an

d ro

ot o

f Ang

elic

a ar

chan

-ge

lica

L. (s

yn. A

. o�

cina

lis H

o�m

.) (a

ngel

ica

arch

ange

lica

root

) Ph

.Eur

.Sp

iritu

s Mel

issae

com

p.(0

4.06

.198

6)

Anh

alon

ium

see

Loph

opho

ra w

illia

msii

Cou

lt.A

nisu

mse

e Pi

mpi

nella

ani

sum

L.

Ant

hylli

s vul

nera

ria L

.Fr

esh

aeria

l par

ts o

f Ant

hylli

s vul

nera

ria L

. at �

ower

ing

Cal

endu

la/T

ropa

eolu

m

com

p. (0

2.03

.199

1)Ap

ocyn

um c

anna

binu

m L

.Fr

esh

unde

rgro

und

part

s of A

pocy

num

can

nabi

num

L.

HA

BSc

illa

com

p.(2

5.10

.199

4)A

ralia

race

mos

a L.

Fres

h un

derg

roun

d pa

rts o

f Ara

lia ra

cem

osa

L.H

AB

Arc

tium

lapp

a L.

Drie

d w

hole

or c

ut ro

ots o

f Arc

tium

lapp

a L.

(A. m

ajor

Gae

rtn.

), A

. m

inus

(Hill

) Ber

nh. a

nd A

. tom

ento

sum

Mill

. also

rela

ted

spec

ies

or h

ybrid

s (A

ster

acea

e), c

olle

cted

in au

tum

n of

the

�rst

yea

r or

sprin

g of

the

seco

nd y

ear

DA

CA

rnic

a/La

ppa

com

p.

(02.

03.1

991)

Aris

aem

a tr

iphy

llum

(L.)

Torr

.Fr

esh

unde

rgro

und

part

s of A

risae

mia

trip

hyllu

m (L

.) To

rr.,

col-

lect

ed b

efor

e th

e le

aves

dev

elop

. (A

rum

trip

hyllu

m)

HA

B

Arm

orac

ia ru

stic

ana

Ph. G

ärtn

., B.

Mey

. et S

cher

b.Fr

esh

leav

es o

f Arm

orac

ia ru

stic

ana

Ph. G

aert

n., B

. Mey

. et S

cher

b.

Arm

orac

ia ru

stic

ana

Ph. G

ärtn

., B.

Mey

. et S

cher

b.Fr

esh

unde

rgro

und

part

s of A

rmor

acia

rust

ican

a Ph

. Gae

rtn.

, B.

Mey

et S

cher

b.Ph

.fr.

Coc

hela

ria a

rmor

acia

(1

2.09

.199

2)A

rnic

a m

onta

na L

.Vo

latil

e oi

l fro

m th

e un

derg

roun

d pa

rts o

f Arn

ica

mon

tana

L.

Vade

mec

um: C

alci

um

silic

icum

com

p.A

rnic

a m

onta

na L

.Fr

esh

�ow

er-h

eads

of A

rnic

a m

onta

na L

.A

rnic

a, F

los

(04.

06.1

986)

Arn

ica

mon

tana

L.

Who

le fr

esh

�ow

erin

g pl

ants

of A

rnic

a m

onta

na L

.H

AB

/ Ph.

fr.A

rnic

a, P

lant

a to

ta

(04.

06.1

986)

Arn

ica

mon

tana

L.

Fres

h un

derg

roun

d pa

rts o

f Arn

ica

mon

tana

L.

Arn

ica

(04.

06.1

986)

Arn

ica

mon

tana

L.

Who

le o

r par

tially

bro

ken,

drie

d �o

wer

-hea

ds o

f Arn

ica

mon

tana

L.

(arn

ica

�ow

er)

HA

B / P

h.Eu

r.A

rnic

a, F

los

(04.

06.1

986)

Arn

ica

mon

tana

L.

Drie

d un

derg

roun

d pa

rts o

f Arn

ica

mon

tana

L.

HA

BA

rnic

a (0

4.06

.198

6)

• Ap

pend

ix 2

.2


90

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erA

rtem

isia

abro

tanu

m L

.Fr

esh

youn

g sh

oots

and

leav

es o

f Art

emisi

a ab

rota

num

L.

HA

B / P

h.fr.

Abr

otan

um (D

AZ

Nr.

29 v

om 2

1.07

.199

4)A

rtem

isia

absin

thiu

m L

.Fr

esh

uppe

r sho

ots w

ith at

tach

ed le

aves

and

�ow

ers a

nd b

asal

le

aves

of A

rtem

isia

absin

thiu

m L

. sep

arat

ely

or a

s a m

ixtu

re.

HA

B C

icho

rium

/Tar

axac

um

com

p.(0

4.06

.198

6)A

rtem

isia

absin

thiu

m L

.Ba

sal l

eave

s or s

light

ly le

afy,

�ow

erin

g to

ps, o

r mix

ture

of t

hese

dr

ied,

who

le o

r cut

org

ans o

f Art

emisi

a ab

sinth

ium

L. (

wor

mw

ood)

HA

B / P

h.Eu

r.G

entia

na co

mp.

(1

2.09

.199

2)A

rum

mac

ulat

um L

.Fr

esh

unde

rgro

und

part

s of A

rum

mac

ulat

um L

., co

llect

ed b

efor

e th

e le

aves

dev

elop

.H

AB

Aru

m m

acul

atum

/Pt

erid

ium

aqu

ilinu

m

(02.

03.1

991)

Aru

m tr

iphy

llum

see

Aris

aem

a tr

iphy

llum

(L.)

Torr

.A

rund

o do

nax

L.Fr

esh

unde

rgro

und

part

s of A

rund

o do

nax

L.Ph

.fr.

Asa

foet

ida

see

Feru

la a

ssa-

foet

ida

L.A

saru

m e

urop

aeum

L.

Fres

h un

derg

roun

d pa

rts o

f phe

nylp

ropa

ne-c

onta

inin

g su

bspe

cies

of

Asa

rum

eur

opae

um L

.H

AB

Asp

erul

a od

orat

ase

e G

aliu

m o

dora

tum

Asp

idiu

m �

lix-m

asse

e D

ryop

teris

�lix

-mas

(L.)

Scho

tt.A

spid

ospe

rma

queb

rach

o-bl

anco

Sc

hlec

hten

d.D

ried

who

le o

r cut

crus

t of A

spid

ospe

rma

queb

rach

o-bl

anco

Sc

hlec

hten

d.D

AC

Ast

raga

lus e

xsca

pus L

.Fr

esh

�ow

erin

g an

d in

frui

t ros

ette

s of A

stra

galu

s exs

capu

s L.

Vade

mec

um: A

stra

ga-

lus e

xsca

pus

Atro

pa b

ella

-don

na L

.W

hole

or c

ut, d

ried

root

s and

rhiz

ome

from

3- t

o 4-

yea

r old

pla

nts

of A

trop

a be

lla-d

onna

L.,

colle

cted

at �

ower

ing

and

with

frui

tD

AC

Bella

donn

a (0

4.06

.198

6)At

ropa

bel

la-d

onna

L.

Fres

h fr

uits

of A

trop

a be

lla-d

onna

L.

Bella

donn

a (0

4.06

.198

6)At

ropa

bel

la-d

onna

L.

Who

le fr

esh

plan

ts o

f Atr

opa

bella

-don

na L

., w

ithou

t woo

dy lo

wer

st

em se

ctio

ns, c

olle

cted

at th

e en

d of

�ow

erin

gH

AB

Bella

donn

a (0

4.06

.198

6)At

ropa

bel

la-d

onna

L.

Fres

h w

hole

�ow

erin

g pl

ants

of A

trop

a be

lla-d

onna

L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)At

ropa

bel

la-d

onna

L.

Fres

h ae

rial p

arts

of A

trop

a be

lla-d

onna

L. w

ithou

t woo

dy lo

wer

st

em se

ctio

ns, c

olle

cted

at th

e be

ginn

ing

of �

ower

ing

Bella

donn

a (0

4.06

.198

6)At

ropa

bel

la-d

onna

L.

Fres

h un

derg

roun

d pa

rts o

f Atr

opa

bella

-don

na L

.Be

llado

nna

(04.

06.1

986)

Aven

a sa

tiva

L.W

hole

fres

h pl

ants

of A

vena

sativ

a L.

, col

lect

ed w

hen

the

grai

n ha

s rip

ened

to th

e m

ilky

stag

eH

AB

Aven

a/Pa

ssi�

ora

com

p.

(03.

07.1

992)

• Appendix 2.2


91

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erAv

ena

sativ

a L.

Fres

h ae

rial p

arts

of A

vena

sativ

a L.

, col

lect

ed w

hen

the

grai

n ha

s rip

ened

to th

e m

ilky

stag

eH

yper

icum

/Pas

si�or

a co

mp.

(DA

Z N

r. 29

vo

m 2

1.07

.199

4)Av

ena

sativ

a L.

Fres

h ae

rial p

arts

of A

vena

sativ

a L.

, col

lect

ed at

�ow

erin

g tim

eH

AB

/ Ph.

fr.Av

ena

sativ

a (D

AZ

Nr.

29 v

om 2

1.07

.199

4)Av

ena

sativ

a L.

Ger

min

ated

frui

ts o

f Ave

na sa

tiva

L.

Mag

nesiu

m p

hosp

hori-

cum

cum

cine

re A

vena

e (0

2.03

.199

1)Av

ena

sativ

a L.

Drie

d m

illed

frui

ts o

f Ave

na sa

tiva

L.Ba

llota

nig

ra L

.Fr

esh

who

le p

lant

of B

allo

ta n

igra

L. a

t �ow

erin

gPh

.fr.

Balsa

mum

per

uvia

num

see

Myr

oxyl

on b

alsa

mum

(L.)

Har

ms

Bam

busa

see

Phyl

lost

achy

s viri

digl

auce

scen

s (C

arr.)

A. e

t C. R

iv.Ba

mbu

sa a

rund

inac

ea (R

etz.)

W

illd,

Bam

busa

vul

garis

Sch

rad.

ex

J. C

. Wen

dl.

Fres

h sh

oot j

oint

s of B

ambu

sa a

rund

inac

ea (R

etz.)

Will

d an

d/or

Ba

mbu

sa v

ulga

ris S

chra

d. e

x J.

C. W

endl

Bella

donn

ase

e At

ropa

bel

la-d

onna

L.

Belli

s per

enni

s L.

Who

le fr

esh

�ow

erin

g pl

ants

of B

ellis

per

enni

s L.

HA

B / P

h.fr.

Sym

phyt

um co

mp.

(1

2.09

.199

2)Be

llis p

eren

nis L

.Fr

esh

aeria

l par

ts o

f Bel

lis p

eren

nis L

. at �

ower

ing

Belli

s/Tr

opae

olum

(0

2.03

.199

1)Be

nzoe

see

Styr

ax to

nkin

ensis

(Pie

rre)

Cra

ib e

x H

artw

ich

Berb

eris

aqui

foliu

mse

e M

ahon

ia a

quifo

lium

(Pur

sh) N

utt.

Berb

eris

vulg

aris

L.Fr

esh

aeria

l par

ts o

f Ber

beris

vul

garis

L. a

t �ow

erin

gBe

rber

is/Pr

osta

ta co

mp.

(1

2.09

.199

2)Be

rber

is vu

lgar

is L.

Fres

h un

derg

roun

d pa

rts o

f Ber

beris

vul

garis

L.

Berb

eris/

Urt

ica

uren

s, H

erba

(03.

07.1

992)

Berb

eris

vulg

aris

L.W

hole

, ful

ly ri

pene

d be

rrie

s of B

erbe

ris v

ulga

ris L

. str

ippe

d o�

the

frui

t sta

lks

HA

BBe

rber

is, F

ruct

us

(07.

04.1

988)

Berb

eris

vulg

aris

L.Fr

esh

who

le p

lant

incl

udin

g be

rrie

s of B

erbe

ris v

ulga

ris L

.Be

rber

is, P

lant

a to

ta /

Urt

ica

uren

s (0

2.03

.199

1)Be

rber

is vu

lgar

is L.

Drie

d ba

rk o

f aer

ial a

nd u

nder

grou

nd p

arts

of B

erbe

ris v

ulga

ris L

.H

AB

Berb

eris,

Cor

tex

(03.

07.1

992)

• Ap

pend

ix 2

.2


92

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erBe

rber

is vu

lgar

is L.

Drie

d ba

rk o

f und

ergr

ound

par

ts o

f Ber

beris

vul

garis

L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)Be

rber

is vu

lgar

is L.

Drie

d un

derg

roun

d pa

rts o

f Ber

beris

vul

garis

L.

Berb

eris/

Che

lidon

ium

co

mp.

(02.

03.1

991)

Beta

vul

garis

L.

Sacc

haru

m B

etae

(cru

de b

eet s

ugar

)Be

toni

case

e St

achy

s o�

cina

lis (L

.) Tr

ev.

Betu

la p

endu

la R

oth

Fres

h yo

ung

leav

es o

f Bet

ula

pend

ula

Roth

.H

AB

Betu

la, F

oliu

m

(04.

06.1

986)

Betu

la p

endu

la R

oth

Drie

d w

hite

par

ts o

nly

of b

ark

from

trun

k an

d br

anch

es o

f Bet

ula

pend

ula

Roth

HA

BBe

tula

, Cor

tex

(07.

04.1

988)

Betu

la p

endu

la R

oth,

Bet

ula

pu-

besc

ens E

hrha

rtW

hole

or f

ragm

ente

d dr

ied

leav

es o

f Bet

ula

pend

ula

Roth

and

/or

Betu

la p

ubes

cens

Ehr

h., a

s wel

l as h

ybrid

s of b

oth

spec

ies.

(Birc

h le

af)

Ph.E

ur.

Betu

la, F

oliu

m

(04.

06.1

986)

Betu

la p

endu

la R

oth,

Bet

ula

pu-

besc

ens E

hrha

rtFi

nal c

arbo

n re

mai

ning

from

bur

ning

Birc

h w

ood

HA

BC

arbo

Bet

ulae

(0

4.06

.198

6)Bo

ldo

see

Peum

us b

oldu

s Mol

.Bo

rago

o�

cina

lis L

.Fr

esh

leav

es o

f Bor

ago

o�ci

nalis

L.

Bora

go (0

2.03

.199

1)Bo

rago

o�

cina

lis L

.Fr

esh

aeria

l par

ts o

f Bor

ago

o�ci

nalis

L. a

t �ow

erin

gBo

rago

(02.

03.1

991)

Bosw

ellia

spec

ies,

part

icul

arly

Bo

swel

lia c

arte

ri Bi

rdw

ood

see

Bosw

ellia

spec

ies,

part

icul

arly

Bos

wel

lia sa

cra

Flue

ckig

er

Bosw

ellia

spec

ies,

part

icul

arly

Bo

swel

lia sa

cra

Flue

ckig

erSo

lidi�

ed g

um-r

esin

obt

aine

d fr

om in

cisio

ns in

the

shru

bs o

r tre

es

of m

embe

rs o

f the

gen

us B

osw

ellia

, par

ticul

arly

Bos

wel

lia c

arte

ri Bi

rdw

ood

(Syn

. Bos

wel

lia sa

cra

Flue

ckig

er) a

nd/o

r Bos

swel

lia

frer

eana

Bird

woo

d

(DA

C, P

h.Eu

r., B

. ser

-ra

ta)

Auru

m co

mp.

(0

5.12

.198

9)

Botr

ychi

um lu

naria

L.

Fres

h ae

rial p

arts

of B

otry

chiu

m lu

naria

L.

Bras

sica

nigr

a (L

.) W

.D.J.

Koc

hRi

pe d

ried

seed

s of B

rass

ica

nigr

a (L

.) Ko

ch (S

inap

is ni

gra)

DA

CA

escu

lus/

Cer

a co

mp.

(0

2.03

.199

1)Br

yoni

a cr

etic

a L.

ssp.

dio

ica

(Jac

q.) T

utin

Fres

h ro

ot o

f Bry

onia

cret

ica

L. ss

p. d

ioic

a (J

acq.

) Tut

in o

r Bry

onia

al

ba L

., ha

rves

ted

befo

re th

e pl

ant c

omes

into

�ow

erH

AB

Bryo

nia

(03.

07.1

992)

Bryo

nia

cret

ica

L. ss

p. d

ioic

a (J

acq.

) Tut

inFr

esh

root

of B

ryon

ia cr

etic

a L.

ssp.

dio

ica

(Jac

q.) T

utin

, har

vest

ed

befo

re sh

oots

are

pro

duce

dH

AB

Bryo

nia

(03.

07.1

992)

Bryo

nia

cret

ica

L. ss

p. d

ioic

a (J

acq.

) Tut

inFr

esh

unde

rgro

und

part

s of B

ryon

ia cr

etic

a L.

ssp.

dio

ica

(Jac

q.)

Tutin

or B

ryon

ia a

lba

L.Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

• Appendix 2.2


93

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erBr

yoph

yllu

m d

aigr

emon

tianu

m

(Ray

m.-H

amet

et H

. Per

rier)

A.

Berg

er a

nd B

ryop

hyllu

m p

inna

-tu

m (L

am.)

Oke

n

Fres

h le

aves

of B

ryop

hyllu

m d

aigr

emon

tianu

m (R

aym

.-Ham

et e

t H

. Per

rier)

A. B

erge

r and

Kal

anch

oe p

inna

ta (L

am.)

Pers

., ha

rves

t-ed

in th

e �r

st y

ear o

f gro

wth

HA

BBr

yoph

yllu

m

(04.

06.1

986)

Bryo

phyl

lum

pin

natu

m (L

am.)

Oke

nFr

esh

pres

sed

juic

e fr

om le

aves

of B

ryop

hyllu

m p

inna

tum

(Lam

.) O

ken

Bryo

phyl

lum

(0

4.06

.198

6)Br

yoph

yllu

m p

inna

tum

(Lam

.) O

ken

Fres

h le

aves

of B

ryop

hyllu

m p

inna

tum

(Lam

.) O

ken,

har

vest

ed in

th

e �r

st y

ear o

f gro

wth

HA

BBr

yoph

yllu

m

(04.

06.1

986)

Buxu

s sem

perv

irens

L.

Fres

h, y

oung

leaf

y br

anch

es o

f Bux

us se

mpe

rvire

ns L

.Ph

.fr.

Cac

tus g

rand

i�or

usSe

e Se

leni

cere

us g

rand

i�or

us (L

.) Br

itt. e

t Ros

eC

ajep

uti a

ethe

role

umSe

e M

elal

euca

leuc

aden

dra

(L.)

L.C

alam

usSe

e A

coru

s cal

amus

L.

Cal

endu

la o

�ci

nalis

L.

Fres

h �o

wer

hea

ds o

f Cal

endu

la o

�ci

nalis

L.

Cal

endu

la (0

4.06

.198

6)C

alen

dula

o�

cina

lis L

.Fr

esh

aeria

l par

ts o

f Cal

endu

la o

�ci

nalis

L.,

colle

cted

at �

ower

ing

time

HA

BC

alen

dula

(04.

06.1

986)

Cal

endu

la o

�ci

nalis

L.

Drie

d �o

wer

hea

ds o

f Cal

endu

la o

�ci

nalis

L.

Euph

rasia

com

p.

(02.

09.1

987)

Cal

endu

la o

�ci

nalis

L.

Who

le o

r cut

, drie

d, a

nd fu

lly o

pene

d �o

wer

s tha

t hav

e be

en

deta

ched

from

the

rece

ptac

le o

f the

cul

tivat

ed, d

oubl

e-�o

wer

ed

varie

ties o

f Cal

endu

la o

�ci

nalis

L. (

Cal

endu

la �

ower

s)

Ph.E

ur.

Cal

endu

la o

�ci

nalis

L.

Drie

d ae

rial p

arts

of C

alen

dula

o�

cina

lis L

., co

llect

ed at

�ow

erin

g tim

eA

rnic

a co

mp.

/Cup

rum

(0

4.06

.198

6)C

apse

lla b

ursa

-pas

toris

(L.)

Med

.D

ried

aeria

l par

ts o

f Cap

sella

bur

sa-p

asto

ris (L

.) M

edik

, col

lect

ed at

�o

wer

ing

time

HA

BC

apse

lla b

ursa

-pas

toris

(1

2.09

.199

2)C

apsic

um a

nnuu

m L

.D

ried

ripe

frui

ts o

f Cap

sicum

ann

uum

L.

HA

B / P

h.fr.

Kas

tani

en-H

aart

oni-

kum

(04.

06.1

986)

Car

amel

see

Sacc

haru

m o

�ci

naru

m L

.C

ardu

us b

ened

ictu

sse

e C

nicu

s ben

edic

tus L

.C

ardu

us m

aria

nus

see

Sily

bum

mar

ianu

m (L

.) G

aert

n.C

arex

are

naria

L.

Drie

d rh

izom

e of

Car

ex a

rena

ria L

., co

llect

ed in

sprin

gSo

ldne

r / S

tellm

ann

(201

1), I

ndiv

idue

lle

Pädi

atrie

, p. 1

90-1

98

• Ap

pend

ix 2

.2


94

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erC

arum

car

vi L

.O

il ob

tain

ed b

y st

eam

dist

illat

ion

from

the

dry

frui

ts o

f Car

um

carv

i L. (

cara

way

oil)

Ph.E

ur.

Ole

um la

ctag

ogum

(0

2.09

.198

7)C

arum

car

vi L

.W

hole

, dry

mer

icar

p of

Car

um c

arvi

L. (

cara

way

frui

t)H

AB

/ Ph.

Eur.

Car

um c

arvi

com

p.

(02.

03.1

991)

Car

yoph

yllu

sse

e Sy

zygi

um a

rom

atic

um (L

.) M

err.

et L

. M. P

erry

Cas

sia a

ngus

tifol

ia V

ahl.,

Cas

sia

senn

a L.

Drie

d le

a�et

s of C

assia

senn

a L.

(C. a

cutif

olia

Del

il) ,

know

n as

Al-

exan

dria

n or

Kha

rtou

m se

nna,

or C

assia

ang

ustif

olia

Vah

l, kn

own

as T

inne

velly

senn

a, o

r a m

ixtu

re o

f the

2 sp

ecie

s

Ph.fr

. Fo

rmul

aire

de

med

.an

thr.

(201

0)

Cas

sia a

ngus

tifol

ia V

ahl.,

Cas

sia

senn

a L.

Drie

d le

a�et

s of C

assia

senn

a L.

(C. a

cutif

olia

Del

ile),

know

n as

Al-

exan

dria

n or

Kha

rtou

m se

nna,

or C

assia

ang

ustif

olia

Vah

l., k

now

n as

Tin

neve

lly se

nna,

or a

mix

ture

of t

he tw

o sp

ecie

s. (s

enna

leaf

)

Ph.E

ur.

Cen

taur

ium

com

p.(0

4.06

.198

6)

Cas

sia se

nna

L.

(C. a

cutif

olia

Del

ile)

Drie

d fr

uit o

f Cas

sia se

nna

L. (s

enna

pod

s, al

exan

dria

n)Ph

.Eur

.A

rtem

isia

com

p.(0

2.03

.199

1)C

aulo

phyl

lum

thal

ictr

oide

s (L.

) M

ichx

.Fr

esh

unde

rgro

und

part

s of C

aulo

phyl

lum

thal

ictr

oide

s (L.

) Mi-

chx.

, har

vest

ed in

late

sum

mer

HA

B

Cau

loph

yllu

m th

alic

troi

des (

L.)

Mic

hx.

Drie

d un

derg

roun

d pa

rts o

f Cau

loph

yllu

m th

alic

troi

des (

L.) M

ich-

aux.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)C

eano

thus

am

eric

anus

L.

Drie

d le

aves

of C

eano

thus

am

eric

anus

L.

Ph.fr

. / H

AB

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Cen

taur

ium

ery

thra

ea R

afn.

Fres

h w

hole

pla

nts o

f Cen

taur

ium

ery

thra

ea R

afn.

, col

lect

ed at

�o

wer

ing

time

Cen

taur

ium

ery

thra

ea R

afn.

Fres

h ae

rial p

arts

of C

enta

uriu

m e

ryth

raea

Raf

n.C

icho

rium

/Tar

axac

um

com

p. (0

4.06

.198

6)C

enta

uriu

m e

ryth

raea

Raf

n.W

hole

or f

ragm

ente

d dr

ied

�ow

erin

g ae

rial p

arts

of C

enta

uriu

m

eryt

hrae

a Ra

fn s.

l. in

clud

ing

C. m

ajus

(H. e

t L.)

Zeltn

er a

nd C

. suf

-fr

utic

osum

(Gris

eb.)

Ronn

. (sy

n.: E

ryth

raea

cent

auriu

m P

erso

on;

C. u

mbe

llatu

m G

ilibe

rt; C

. min

us G

ars.)

(cen

taur

y)

Ph.E

ur.

Cen

taur

ium

com

p.

(04.

06.1

986)

Cen

tella

asia

tica

(L.)

Urb

.D

ried,

frag

men

ted

aeria

l par

ts o

f Cen

tella

asia

tica

(L.)

Urb

anPh

.fr.

Cep

ase

e A

llium

cepa

L.

Cep

hael

is ip

ecac

uanh

ase

e Ps

ycho

tria

ipec

acua

nha

(Bro

t.) S

toke

s

• Appendix 2.2


95

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erC

epha

elis

ipec

acua

nha

(Bro

t.)

A. R

ich.

, Cep

hael

is ac

umin

ata

Kar

sten

Frag

men

ted

and

drie

d un

derg

roun

d or

gans

of C

epha

elis

ipec

acua

-nh

a (B

rot.)

A. R

ich.

, kno

wn

as M

atto

Gro

sso

ipec

acua

nha,

or o

f C

epha

elis

acum

inat

a K

arst

en, k

now

n as

Cos

ta R

ica

ipec

acua

nha,

or

of a

mix

ture

of b

oth

spec

ies.

(ipec

acua

nhae

root

)

Ph.fr

. / P

h.Eu

r.Fo

rmul

aire

de

med

.an

thr.

(201

0)

Cet

raria

isla

ndic

a (L

.) A

ch.

Who

le o

r cut

, drie

d th

allu

s of C

etra

ria is

land

ica

(L.)

Ach

ariu

s s.l.

(ic

elan

d m

oss)

HA

B / P

h.Eu

r.C

etra

ria is

land

ica

(04.

06.1

986)

Cha

mae

liriu

m lu

teum

(L.)

A.

Gra

yD

ried

unde

rgro

und

part

s of C

ham

aelir

ium

lute

um (L

.) A

. Gra

y

Cha

mom

illa

recu

tita

(L.)

Raus

cher

tse

e M

atric

aria

recu

tita

L.

Che

irant

hus c

heiri

L.

Fres

h w

hole

�ow

erin

g pl

ant o

f Che

irant

hus c

heiri

L.

Che

lidon

ium

maj

us L

.Fr

esh

rhiz

ome

and

adhe

rent

root

s of C

helid

oniu

m m

ajus

L.,

col-

lect

ed d

urin

g la

te au

tum

n or

on

the

appe

aran

ce o

f the

�rs

t sho

ots

HA

BC

helid

oniu

m

(12.

09.1

992)

Che

lidon

ium

maj

us L

.Fr

esh

�ow

ers o

f Che

lidon

ium

maj

us L

.H

AB

Che

lidon

ium

(1

2.09

.199

2)C

helid

oniu

m m

ajus

L.

Fres

h ae

rial p

arts

of C

helid

oniu

m m

ajus

L.,

colle

cted

at �

ower

ing

time

Che

lidon

ium

(1

2.09

.199

2)C

helid

oniu

m m

ajus

L.

Fres

h w

hole

�ow

erin

g pl

ants

of C

helid

oniu

m m

ajus

L.

Ph.fr

.C

him

aphi

la u

mbe

llata

(L.)

Bart

onD

ried

aeria

l par

ts o

f Chi

map

hila

um

bella

ta (L

.) Ba

rton

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)C

hina

see

Cin

chon

a pu

besc

ens V

ahl

Chl

orop

hyce

aeFr

esh

�al

li of

alg

ae fr

om th

e ge

nus C

lado

phor

a or

Oed

ogon

ium

or

oth

er g

ener

a of

�la

men

tous

org

anise

d gr

een

alga

e fr

om th

e cl

ass

Chl

orop

hyce

ae.

Arg

entu

m n

itric

um

com

p. (0

2.03

.199

1)

Cho

ndod

endr

on to

men

tosu

m

Ruiz

et P

av.

Drie

d ro

ots o

f Cho

ndod

endr

on to

men

tosu

m R

uiz e

t Pav

.Ph

.fr.

Chr

ysos

plen

ium

alte

rnifo

lium

L.

Who

le fr

esh

plan

ts o

f Chr

ysos

plen

ium

alte

rnifo

lium

L.

Chr

ysos

plen

ium

com

p.

(25.

10.1

994)

Cic

horiu

m in

tybu

s L.

Who

le fr

esh

�ow

erin

g pl

ants

of C

icho

rium

inty

bus L

.H

AB

Cic

horiu

m (0

3.07

.199

2)C

icho

rium

inty

bus L

.D

ried

who

le p

lant

s of C

icho

rium

inty

bus L

. var

. int

ybus

and

Cic

ho-

rium

inty

bus L

. var

. sat

ivum

DC

, col

lect

ed at

�ow

erin

g tim

e. �

e to

ugh

mid

dle

stem

sect

ions

are

not

use

d.

HA

BC

icho

rium

(03.

07.1

992)

• Ap

pend

ix 2

.2


96

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erC

icho

rium

inty

bus L

.D

ried

root

of C

icho

rium

inty

bus L

. ssp

. int

ybus

and

Cic

horiu

m

inty

bus L

. ssp

. sat

ivum

(DC

) Jan

chen

, col

lect

ed at

�ow

erin

g tim

eC

icho

rium

(03.

07.1

992)

Cim

icifu

ga ra

cem

osa

(L.)

Nut

t.Fr

esh

rhiz

ome

and

adhe

rent

root

s of C

imifu

ga ra

cem

osa

(L.)

Nut

t.H

AB

Cim

icifu

ga co

mp.

(0

2.09

.198

7)C

inch

ona

pube

scen

s Vah

lW

hole

or c

ut, d

ried

bark

of C

inch

ona

pube

scen

s Vah

l (C

inch

ona

succ

irubr

a Pa

v.), o

f C. c

alisa

ya W

edd.

, of C

. led

geria

na M

oens

ex

Trim

en o

r of t

heir

varie

ties o

r hyb

rids (

cinc

hona

bar

k)

HA

B / P

h.Eu

r.A

coni

tum

/Chi

na co

mp.

(1

2.09

.199

2)

Cin

erar

ia m

ariti

ma

see

Sene

cio

bico

lor (

Will

d.) T

od.

Cin

nam

omum

ver

um J.

S. P

resl

Drie

d ba

rk, f

reed

from

the

oute

r cor

k an

d th

e un

derly

ing

pare

n-ch

yma,

of t

he sh

oots

gro

wn

on c

ut st

ock

of C

inna

mom

umve

rum

J.

S. P

resl

(cin

nam

on)

HA

B / P

h.Eu

r.Sp

iritu

s Mel

issae

com

p.

(04.

06.1

986)

Ciss

us g

ongy

lode

s (Ba

k.) B

urch

.Fr

esh

aeria

l roo

ts o

f Ciss

us g

ongy

lode

s (Ba

k.) B

urch

.C

issus

-Oss

a (0

3.07

.199

2)C

itrul

lus c

oloc

ynth

is (L

.) Sc

hrad

.D

ried

pulp

of C

itrul

lus c

oloc

ynth

is (L

.) Sc

hrad

.Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Citr

ullu

s col

ocyn

this

(L.)

Schr

ad.

Fres

h pe

eled

unr

ipe

frui

t of C

itrul

lus c

oloc

ynth

is (L

.) Sc

hrad

. w

ithou

t see

dsC

oloc

ynth

is (0

7.04

.198

8)C

itrul

lus c

oloc

ynth

is (L

.) Sc

hrad

.D

ried

peel

ed fr

uit o

f Citu

llus c

oloc

ynth

is (L

.) Sc

hrad

. with

out s

eeds

HA

BC

oloc

ynth

is (0

7.04

.198

8)C

itrus

lim

on (L

.) Bu

rm. f

.Es

sent

ial o

il ob

tain

ed b

y su

itabl

e m

echa

nica

l mea

ns, w

ithou

t the

ai

d of

hea

t, fr

om th

e fr

esh

peel

of C

itrus

lim

on (L

.) Bu

rman

. �l.

(lem

on o

il)

Ph.E

ur.

Spiri

tus M

eliss

ae co

mp.

(0

4.06

.198

6)

Citr

us li

mon

(L.)

Burm

. f.

Fres

h pr

esse

d ju

ice

from

the

frui

t of C

itrus

lim

on (L

.) Bu

rman

. �l.

Citr

us/C

ydon

ia

(04.

06.1

986)

Citr

us li

mon

(L.)

Burm

. f.

Fres

h fr

uit o

f Citr

us li

mon

(L.)

Burm

an. �

l.C

itrus

/Cyd

onia

(0

4.06

.198

6)C

itrus

med

ica

var.

limon

umse

e C

itrus

lim

on (L

.) Bu

rman

. �l.

Cla

dina

rang

iferin

a (L

.) N

yl.

Drie

d th

allu

s of C

ladi

na ra

ngife

rina

(L.)

Nyl

.Li

chen

es co

mp.

(0

4.06

.198

6)C

lavi

ceps

pur

pure

a (F

r.) T

ul.

Drie

d sc

lero

tum

of C

lavi

ceps

pur

pure

a (F

ries)

Tul

asne

, gro

wn

on

rye

plan

ts (S

ecal

e ce

real

e L.

) and

drie

d at

a te

mpe

ratu

re n

ot e

xcee

d-in

g 40

°C (S

ecal

e co

rnut

um)

HA

BBl

eigl

anz/

Seca

le co

mp.

(1

2.09

.199

2)

Cle

mat

is re

cta

L.Fr

esh,

you

ng le

afy

bran

ches

of C

lem

atis

rect

a L.

, col

lect

ed at

�ow

-er

ing

time

Ph.fr

.

• Appendix 2.2


97

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erC

lem

atis

rect

a L.

Fres

h ae

rial p

arts

of o

f Cle

mat

is re

cta

L., c

olle

cted

at �

ower

ing

time

HA

BVa

dem

ecum

: Cle

mat

is re

cta

Cni

cus b

ened

ictu

s L.

Fres

h ae

rial p

arts

of C

nicu

s ben

edic

tus L

., co

llect

ed at

�ow

erin

g tim

eH

AB

Bora

go co

mp.

(1

2.09

.199

2)C

occu

lus

see

Ana

mirt

a co

ccul

us W

ight

et A

rn.

Coc

hlea

ria a

rmor

acia

see

Arm

orac

ia ru

stic

ana

Ph. G

ärtn

., B.

Mey

. et S

cher

b.C

ochl

earia

o�

cina

lis L

.Fr

esh

aeria

l par

ts o

f Coc

hlea

ria o

�ci

nalis

L.,

colle

cted

at th

e st

art

of �

ower

ing

time

HA

BC

ochl

earia

o�

cina

lis

(07.

04.1

988)

Coc

hlea

ria o

�ci

nalis

L.

Drie

d ae

rial p

arts

of C

ochl

earia

o�

cina

lis L

., co

llect

ed at

the

begi

n-ni

ng o

f the

�ow

erin

g tim

eLe

vist

icum

com

p.

(02.

09.1

987)

Co�

ea a

rabi

ca L

.D

ried

roas

ted

seed

s of C

o�ea

ara

bica

L.

Aven

a sa

tiva

com

p.

(04.

06.1

986)

Co�

ea a

rabi

ca L

., C

o�ea

can

epho

-ra

Pie

rre

ex F

roeh

ner a

nd th

eir

varie

ties.

Drie

d gr

ey-g

reen

seed

s of C

o�ea

ara

bica

L.,

de C

o�ea

can

epho

ra

Pier

re e

x Fr

oehn

er a

nd th

eir v

arie

ties.

Ph.fr

.

Co�

ea a

rabi

ca L

.Ri

pe, d

ried,

unr

oast

ed se

eds o

f Co�

ea a

rabi

ca L

. with

the

seed

coat

(s

ilver

skin

) lar

gely

rem

oved

HA

B

Col

chic

um au

tum

nale

L.

Fres

h co

rms o

f Col

chic

um au

tum

nale

L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)C

olch

icum

autu

mna

le L

.Fr

esh

corm

s of C

olch

icum

autu

mna

le L

., co

llect

ed at

�ow

erin

g tim

e an

d fr

ee fr

om �

brou

s roo

tsH

AB

Col

chic

um (0

4.06

.198

6)

Col

chic

um au

tum

nale

L.

Fres

h w

hole

, �ow

erin

g pl

ant o

f Col

chic

um au

tum

nale

L.

Col

chic

um (0

4.06

.198

6)C

ollin

soni

a ca

nade

nsis

L.

Drie

d rh

izom

e of

Col

linso

nia

cana

dens

is L.

Ph.fr

.C

oloc

ynth

isse

e C

itrul

lus c

oloc

ynth

is (L

.) Sc

hrad

.C

omm

ipho

ra Ja

cq. S

peci

esG

um-r

esin

, har

dene

d in

air,

obt

aine

d by

inci

sion

or p

rodu

ced

by

spon

tane

ous e

xuda

tion

from

the

stem

and

bra

nche

s of C

omm

ipho

-ra

mol

mol

Eng

ler a

nd/o

r oth

er sp

ecie

s of C

omm

ipho

ra (m

yrrh

)

Ph.E

ur.

Auru

m co

mp.

(0

5.12

.198

9)

Con

ium

mac

ulat

um L

.Fr

esh

�ow

erhe

ads o

f Con

ium

mac

ulat

um L

., co

llect

ed at

the

end

of

�ow

erin

g tim

ePh

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Con

ium

mac

ulat

um L

.Fr

esh,

aer

ial p

arts

of t

he �

ower

ing,

but

not

yet

frui

ting

spec

imen

s of

Con

ium

mac

ulat

um L

.H

AB

Con

ium

mac

ulat

um

(02.

09.1

987)

• Ap

pend

ix 2

.2


98

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erC

onva

llaria

maj

alis

L.Fr

esh

aeria

l par

ts o

f Con

valla

ria m

ajal

is L.

, col

lect

ed at

�ow

erin

g tim

eH

AB

Con

valla

ria

(03.

07.1

992)

Con

valla

ria m

ajal

is L.

Fres

h w

hole

, �ow

erin

g p

lant

s of C

onva

llaria

maj

alis

L.C

onva

llaria

/Prim

ula

com

p. (1

2.09

.199

2)C

onva

llaria

maj

alis

L.Fr

esh

�ow

ers o

f Con

valla

ria m

ajal

is L.

Con

valla

ria

(03.

07.1

992)

Cor

iand

rum

sativ

um L

.D

ried

crem

ocar

p of

Cor

iand

rium

sativ

um L

. (co

riand

er)

Ph.E

ur.

Spiri

tus M

eliss

ae co

mp.

(0

4.06

.198

6)C

oryd

alis

cava

(L.)

Cla

irv.

Fres

h un

derg

roun

g pa

rts o

f Cor

ydal

is ca

va (L

.) C

lair

v.C

rata

egus

laev

igat

a (P

oir.)

DC

., C

rata

egus

mon

ogyn

a Ja

cq.

emen

d. L

indm

.

Fres

h le

aves

and

ripe

frui

t of C

rata

egus

laev

igat

a (P

oir.)

DC

. and

C

rata

egus

mon

ogyn

a Ja

cq. e

men

d. L

indm

anC

rata

egus

(02.

09.1

987)

Cra

taeg

us la

evig

ata

(Poi

r.) D

C.,

Cra

taeg

us m

onog

yna

Jacq

. em

end.

Lin

dm.

Fres

h rip

e fr

uits

of C

rata

egus

laev

igat

a (P

oir)

DC

., C

rata

egus

mo-

nogy

na Ja

cq. e

men

d. L

indm

., th

eir h

ybrid

s and

mix

ture

s the

reof

HA

BC

rata

egus

(02.

09.1

987)

Cra

taeg

us la

evig

ata

(Poi

r.) D

C.,

Cra

taeg

us m

onog

yna

Jacq

. em

end.

Lin

dm.

Who

le o

r cut

, drie

d �o

wer

-bea

ring

bran

ches

of C

rata

egus

mo-

nogy

na Ja

cq. (

Lind

m.),

C. l

aevi

gata

(Poi

r.) D

C. (

syno

nym

s: C

.oxy

acan

thoi

des �

uill.

; C. o

xyac

anth

a au

ct.)

or th

eir h

ybrid

s or

, mor

e ra

rely,

othe

r Eur

opea

n C

rata

egus

spec

ies i

nclu

ding

C.

pent

agyn

a W

alds

t. et

Kit.

ex

Will

d., C

. nig

ra W

alds

t. et

Kit.

and

C.

azar

olus

L. (

haw

thor

n le

af a

nd �

ower

)

Ph.E

ur.

Cra

taeg

us (0

2.09

.198

7)

Cro

cus s

ativ

us L

.D

ried

stig

mas

of C

rocu

s sat

iva

L., u

sual

ly jo

ined

by

the

base

to a

sh

ort s

tyle

. (sa

�ron

for h

omoe

opat

hic p

repa

ratio

ns)

HA

B / P

h.Eu

r.K

aliu

m a

cetic

um co

mp.

(0

3.07

.199

2)C

roto

n tig

lium

L.

Drie

d se

eds o

f Cro

ton

tigliu

m L

.Ph

.fr.

Cucu

rbita

pep

o L.

Fres

h �o

wer

s of C

ucur

bita

pep

o L.

Apat

it / P

hosp

horu

s co

mp.

(04.

06.1

986)

Cucu

rbita

pep

o L.

Drie

d pu

lp o

f pum

pkin

s of C

ucur

bita

max

ima

Duc

h.Va

dem

ecum

: Che

lido-

nium

/Cur

cum

a co

mp.

Cupr

essu

s sem

perv

irens

LFr

esh

leaf

y br

anch

es o

f Cup

ress

us se

mpe

rvire

ns L

. with

cone

sPh

.fr.

Curc

uma

xant

horr

hiza

Rox

b.D

ried

rhiz

ome,

cut i

n sli

ces,

of C

ucur

ma

xant

horr

hiza

Rox

b. (C

. xa

ntho

rrhi

za D

. Die

tric

h). (

turm

eric

, Jav

anes

e)Ph

.Eur

.C

helid

oniu

m/C

urcu

ma

(04.

06.1

986)

Cyd

onia

obl

onga

Mill

.Fr

esh

ripe

frui

ts o

f Cyd

onia

obl

onga

Mill

.C

ydon

ia, F

ruct

us

(02.

03.1

991)

• Appendix 2.2


99

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erC

ymbo

pogo

n w

inte

rianu

s Jow

ittO

il ob

tain

ed b

y st

eam

dist

illat

ion

from

the

fres

h or

par

tially

drie

d ae

rial p

arts

of C

ymbo

pogo

n w

inte

rianu

s Jow

itt (c

itron

ella

e oi

l)Ph

.Eur

.C

itron

ella

e ae

ther

o-le

um (0

2.03

.199

1)C

ynar

a sc

olym

us L

.Fr

esh

leav

es o

f Cyn

ara

scol

ymus

L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)C

ytisu

s sco

pariu

s (L.

) Lin

k.Fr

esh

youn

g tip

s of s

hoot

s of C

ytisu

s sco

pariu

s (L.

) Lin

k. w

ith �

ow-

ers a

nd le

aves

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)C

ytisu

s sco

pariu

s (L.

) Lin

k.Fr

esh

aeria

l par

ts o

f Cyt

isus s

copa

rius (

L.) L

ink

at �

ower

ing

time

Saro

tham

nus c

omp.

(0

3.07

.199

2)D

aphn

e m

ezer

eum

L.

Fres

h ba

rk fr

om th

e br

anch

es o

f Dap

hne

mez

ereu

m L

., co

llect

ed

prio

r to

�ow

erin

gH

AB

Mez

ereu

m (0

3.07

.199

2)

Dat

ura

stra

mon

ium

L.

Fres

h ae

rial p

arts

of D

atur

a st

ram

oniu

m L

., co

llect

ed at

�ow

erin

g tim

eH

AB

/ Ph.

fr.St

ram

oniu

m

(02.

03.1

991)

Del

phin

ium

stap

hisa

gria

L.

Drie

d rip

e se

eds o

f Del

phin

ium

stap

hisa

gria

L.

HA

B / P

h.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Dig

italis

pur

pure

a L.

Fres

h le

aves

from

two-

year

-old

spec

imen

s of D

igita

lis p

urpu

rea

L.,

colle

cted

bef

ore

�ow

erin

g tim

eH

AB

Dig

italis

pur

pure

a (0

2.09

.198

7)D

olic

hos p

rurie

nsse

e M

ucun

a pr

urie

ns (L

.) D

C.

Dro

sera

rotu

ndifo

lia L

., D

rose

ra

inte

rmed

ia H

ayne

, Dro

sera

an-

glic

a H

uds.

Who

le fr

esh

plan

ts o

f Dro

sera

rotu

ndifo

lia L

., D

rose

ra in

term

edia

H

ayne

and

Dro

sera

ang

lica

Hud

s., si

ngle

spec

ies o

r mix

ed, c

ol-

lect

ed at

the

star

t of �

ower

ing

HA

BPl

anta

go co

mp.

(1

2.09

.199

2)

Dro

sera

rotu

ndifo

lia L

., D

rose

ra

inte

rmed

ia H

ayne

, Dro

sera

an-

glic

a H

uds.

Who

le d

ried

plan

ts o

f di�

eren

t Dro

sera

spec

ies,

mai

nly

Dro

sera

ro

tund

ifolia

L.,

Dro

sera

inte

rmed

ia H

ayne

and

Dro

sera

ang

lica

Hud

s. (D

. lon

gifo

lia L

.)

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)

Dry

opte

ris �

lix-m

as (L

.) Sc

hott.

Fres

h rh

izom

e of

Dry

opte

ris �

lix-m

as (L

.) Sc

hott,

with

root

sA

quili

num

com

p.

(12.

09.1

992)

Dry

opte

ris �

lix-m

as (L

.) Sc

hott.

Fres

h ae

rial p

arts

of D

ryop

teris

�lix

-mas

(L.)

Scho

tt.A

spid

ium

/Sal

ix co

mp.

(0

4.06

.198

6)D

ryop

teris

�lix

-mas

(L.)

Scho

tt.Ri

pe sp

ores

of D

ryop

teris

�lix

-mas

(L.)

Scho

tt.A

garic

us co

mp.

/Pho

s-ph

orus

(05.

12.1

989)

Dul

cam

ara

see

Sola

num

dul

cam

ara

L.Ec

hina

cea

angu

stifo

lia D

C.,

Echi

-na

cea

palli

da (N

utt.)

Nut

t.W

hole

fres

h �o

wer

ing

plan

ts o

f Ech

inac

ea a

ngus

tifol

ia D

C. a

nd

Echi

nace

a pa

llida

(Nut

t.) N

utt.,

sing

le sp

ecie

s or m

ixed

HA

B

Echi

nace

a an

gust

ifolia

DC

.W

hole

fres

h �o

wer

ing

plan

ts o

f Ech

inac

ea a

ngus

tifol

ia D

C.

HA

BEc

hina

cea

(07.

04.1

988)

• Ap

pend

ix 2

.2


100

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erEc

hina

cea

palli

da (N

utt.)

Nut

t.Fr

esh

�ow

erin

g pl

ants

of E

chin

acea

pal

lida

(Nut

t.) N

utt.

HA

BEc

hina

cea/

Qua

rz co

mp.

(0

2.03

.199

1)Ec

hina

cea

palli

da (N

utt.)

Nut

t.Fr

esh

aeria

l par

ts o

f Ech

inac

ea p

allid

a (N

utt.)

Nut

t., co

llect

ed at

�o

wer

ing

time

Echi

nace

a (0

7.04

.198

8)

Echi

nace

a pa

llida

(Nut

t.) N

utt.

Fres

h un

derg

roun

d pa

rts o

f Ech

inac

ea p

allid

a (N

utt.)

Nut

t.A

rgen

tum

/Ech

inac

ea

(05.

12.1

989)

Echi

nace

a pu

rpur

ea (L

.) M

oenc

hW

hole

fres

h �o

wer

ing

plan

ts o

f Ech

inac

ea p

urpu

rea

(L.)

Moe

nch

HA

BEc

hina

cea

(07.

04.1

988)

Elym

us re

pens

(L.)

Gou

ldFr

esh

unde

rgro

und

part

s of E

lym

us re

pens

(L.)

Gou

ldH

AB

Agr

opyr

on co

mp.

(0

7.04

.198

8)Eq

uise

tum

arv

ense

L.

Fres

h, g

reen

, ste

rile

shoo

ts o

f Equ

isetu

m a

rven

se L

.H

AB

Equi

setu

m a

rven

se

(04.

06.1

986)

Equi

setu

m a

rven

se L

.W

hole

or c

ut, d

ried

ster

ile a

eria

l par

ts o

f Equ

isetu

m a

rven

se L

. (e

quise

tum

stem

)Ph

.Eur

.Eq

uise

tum

arv

ense

(0

4.06

.198

6)Eq

uise

tum

�uv

iatil

e L

see

Equi

setu

m li

mos

um L

. Eq

uise

tum

lim

osum

L.

Fres

h ae

rial p

arts

of E

quise

tum

lim

osum

L.

Sold

ner/

Ste

llman

n (2

011)

Indi

vidu

elle

Pä

diat

rie

Eryt

hrae

a ce

ntau

rium

see

Cen

taur

ium

ery

thra

ea R

afn.

Esch

scho

lzia

cal

iforn

ica

Cha

m.

Who

le fr

esh

�ow

erin

g pl

ants

of E

schs

chol

zia

calif

orni

ca C

ham

.Ph

.fr.

Euca

lypt

us g

lobu

lus L

abill

.Es

sent

ial o

il ob

tain

ed b

y st

eam

dist

illat

ion

and

rect

i�ca

tion

from

th

e fr

esh

leav

es o

r the

fres

h te

rmin

al b

ranc

hlet

s of v

ario

us sp

e-ci

es o

f Euc

alyp

tus r

ich

in 1

,8-c

ineo

le. �

e sp

ecie

s mai

nly

used

are

Eu

caly

ptus

glo

bulu

s Lab

ill.,

Euca

lypt

us p

olyb

ract

ea R

.T.B

aker

and

Eu

caly

ptus

smith

ii R.

T.Ba

ker (

euca

lypt

us o

il)

Ph.E

ur.

Euca

lypt

i aet

hero

leum

(0

2.09

.198

7)

Euca

lypt

us g

lobu

lus L

abill

.Fr

esh

leav

es o

f Euc

alyp

tus g

lobu

lus L

abill

.Cu

prum

sulfu

ricum

/Eu

caly

ptus

(25.

10.1

994)

Euca

lypt

us g

lobu

lus L

abill

.W

hole

or c

ut d

ried

leav

es o

f old

er b

ranc

hes o

f Euc

alyp

tus g

lobu

lus

Labi

ll. (e

ucal

yptu

s lea

f)H

AB

/ Ph.

Eur.

Bryo

nia/

Eupa

toriu

m

com

p. (0

4.06

.198

6)Eu

geni

a ca

ryop

hylla

tase

e Sy

zygi

um a

rom

atic

um (L

.) M

err.

et L

. M. P

erry

Eupa

toriu

m c

anna

binu

m L

.Fr

esh

�ow

erin

g ae

rial p

arts

of E

upat

oriu

m c

anna

binu

m L

.A

coni

tum

/Chi

na co

mp.

(1

2.09

.199

2)

• Appendix 2.2


101

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erEu

pato

rium

per

folia

tum

L.

Fres

h ae

rial p

arts

of E

upat

oriu

m p

erfo

liatu

m L

., co

llect

ed at

star

t of

�ow

erin

gH

AB

/ Ph.

fr.Br

yoni

a/Eu

pato

rium

co

mp.

(04.

06.1

986)

Euph

orbi

a re

sinife

ra O

. Ber

g.H

arde

ned

late

x fr

om E

upho

rbia

resin

ifera

O. B

erg

HA

BFo

rmul

aire

de

med

.an

thr.

(201

0)Eu

phra

sia st

ricta

Wol

� ex

F.J.

Lehm

. and

Eup

hras

ia o

�ci

nalis

L.

subs

p. ro

stko

vian

a (H

ayne

) Tow

ns

Who

le fr

esh

plan

ts o

f Eup

hras

ia st

ricta

Wol

� ex

F.J.

Lehm

. and

Eu

phra

sia o

�ci

nalis

L. s

ubsp

. ros

tkov

iana

(Hay

ne) T

owns

, the

ir hy

brid

s and

mix

ture

s the

reof

, col

lect

ed at

�ow

erin

g tim

e

HA

BEu

phra

sia (0

5.12

.198

9)

Euph

rasia

o�

cina

lis L

.W

hole

fres

h pl

ants

of E

uphr

asia

o�

cina

lis L

., co

llect

ed at

�ow

erin

g tim

ePh

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Fagu

s syl

vatic

a L.

Bran

ch a

nd tr

unk

woo

d of

Fag

us si

lvat

ica

L.A

grop

yron

com

p.

(07.

04.1

988)

Feru

la a

ssa-

foet

ida

L.D

ried

gum

resin

from

Fer

ula

spec

ies s

uch

as F

erul

a as

sa-fo

etid

a L.

an

d Fe

rula

foet

ida

(Bun

ge) R

egel

. (A

sa fo

etid

a)H

AB

Filip

endu

la u

lmar

ia (L

.) M

axim

.Fr

esh

aeria

l par

ts o

f Fili

pend

ula

ulm

aria

(L.)

Max

im. c

olle

cted

at

�ow

eing

tim

e.H

AB

Betu

la/M

andr

agor

a co

mp.

(25.

10.1

994)

Filip

endu

la u

lmar

ia (L

.) M

axim

.Fr

esh

in�o

rece

nce

of F

ilipe

ndul

a ul

mar

ia (L

.) M

axim

. (Sp

iraea

ul

mar

ia L

.)Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Filix

-mas

see

Dry

opte

ris �

lix-m

as (L

.) Sc

hott.

Foen

icul

um v

ulga

re M

ill.

Esse

ntia

l oil

obta

ined

by

stea

m d

estil

latio

n fr

om th

e rip

e fr

uits

of

Foen

icul

um v

ulga

re M

iller

ssp.

vul

gare

var

. Vul

gare

(bitt

er-fe

nnel

fr

uit o

il)

Ph.E

ur.

Berb

eris/

Juni

peru

s co

mp.

(03.

07.1

992)

Foen

icul

um v

ulga

re M

ill.

Drie

d cr

emoc

arps

and

mer

icar

ps o

f Foe

nicu

lum

vul

gare

Mill

. sp.

vu

lgar

e (fe

nnel

, bitt

er)

HA

B/Ph

.Eur

.Sp

ecie

s Car

vi co

mp.

(0

4.06

.198

6)Fr

agar

ia v

esca

L.

Fres

h, ri

pe fa

lse-f

ruits

of F

raga

ria v

esca

LFr

agar

ia/U

rtic

a co

mp.

(0

3.07

.199

2)Fr

agar

ia v

esca

L.

Drie

d, w

hole

or c

ut le

aves

, col

lect

ed at

�ow

erin

g tim

e of

Fra

garia

ve

sca

L., F

raga

ria m

osch

ata

Wes

t., F

raga

ria v

iridi

s Wes

t., F

raga

ria

x an

anas

sa (D

uch.

) Gue

des (

Rosa

ceae

), th

eir h

ybrid

s as w

ell a

s hy

brid

s with

oth

er F

raga

ria sp

ecie

s or m

ixtu

res o

f the

m

DA

CFr

agar

ia/V

itis

(04.

06.1

986)

Fran

gula

aln

usse

e Rh

amnu

s fra

ngul

a L.

Frax

inus

am

eric

ana

L.D

ried

bark

from

bra

nche

s of F

raxi

nus a

mer

ican

a L.

Ph.fr

.Fu

cus v

esic

ulos

us L

.Fr

esh

thal

lus o

f Fuc

us v

esic

ulos

us L

.(P

h.fr.

)Tr

opae

olum

com

p.

(02.

03.1

991)

• Ap

pend

ix 2

.2


102

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erFu

cus v

esic

ulos

us L

., Fu

cus s

er-

ratu

s L.,

Asc

ophy

llum

nod

osum

Le

Jolis

. (Ke

lp)

Frag

men

ted

drie

d th

allu

s of F

ucus

ves

icul

osus

L.,

or F.

serr

atus

L.,

or A

scop

hyllu

m n

odos

um L

e Jo

lis. (

kelp

)Ph

.Eur

.

Fum

aria

o�

cina

lis L

.Fr

esh

aeria

l par

ts o

f Fum

aria

o�

cina

lis L

., co

llect

ed at

�ow

erin

g tim

eH

AB

Trop

aeol

um co

mp.

(0

2.03

.199

1)G

alan

thus

niv

alis

L.Fr

esh

who

le �

ower

ing

plan

t of G

alan

thus

niv

alis

L.Va

dem

ecum

(com

bina

-tio

n se

e H

ippo

cam

pus)

Gal

lae

turc

icae

Oak

appl

es p

rodu

ced

on y

oung

shoo

ts o

f Que

rcus

infe

ctor

ia O

l-iv

ier b

y th

e st

ing

of th

e dy

er’s

gall

was

p A

ndric

us g

alla

e tin

ctor

iae

Oliv

ier

HA

B

Gal

ium

odo

ratu

m (L

.) Sc

op.

Fres

h le

aves

of G

aliu

m o

dora

tum

(L.)

Scop

.G

else

miu

m se

mpe

rvire

ns (L

.) Ja

ume

St. -

Hil.

Fres

h un

derg

roun

d pa

rts o

f Gel

sem

ium

sem

perv

irens

(L.)

Jaum

e St

.-Hil.

HA

BG

else

miu

m

(02.

09.1

987)

Gel

sem

ium

sem

perv

irens

(L.)

Jaum

e St

. - H

il.Fr

esh

unde

rgro

und

part

s of G

else

miu

m se

mpe

rvire

ns (L

.) Ja

ume

St.-H

il.Ph

.fr.

Gel

sem

ium

(0

2.09

.198

7)G

else

miu

m se

mpe

rvire

ns (L

.) D

ried

unde

rgro

und

part

s of G

else

miu

m se

mpe

rvire

ns (L

.) G

else

miu

m

(02.

09.1

987)

Gen

ista

scop

aria

see

Cyt

isus s

copa

rius (

L.) L

ink.

Gen

tiana

lute

a L.

Fres

h un

derg

roun

d pa

rts o

f Gen

tiana

lute

a L.

HA

B / P

h.fr.

Gen

tiana

lute

a (0

4.06

.198

6)G

entia

na lu

tea

L.D

ried,

frag

men

ted

unde

rgro

und

orga

ns o

f Gen

tiana

lute

a L.

(gen

-tia

n ro

ot)

Ph.E

ur.

Gen

tiana

lute

a (0

4.06

.198

6)G

eran

iace

aese

e Pe

larg

oniu

m sp

ecie

sG

eum

urb

anum

L.

Fres

h un

derg

roun

d pa

rts o

f Geu

m u

rban

um L

.H

AB

Geu

m u

rban

um

(03.

07.1

992)

Gin

kgo

bilo

ba L

.Fr

esh

leav

es o

f Gin

kgo

bilo

ba L

.H

AB

/ Ph.

fr.G

inse

ngse

e Pa

nax

gins

eng

C.A

. Mey

.G

lech

oma

hede

race

a L.

Fres

h w

hole

�ow

erin

g pl

ant o

f Gle

chom

a he

dera

cea

L.Ph

.fr.

Gle

chom

a he

dera

cea

L.D

ried

�ow

erin

g pl

ant o

f Gle

chom

a he

dera

cea

L.G

naph

aliu

mse

e Le

onto

podi

um a

lpin

um C

ass.

Gra

min

eae

Drie

d in

�ore

scen

ce o

f sev

eral

Gra

min

eae

spec

ies o

btai

ned

from

ha

y (h

ay �

ower

s, ha

y bl

osso

ms)

• Appendix 2.2


103

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erH

amam

elis

virg

inia

na L

.Fr

esh

bark

and

leav

es o

f Ham

amel

is vi

rgin

iana

L.

Ham

amel

is (0

3.07

.199

2)H

amam

elis

virg

inia

na L

.Fr

esh

bark

of H

amam

elis

virg

inia

na L

.H

AB

Ham

amel

is (0

3.07

.199

2)H

amam

elis

virg

inia

na L

.Fr

esh

leav

es o

f Ham

amel

is vi

rgin

iana

L.

HA

BH

amam

elis

(03.

07.1

992)

Ham

amel

is vi

rgin

iana

L.

Fres

h �o

wer

ing

bran

ches

of H

amam

elis

virg

inia

na L

., co

llect

ed in

la

te au

tum

nH

AB

34H

amam

elis

dest

illat

a (2

5.10

.199

4)H

amam

elis

virg

inia

na L

.D

ried

bark

from

the

stem

s and

bra

nche

s of H

amam

elis

virg

inia

na

L.H

AB

Ham

amel

is (0

3.07

.199

2)H

amam

elis

virg

inia

na L

.D

ried

leav

es a

nd d

ried

bark

from

the

stem

s and

bra

nche

s of H

ama-

mel

is vi

rgin

iana

L.

Lotio

Pru

ni co

mp.

(0

4.06

.198

6)H

amam

elis

virg

inia

na L

.W

hole

or c

ut, d

ried

leaf

of H

amam

elis

virg

inia

na L

. (ha

mam

elis

leaf

)Ph

.Eur

.St

ibiu

m co

mp

(04.

06.1

986)

Har

pago

phyt

um p

rocu

mbe

ns

(Bur

ch.)

DC

Cut a

nd d

ried,

tube

rous

seco

ndar

y ro

ots o

f Har

pago

phyt

um p

ro-

cum

bens

DC

. and

/or H

arpa

goph

ytum

zeyh

eri D

ecne

(dev

il’s cl

aw

root

)

Ph.E

ur. /

Ph.

fr.H

arpa

goph

ytum

, Rad

ix

(03.

07.1

992)

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Hel

iant

hus t

uber

osus

L.

Fres

h tu

bers

of H

elia

nthu

s tub

eros

us L

., co

llect

ed in

late

autu

mn

HA

BH

elle

boru

s nig

er L

.Fr

esh

who

le �

ower

ing

plan

ts o

f Hel

lebo

rus n

iger

L.

Hel

lebo

rus n

iger

(0

4.06

.198

6)H

elle

boru

s nig

er L

.Fr

esh

who

le p

lant

s of H

elle

boru

s nig

er L

.H

elle

boru

s nig

er

(04.

06.1

986)

Hel

lebo

rus n

iger

L.

Who

le fr

esh

plan

t col

lect

ed in

sum

mer

and

fres

h �o

wer

ing

shoo

ts

colle

cted

in w

inte

r of H

elle

boru

s nig

er L

.H

elon

ias d

ioic

ase

e C

ham

aelir

ium

lute

um (L

.) A

. Gra

yH

erac

leum

man

tega

zzia

num

So

mm

ier &

Lev

ier

Who

le fr

esh

plan

t of H

erac

leum

man

tega

zzia

num

Som

mie

r &

Levi

erH

ibisc

us sa

bdar

i�a

L.W

hole

or c

ut d

ried

caly

ces a

nd e

pica

lyce

s of H

ibisc

us sa

bdar

i�a

L.,

colle

cted

dur

ing

frui

ting

(ros

elle

)Ph

.Eur

.

Hip

poph

aë rh

amno

ides

L.

Fres

h br

anch

es o

f Hip

poph

aë rh

amno

ides

L. w

ith fr

uit

Hip

poph

aë rh

amno

ides

L.

Fres

h fr

uits

of H

ippo

phaë

rham

noid

es L

.

• Ap

pend

ix 2

.2


104

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erH

ippo

phaë

rham

noid

es L

.Fa

tty o

il ob

tain

ed fr

om th

e se

eds a

nd/o

r fru

it of

Hip

poph

aë rh

am-

noid

es L

.H

orde

um v

ulga

re L

.Ex

trac

t obt

aine

d fr

om d

ried

germ

inat

ed fr

uits

of H

orde

um v

ulga

re

L. (m

alt)

Siru

pus �

ymi c

omp.

(0

4.06

.198

6)H

oya

carn

osa

(L.f.

) R. B

r.N

ecta

r of t

he �

ower

s of H

oya

carn

osa

(L.f.

) R. B

r.C

enta

uriu

m co

mp.

(0

4.06

.198

6)H

umul

us lu

pulu

s L.

Fres

h cr

eepe

rs w

ith le

aves

and

frui

ts o

f Hum

ulus

lupu

lus L

.Av

ena/

Pass

i�or

a co

mp.

(0

3.07

.199

2)H

umul

us lu

pulu

s L.

Fres

h fe

mal

e in

�ore

scen

ces o

f Hum

ulus

lupu

lus L

., co

llect

ed b

efor

e th

e se

eds h

ave

ripen

ed a

nd co

ntai

ning

as f

ew se

eds a

s pos

sible

HA

BAv

ena

sativ

a co

mp.

(0

4.06

.198

6)H

umul

us lu

pulu

s L.

Drie

d, g

ener

ally

who

le, f

emal

e in

�ore

scen

ces o

f Hum

ulus

lupu

lus

L. (h

op st

robi

le)

Ph.E

ur.

Hyd

rast

is ca

nade

nsis

L.D

ried

unde

rgro

und

part

s of H

ydra

stis

cana

dens

is L.

Ph.

Eur.:

Who

le

or c

ut, d

ried

rhiz

ome

and

root

of H

ydra

stis

cana

dens

is L

HA

B / U

SP /

Ph.fr

.Ec

hina

cea

com

p.(0

4.06

.198

6)H

ydro

coty

le a

siatic

ase

e C

ente

lla a

siatic

a (L

.) U

rb.

Hyo

scya

mus

nig

er L

.Fr

esh

�ow

erin

g ae

rial p

arts

of H

yosc

yam

us n

iger

L.

Hyo

scya

mus

(0

4.06

.198

6)H

yosc

yam

us n

iger

L.

Who

le, f

resh

�ow

erin

g pl

ants

of H

yosc

yam

us n

iger

L (h

yosc

yam

us

for h

omoe

opat

hic p

repa

ratio

ns)

HA

B / P

h.Eu

r.H

yosc

yam

us

(04.

06.1

986)

Hyp

eric

um p

erfo

ratu

m L

.Fr

esh

�ow

ers o

f Hyp

eric

um p

erfo

ratu

m L

.H

yper

icum

(0

2.09

.198

7)H

yper

icum

per

fora

tum

L.

Fres

h ae

rial p

arts

of H

yper

icum

per

fora

tum

L.,

colle

cted

at �

ower

-in

g tim

eH

AB

Hyp

eric

um

(02.

09.1

987)

Hyp

ogym

nia

phys

odes

(L.)

Nyl

.D

ried

thal

lus o

f Hyp

ogym

nia

phys

odes

(L.)

Nyl

. (Pa

rmel

ia p

hy-

sode

s (L.

) Ach

.)Ig

natia

See

Stry

chno

s ign

atii

Berg

ius

Impe

rato

ria o

stru

thiu

mSe

e Pe

uced

anum

ost

ruth

ium

(L.)

W. D

. J. K

och

Ipec

acua

nha

See

Psyc

hotr

ia ip

ecac

uanh

a (B

rot.)

Sto

kes

Ipec

acua

nha

(Ipec

acua

nhae

radi

x)Se

e C

epha

elis

ipec

acua

nha

(Bro

t.) A

. Ric

h., C

epha

elis

acum

inat

a K

arst

enIr

is ge

rman

ica

L.Fr

esh

rhiz

ome

of Ir

is ge

rman

ica

L.Ir

is ge

rman

ica

L.D

ried

peel

ed rh

izom

e of

Iris

germ

anic

a L.

, Iris

ger

man

ica

var.

�ore

ntin

a L.

and

Iris

palli

da L

amar

ckLo

tio P

runi

com

p.

(04.

06.1

986)

• Appendix 2.2


105

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erIr

is ve

rsic

olor

L.

Fres

h un

derg

roun

d pa

rts (

rhiz

ome

incl

udin

g ro

ots)

of I

ris v

ersi-

colo

r L. c

olle

cted

at �

ower

ing

time

Ph.fr

.

Iris

vers

icol

or L

.Fr

esh

unde

rgro

und

part

s of I

ris v

ersic

olor

L.

HA

BJu

glan

s reg

ia L

.D

ried

oute

r mem

bran

e fr

om th

e se

ed o

f Jug

lans

regi

a L.

Car

pellu

m M

ali c

omp.

(2

5.10

.199

4)

Jugl

ans r

egia

L.

Drie

d le

aves

of J

ugla

ns re

gia

L.D

AC

Jugl

ans r

egia

L.

Fres

h le

aves

and

unr

ipe

frui

t of J

ugla

ns re

gia

L.Ju

glan

s reg

ia co

mp.

(25.

10.1

994)

Juni

peru

s com

mun

is L.

Esse

ntia

l oil

obta

ined

by

stea

m d

istill

atio

n fr

om th

e rip

e, no

n-fe

r-m

ente

d be

rry

cone

s of J

unip

erus

com

mun

is L.

(jun

iper

oil)

Ph.E

ur.

Berb

eris/

Juni

peru

s co

mp.

(03.

07.1

992)

Juni

peru

s com

mun

is L.

Fres

h rip

e co

ne b

erry

of J

unip

erus

com

mun

is L.

DA

B 9

Trop

aeol

um co

mp.

(0

2.03

.199

1)Ju

nipe

rus c

omm

unis

L.D

ried

tips o

f sho

ots o

f Jun

iper

us co

mm

unis

L.C

icho

rium

/Tar

axac

um

com

p. (0

4.06

.198

6)Ju

nipe

rus c

omm

unis

L.D

ried

ripe

cone

ber

ry o

f Jun

iper

us co

mm

unis

L. (j

unip

er)

HA

B / P

h.Eu

r. Be

tula

/Juni

peru

s (0

2.03

.199

1)Ju

nipe

rus s

abin

a L.

Fres

h, st

ill u

nlig

ni�e

d, g

row

ing

tips o

f tw

igs o

f Jun

iper

us sa

bina

L.,

with

adh

eren

t lea

ves

HA

BC

olch

icum

/Sab

ina

(04.

06.1

986)

Kal

anch

oe d

aigr

emon

tiana

see

Bryo

phyl

lum

dai

grem

ontia

num

(Ray

m.-H

amet

et H

. Per

rier)

A

. Ber

ger

Kal

anch

oe p

inna

tase

e Br

yoph

yllu

m p

inna

tum

(Lam

.) O

ken

Kal

mia

latif

olia

L.

Fres

h le

aves

of K

alm

ia la

tifol

ia L

.H

AB

/ Ph.

fr.K

ram

eria

tria

ndra

Rui

z et P

av.

Drie

d, u

sual

ly fr

agm

ente

d, u

nder

grou

nd o

rgan

s of K

ram

eria

tria

n-dr

a Ru

iz a

nd P

avon

. (rh

atan

y ro

ot)

HA

B / P

h.Eu

r.Ra

tanh

ia co

mp.

(03.

07.1

992)

Kre

osot

umse

e Fa

gus s

ilvat

ica

L.La

miu

m a

lbum

L.

Who

le fr

esh

�ow

erin

g pl

ant o

f Lam

ium

alb

um L

.Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Lam

ium

alb

um L

.D

ried

�ow

ers o

f Lam

ium

alb

um L

.H

AB

Arg

entu

m/Q

uerc

us

com

p. (0

4.06

.198

6)La

ppa

maj

orse

e A

rctiu

m la

ppa

L.La

rix d

ecid

ua M

ill.

Balsa

m o

btai

ned

from

hol

es d

rille

d in

the

trun

ks o

f Lar

ix d

ecid

ua

Mill

. (Te

rebi

nthi

na la

ricin

a )

HA

BRe

sina

Laric

is (0

2.09

.198

7)La

urus

nob

ilis L

.Fr

esh

leav

es o

f Lau

rus n

obili

s L.

• Ap

pend

ix 2

.2


106

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erLa

vand

ula

angu

stifo

lia M

ill.

Esse

ntia

l oil

obta

ined

by

stea

m d

istill

atio

n fr

om th

e �o

wer

ing

tops

of L

avan

dula

ang

ustif

olia

Mill

. (La

vand

ula

o�ci

nalis

Cha

ix)

(lave

nder

oil)

Ph.E

ur.

Lave

ndel

öl (0

4.06

.198

6)

Lava

ndul

a an

gust

ifolia

Mill

.Fr

esh

�ow

ers o

f Lav

andu

la a

ngus

tifol

ia M

ill.

HA

BLa

vand

ula

angu

stifo

lia M

ill.

Fres

h �o

wer

ing

stem

s of L

avan

dula

ang

ustif

olia

Mill

.Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Lava

ndul

a an

gust

ifolia

Mill

.D

ried

�ow

er o

f Lav

andu

la a

ngus

tifol

ia M

ill. (

L. o

�ci

nalis

Cha

ix)

(lave

nder

�ow

er)

HA

B / P

h.Eu

r. A

escu

lus/

Lava

ndul

a

sicca

ta (2

5.10

.199

4)Le

dum

pal

ustr

e L.

Drie

d tip

s of t

wig

s of L

edum

pal

ustr

e L.

HA

BLe

onto

podi

um a

lpin

um C

ass.

Who

le fr

esh

plan

ts o

f Leo

ntop

odiu

m a

lpin

um C

ass.

Apis

com

p.

(04.

06.1

986)

Leon

topo

dium

alp

inum

Cas

s.W

hole

drie

d �o

wer

ing

plan

ts o

f Leo

ntop

odiu

m a

lpin

um C

ass.

Gna

phal

ium

com

p.

(25.

10.1

994)

Leon

urus

car

diac

a L.

Fres

h ae

rial p

arts

of L

eonu

rus c

ardi

aca

L., c

olle

cted

at �

ower

ing

time

HA

BC

imic

ifuga

com

p.(0

2.09

.198

7)Le

ptan

dra

virg

inic

a (L

.) N

utt.

Drie

d un

derg

roun

d pa

rts o

f Lep

tand

ra v

irgin

ica

(L.)

Nut

t.Le

vist

icum

o�

cina

le W

. D. J

. Ko

chW

hole

or c

ut d

ried

rhiz

ome

and

root

of L

evist

icum

o�

cina

le K

och.

(lo

vage

root

)Ph

.Eur

.Le

vist

icum

(04.

06.1

986)

Levi

stic

um o

�ci

nale

W. D

. J.

Koch

Who

le fr

esh

plan

t of L

evist

icum

o�

cina

le W

. D. J

. Koc

h

Levi

stic

um o

�ci

nale

W. D

. J.

Koch

Fres

h un

derg

roun

d pa

rts o

f Lev

istic

um o

�ci

nale

W. D

. J. K

och

HA

BLe

vist

icum

(04.

06.1

986)

Levi

stic

um o

�ci

nale

W. D

. J.

Koch

Fres

h �o

wer

s of L

evist

icum

o�

cina

le W

. D. J

. Koc

hLe

vist

icum

(04.

06.1

986)

Levi

stic

um o

�ci

nale

W. D

. J.

Koch

Fres

h le

aves

of L

evist

icum

o�

cina

le W

. D. J

. Koc

hD

er M

erku

rsta

b 4/

2007

: p.

345

Liliu

m la

ncifo

lium

�un

b.W

hole

fres

h �o

wer

ing

plan

ts o

f Lili

um la

ncifo

lium

�un

b.Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Liliu

m la

ncifo

lium

�un

b.Fr

esh

part

s of L

ilium

lanc

ifoliu

m �

unb.

, with

pout

bul

bs, c

olle

cted

at

�ow

erin

g tim

eH

AB

Arg

entu

m/Q

uerc

us

com

p. (0

4.06

.198

6)Li

lium

lanc

ifoliu

m �

unb.

Fres

h ae

rial p

arts

of L

ilium

lanc

ifoliu

m �

unb.

, col

lect

ed at

�ow

er-

ing

time

and

incl

udin

g bu

lbils

Maj

oran

a/�

uja

com

p.

(02.

03.1

991)

Liliu

m ti

grin

umSe

e Li

lium

lanc

ifoliu

m �

unb.

• Appendix 2.2


107

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erLi

num

usit

atiss

imum

L.

Fatty

oil

obta

ined

by

cold

exp

ress

ion

from

ripe

seed

s of L

inum

us

itatis

simum

L. (

linse

ed o

il, v

irgin

) Ph

.Eur

.

Linu

m u

sitat

issim

um L

.D

ried,

ripe

seed

s of L

inum

usit

atiss

imum

L. (

linse

ed)

Ph.E

ur.

Lits

ea c

ubeb

a Pe

rs.

Esse

ntia

l oil

obta

ined

by

stea

m d

istill

atio

n fr

om th

e fr

uit o

f Lits

ea

cube

ba P

ers.

Loba

ria p

ulm

onar

ia (L

.) H

o�m

.D

ried

thal

lus o

f Lob

aria

pul

mon

aria

(L.)

Ho�

m.

HA

B / P

h.fr.

Lich

enes

com

p.(0

4.06

.198

6)Lo

belia

in�a

ta L

.Fr

esh

�ow

erin

g ae

rial p

arts

of L

obel

ia in

�ata

L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)Lo

belia

in�a

ta L

.W

hole

fres

h �o

wer

ing

plan

ts o

f Lob

elia

in�a

ta L

.H

AB

Lobe

lia in

�ata

(0

7.04

.198

8)Lo

phop

hora

will

iam

sii C

oult.

Who

le fr

esh

plan

ts o

f Lop

hoph

ora

will

iam

sii C

oult.

Lyco

pers

icon

lyco

pers

icum

(L.)

Kar

st. e

x Fa

rw.

Fres

h ae

rial p

arts

of L

ycop

ersic

on ly

cope

rsic

um (L

.) K

arst

. ex

Farw

., co

llect

ed at

�ow

erin

g tim

eH

AB

34D

er M

erku

rsta

b 4/

2005

: p.

271

Lyco

pers

icon

lyco

pers

icum

(L.)

Kar

st. e

x Fa

rw.

Fres

h rip

e fr

uits

of L

ycop

ersic

on ly

cope

rsic

um (L

.) K

arst

. ex

Farw

.

Lyco

podi

um cl

avat

um L

.W

hole

spor

e-be

arin

g pl

ant o

f Lyc

opod

ium

clav

atum

L.

Lyco

podi

um

(25.

10.1

994)

Lyco

podi

um cl

avat

um L

.D

ried

ripe

spor

es o

f Lyc

opod

ium

clav

atum

L.

HA

B / P

h.fr.

Lyco

podi

um

(25.

10.1

994)

Lyco

pus v

irgin

icus

L.

Fres

h ae

rial p

arts

of L

ycop

us v

irgin

icus

L.,

colle

cted

at �

ower

ing

time

HA

B / P

h.fr.

Lyco

pus v

irgin

icus

L.

Who

le fr

esh

plan

t of L

ycop

us v

irgin

icus

L.,

colle

cted

at �

ower

ing

time.

Der

Mer

kurs

tab

5/20

04:

p. 3

59Ly

simac

hia

num

mul

aria

L.

Fres

h �o

wer

ing

aeria

l par

ts o

f Lys

imac

hia

num

mul

aria

L.

Dul

cam

ara/

Lysim

achi

a (0

4.06

.198

6)M

ahon

ia a

quifo

lium

(Pur

sh) N

utt.

Drie

d ba

rk fr

om b

ranc

hes a

nd tw

igs a

nd d

ried

tips o

f tw

igs o

f Ma-

honi

a aq

uifo

lium

(Pur

sh) N

utt.

HA

B

Maj

oran

ase

e O

rigan

um m

ajor

ana

L.M

altu

mse

e H

orde

um v

ulga

re L

.M

alus

sylv

estr

is M

ill.

Cor

e fr

om fr

esh

frui

t of M

alus

sylv

estr

is M

ill. w

ithou

t ker

nel

Car

pellu

m M

ali c

omp.

(2

5.10

.199

4)

• Ap

pend

ix 2

.2


108

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erM

alus

sylv

estr

is M

ill.

Fres

h un

ripe

frui

t of M

alus

sylv

estr

is M

ill.

Mal

va sy

lves

tris

L.W

hole

fres

h �o

wer

ing

plan

t of M

alva

sylv

estr

is L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)M

alva

sylv

estr

is L.

Who

le o

r fra

gmen

ted

drie

d �o

wer

of M

alva

sylv

estr

is L.

or i

ts c

ulti-

vate

d va

rietie

s. (m

allo

w �

ower

)H

AB

/ Ph.

Eur.

Phos

phor

us/M

alva

(25.

10.1

994)

Mal

va sy

lves

tris

L.D

ried

leav

es o

f Mal

va sy

lves

tris

L.

Mal

va/M

illef

oliu

m/

Oxa

lis(0

7.04

.198

8)M

andr

agor

a o�

cina

rum

L.

Fres

h ro

ot o

f Man

drag

ora

o�ci

naru

m L

.M

andr

agor

a (0

4.06

.198

6)M

andr

agor

a o�

cina

rum

L.

Drie

d ro

ots o

f Man

drag

ora

o�ci

naru

m L

. and

Man

drag

ora

autu

m-

nalis

Ber

tol.

HA

BM

andr

agor

a (0

4.06

.198

6)M

arru

bium

vul

gare

L.

Who

le o

r fra

gmen

ted

�ow

erin

g dr

ied

aeria

l par

ts o

f Mar

rubi

um

vulg

are

L., c

olle

cted

at �

ower

ing

time

(whi

te h

oreh

ound

)Ph

.Eur

.Si

rupu

s �ym

i com

p.

(04.

06.1

986)

Mar

um v

erum

see

Teuc

rium

mar

um L

.M

atric

aria

recu

tita

L.Fr

esh

�ow

er h

eads

of M

atric

aria

recu

tita

L. (C

ham

omill

a re

cutit

a (L

.) Ra

usch

ert)

Ana

galli

s/M

alac

hit

com

p. (2

5.10

.199

4)M

atric

aria

recu

tita

L.W

hole

fres

h �o

wer

ing

plan

ts o

f Mat

ricar

ia re

cutit

a L.

HA

B / P

h.fr.

Cha

mom

illa

(12.

09.1

992)

Mat

ricar

ia re

cutit

a L.

Fres

h un

derg

roun

d pa

rts o

f Mat

ricar

ia re

cutit

a L.

(Cha

mom

illa

recu

tita

(L.)

Raus

cher

t) be

fore

�ow

erin

g tim

eC

ham

omill

a, R

adix

(0

4.06

.198

6)M

atric

aria

recu

tita

L.D

ried

capi

tula

of M

atric

aria

recu

tita

L. (C

ham

omill

a re

cutit

a (L

.) Ra

usch

ert)

(mat

ricar

ia �

ower

)Ph

.Eur

. / U

SPC

ham

omill

a (1

2.09

.199

2)M

atric

aria

recu

tita

L.D

ried

root

of M

atric

aria

recu

tita

L. (C

ham

omill

a re

cutit

a (L

.) Ra

usch

ert)

Cha

mom

illa,

Rad

ix

(04.

06.1

986)

Med

icag

o sa

tiva

L.W

hole

fres

h pl

ants

of M

edic

ago

sativ

a L.

, col

lect

ed at

�ow

erin

g tim

ePh

.fr.

Mel

aleu

ca le

ucad

endr

a(L.

) L.

Rect

i�ed

ess

entia

l oil

obta

ined

from

fres

h le

aves

and

bra

nche

s of

di�e

rent

Mel

aleu

ca (s

ub)s

peci

es

(Ph.

Eur.

Tea

Tree

oil:

Ess

entia

l oil

obta

ined

by

stea

m d

istill

atio

n fr

om fo

liage

and

term

inal

bra

nchl

ets o

f Mel

aleu

ca a

ltern

ifolia

(M

aide

n an

d Be

tch)

Che

el, M

. lin

ariif

olia

Sm

ith, M

. diss

iti�o

ra F.

M

uelle

r and

/or o

ther

spec

ies o

f Mel

aleu

ca)

Berb

eris/

Euca

lyp-

tus/

Silic

ea co

mp.

(0

2.03

.199

1)

• Appendix 2.2


109

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erM

elilo

tus o

�ci

nalis

(L.)

Pall.

Fres

h ae

rial p

arts

of M

elilo

tus o

�ci

nalis

(L.)

Pall.

with

out l

igne

ous

stem

s col

lect

ed at

�ow

erin

g tim

eH

AB

/ Ph.

fr.

Mel

issa

indi

cum

see

Cym

bopo

gon

win

teria

nus J

owitt

and

oth

er C

ymbo

pogo

n sp

.M

eliss

a o�

cina

lis L

.Fr

esh

leav

es o

f Mel

issa

o�ci

nalis

L.

Mel

issa

Cupr

o cu

lta

(25.

10.1

994)

Mel

issa

o�ci

nalis

L.

Fres

h ae

rial p

arts

of M

eliss

a o�

cina

lis L

., be

fore

�ow

erin

g tim

ePh

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Mel

issa

o�ci

nalis

L.

Fres

h ae

rial p

arts

of M

eliss

a o�

cina

lis L

.M

eliss

a/Se

pia

com

p.

(02.

03.1

991)

Mel

issa

o�ci

nalis

L.

Drie

d le

af o

f Mel

issa

o�ci

nalis

L. (

mel

issa

leaf

)Ph

.Eur

.M

ajor

ana/

Mel

issa

(02.

09.1

987)

Mel

issa

o�ci

nalis

L.

Drie

d ae

rial p

arts

of M

eliss

a o�

cina

lis L

.M

eliss

a co

mp.

(0

3.07

.199

2)M

enth

a pi

perit

a L.

Esse

ntia

l oil

obta

ined

by

stea

m d

istill

atio

n fr

om th

e fr

esh

aeria

l pa

rts o

f the

�ow

erin

g pl

ant o

f Men

tha

x pi

perit

a L.

(pep

perm

int

oil)

Ph.E

ur.

Berb

eris/

Che

lidon

ium

co

mp.

(02.

03.1

991)

Men

tha

pipe

rita

L.W

hole

fres

h �o

wer

ing

plan

t of M

enth

a x

pipe

rita

L.M

enth

a pi

perit

a L.

Who

le o

r cut

drie

d le

aves

of M

enth

a x

pipe

rita

L.

(pep

perm

int l

eave

s)Ph

.Eur

.C

enta

uriu

m co

mp.

(04.

06.1

986)

Men

yant

hes t

rifol

iata

L.

Who

le fr

esh

�ow

erin

g pl

ant o

f Men

yant

hes t

rifol

iata

L.

Ph.fr

.M

ercu

rialis

per

enni

s L.

Fres

h ae

rial p

arts

of M

ercu

rialis

per

enni

s L.,

colle

cted

at �

ower

ing

time

HA

BM

ercu

rialis

/ Ro

-sa

e ae

ther

oleu

m

(02.

03.1

991)

Mer

curia

lis p

eren

nis L

.W

hole

fres

h �o

wer

ing

plan

t of M

ercu

rialis

per

enni

s L.

HA

BM

ercu

rialis

per

enni

s (0

2.03

.199

1)M

ercu

rialis

per

enni

s L.

Who

le d

ried

�ow

erin

g pl

ant o

f Mer

curia

lis p

eren

nis L

.C

alen

dula

/Mer

curia

lis

com

p. (0

7.04

.198

8)M

ezer

eum

See

Dap

hne

mez

ereu

m L

.M

illef

oliu

mSe

e A

chill

ea m

illef

oliu

m L

.M

omor

dica

bal

sam

ina

L.Fr

esh

frui

t of M

omor

dica

bal

sam

ina

L.M

onot

ropa

uni

�ora

L.

Who

le d

ried

plan

t of M

onot

ropa

uni

�ora

L.

• Ap

pend

ix 2

.2


110

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erM

ucun

a pr

urie

ns (L

.) D

CD

ried

hairs

from

the

frui

ts o

f Muc

una

prur

iens

(L.)

DC

(Ph.

fr.:

Dol

icho

s pru

riens

)H

AB

/ Ph.

fr.

Myr

istic

a fr

agra

ns V

an H

outte

Drie

d se

ed k

erne

l of M

yrist

ica

frag

rans

Van

Hou

ttePh

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Myr

istic

a fr

agra

ns H

outt.

Drie

d, u

sual

ly li

me-

trea

ted

seed

s of M

yrist

ica

frag

rans

Hou

tt., w

ith

aril

and

test

a re

mov

edH

AB

Spiri

tus M

eliss

ae co

mp.

(04.

06.1

986)

Myr

istic

a se

bife

rase

e V

irola

sebi

fera

Aub

l.M

yrox

ylon

bal

sam

um (L

.) H

arm

sBa

lsam

obt

aine

d fr

om th

e sc

orch

ed a

nd w

ound

ed tr

unk

of M

y-ro

xylo

n ba

lsam

um (L

.) H

arm

s var

. per

eira

e (R

oyle

) Har

ms (

peru

ba

lsam

)

Ph.E

ur.

Berb

eris/

Euca

lyp-

tus/

Silic

ea co

mp.

(0

2.03

.199

1)M

yrrh

ase

e C

omm

ipho

ra Ja

cq. s

peci

esN

astu

rtiu

m o

�ci

nale

R. B

r.W

hole

fres

h pl

ant o

f Nas

turt

ium

o�

cina

le R

. Br.

Nas

turt

ium

o�

cina

le R

. Br.

Fres

h ae

rial p

arts

of N

astu

rtiu

m o

�ci

nale

R. B

r., co

llect

ed at

�ow

-er

ing

time

HA

BN

astu

rtiu

m M

ercu

rio

cultu

m (2

5.10

.199

4)N

astu

rtiu

m o

�ci

nale

R. B

r.D

ried

aeria

l par

ts o

f Nas

turt

ium

o�

cina

le R

. Br.

Mer

curiu

s viv

us co

mp.

(0

2.09

.198

7)N

icot

iana

taba

cum

L.

Fres

h le

aves

of N

icot

iana

taba

cum

L.

HA

BTa

bacu

m (0

4.06

.198

6)N

icot

iana

taba

cum

L.

Drie

d fe

rmen

ted

leav

es o

f Nic

otia

na ta

bacu

m L

.Ta

bacu

m (0

4.06

.198

6)N

icot

iana

taba

cum

L.

Drie

d un

ferm

ente

d le

aves

of N

icot

iana

taba

cum

L.

HA

BTa

bacu

m (0

4.06

.198

6)N

ux m

osch

ata

see

Myr

istic

a fr

agra

ns V

an H

outte

Nux

vom

ica

see

Stry

chno

s nux

-vom

ica

L.O

cim

um b

asili

cum

L.

Fres

h ae

rial p

arts

of O

cim

um b

asili

cum

L.,

colle

cted

prio

r to

�ow

-er

ing

HA

BBa

silic

um co

mp.

(07.

04.1

988)

Oci

mum

bas

ilicu

m L

.D

ried

�ow

erin

g ae

rial p

arts

of O

cim

um b

asili

cum

L.

Sal M

aris

com

p.

(04.

06.1

986)

O

liban

umse

e Bo

swel

lia sp

ecie

sO

nopo

rdum

aca

nthi

um L

.Fr

esh

leav

es o

f Ono

pord

um a

cant

hium

L.

Che

lidon

ium

com

p.

(04.

06.1

986)

Ono

pord

um a

cant

hium

L.

Fres

h �o

wer

head

of O

nopo

rdum

aca

nthi

um L

.O

nopo

rdum

/Prim

ula

com

p. (2

5.10

.199

4)O

rchi

s spe

cies

or O

phry

deae

trib

eFi

lial t

uber

s of d

i�er

ent s

peci

es o

f the

gen

us O

rchi

s L. (

Orc

hida

-ce

ae) o

r oth

er su

itabl

e in

tra-

and

inte

rgen

eric

Orc

his-

Hyb

rids o

f th

e tr

ibe

Oph

ryde

ae, w

hich

hav

e be

en b

lanc

hed

in b

oilin

g w

ater

an

d dr

ied

Cer

ebel

lum

com

p.

(02.

03.1

991)

• Appendix 2.2


111

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erO

rigan

um m

ajor

ana

L.Fr

esh

aeria

l par

ts o

f Orig

anum

maj

oran

a L.

, col

lect

ed at

�ow

erin

g tim

eH

AB

Maj

oran

a (0

7.04

.198

8)

Orig

anum

maj

oran

a L.

Drie

d ae

rial p

arts

of O

rigan

um m

ajor

ana

L.M

ajor

ana

(07.

04.1

988)

Orig

anum

maj

oran

a L.

Ripe

frui

t of O

rigan

um m

ajor

ana

L.C

apse

lla/M

ajor

ana

com

p. (0

4.06

.198

6)

Orn

ithog

alum

um

bella

tum

L.

Who

le fr

esh

plan

t of O

rnith

ogal

um u

mbe

llatu

m L

.O

xalis

ace

tose

lla L

.Fr

esh

leav

es o

f Oxa

lis a

ceto

sella

L.

HA

BO

xalis

(02.

09.1

987)

Oxa

lis a

ceto

sella

L.

Who

le fr

esh

�ow

erin

g pl

ant o

f Oxa

lis a

ceto

sella

L.

Oxa

lis (0

2.09

.198

7)O

xalis

ace

tose

lla L

.D

ried

�ow

erin

g pl

ant o

f Oxa

lis a

ceto

sella

LO

xalis

(02.

09.1

987)

Paeo

nia

o�ci

nalis

L. e

men

d.

Will

d.Fr

esh

unde

rgro

und

part

s of P

aeon

ia o

�ci

nalis

L. e

men

d. W

illd.

, co

llect

ed d

urin

g sp

ring

HA

BH

irudo

com

p.

(25.

10.1

994)

Pana

x gi

nsen

g C

.A. M

eyer

Who

le o

r cut

drie

d ro

ot, d

esig

nate

d w

hite

gin

seng

; tre

ated

with

st

eam

and

then

drie

d, d

esig

nate

d re

d gi

nsen

g of

Pan

ax g

inse

ng

C.A

. Mey

er. (

gins

eng)

Ph.E

ur. /

USP

/ H

AB

Vade

mec

um: G

inse

ng

Papa

ver r

hoea

s L.

Fres

h �o

wer

s of P

apav

er rh

oeas

L.

HA

BPa

pave

r rho

eas

(02.

03.1

991)

Papa

ver s

omni

feru

m L

.Fr

esh

late

x ob

tain

ed fr

om in

cisio

ns in

unr

ipe

frui

t of P

apav

er

som

nife

rum

L.

Papa

ver s

omni

feru

m

(07.

04.1

988)

Papa

ver s

omni

feru

m L

.Fr

esh

unrip

e fr

uit o

f Pap

aver

som

nife

rum

L.

Papa

ver s

omni

feru

m

(07.

04.1

988)

Paris

qua

drifo

lia L

.W

hole

fres

h pl

ants

of P

aris

quad

rifol

ia L

., co

llect

ed w

hen

the

frui

ts

have

ripe

ned

HA

B

Parm

elia

see

Hyp

ogym

nia

phys

odes

(L.)

Nyl

.Pa

ssi�

ora

caer

ulea

L.

Fres

h ae

rial p

arts

of P

assi�

ora

caer

ulea

L. c

olle

cted

at �

ower

ing

time

Pass

i�or

a co

mp.

(2

5.10

.199

4)Pa

ssi�

ora

inca

rnat

a L.

Fres

h ae

rial p

arts

of P

assi�

ora

inca

rnat

a L.

HA

B / P

h.fr.

Aven

a sa

tiva

com

p.

(04.

06.1

986)

Peat

Fres

h m

oist

pea

t fro

m m

oorla

nd [e

.g. u

plan

d m

oor]

Solu

m u

ligin

osum

co

mp.

(02.

03.1

991)

Pela

rgon

ium

spec

ies

Esse

ntia

l oil

obta

ined

by

stea

m d

estil

latio

n fr

om th

e ae

rial p

arts

of

suita

ble

spec

ies o

f Pel

argo

nium

e.g.

Pel

argo

nium

gra

veol

ens A

it.Ro

sae

aeth

erol

eum

/Si

licea

collo

idal

is co

mp.

(0

3.07

.199

2)

• Ap

pend

ix 2

.2


112

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erPe

tasit

es h

ybrid

us (L

.) Ph

. Gae

rtn.

B.

Mey

. et S

cher

bFr

esh

rhiz

ome

of P

etas

ites h

ybrid

us (L

.) Ph

. Gae

rtn.

B. M

ey. e

t Sc

herb

. with

atta

ched

root

sPe

tasit

es co

mp.

(1

2.09

.199

2)Pe

tasit

es h

ybrid

us (L

.) Ph

. Gae

rtn.

B.

Mey

. et S

cher

b.W

hole

fres

h �o

wer

ing

plan

t of P

etas

ites h

ybrid

us (L

.) Ph

. Gae

rtn.

B.

Mey

. et S

cher

b.Pe

tasit

es, P

lant

a to

ta

(12.

09.1

992)

Petr

osel

inum

crisp

um (M

ill.)

Nym

. ex

A. W

. Hill

Who

le fr

esh

�ow

erin

g pl

ants

of P

etro

selin

um cr

ispum

(Mill

.) N

ym.

ex A

. W. H

ill co

nvar

. cris

pum

, col

lect

ed at

the

star

t of �

ower

ing

HA

B

Petr

osel

inum

crisp

um (M

ill.)

Nym

. ex

A. W

. Hill

Drie

d ro

ots o

f Pet

rose

linum

crisp

um (M

ill.)

Nym

. ex

A. W

. Hill

ssp.

tu

bero

sum

(Ber

nh. e

x Rc

hb.)

Peuc

edan

um o

stru

thiu

m (L

.) W

. D

. J. K

och

Fres

h rh

izom

e of

Peu

ceda

num

ost

ruth

ium

(L.)

W.D

.J. K

och

Cic

horiu

m/T

arax

acum

co

mp.

(04.

06.1

986)

Peum

us b

oldu

s Mol

.W

hole

or f

ragm

ente

d dr

ied

leaf

of P

eum

us b

oldu

s Mol

ina

(bol

do

leaf

)H

AB

/ Ph.

Eur.

/Ph.

fr.

Phyl

lant

hus n

iruri

hort

. non

L.

Drie

d un

derg

roun

d pa

rts o

f Phy

llant

hus n

iruri

hort

. non

L.

Phyl

litis

scol

open

driu

m (L

.) N

ewm

.Fr

esh

spor

e-be

arin

g le

aves

of P

hylli

tis sc

olop

endr

ium

(L.)

New

m.

Aqu

ilinu

m co

mp.

(1

2.09

.199

2)Ph

yllo

stac

hys v

iridi

glau

cesc

ens

(Car

r.) A

. et C

. Riv.

Nod

es fr

om th

e st

em o

f Phy

llost

achy

s spe

cies

, esp

ecia

lly P

hyllo

-st

achy

s viri

digl

auce

scen

s (C

arr.)

A. e

t C. R

iv., c

olle

cted

in su

mm

erBa

mbu

sa (0

2.03

.199

1)

Phyt

olac

ca a

mer

ican

a L.

Fres

h ro

ots o

f Phy

tola

cca

amer

ican

a L.

, col

lect

ed d

urin

g au

tum

nH

AB

Phyt

olac

ca co

mp.

(2

5.10

.199

4)Ph

ytol

acca

am

eric

ana

L.Fr

esh

ripe

frui

ts o

f Phy

tola

cca

amer

ican

a L.

HA

BPi

cea

abie

s (L.

) Kar

st.

Esse

ntia

l oil

obta

ined

by

stea

m d

istill

atio

n of

nee

dles

and

tips

of

bra

nche

s or b

ranc

hes o

f Pic

ea a

bies

(L.)

Kar

sten

and

of A

bies

sib

irica

Led

ebou

r or o

ther

spec

ies o

f the

gen

era

Abi

es a

nd P

icea

DA

BSa

lvia

e ae

ther

oleu

m

com

p. (0

7.04

.198

8)

Pice

a ab

ies (

L.) K

arst

.Fr

esh

youn

g tip

s of s

hoot

s of P

icea

abi

es (L

.) K

arst

.Pe

tasit

es/P

lant

ago

com

p. (1

2.09

.199

2)Pi

cea

nigr

a (L

.) Li

nkD

ried

resin

from

Pic

ea n

igra

(L.)

Link

Pim

pine

lla a

nisu

m L

.Es

sent

ial o

il ob

tain

ed b

y st

eam

dist

illat

ion

of th

e dr

y rip

e fr

uits

of

Pim

pine

lla a

nisu

m L

. (an

ise o

il)Ph

.Eur

.Li

chen

es co

mp.

(04.

06.1

986)

Pim

pine

lla a

nisu

m L

.W

hole

dry

crem

ocar

p of

Pim

pine

lla a

nisu

m L

. (an

iseed

)H

AB

/ Ph.

Eur.

Ferr

um si

licic

um co

mp.

(D

AZ

Nr.

29 v

om

21.0

7.19

94)

Pinu

s mug

o Tu

rra

Esse

ntia

l oil

obta

ined

by

stea

m d

istill

atio

n of

the

fres

h le

aves

and

tw

igs o

f Pin

us m

ugo

Turr

a. A

suita

ble

antio

xida

nt m

ay b

e ad

ded

(dw

arf p

ine

oil)

Ph.E

ur.

Berb

eris/

Juni

peru

s co

mp.

(03.

07.1

992)

• Appendix 2.2


113

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erPi

nus s

peci

esEs

sent

ial o

il ob

tain

ed b

y st

eam

dist

illat

ion,

follo

wed

by

rect

i�ca

-tio

n at

a te

mpe

ratu

re b

elow

180

°C, f

rom

the

oleo

resin

obt

aine

d by

ta

ppin

g Pi

nus p

inas

ter A

iton.

A su

itabl

e an

tioxi

dant

may

be

adde

d (tu

rpen

tine

oil,

Pinu

s pin

aste

r typ

e)

Ph.E

ur.

Pinu

s syl

vest

ris L

.Es

sent

ial o

il ob

tain

ed b

y st

eam

dist

illat

ion

of th

e fr

esh

leav

es a

nd

bran

ches

of P

inus

sylv

estr

is L.

A su

itabl

e an

tioxi

dant

may

be

adde

d (p

ine

sylv

estr

is oi

l)

Ph.E

ur.

Ole

um c

amph

orat

um

com

p. (0

3.07

.199

2)

Pipe

r nig

rum

L.

Drie

d fr

uit o

f Pip

er n

igru

m L

.Pi

per n

igru

m L

.Fr

uit o

f Pip

er n

igru

m L

., co

llect

ed a

nd d

ried

befo

re ri

peni

ngPh

.Eur

.G

entia

na/Z

ingi

ber

com

p. (0

2.03

.199

1)Pi

x be

tulin

aBi

rch

tar s

ee B

etul

a pe

ndul

a Ro

th, B

etul

a pu

besc

ens E

hrha

rtPl

anta

go la

nceo

lata

L.

Who

le o

r cut

drie

d he

rb o

f Pla

ntag

o la

nceo

lata

L. s

.l.D

AB

1999

Plan

tago

lanc

eola

ta L

.Fr

esh

leav

es o

f Pla

ntag

o la

nceo

lata

L.

Bron

chi/P

lant

ago

com

p. (1

2.09

.199

2)Pl

anta

go la

nceo

lata

L.

Who

le o

r fra

gmen

ted,

drie

d le

af a

nd sc

ape

of P

lant

ago

lanc

eola

ta L

. s.l

. (rib

wor

t pla

ntai

n)Ph

.Eur

.

Podo

phyl

lum

pel

tatu

m L

.D

ried

rhiz

ome

of P

odop

hyllu

m p

elta

tum

L.

Ph.fr

.Po

llen

Flow

er p

olle

nPo

lyga

la a

mar

a L.

Fres

h w

hole

�ow

erin

g pl

ant o

f Pol

ygal

a am

ara

L.

HA

B 34

Poly

gona

tum

odo

ratu

m (M

ill.)

Dru

ceFr

esh,

und

ergr

ound

par

ts o

f Pol

ygon

atum

odo

ratu

m (M

ill.)

Dru

ceVe

spa

crab

ro co

mp.

(0

2.03

.199

1)Po

lypo

dium

vul

gare

L.

Fres

h le

aves

of P

olyp

odiu

m v

ulga

re L

.A

spid

ium

/Sal

ix co

mp.

(0

4.06

.198

6)Po

lypo

dium

vul

gare

L.

Fres

h un

derg

roun

d pa

rts o

f Pol

ypod

ium

vul

gare

L.

Popu

lus t

rem

ula

L.Fr

esh

leav

es o

f Pop

ulus

trem

ula

L.Sa

bal/S

olid

ago

com

p. (

DA

Z N

r.29,

21

.07.

1994

)Po

tent

illa

erec

ta (L

.) Ra

eusc

h.W

hole

or c

ut, d

ried

rhiz

ome,

free

d fr

om th

e ro

ots,

of P

oten

tilla

er

ecta

(L.)

Raeu

sch.

(P. t

orm

entil

la S

toke

s) (t

orm

entil

)Ph

.Eur

.C

oral

lium

com

p.(0

2.09

.198

7)Po

tent

illa

erec

ta (L

.) Ra

eusc

h.Fr

esh

unde

rgro

und

part

s of P

oten

tilla

ere

cta

(L.)

Raeu

sch.

, col

-le

cted

dur

ing

sprin

gH

AB

Torm

entil

la

(03.

07.1

992)

Pote

rium

see

Sacr

opot

eriu

m sp

inos

um (L

.) Sp

ach.

Prim

ula

veris

L.

Fres

h �o

wer

s of P

rimul

a ve

ris L

.C

onva

llaria

/Prim

ula

com

p. (1

2.09

.199

2)

• Ap

pend

ix 2

.2


114

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erPr

imul

a ve

ris L

.D

ried

�ow

ers o

f Prim

ula

veris

L.

Ph.fr

.Pr

imul

a co

mp.

(0

2.03

.199

1)Pr

unus

dul

cis (

Mill

.) D

.A.W

ebb

var.

amar

a (D

C.)

Buch

heim

Drie

d, ri

pe se

eds o

f Pru

nus d

ulci

s (M

ill.)

D.A

.Web

b, v

ar. a

mar

a (D

C.)

Buch

heim

HA

B

Prun

us d

ulci

s (M

iller

) D. A

. Web

b va

r. du

lcis

and/

or a

mar

a (D

. C.)

Buch

heim

Fatty

oil

otai

ned

by co

ld e

xpre

ssio

n fr

om th

e rip

e se

eds o

f Pru

nus

dulc

is (M

iller

) D.A

. Web

b va

r. du

lcis

or P

runu

s dul

cis (

Mill

er) D

.A.

Web

b va

r. am

ara

(D.C

.) Bu

chhe

im o

r a m

ixtu

re o

f bot

h va

rietie

s (a

lmon

d oi

l, vi

rgin

)

Ph.E

ur.

Ole

um P

etra

e co

mp.

(0

3.07

.199

2)

Prun

us la

uroc

eras

us L

.Fr

esh

leav

es o

f Pru

nus l

auro

cera

sus L

.H

AB

/ Ph.

fr.Pr

unus

spin

osa

L.Ju

ice

from

the

frui

t of P

runu

s spi

nosa

L.

Lotio

Pru

ni co

mp.

(0

4.06

.198

6)Pr

unus

spin

osa

L.Fr

esh

�ow

ers a

nd y

oung

tips

of s

hoot

s of P

runu

s spi

nosa

L.

Prun

us sp

inos

a (0

5.12

.198

9)Pr

unus

spin

osa

L.Fr

esh

�ow

ers o

f Pru

nus s

pino

sa L

., co

llect

ed b

efor

e th

e pe

tals

drop

o�

HA

B

Prun

us sp

inos

a L.

Fres

h fr

uit o

f Pru

nus s

pino

sa L

.Pr

unus

spin

osa

(05.

12.1

989)

Prun

us sp

inos

a L.

Fres

h yo

ung

tips o

f sho

ots o

f Pru

nus s

pino

sa L

., co

llect

ed so

me

wee

ks a

�er �

ower

ing

HA

BPr

unus

spin

osa

(05.

12.1

989)

Prun

us sp

inos

a L.

Fully

ope

ned

drie

d �o

wer

s of P

runu

s spi

nosa

L.

DA

C

Prun

us sp

inos

a (0

5.12

.198

9)Ps

ycho

tria

ipec

acua

nha

(Bro

t.)

Stok

esD

ried

unde

rgro

und

orga

ns o

f Psy

chot

ria ip

ecac

uanh

a (B

rot.)

St

okes

.H

AB

Ipec

acua

nha

(02.

09.1

987)

Ptel

ea tr

ifolia

ta L

. Fr

esh

bark

from

you

ng b

ranc

hes o

f Pte

lea

trifo

liata

L.

Ph.fr

.Pt

erid

ium

aqu

ilinu

m (L

.) Ku

hnFr

esh

leav

es o

f Pte

ridiu

m a

quili

num

(L.)

Kuhn

Aqu

ilinu

m co

mp.

(1

2.09

.199

2)Pu

lmon

aria

o�

cina

lis L

.Fr

esh

aeria

l par

ts o

f Pul

mon

aria

o�

cina

lis L

., co

llect

ed at

�ow

erin

g tim

eH

AB

Pulsa

tilla

vul

garis

Mill

.W

hole

fres

h �o

wer

ing

plan

ts o

f Pul

satil

la v

ulga

ris M

ill.

HA

B / P

h.fr.

Pulsa

tilla

(04.

06.1

986)

Pulsa

tilla

vul

garis

Mill

.Fr

esh

�ow

ers o

f Pul

satil

la v

ulga

ris M

ill. w

ith ap

ical

leaf

hus

k.Pu

lsatil

la (0

4.06

.198

6)Py

rus m

alus

See

Mal

us sy

lves

tris

Mill

.Q

uebr

acho

See

Asp

idos

perm

a qu

ebra

cho-

blan

co S

chle

chte

nd.

Que

rcus

robu

r L. a

nd Q

uerc

us

petr

aea

(Mat

t.) L

iebl

.Fr

esh

bark

from

you

ng tw

igs,

bran

ches

and

shoo

ts o

f Que

rcus

ro

bur L

. and

Que

rcus

pet

raea

(Mat

t.) L

iebl

.Q

uerc

us, C

orte

x (0

2.03

.199

1)

• Appendix 2.2


115

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erQ

uerc

us ro

bur L

., Q

uerc

us p

e-tr

aea

(Mat

t.) L

iebl

. and

Que

rcus

pu

besc

ens W

illd.

Cut a

nd d

ried

bark

from

the

fres

h yo

ung

bran

ches

of Q

uerc

us ro

-bu

r L.,

Q. p

etra

ea (M

att.)

Lie

bl. a

nd Q

. pub

esce

ns W

illd.

(oak

bar

k)H

AB

/ Ph.

Eur.

Que

rcus

, Cor

tex

(02.

03.1

991)

Ranu

ncul

us b

ulbo

sus L

.W

hole

fres

h �o

wer

ing

plan

ts o

f Ran

uncu

lus b

ulbo

sus L

.H

AB

/ Ph.

fr.Ra

phan

us sa

tivus

L.

Fres

h un

derg

roun

d pa

rts o

f Rap

hanu

s sat

ivus

L. v

ar. n

iger

(Mill

.) S.

Ke

rner

.H

AB

Raph

anus

sativ

us L

.D

ried

root

of R

apha

nus s

ativ

us L

. var

. nig

er (M

iller

) Ker

ner

Ph.fr

.Ra

tanh

iase

e K

ram

eria

tria

ndra

Rui

z. et

Pav

.Ra

uvol

�a se

rpen

tina

(L.)

Bent

h.W

hole

or c

ut, d

ried

root

s of R

auvo

l�a

serp

entin

a (L

.) Be

ntha

m e

x Ku

rzH

AB

/ DA

BRa

uwol

�a se

rpen

tina

(02.

09.1

987)

Resin

a La

ricis

see

Larix

dec

idua

Mill

.Rh

amnu

s fra

ngul

a L.

Fres

h ba

rk o

f the

stem

s and

bra

nche

s of R

ham

nus f

rang

ula

L.H

AB

Trop

aeol

um co

mp.

(0

2.03

.199

1)Rh

amnu

s pur

shia

na D

.C.

Drie

d, w

hole

or f

ragm

ente

d ba

rk o

f Rha

mnu

s pur

shia

na D

.C.

(Fra

ngul

a pu

rshi

ana

(DC

.) A

. Gra

y ex

J.G

. Coo

per)

(cas

cara

)Ph

.Eur

.

Rheu

m o

�ci

nale

Bai

ll., R

heum

pa

lmat

um L

.W

hole

or c

ut, d

ried

unde

rgro

und

part

s of R

heum

pal

mat

um L

. or

Rheu

m o

�ci

nale

Bai

llon

or o

f hyb

rids o

f the

se tw

o sp

ecie

s or o

f a

mix

ture

. �e

unde

rgro

und

part

s are

o�e

n di

vide

d; th

e st

em a

nd

mos

t of t

he b

ark

with

the

root

lets

are

rem

oved

(rhu

barb

)

Ph.E

ur. /

Ph.

fr.

Rheu

m rh

apon

ticum

L.

Who

le o

r cut

, drie

d un

derg

roun

d pa

rts o

f Rhe

um rh

apon

ticum

L.

Vade

mec

um: R

heum

rh

apon

ticum

Rh

odod

endr

on ch

rysa

nthu

m P

all.

Drie

d le

afy

twig

s of R

hodo

dend

ron

cam

pylo

carp

um H

ook.

f.

or R

hodo

dend

ron

chry

sant

hum

Pal

l., th

eir h

ybrid

s, or

mix

ture

s th

ereo

f

HA

B

Rhod

oden

dron

ferr

ugin

eum

L.

Fres

h le

afy

twig

s of R

hodo

dend

ron

ferr

ugin

eum

L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)Rh

odod

endr

on fe

rrug

ineu

m L

.Fr

esh

�ow

erin

g le

afy

twig

s of R

hodo

dend

ron

ferr

ugin

eum

L.

Rhus

toxi

code

ndro

n L.

Fres

h, y

oung

leaf

y br

anch

es o

f Rhu

s to

xico

dend

ron

L., c

olle

cted

at

the

end

of su

mm

erPh

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Rhus

toxi

code

ndro

n L.

Fres

h, y

oung

, not

yet

lign

i�ed

shoo

ts o

f Tox

icod

endr

on q

uerc

ifo-

lium

(Mic

hx.)

Gre

ene,

with

leav

esH

AB

/ BP

Rhus

toxi

code

ndro

n (0

5.12

.198

9)Ri

bes n

igru

m L

.Fr

esh

leav

es o

f Rib

es n

igru

m L

.Ph

.fr.

Rici

nus c

omm

unis

L.Fa

tty o

il ob

tain

ed b

y co

ld e

xpre

ssio

n fr

om th

e se

eds o

f Ric

inus

co

mm

unis

L. (c

asto

r oil,

virg

in)

Ph.E

ur.

Berb

eris/

Che

lidon

ium

co

mp.

(02.

03.1

991)

• Ap

pend

ix 2

.2


116

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erRi

cinu

s com

mun

is L.

Drie

d se

eds o

f Ric

inus

com

mun

is L.

Ph.fr

.Ro

bini

a ps

eudo

acac

ia L

.Fr

esh

bark

from

you

ng b

ranc

hes o

f Rob

inia

pse

udo-

acac

ia L

.H

AB

/ Ph.

fr.Ro

bini

a co

mp.

(1

2.09

.199

2)Ro

bini

a ps

eudo

acac

ia L

.Fr

esh

bark

of R

obin

ia p

seud

oaca

cia

L.Ro

sa c

anin

a L.

Rose

hip

s mad

e up

by

the

rece

ptac

le a

nd th

e re

mai

ns o

f the

drie

d se

pals

of R

osa

cani

na L

., R.

pen

dulin

a L.

and

oth

er R

osa

spec

ies,

with

the

ache

nes r

emov

ed (d

og ro

se)

Ph.E

ur.

Rosa

cent

ifolia

L.

Fres

h pe

tals

of R

osa

cent

ifolia

L.

Rosa

, Flo

s (02

.03.

1991

)Ro

sa L

.Es

sent

ial o

il ob

tain

ed b

y st

eam

des

tilla

tion

from

fres

h �o

wer

s of

suita

ble

spec

ies o

f the

gen

us R

osa,

par

ticul

arly

Ros

a ga

llica

L.,

Rosa

da

mas

cena

Mill

. and

Ros

a ce

ntifo

lia L

.

Rosa

, Flo

s (02

.03.

1991

)

Rosa

L.

Subs

tanc

e ob

tain

ed b

y st

epw

ise e

xtra

ctio

n w

ith p

etro

leth

er a

nd

alco

hol f

rom

fres

h �o

wer

s of R

osa

dam

asce

na L

. and

Ros

a ce

ntifo

-lia

L.

Auru

m/L

avan

dula

e ae

ther

oleu

m/R

osa

(04.

06.1

986)

Rosa

L.

Fres

h �o

wer

s of s

uita

ble

spec

ies o

f the

gen

us R

osa

L., p

artic

ular

ly

dark

red

tea

hybr

ids

Rosa

, Flo

s (02

.03.

1991

)

Rosa

L.

Drie

d bu

ds a

nd p

etal

s of s

uita

ble

spec

ies o

f the

gen

us R

osa

L., p

ar-

ticul

arly

Ros

a ga

llica

L.,

Rosa

cent

ifolia

L.,

Rosa

dam

asce

na M

ill. a

s w

ell a

s dar

k re

d te

a hy

brid

s

Rosa

, Flo

s (02

.03.

1991

)

Rosm

arin

us o

�ci

nalis

L.

Esse

ntia

l oil

obta

ined

by

stea

m d

istill

atio

n fr

om th

e �o

wer

ing

aeria

l pa

rts o

f Ros

mar

inus

o�

cina

lis L

. (ro

sem

ary

oil)

Ph.E

ur.

Rosm

arin

öl(0

4.06

.198

6)Ro

smar

inus

o�

cina

lis L

.Fr

esh

leav

es o

f Ros

mar

inus

o�

cina

lis L

.H

AB

Rosm

arin

us(0

2.09

.198

7)Ro

smar

inus

o�

cina

lis L

.Fr

esh

�ow

erin

g tw

igs o

f Ros

mar

inus

o�

cina

lis L

.Ph

.fr.

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Rosm

arin

us o

�ci

nalis

L.

Who

le d

ried

leaf

of R

osm

arin

us o

�ci

nalis

L. (

rose

mar

y le

af)

HA

B / P

h.Eu

r.Ro

smar

inus

(02.

09.1

987)

Rum

ex cr

ispus

L.

Fres

h un

derg

roun

d pa

rts o

f Rum

ex cr

ispus

L.,

harv

este

d at

the

end

of th

e ve

geta

tion

perio

dH

AB

Ruta

gra

veol

ens L

.Fr

esh

aeria

l par

ts o

f Rut

a gr

aveo

lens

L.,

colle

cted

at th

e st

art o

f �o

wer

ing

HA

BC

helid

oniu

m/T

ereb

in-

thin

a la

ricin

a co

mp.

(0

2.03

.199

1)Ru

ta g

rave

olen

s L.

Fres

h, a

eria

l, un

ligni

�ed

part

s of R

uta

grav

eole

ns L

. bef

ore

�ow

er-

ing

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)

• Appendix 2.2


117

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erSa

badi

llase

e Sc

hoen

ocau

lon

o�ci

nale

(Cha

m. e

t Sch

lech

tend

.) A

. Gra

ySa

bal s

erru

latu

mse

e Se

reno

a re

pens

(Bar

tr.) S

mal

l.Sa

bina

see

Juni

peru

s sab

ina

L.Sa

ccha

rum

o�

cina

rum

L.

Car

amel

obt

aine

d th

roug

h th

e ro

astin

g of

Sac

char

um o

�ci

naru

m

L.Sa

ccha

rum

tost

umse

e Sa

ccha

rum

o�

cina

rum

L.

Salix

alb

a ss

p. v

itelli

na (L

.) A

r-ca

ng.

Fres

h ba

rk a

nd le

aves

of S

alix

alb

a ss

p. v

itelli

na (L

.) A

rcha

ng.

Rhus

/Sal

ix co

mp.

(2

5.10

.199

4)Sa

lix sp

ecie

sFr

esh

leav

es o

f Sal

ix a

lba,

ssp.

alb

a L.

and

/or s

sp. v

itelli

na (L

.) A

r-ca

ng. a

nd/o

r Sal

ix p

urpu

rea

L. a

nd/o

r Sal

ix v

imin

alis

L.A

spid

ium

/Sal

ix co

mp.

(0

4.06

.198

6)Sa

lix p

urpu

rea

L.Fr

esh

bark

and

leav

es o

f Sal

ix p

urpu

rea

L.Rh

us/S

alix

com

p.

(25.

10.1

994)

Salix

spec

ies

Who

le o

r fra

gmen

ted

drie

d ba

rk o

f you

ng b

ranc

hes o

r who

le d

ried

piec

es o

f cur

rent

-yea

r tw

igs o

f var

ious

spec

ies o

f gen

us S

alix

incl

ud-

ing

S. p

urpu

rea

L., S

. dap

hnoi

des V

ill. a

nd S

. fra

gilis

L. (

will

ow

bark

)

Ph.E

ur.

Salix

vim

inal

is L.

Fres

h ba

rk a

nd le

aves

of S

alix

vim

inal

is L.

Rhus

/Sal

ix co

mp.

(2

5.10

.199

4)Sa

lvia

o�

cina

lis L

.�

ujon

e-ric

h es

sent

ial o

il ob

tain

ed b

y st

eam

dist

illat

ion

from

the

aeria

l par

ts o

f Sal

via

o�ci

nalis

L.

DA

CM

ajor

ana/

�uj

a co

mp.

(0

2.03

.199

1)Sa

lvia

o�

cina

lis L

.Fr

esh

leav

es o

f Sal

via

o�ci

nalis

L.

HA

BA

rcha

ngel

ica/

Pyrit

co

mp.

(02.

03.1

991)

Salv

ia o

�ci

nalis

L.

Who

le o

r cut

drie

d le

aves

of S

alvi

a o�

cina

lis L

. (sa

ge le

af)

Ph.E

ur.

Frag

aria

/Urt

ica

com

p.

(03.

07.1

992)

Sam

bucu

s nig

ra L

.Fr

esh

pith

from

bra

nche

s of S

ambu

cus n

igra

L.

Sam

bucu

s com

p.

(05.

12.1

989)

Sam

bucu

s nig

ra L

.D

ried

pith

from

bra

nche

s of S

ambu

cus n

igra

L.

Sam

bucu

s com

p.

(05.

12.1

989)

Sam

bucu

s nig

ra L

.Fr

esh

in�o

resc

ence

of S

ambu

cus n

igra

L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)Sa

mbu

cus n

igra

L.

Fres

h in

�ore

scen

ces o

f Sam

bucu

s nig

ra L

.Sa

mbu

cus c

omp.

(0

5.12

.198

9)

• Ap

pend

ix 2

.2


118

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erSa

mbu

cus n

igra

L.

Drie

d �o

wer

s of S

ambu

cus n

igra

L. (

elde

r �ow

er)

Ph.E

ur.

Mal

va co

mp.

(0

3.07

.199

2)Sa

mbu

cus n

igra

L.

Drie

d in

�ore

scen

ce o

f Sam

bucu

s nig

ra L

.Fl

ores

Sam

buci

com

p./

Qua

rz (0

7.04

.198

8)Sa

mbu

cus n

igra

L.

Equa

l par

ts o

f fre

sh le

aves

and

in�o

resc

ence

s of S

ambu

cus n

igra

L.

HA

BSa

mbu

cus/

Teuc

rium

co

mp.

(25.

10.1

994)

Sang

uina

ria c

anad

ensis

L.

Drie

d un

derg

roun

d pa

rts o

f San

guin

aria

can

aden

sis L

., co

llect

ed in

au

tum

nH

AB

Oxa

lis co

mp.

(04.

06.1

986)

Sani

cula

eur

opae

a L.

Fres

h w

hole

�ow

erin

g pl

ant o

f San

icul

a eu

ropa

ea L

.Ph

.fr. /

HA

BC

icho

rium

com

p.(0

3.07

.199

2)Fo

rmul

aire

de

med

.an

thr.

(201

0)Sa

nicu

la e

urop

aea

L.Fr

esh

aeria

l par

ts o

f San

icul

a eu

ropa

ea L

., co

llect

ed at

�ow

erin

g tim

eH

AB

Sapo

naria

o�

cina

lis L

. Fr

esh

who

le �

ower

ing

plan

t of S

apon

aria

o�

cina

lis L

.Ph

.fr.

Sarc

opot

eriu

m sp

inos

um (L

.) Sp

ach.

Drie

d ba

rk fr

om th

e ro

ots o

f Sar

copo

teriu

m sp

inos

um (L

.) Sp

ach.

Saro

tham

nus s

copa

rius

see

Cyt

isus s

copa

rius (

L.) L

ink.

Sars

apar

illa

see

Smila

x re

gelii

Kill

. et C

. V. M

orto

n, S

mila

x m

edic

a Sc

hlec

hten

d.

et C

ham

. etc

.Sc

hoen

ocau

lon

o�ci

nale

(Cha

m.

et S

chle

chte

nd.)

A. G

ray

Drie

d rip

e se

eds o

f Sch

oeno

caul

on o

�ci

nale

(Cha

m. e

t Sch

lech

-te

nd.)

A. G

ray.

HA

B / P

h.fr.

Ferr

um p

hosp

horic

um

com

p. (0

4.06

.198

6)Sc

illa

see

Urg

inea

mar

itim

a (L

.) Ba

k. s.

l.Sc

olop

endr

ium

see

Phyl

litis

scol

open

driu

m (L

.) N

ewm

.Sc

roph

ular

ia n

odos

a L.

Fr

esh

who

le �

ower

ing

plan

t of S

crop

hula

ria n

odos

a L.

Ph.fr

.Sc

utel

laria

late

rifol

ia L

. D

ried

who

le �

ower

ing

plan

t of S

cute

llaria

late

rifol

ia L

.Se

cale

corn

utum

see

Cla

vice

ps p

urpu

rea

(Fr.)

Tul

.Se

dum

acr

e L.

Fres

h ae

rial p

arts

of S

edum

acr

e L.

, col

lect

ed at

�ow

erin

g tim

eH

AB

Sedu

m a

cre

L.Fr

esh

aeria

l par

ts o

f Sed

um a

cre

L.Se

dum

tele

phiu

m L

.Fr

esh,

aer

ial p

arts

of �

ower

ing

Sedu

m te

leph

ium

L. (

Sedu

m p

ur-

pure

um L

.)Se

dum

pur

pure

um

(07.

04.1

988)

Sele

nice

reus

gra

ndi�

orus

(L.)

Britt

. et R

ose

Fres

h yo

ung

stem

and

�ow

ers o

f Sel

enic

ereu

s gra

ndi�

orus

(L.)

Britt

. et R

ose.

(Cac

tus)

HA

BC

actu

s gra

ndi�

orus

(1

2.09

.199

2)

• Appendix 2.2


119

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erSe

mec

arpu

s ana

card

ium

L.

Drie

d fr

uit o

f Sem

ecar

pus a

narc

ardi

um L

. (A

naca

rdiu

m o

rient

ale

L.) (

orie

ntal

cas

hew

for h

omoe

opat

hic p

repa

ratio

ns)

HA

B / P

h.Eu

r.

Sene

cio

bico

lor (

Will

d.) T

od.

Fres

h ae

rial p

arts

of S

enec

io b

icol

or (W

illd.

) Tod

., co

llect

ed b

efor

e �o

wer

ing

Cin

erar

ia m

ariti

ma

(12.

09.1

992)

Sene

cio

jaco

baea

L.

Fres

h ae

rial p

arts

of S

enec

io ja

coba

ea L

., co

llect

ed at

�ow

erin

g tim

eSe

neci

o co

mp.

(1

2.09

.199

2)Se

neci

o vu

lgar

is L.

Fres

h w

hole

�ow

erin

g pl

ant o

f Sen

ecio

vul

garis

L.

Sene

gase

e Po

lyga

la se

nega

L.

Senn

ase

e C

assia

ang

ustif

olia

Vah

l.Se

reno

a re

pens

(Bar

tr.) S

mal

lD

ried

ripe

frui

t of S

eren

oa re

pens

(Bar

tr.) S

mal

l.U

SP /

Ph.fr

.Sa

bal/S

olid

ago

com

p.(D

AZ

Nr.2

9,

21.0

7.19

94)

Sere

noa

repe

ns (B

artr.

) Sm

all

Fres

h rip

e fr

uits

of S

eren

oa re

pens

(Bar

tr.) S

mal

l. (S

abal

serr

ula-

tum

)H

AB

Sily

bum

mar

ianu

m (L

.) G

aert

n.M

atur

e fr

uit,

devo

id o

f the

pap

pus,

of S

ilybu

m m

aria

num

(L.)

Gae

rtne

r (m

ilk-t

hist

le fr

uit)

HA

B / P

h.Eu

r. / P

h.fr.

/ U

SPC

ardu

us m

aria

nus

(04.

06.1

986)

Smila

x sp

ecie

sD

ried

unde

rgro

und

part

s of S

mila

x ar

istol

ochi

ifolia

Mill

. S. m

edic

a Sc

hlec

hten

d. e

t Cha

m) a

nd re

late

d sp

ecie

sPh

.fr.

Sola

num

dul

cam

ara

L.Fr

esh

�ow

ers o

f Sol

anum

dul

cam

ara

L.D

ulca

mar

a/Ly

simac

hia

(04.

06.1

986)

Sola

num

dul

cam

ara

L.Fr

esh

shoo

ts o

f Sol

anum

dul

cam

ara

L., c

olle

cted

prio

r to

�ow

erin

gH

AB

Sola

num

dul

cam

ara

L.Fr

esh

youn

g le

afy

bran

ches

of S

olan

um d

ulca

mar

a L.

Sola

num

dul

cam

ara

L.D

ried,

lign

i�ed

stem

s of S

olan

um d

ulca

mar

a L.

(Dul

cam

ara,

Stip

i-te

s)D

AB6

Erg

.B.

Siru

pus �

ymi c

omp.

(0

4.06

.198

6)So

lanu

m ly

cope

rsic

umSe

e Ly

cope

rsic

on ly

cope

rsic

um (L

.) K

arst

. ex

Farw

.So

lidag

o vi

rgau

rea

L.Fr

esh

in�o

resc

ence

of S

olid

ago

virg

aure

a L.

Ph.fr

. / H

AB

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Solid

ago

virg

aure

a L.

Fres

h ae

rial p

arts

of S

olid

ago

virg

aure

a L.

, col

lect

ed at

�ow

erin

g tim

eSo

lidag

o vi

rgau

rea

(D

AZ

Nr.

29 v

om

21.0

7.19

94)

Solu

m u

ligin

osum

se

e pe

at

• Ap

pend

ix 2

.2


120

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erSp

artiu

m sc

opar

ium

See

Cyt

isus s

copa

rius (

L.) L

ink.

Spig

elia

ant

helm

ia L

.D

ried,

who

le �

ower

ing

plan

t of S

pige

lia a

nthe

lmia

L.

Ph.fr

.Sp

igel

ia a

nthe

lmia

L.

Drie

d ae

rial p

arts

of S

pige

lia a

nthe

lmia

L.

HA

BSp

inac

ia o

lera

cea

L.Fr

esh

unde

rgro

und

part

s of S

pina

cia

oler

acea

L.

Sene

cio

com

p.

(12.

09.1

992)

Spira

ease

e Fi

lipen

dula

ulm

aria

(L.)

Max

im.

Spiri

to e

x vi

noSe

e V

itis v

inife

ra L

.St

achy

s o�

cina

lis (L

.) Tr

ev.

Fres

h ae

rial p

arts

of S

tach

ys o

�ci

nalis

(L.)

Trev

., co

llect

ed at

�ow

-er

ing

time

HA

BBe

toni

ca/R

osm

arin

us(1

2.09

.199

2)St

aphi

sagr

iase

e D

elph

iniu

m st

aphi

sagr

ia L

.St

ella

ria m

edia

(L.)

Fres

h w

hole

pla

nt o

f Ste

llaria

med

ia (L

.)St

icta

see

Loba

ria p

ulm

onar

ia (L

.) H

o�m

.St

ram

oniu

mse

e D

atur

a st

ram

oniu

m L

.St

roph

anth

us k

ombe

Oliv

.Fa

tty o

il fr

om th

e se

eds o

f Str

opha

nthu

s kom

be O

liv.

Ole

um S

trop

hant

hi

(03.

07.1

992)

Stro

phan

thus

kom

be O

liv.

Drie

d rip

e se

eds o

f Str

opha

nthu

s kom

bé O

liv.

Stro

phan

thus

kom

bé

(02.

09.1

987)

Stry

chno

s ign

atii

Berg

ius

Drie

d rip

e se

eds o

f Str

ychn

os ig

natii

Ber

gius

.H

AB

/ Ph.

fr.Ig

natia

(02.

09.1

987)

Stry

chno

s nux

-vom

ica

L.D

ried

ripe

seed

s of S

tryc

hnos

nux

-vom

ica

L.H

AB

/ Ph.

fr.N

ux v

omic

a (0

4.06

.198

6)St

yrax

tonk

inen

sis (P

ierr

e) C

raib

ex

Har

twic

hBa

lsam

obt

aine

d th

roug

h in

cisio

ns m

ade

into

the

trun

k of

Sty

rax

tonk

inen

sis (P

ierr

e) C

raib

ex

Har

twic

h (S

tyra

cace

ae)

DA

C

Sym

phyt

um o

�ci

nale

L.

Fres

h un

derg

roun

d pa

rts o

f Sym

phyt

um o

�ci

nale

L.

Ph.fr

. / B

PSt

annu

m/S

ymph

ytum

co

mp.

(12.

09.1

992)

Sym

phyt

um o

�ci

nale

L.

Fres

h ae

rial p

arts

of S

ymph

ytum

o�

cina

le L

., co

llect

ed at

�ow

erin

g tim

eC

alen

dula

/Urt

ica

com

p.

(12.

09.1

992)

Syzy

gium

aro

mat

icum

(L.)

Mer

r. et

L. M

. Per

ryEs

sent

ial o

il ob

tain

ed b

y st

eam

dist

illat

ion

from

the

drie

d �o

wer

bu

ds o

f Syz

ygiu

m a

rom

atic

um (L

.) M

erill

et L

. M. P

erry

(syn

. Eug

e-ni

a ca

ryop

hyllu

s [C

. Spr

eng.

] Bul

lock

et S

.G. H

arris

on) (

clov

e oi

l)

Ph.E

ur.

Rata

nhia

com

p.(0

3.07

.199

2)

Syzy

gium

aro

mat

icum

(L.)

Mer

r. et

L. M

. Per

ryW

hole

�ow

er b

uds o

f Syz

ygiu

m a

rom

atic

um (L

.) M

erill

et L

.M.

Perr

y (s

yn. E

ugen

ia c

aryo

phyl

lus [

C. S

pren

g.] B

ullo

ck e

t S.G

. Har

-ris

on) d

ried

until

they

bec

ome

redd

ish-b

row

n (c

love

)

Ph.E

ur.

Abs

inth

ium

/ C

aryo

phyl

li co

mp.

(02.

09.1

987)

Syzy

gium

jam

bos (

L.) A

lston

Drie

d se

eds o

f Syz

ygiu

m ja

mbo

s (L.

) Alst

on

• Appendix 2.2


121

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erTa

bacu

mSe

e N

icot

iana

taba

cum

L.

Tana

cetu

m v

ulga

re L

.Fr

esh

aeria

l par

ts o

f Tan

acet

um v

ulga

re L

., co

llect

ed at

�ow

erin

g tim

e, w

ithou

t ste

ms

HA

B

Tara

xacu

m o

�ci

nale

agg

. F.H

. W

igg.

Who

le fr

esh

�ow

erin

g pl

ants

of T

arax

acum

o�

cina

le a

gg. F

.H.

Wig

g.H

AB

/ Ph.

fr.Ta

raxa

cum

(2

5.10

.199

4)Ta

raxa

cum

o�

cina

le a

gg. F

.H.

Wig

g.Fr

esh

unde

rgro

und

part

s of T

arax

acum

o�

cina

le a

gg. F

.H. W

igg.

co

llect

ed in

autu

mn

(aut

umna

le) o

r spr

ing

(ver

nale

)Ta

raxa

cum

(2

5.10

.199

4)Ta

rtar

us cr

udus

See

Viti

s vin

ifera

L.

Teuc

rium

mar

um L

.Fr

esh

�ow

erin

g, a

eria

l par

ts o

f Teu

criu

m m

arum

L.

Teuc

rium

mar

um L

.Fr

esh

aeria

l par

ts o

f Teu

criu

m m

arum

L.,

with

out l

igni

�ed

sect

ions

of

twig

sH

AB

Teuc

rium

scor

odon

ia L

.Fr

esh

aeria

l par

ts o

f �ow

erin

g pl

ants

of T

eucr

ium

scor

odon

ia L

.H

AB

/ Ph.

fr.K

aliu

m/T

eucr

ium

co

mp.

(25.

10.1

994)

Teuc

rium

scor

odon

ia L

.D

ried

aeria

l par

ts o

f �ow

erin

g pl

ants

of T

eucr

ium

scor

odon

ia L

.Sp

ecie

s pul

mon

ales

(0

7.04

.198

8)�

uja

occi

dent

alis

L.Fr

esh

leaf

y br

anch

es o

f �uj

a oc

cide

ntal

is L.

, col

lect

ed p

refe

rabl

y in

sp

ring

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)�

uja

occi

dent

alis

L.Fr

esh,

leaf

y, on

e-ye

ar-o

ld tw

igs o

f �uj

a oc

cide

ntal

is L.

HA

B�

uja

occi

dent

alis

(07.

04.1

988)

�ym

us se

rpyl

lum

L. e

men

d. M

ill.

Drie

d, w

hole

or c

ut, �

ower

ing

aeria

l sho

ots o

f �

ymus

serp

yllu

m

L. se

nsu

latio

reD

AB

Siru

pus �

ymi c

omp.

(04.

06.1

986)

�ym

us v

ulga

ris L

.Es

sent

ial o

il ob

tain

ed b

y st

eam

dist

illat

ion

from

the

fres

h �o

wer

ing

aeria

l par

ts o

f �ym

us v

ulga

ris L

., T.

zygi

s L. o

r a m

ixtu

re o

f bot

h sp

ecie

s. (t

hym

e oi

l, th

ymol

type

)

Ph.E

ur.

�ym

i aet

hero

leum

(2

5.10

.199

4)

�ym

us v

ulga

ris L

.Fr

esh

aeria

l par

ts o

f �ym

us v

ulga

ris L

., co

llect

ed at

�ow

erin

g tim

eH

AB

�ym

us v

ulga

ris L

.W

hole

leav

es a

nd �

ower

s sep

arat

ed fr

om th

e pr

evio

usly

drie

d st

ems

of �

ymus

vul

garis

L. o

r �ym

us zy

gis L

. or a

mix

ture

of b

oth

spe-

cies

. (th

yme)

Ph.E

ur.

Siru

pus �

ymi c

omp.

(04.

06.1

986)

Tilia

cord

ata

Mill

er, T

ilia

plat

y-ph

yllo

s Sco

poli

Fres

h in

�ore

scen

ce o

f Tili

a co

rdat

a M

iller

and

Tili

a pl

atyp

hyllo

s Sc

opol

iFl

ores

Sam

buci

/Qua

rz(0

7.04

.198

8)Ti

lia co

rdat

a M

iller

, Tili

a pl

aty-

phyl

los S

copo

liW

hole

, drie

d in

�ore

scen

ce o

f Tili

a co

rdat

a M

iller

, of T

ilia

plat

y-ph

yllo

s Sco

p., o

f Tili

a x

vulg

aris

Hey

ne o

r a m

ixtu

re o

f the

se (l

ime

�ow

er)

Ph.E

ur.

Mal

va co

mp.

(0

3.07

.199

2)

• Ap

pend

ix 2

.2


122

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erTo

rmen

tilla

see

Pote

ntill

a er

ecta

(L.)

Raeu

sch.

Toxi

code

ndro

nse

e To

xico

dend

ron

quer

cifo

lium

(Mic

hx.)

Gre

ene

Toxi

code

ndro

n qu

erci

foliu

m

(Mic

hx.)

Gre

ene

see

Rhus

toxi

code

ndro

n L.

Triti

cum

aes

tivum

L.

Fatty

oil

obta

ined

from

the

germ

of t

he g

rain

of T

ritic

um a

estiv

um

L. b

y co

ld e

xpre

ssio

n or

oth

er su

itabl

e m

echa

nica

l mea

ns (w

heat

-ge

rm o

il)

Ph.E

ur.

Triti

cum

aes

tivum

L. e

men

d. F

iori

et P

aol.

Fres

h �o

wer

s of T

ritic

um a

estiv

um L

. em

end.

Fio

ri et

Pao

l.

Triti

cum

aes

tivum

L. e

men

d. F

iori

et P

aol.

Fres

h ge

rmin

ated

frui

t of T

ritic

um a

estiv

um L

. em

end.

Fio

ri et

Pa

ol.

Ph.fr

.H

irnst

amm

/Trit

icum

(2

8. S

erie

) (D

AZ

Nr.

29

vom

21.

07.1

994)

Triti

cum

aes

tivum

L. e

men

d. F

iori

et P

aol.

Fres

h pa

rts p

roje

ctin

g ou

t of t

he in

�ore

senc

e sp

ikel

et o

f Trit

icum

ae

stiv

um L

. em

end.

Fio

ri et

Pao

l.Tr

iticu

m a

estiv

um L

. em

end.

Fio

ri et

Pao

l.D

ried

germ

of t

he g

rain

of T

ritic

um

aest

ivum

L. e

men

d Fi

ori e

t Pao

l. (w

heat

-ger

m)

Levi

stic

um co

mp.

(0

2.09

.198

7)Tr

iticu

m a

estiv

um L

. em

end.

Fio

ri et

Pao

l.W

heat

glu

ten

Triti

cum

repe

nsse

e El

ymus

repe

ns (L

.) G

ould

Tric

itum

vul

gare

Drie

d in

�ore

scen

ces o

f Trit

icum

aes

tivum

L. e

men

d. F

iori

et P

aol.

Flor

es T

ritic

i com

p.

(12.

9.19

92)

Trop

aeol

um m

ajus

L.

Fres

h ae

rial p

arts

of T

ropa

eolu

m m

ajus

L.,

colle

cted

at �

ower

ing

time

Trop

aeol

um co

mp.

(0

2.03

.199

1)Tu

lipa

silve

stris

L.

Fres

h w

hole

�ow

erin

g pl

ant o

f Tul

ipa

silve

stris

L.

Vade

mec

um: T

ulip

aU

rgin

ea m

ariti

ma

(L.)

Bak.

Fres

h, �

eshy

scal

e le

aves

of t

he re

d-sc

aled

subs

peci

es o

f Urg

inea

m

ariti

ma

(L.)

Bak.

sens

u la

tiore

(e.g

. Urg

inea

num

idic

a [J

ord.

et

Four

r.] G

rey)

with

a cl

early

det

ecta

ble

scill

irosid

e co

nten

t

HA

B

Urg

inea

mar

itim

a va

r. ru

bra

(L.)

Bake

rFr

esh

bulb

of U

rgin

ea m

ariti

ma

var.

rubr

a (L

.) Ba

ker

Ado

nis/

Scill

a co

mp.

(2

5.10

.199

4)U

rtic

a di

oica

L.

Fres

h le

aves

of U

rtic

a di

oica

L.

Urt

ica

dioi

ca

(02.

09.1

987)

Urt

ica

dioi

ca L

.W

hole

,fres

h, �

ower

ing

plan

ts o

f Urt

ica

dioi

ca L

. (C

omm

on st

ing-

ing

nettl

e fo

r hom

oeop

athi

c pre

para

tions

) H

AB

/ Ph.

Eur.

Urt

ica

dioi

ca

(02.

09.1

987)

• Appendix 2.2


123

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erU

rtic

a di

oica

L.

Fres

h ae

rial p

arts

of U

rtic

a di

oica

L.

Urt

ica

dioi

ca

(02.

09.1

987)

Urt

ica

dioi

ca L

.W

hole

or c

ut d

ried

leav

es o

f Urt

ica

dioi

ca L

., U

rtic

a ur

ens L

., or

a

mix

ture

of t

he 2

spec

ies (

nettl

e le

af)

Ph.E

ur.

Urt

ica

dioi

ca L

.D

ried

leav

es o

f Urt

ica

dioi

ca L

.U

rtic

a di

oica

L.

Drie

d �o

wer

s of U

rtic

a di

oica

L.

Cap

sella

/Maj

oran

a co

mp.

(04.

06.1

986)

Urt

ica

dioi

ca L

.D

ried,

aer

ial p

arts

with

max

imum

3 m

m th

ick

stem

s of U

rtic

a di

o-ic

a L.

, col

lect

ed sh

ortly

bef

ore

�ow

erin

gU

rtic

a di

oica

(0

2.09

.198

7)U

rtic

a ur

ens L

.Fr

esh,

who

le �

ower

ing

plan

t of U

rtic

a ur

ens L

.Ph

.fr.

Berb

eris,

Pla

nta

tota

/ U

rtic

a ur

ens

(02.

03.1

991)

Form

ulai

re d

e m

ed.

anth

r. (2

010)

Urt

ica

uren

s L.

Fres

h, w

hole

pla

nt o

f Urt

ica

uren

s L.

Urt

ica

uren

s L.

Fres

h, �

ower

ing

aeria

l par

ts o

f Urt

ica

uren

s L.

HA

B / B

PA

rnic

a/U

rtic

a ur

ens

(04.

06.1

986)

Urt

ica

uren

s L.

Drie

d, a

eria

l par

ts o

f Urt

ica

uren

s L.

Usn

ea b

arba

ta (L

.) W

igg.

Drie

d th

allu

s fro

m U

snea

P. B

r. ex

Ada

ns. s

peci

es, e

spec

ially

Usn

ea

barb

ata

(L.)

Wig

g.Li

chen

es co

mp.

(0

4.06

.198

6)Va

ccin

ium

myr

tillu

s L.

Drie

d rip

e fr

uit o

f Vac

cini

um m

yrtil

lus L

. (bi

lber

ry fr

uit,

drie

d)

Ph.E

ur.

Vacc

iniu

m v

itis-

idae

a L.

Leaf

y tw

igs w

ith fr

esh

frui

ts o

f Vac

cini

um v

itis-

idae

a L.

Vale

riana

o�

cina

lis L

.Fr

esh

�ow

ers o

f Val

eria

na o

�ci

nalis

L.

Vale

riana

o�

cina

lis L

.Fr

esh,

und

ergr

ound

par

ts o

f Val

eria

na o

�ci

nalis

L.

Ph.fr

.Fo

rmul

aire

de

med

.an

thr.

(201

0)Va

leria

na o

�ci

nalis

L.

Fres

h un

derg

roun

d pa

rts o

f Val

eria

na o

�ci

nalis

L. s

ensu

latio

reH

AB

Vale

riana

com

p.

(03.

07.1

992)

Vale

riana

o�

cina

lis L

.D

ried,

who

le o

r fra

gmen

ted

unde

rgro

und

part

s of V

aler

iana

of-

�cin

alis

L. s.

l., in

clud

ing

the

rhiz

ome

surr

ound

ed b

y th

e ro

ots a

nd

stol

ons (

vale

rian

root

)

Ph.E

ur. /

USP

Vauc

heria

DC

spec

ies

Fres

h, w

hole

org

anism

of V

auch

eria

DC

spec

ies

Vauc

heria

(25.

10.1

994)

Vera

trum

alb

um L

.C

aref

ully

drie

d rh

izom

e w

ith at

tach

ed ro

ots o

f Ver

atru

m a

lbum

L.

HA

BD

rose

ra/Ip

ecac

uanh

a co

mp.

(04.

06.1

986)

Vera

trum

alb

um L

.Fr

esh,

und

ergr

ound

par

ts o

f Ver

atru

m a

lbum

L.

Ph.fr

.Ve

ratr

um a

lbum

(0

4.06

.198

6)

• Ap

pend

ix 2

.2


124

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erVe

rbas

cum

den

si�or

um B

erto

l.Fr

esh,

unr

ipe

frui

ts o

f Ver

basc

um d

ensi�

orum

Ber

tol.

Verb

ascu

m co

mp.

(1

2.09

.199

2)Ve

rbas

cum

den

si�or

um B

erto

l.Fr

esh

aeria

l par

ts o

f Ver

basc

um d

ensi�

orum

Ber

tol.

with

out w

oody

st

ems,

colle

cted

at �

ower

ing

time

HA

B

Verb

ascu

m d

ensi�

orum

Ber

tol.

Drie

d fr

uit o

f Ver

basc

um d

ensi�

orum

Ber

tol.

Vero

nica

o�

cina

lis L

.D

ried

aeria

l par

ts o

f Ver

onic

a o�

cina

lis L

., co

llect

ed at

�ow

erin

g tim

eH

AB

Vero

nica

o�

cina

lis

(25.

10.1

994)

Vin

ca m

inor

L.

Fres

h, w

hole

�ow

erin

g pl

ant o

f Vin

ca m

inor

L.

Ph.fr

.V

inum

see

Viti

s vin

ifera

L.

Vio

la tr

icol

or L

.Fr

esh,

who

le �

ower

ing

plan

t of V

iola

tric

olor

L. a

nd /

or V

iola

ar

vens

is M

urra

yPh

.fr.

Vio

la tr

icol

or L

.Fr

esh

aeria

l par

ts o

f Vio

la tr

icol

or L

., co

llect

ed at

�ow

erin

g tim

eH

AB

Trop

aeol

um co

mp.

(0

2.03

.199

1)V

iola

tric

olor

L.

Drie

d, �

ower

ing

aeria

l par

ts o

f Vio

la a

rven

sis M

urra

y an

d/or

Vio

la

tric

olor

L. (

wild

pan

sy �

ower

ing

aeria

l par

ts)

Ph.E

ur.

Viro

la se

bife

ra A

ubl.

Fres

h ju

ice

of V

irola

sebi

fera

Aub

l. ob

tain

ed b

y in

cisin

g th

e ba

rk,

and

pres

erve

d w

ith a

n ap

prox

imat

ely

equa

l vol

ume

of E

than

ol (9

6 pe

r cen

t) (P

h.Eu

r.)

HA

BM

yrist

ica

sebi

fera

co

mp.

(07.

04.1

988)

Visc

um a

lbum

L.

Fres

h pl

ant i

nclu

ding

frui

t and

hau

stor

ium

of V

iscum

alb

um L

. ssp

. ab

ietis

(Wie

sb.)

Abr

om. (

Hos

t tre

e: A

bies

spec

ies)

Visc

um a

lbum

(0

4.06

.198

6)V

iscum

alb

um L

.Fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f Visc

um a

lbum

ssp.

abi

etis

(Bec

k) (W

iesb

.) A

brom

. (H

ost t

ree:

Abi

es a

lba

Mill

. (A

bies

pec

ti-na

ta (L

am.)

DC

); �r

)

Visc

um a

lbum

(0

4.06

.198

6)

Visc

um a

lbum

L.

Fres

h pl

ant i

nclu

ding

frui

t and

hau

stor

ium

of V

iscum

alb

a L.

ssp.

al

bum

(Hos

t tre

es: P

opul

us sp

ecie

s)V

iscum

com

p.

(25.

10.1

994)

Visc

um a

lbum

L.

Fres

h pl

ant i

nclu

ding

frui

t and

hau

stor

ium

of V

iscum

alb

um L

. ssp

. au

stria

cum

(Wie

sb.)

Vollm

. (H

ost t

ree:

Pin

us sp

ecie

s)V

iscum

alb

um

(04.

06.1

986)

Visc

um a

lbum

L.

Fres

h pl

ant e

xclu

ding

hau

stor

ium

of V

iscum

alb

um ss

p. a

lbum

L.

(Hos

t tre

e: M

alus

dom

estic

a Bo

ekh.

; App

le tr

ee)

Visc

um a

lbum

(0

4.06

.198

6)V

iscum

alb

um L

.Fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f Visc

um a

lbum

ssp.

aust

riacu

m

(Wie

sb.)

Vollm

. (H

ost t

ree:

Pin

us sy

lves

tris

L.; P

ine)

V

iscum

alb

um

(04.

06.1

986)

• Appendix 2.2


125

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

de�n

ition

of t

he p

art u

sed

Refe

renc

e to

Stan

dard

sEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic

med

icin

eKC

mon

ogra

ph (d

ate)

Oth

erV

iscum

alb

um L

.Fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f Visc

um a

lbum

ssp.

alb

um L

. (H

ost t

ree:

Que

rcus

robu

r L.,

Que

rcus

pet

raea

(Mat

t.) L

iebl

.; O

ak)

Visc

um a

lbum

(0

4.06

.198

6)V

iscum

alb

um L

.Fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f Visc

um a

lbum

ssp.

alb

um L

. (H

ost t

ree:

Ulm

us c

aprin

ifolia

Gle

d. [U

lmus

cam

pest

ris L

.], U

lmus

gl

abra

Hud

s.; E

lm)

Visc

um a

lbum

(0

4.06

.198

6)

Visc

um a

lbum

L.

Fres

h le

afy

shoo

ts a

nd fr

uits

of V

iscum

alb

um L

.H

AB

Visc

um a

lbum

L.

Fres

h ha

usto

rium

of V

iscum

alb

um L

ssp.

alb

um (H

ost t

ree:

Mal

us

spec

ies)

Visc

um a

lbum

(0

4.06

.198

6)V

iscum

alb

um L

.Fr

esh

shoo

ts co

llect

ed in

sum

mer

and

�ow

ers c

olle

cted

in w

inte

r of

Visc

um a

lbum

L. s

sp. a

lbum

(Hos

t tre

e: S

alix

alb

a)V

iscum

alb

um L

.Fr

esh

aeria

l par

ts in

clud

ing

frui

t of V

iscum

alb

um L

. (H

ost t

rees

: Ap

ple,

Birc

h, F

ir, P

ine,

Lim

e)V

iscum

alb

um L

.D

ried

plan

t inc

ludi

ng fr

uit o

f Visc

um a

lbum

L. s

sp. a

lbum

(Hos

t tr

ees:

Oak

spec

ies)

with

out h

aust

oriu

m.

Visc

um a

lbum

L.

Drie

d pl

ant i

nclu

ding

frui

t and

hau

stor

ium

of V

iscum

alb

um L

. ssp

. al

bum

(Hos

t tre

es: C

rata

egus

spec

ies)

V

iscum

alb

um

(04.

06.1

986)

Visc

um a

lbum

L.

Drie

d pl

ant i

nclu

ding

frui

t and

hau

stor

ium

of V

iscum

alb

um L

. ssp

. al

bum

(Hos

t tre

es: S

alix

spec

ies)

Visc

um a

lbum

(0

4.06

.198

6)V

iscum

alb

um L

.D

ried

bran

ches

with

leav

es, �

ower

s and

frui

t of V

iscum

alb

um L

. ss

p. a

lbum

(Hos

t tre

es: M

alus

spec

ies)

Visc

um a

lbum

(0

4.06

.198

6)V

itex

agnu

s-ca

stus

L.

who

le, r

ipe,

drie

d fr

uits

of V

itex

agnu

s-ca

stus

L. (

agnu

s cas

tus f

ruit)

HA

B / P

h.Eu

r. / U

SP /

Ph.fr

.M

eliss

a/Ph

osph

orus

co

mp.

(03.

07.1

992)

Viti

s vin

ifera

L.

Dist

illed

red

win

e vi

nega

r (ac

etum

vin

i des

tilla

tum

)K

aliu

m a

cetic

um co

mp.

(0

3.07

.199

2)V

itis v

inife

ra L

.Re

d w

ine

vine

gar (

acet

um v

ini)

Viti

s vin

ifera

L.

Drie

d le

aves

of V

itis v

inife

ra L

.V

itis c

omp.

(0

4.06

.198

6)V

itis v

inife

ra L

.D

istill

ate

of w

ine

Viti

s vin

ifera

L.

Cre

am o

f tar

tar (

Tart

arus

crud

us)

Viti

s vin

ifera

L.

Whi

te w

ine

Zea

may

s L.

Fres

h st

igm

a an

d st

yle

of Z

ea m

ays L

.Ph

.fr.

Zing

iber

o�

cina

le R

osc.

Drie

d, w

hole

or c

ut rh

izom

e of

Zin

gibe

r o�

cina

le R

osco

e, w

ith th

e co

rk re

mov

ed, e

ither

com

plet

ely

or fr

om th

e w

ide,

�at s

urfa

ces o

nly

(gin

ger)

HA

B / P

h.Eu

r. / U

SPG

entia

na/Z

ingi

ber

com

p. (0

2.03

.199

1)

• Ap

pend

ix 2

.2


126

• Appendix 2.3


127

APPENDIX 2.3

List of starting materials of zoological originAdditional Information, see p. 21 and pp. 67-73 Abbreviation *: p. 67

• Ap

pend

ix 2

.3


• Appendix 2.3

128

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Aci

dum

For

mic

ae

(Aci

dum

form

icic

um e

fo

rmic

a; A

cidu

m F

or-

mic

ae v

enen

um)

Seve

ral s

peci

es o

f woo

d an

ts

of th

e Sub

genu

s For

mica

s.

str. (

e.g. F

orm

ica lu

gu-

bris

ZETT

., F.

polyc

tena

FÖ

RSTE

R., F

. par

alug

ubris

SE

IFER

T or

F. ru

fa L

.)

Aqu

eous

solu

tion

of th

e se

cret

ion

of w

ood

ants

of t

he S

ubge

nus F

orm

ica

s. st

r.,

cont

aini

ng n

ot le

ss th

an 1

,2%

m/m

of

form

ic a

cid

List

e H

AS

(10.

2012

)

Am

bra

grise

aPh

yset

er ca

todo

n L.

(Phy

sete

r m

acro

ceph

alus

L.)

Subs

tanc

e pr

oduc

ed in

the d

iges

tive s

yste

m

of th

e sp

erm

wha

leH

AB

/ Ph.

Fr.

Zinc

um v

aler

iani

cum

co

mp.

(25.

10.1

994)

Am

nion

Bos t

auru

s L.

Am

nion

from

the

bovi

ne fo

etus

Va

dem

ecum

: Am

nion

Anu

sBo

s tau

rus L

.A

nus f

rom

the

calf

Prun

us/R

osm

arin

us co

mp.

(0

2.03

.199

1)A

orta

Bos t

auru

s L.

Di�

eren

t sec

tions

of t

he a

orta

from

the

calf

Vade

mec

um [m

entio

ned

unde

r: At

ropa

bel

lado

nna

e ra

dice

]A

orta

Ory

ctol

agus

cu

nicu

lus L

.A

orta

from

the

rabb

itIV

AA

stat

emen

t 201

3

Apis

mel

li�ca

Apis

mell

ifera

L.

Who

le w

orke

r bee

HA

B / P

h. F

r. / P

h.

Eur.

Apis

mel

li�ca

(07.

04.1

988)

Apis

regi

naAp

is m

ellife

ra L

.W

hole

que

en ce

ll

with

larv

ae a

nd

nour

ishin

g sa

p

Apis

regi

na/A

urum

com

p.

(02.

03.1

991)

Apisi

num

Apis

mell

ifera

L.

Drie

d po

ison

from

the

hone

y be

eH

AB

/ Ph.

Fr.

Zinn

ober

com

p.

(02.

09.1

987)

Appe

ndix

ve

rmifo

rmis

Ory

ctol

agus

cuni

culu

s L.

Verm

iform

pro

cess

of t

he b

lind

gut f

rom

th

e ra

bbit

Der

Mer

kurs

tab:

So

nder

he�

1999

Ara

nea

avic

ular

isAv

icula

ria

avicu

laria

L.

Who

le b

ird sp

ider

IVA

A st

atem

ent 2

013

Ara

nea

diad

ema

Aran

eus d

iade

mat

us

CLER

CKW

hole

dia

dem

spid

erVa

dem

ecum

: Ara

nea

Art

eria

bas

ilaris

*Bo

s tau

rus L

.A

rter

ia b

asila

ris fr

om th

e ca

lf IV

AA

stat

emen

t 201

3A

rter

ia b

rach

ialis

Bos t

auru

s L.

Art

eria

bra

chia

lis fr

om th

e ca

lf IV

AA

stat

emen

t 201

3A

rter

ia c

arot

is co

mm

u-ni

s et s

inus

car

otic

usBo

s tau

rus L

.Pa

rts f

rom

the

Art

eria

car

otis

com

mun

is de

xtra

and

sini

stra

from

the

calf

Vade

mec

um: A

rter

ia

caro

tis co

mm

unis

et si

nus

caro

ticus


• Ap

pend

ix 2

.3

129

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Art

eria

cere

bri m

edia

*Bo

s tau

rus L

. A

rter

ia c

arot

is ce

rebr

alis

and

its ra

mi�

ca-

tions

from

the

calf

Vade

mec

um:

Art

eria

cere

bri m

edia

Art

eria

coel

iaca

se

e Tr

uncu

s coe

liacu

sIV

AA

stat

emen

t 201

3A

rter

ia co

rona

riaBo

s tau

rus L

. A

rter

ia co

rona

ria fr

om th

e ca

lf Va

dem

ecum

: A

rter

ia co

rona

ria

Art

eria

fem

oral

isBo

s tau

rus L

. A

rter

ia fe

mor

alis

from

the

calf

Vade

mec

um [m

entio

ned

unde

r: Se

cale

/Ble

igla

nz

com

p.]

Art

eria

oph

thal

mic

a*Bo

s tau

rus L

. A

rter

ia o

phth

alm

ica

exte

rna

from

the

calf

Vade

mec

um:

Art

eria

oph

thal

mic

aA

rter

ia p

oplit

eaBo

s tau

rus L

.A

rter

ia p

oplit

ea fr

om th

e ca

lfBl

eigl

anz/

Seca

le co

mp.

(1

2.09

.199

2)A

rter

ia p

ulm

onal

isBo

s tau

rus L

. A

rter

ia p

ulm

onal

is fr

om th

e ca

lf IV

AA

stat

emen

t 201

3A

rter

ia re

nalis

Bos t

auru

s L.

Art

eria

rena

lis fr

om th

e ca

lf IV

AA

stat

emen

t 201

3A

rter

iae*

Bos t

auru

s L.

Part

s of A

rter

ia b

asila

ris, A

rter

ia b

rach

ia-

lis, A

rter

ia co

rona

ria, A

rter

ia fe

mor

alis,

A

rter

ia m

esen

teric

a, A

rter

ia p

ulm

onal

is an

d A

rter

ia re

nalis

from

the

calf

Vade

mec

um: A

rter

iae

Art

icul

atio

Bos t

auru

s L.

�e

follo

win

g ar

ticul

atio

ns: c

ubits

, gen

us,

hum

eri,

radi

ocar

pa, s

acro

iliac

a, su

btal

aris,

ta

locr

ural

is, te

mpo

rom

andi

bula

ris

List

e H

AS

(10.

2012

) A

BMA-

Vade

mec

um:

Art

icul

atio

-Arg

entu

m

Sirim

im P

. 49

Art

icul

atio

coxa

eBo

s tau

rus L

.H

ip jo

int w

ith e

qual

par

ts fr

om th

e ac

etab

-ul

um, C

aput

fem

oris,

join

t car

tilag

e an

d Li

gam

entu

m c

apiti

s fem

oris

from

the

calf

Art

icul

atio

coxa

e (2

5.10

.199

4)

Art

icul

atio

cub

itiBo

s tau

rus L

. El

bow

join

t with

par

ts fr

om th

e bo

nes t

hat

form

the

join

t, jo

int c

artil

age,

part

s of j

oint

ca

psul

e, sy

novi

a an

d pa

rts o

f the

liga

men

ts

from

the

calf

IVA

A st

atem

ent 2

013

Art

icul

atio

gen

usBo

s tau

rus L

. K

nee

join

t with

par

ts fr

om th

e bo

nes t

hat

form

the

join

t, m

enisc

us, j

oint

cap

sule

, lig

amen

ts, c

artil

age

and

syno

via

from

the

calf

Art

icul

atio

gen

us

(25.

10.1

994)


• Appendix 2.3

130

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Art

icul

atio

hum

eri

Bos t

auru

s L.

Shou

lder

join

t with

par

ts o

f the

bon

es th

at

form

the

join

t, ca

rtila

ge, p

arts

of t

he jo

int

caps

ule

and

the

Burs

a in

tert

uber

cula

ris

from

the

calf

Vade

mec

um

[men

tione

d un

der:

Aco

nit

Schm

erzö

l]

Art

icul

atio

in

terp

hala

ngea

Bos t

auru

s L.

Part

s of t

he to

e jo

int f

rom

the

fore

ex

trem

ities

from

the

calf

Car

tilag

o/Ec

hina

cea

com

p.

(25.

10.1

994)

Art

icul

atio

ra

dioc

arpe

aBo

s tau

rus L

.Ra

dioc

arpa

l joi

nt w

ith p

arts

of t

he b

ones

, ca

rtila

ge, l

igam

ents

and

join

t cap

sule

that

fo

rm th

e pr

oxim

al c

arpa

l joi

nt fr

om th

e ca

lf

IVA

A st

atem

ent 2

013

Art

icul

atio

sa

croi

liaca

Bos t

auru

s L.

Part

s of I

lium

and

sacr

um fr

om th

e jo

int

area

, joi

nt c

apsu

le a

nd li

gam

ents

from

the

calf

Der

Mer

kurs

tab:

So

nder

he�

1999

Art

icul

atio

subt

alar

isBo

s tau

rus L

. Pa

rts o

f the

car

tilag

e, jo

int c

apsu

le a

nd

syno

via

of th

e pa

rt d

istal

to th

e O

s cen

tro-

quar

tale

of t

he jo

int l

ike

unio

n be

twee

n Ta

lus a

nd C

alca

neus

from

the

calf

Art

icul

atio

talo

crur

alis

com

p. (1

2.09

.199

2)

Art

icul

atio

ta

locr

ural

isBo

s tau

rus L

.Pa

rts o

f the

bon

es fo

rmin

g th

e jo

int,

Tibi

a an

d Ta

lus,

of th

e jo

int c

apsu

le, l

igam

ents

as

wel

l as s

ynov

ia o

f the

ank

le jo

int f

rom

th

e ca

lf

Art

icul

atio

talo

crur

alis

com

p. (1

2.09

.199

2)

Art

icul

atio

te

mpo

rom

andi

bula

risBo

s tau

rus L

.Pa

rts o

f the

Os m

andi

bula

re a

nd o

f the

O

s tem

pora

le in

the

join

t are

a, o

f the

join

t ca

psul

e, of

the

ligam

ents

, of c

artil

age,

as

wel

l as s

ynov

ia fr

om th

e ca

lf

IVA

A st

atem

ent 2

013

Art

icul

atio

nes

inte

rcar

peae

Bos t

auru

s L.

Part

s of t

he b

ones

form

ing

the

join

t, of

the

cart

ilage

like

surf

ace

of th

e ar

ticul

atio

n, a

s w

ell a

s syn

ovia

from

the

calf

IVA

A st

atem

ent 2

013

Art

icul

atio

nes i

nter

ver-

tebr

ales

cerv

ical

esBo

s tau

rus L

.Re

gion

of t

he ce

rvix

: Par

ts o

f the

bon

e pr

o-ce

ssus

that

par

ticip

ate

to th

e in

terv

erte

bral

jo

ints

, car

tilag

e an

d jo

int c

apsu

les,

as w

ell

as sy

novi

a fr

om th

e ca

lf

IVA

A st

atem

ent 2

013

Art

icul

atio

nes i

nter

ver-

tebr

ales

lum

bale

sBo

s tau

rus L

.Re

gion

of t

he lo

in: P

arts

of t

he b

one

pro-

cess

us th

at p

artic

ipat

e to

the

inte

rver

tebr

al

join

ts, c

artil

age

and

join

t cap

sule

s, as

wel

l as

syno

via

from

the

calf

IVA

A st

atem

ent 2

013


• Ap

pend

ix 2

.3

131

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Asc

idia

Seve

ral s

peci

es o

f pro

to-

Cho

rdat

es o

f Asc

idia

gro

up�

e w

hole

hea

ring

orga

nA

BMA-

Vade

mec

um

Art

eria

e-Ba

rium

Siri

mim

P.

48

Ast

eria

s rub

ens

Aste

rias r

uben

s L.

�e

who

le st

ar�s

h IV

AA

stat

emen

t 201

3At

las*

Bos t

auru

s L.

Part

s of t

he A

tlas (

1. ce

rvic

al) f

rom

the

calf

IVA

A st

atem

ent 2

013

Audi

tum

Bos t

auru

s L.

�e

who

le h

earin

g or

gan

ABM

A-Va

dem

ecum

Au

ditu

m-A

rgen

tum

Si

rimim

P. 5

1Au

ditu

m in

tern

umBo

s tau

rus L

.In

tern

al h

earin

g or

gan

ABM

A-Va

dem

ecum

La

byrin

thus

-Mer

curiu

s Si

rimim

P. 1

61A

xis*

Bos t

auru

s L.

Part

s of t

he A

xis (

2. ce

rvic

al) f

rom

the

calf

IVA

A st

atem

ent 2

013

Badi

aga

Seve

ral s

peci

es o

f fre

sh w

a-te

r spo

nges

and

Eph

ydat

ia

�uvi

atili

s L.

�e

who

le fr

esh

anim

alA

BMA-

Vade

mec

um

Lary

nx-M

anga

num

Sir-

imim

P. 1

63Bl

atta

orie

ntal

isBl

atta

orie

ntal

is L.

�e

who

le fr

esh

or d

ried

anim

al

IVA

A st

atem

ent 2

013

Both

rops

Both

rops

lanc

eola

tus

BON

ATER

REPo

ison

from

Bot

hrop

s lan

ceol

atus

Der

Mer

kurs

tab

1993

; 46

(3):

288-

297

Both

rops

jara

cara

see

Lach

esis

lanc

eola

tus

Bron

chi

Bos t

auru

s L.

Bron

chi f

rom

the

calf

Bron

chi/P

lant

ago

com

p.

(12.

09.1

992)

Bron

chi

Ory

ctol

agus

cuni

culu

s L.

Bron

chi f

rom

the

rabb

itBr

onch

i/Pla

ntag

o co

mp.

(1

2.09

.199

2)Bu

fo ra

naBu

fo b

ufo

L.

Skin

of t

he b

ack

from

the

toad

Der

Mer

kurs

tab

2000

; 53

(4):

259-

260

Bulb

us o

lfact

oriu

s*Bo

s tau

rus L

.Bu

lbus

olfa

ctor

ius o

f bot

h he

misp

here

s of

the

cere

brum

from

the

calf

Vade

mec

um: B

ulbu

s ol

fact

oriu

s Bu

rsae

art

icul

atio

nis

hum

eri-K

ompl

exBo

s tau

rus L

.Pa

rts o

f Bur

sa m

uscu

li in

fras

pina

m a

nd

Burs

a in

tert

uber

cula

ris h

umer

i fro

m th

e ca

lf

Vade

mec

um: B

ursa

e ar

ticul

atio

nis h

umer

i-Ko

mpl

exC

alca

rea

carb

onic

a os

trea

rum

see

Con

chae


• Appendix 2.3

132

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Cal

cium

car

boni

cum

H

ahne

man

nise

e C

onch

ae

Can

thar

isLy

tta v

esica

toria

L.

As f

ar a

s pos

sible

inta

ct sp

ecim

ens,

kille

d an

d dr

ied

at a

tem

pera

ture

not

exc

eedi

ng

40°C

HA

B C

anth

aris

(04.

06.1

986)

Vade

mec

um: C

anth

aris

Car

dia

Sus s

crof

a

dom

estic

a L.

Car

dia,

par

ts o

f the

wal

l of t

he st

omac

h in

th

e re

gion

of t

he e

ntra

nce

into

the

stom

ach

from

the

pig

Vade

mec

um: C

ardi

a

Car

tilag

o ar

ticul

aris

Bos t

auru

s L.

Car

tilag

e of

the

hip,

kne

e an

d sh

ould

er

join

ts fr

om th

e ca

lfC

artil

ago

com

p.

(12.

09.1

992)

Car

tilag

o ar

ticul

aris

coxa

eBo

s tau

rus L

.C

artil

age

of th

e hi

p jo

int f

rom

the

calf

IVA

A st

atem

ent 2

013

Car

tilag

o ar

ticul

aris

genu

sBo

s tau

rus L

.C

artil

age

of th

e kn

ee jo

int f

rom

the

calf

Der

Mer

kurs

tab:

So

nder

he�

1999

Cav

um ty

mpa

ni*

Bos t

auru

s L.

Part

s of t

he w

all o

f the

Cav

um ty

mpa

ni,

as w

ell a

s aud

itory

bon

es fr

om th

e ca

lfVa

dem

ecum

: C

avum

tym

pani

C

era

�ava

Apis

mell

ifera

L.

Bees

wax

obt

aine

d by

mel

ting

the

empt

y ho

neyc

ombs

, was

hing

and

elim

inat

ion

of

fore

ign

mat

ter

Ph. E

ur.

Plan

tago

com

p.

(12.

09.1

992)

Cer

ebel

lum

*Bo

s tau

rus L

.C

ereb

ellu

m fr

om th

e ca

lf C

ereb

ellu

m co

mp.

(0

2.03

.199

1)C

ereb

ellu

mO

ryct

olag

us cu

nicu

lus L

.C

ereb

ellu

m fr

om th

e ra

bbit

Cer

ebel

lum

com

p.

(02.

03.1

991)

Cer

ebru

mBo

s tau

rus L

.C

ereb

rum

from

the

calf

Arn

ica-

Cer

ebru

m

(12.

09.1

992)

Cer

ebru

m, r

egio

mo-

toric

a*Bo

s tau

rus L

.G

rey

mat

ter o

f the

Gyr

us p

raec

entr

alis

belo

ngin

g to

the

Lobu

s fro

ntal

is of

bot

h he

misp

here

s fro

m th

e ca

lf

Vade

mec

um:

Cer

ebru

m,

regi

o m

otor

ica

Cer

vix

uter

iBo

s tau

rus L

.Pa

rts o

f the

nec

k of

ute

rus f

rom

the

cow

IV

AA

stat

emen

t 201

3C

ircul

us a

rter

iosu

s ce

rebr

i*Bo

s tau

rus L

.C

ircul

us a

rter

iosu

s cer

ebri

of th

e pi

tuita

ry

sha�

from

the

calf

IVA

A st

atem

ent 2

013

Coc

cus c

acti

Dac

tylo

pius

co

ccus

CO

STA

�e

drie

d, fe

rtili

zed,

fem

ale

of D

acty

lopi

us

cocc

us C

osta

H

AB

/ Ph.

Fr.

IVA

A st

atem

ent 2

013


• Ap

pend

ix 2

.3

133

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Coc

hlea

*Bo

s tau

rus L

.Pa

rts o

f the

coch

lea

from

the

skel

etou

s as

wel

l as d

erm

al p

arts

of t

he in

ner e

ar fr

om

the

calf

Vade

mec

um: C

ochl

ea

Cod

live

r oil

(typ

e B)

see

jeco

ris a

selli

ole

um

Col

onSu

s scr

ofa

dom

estic

a L.

Col

on fr

om th

e pi

g C

olon

(25.

10.1

994)

Col

on si

gmoi

deum

Sus s

crof

a do

mes

tica

L.C

olon

sigm

oide

um, p

arts

of t

he �

nal t

ract

of

the

Col

on d

esce

nden

s fro

m th

e pi

g Va

dem

ecum

[men

tione

d un

der:

Er

ysid

oron

® 1;

Mer

curiu

s vi

vus n

atur

alis]

Col

umna

Bos t

auru

s L.

Spin

al co

rd o

btai

ned

from

foet

us o

f Bos

ta

urus

L.

ABM

A-Va

dem

ecum

: C

olum

na-A

rgen

tum

Si

rimim

P. 9

7C

olum

na a

nter

ior*

Bos t

auru

s L.

Part

s of t

he co

lum

na a

nter

ior o

f the

spin

al

chor

d fr

om th

e ca

lf IV

AA

stat

emen

t 201

3

Col

umna

pos

terio

r*Bo

s tau

rus L

.Pa

rts o

f the

colu

mna

pos

terio

r of d

i�er

ent

part

s of t

he sp

inal

chor

d fr

om th

e ca

lf IV

AA

stat

emen

t 201

3

Con

chae

Ostr

ea ed

ulis

L.

�e

inne

r par

ts o

f the

shel

ls of

the

oyst

er

HA

B / P

h. F

r. C

onch

ae (0

4.06

.198

6)Va

dem

ecum

: Con

chae

C

onju

nctiv

aBo

s tau

rus L

.C

onju

nctiv

a fr

om th

e ca

lf C

onju

nctiv

a co

mp.

(2

5.10

.199

4)C

onne

ctiv

e tis

sue

see

Text

us

conn

ectiv

usC

orBo

s tau

rus L

.C

or (h

eart

) fro

m th

e ca

lf C

or (2

5.10

.199

4)C

orBo

s tau

rus L

.Pa

rts o

f the

epi

card

ium

, myo

card

ium

, en

doca

rdiu

m a

nd th

e ar

teria

l mus

cula

ture

of

the

hear

t fro

m th

e ca

lf

Cor

(25.

10.1

994)

Cor

alliu

mSe

vera

l spe

cies

of r

ed C

oral

Secr

etio

n ob

tain

ed b

y tr

itura

tion

of fr

esh

anim

alA

BMA-

Vade

mec

um:

Cor

alliu

m ru

brum

P. 1

04C

oral

lium

rubr

umCo

ralli

um

rubr

um L

.Fr

agm

ente

d pa

rts o

f the

chal

k sk

elet

on

from

Cor

alliu

m ru

brum

, con

tain

ing

at

leas

t 82

per c

ent C

aCO

3 (M

r 100

,1)

HA

B K

aliu

m a

cetic

um co

mp.

(0

3.07

.199

2)

Cor

nea

Bos t

auru

s L.

Cor

nea

from

the

calf

Cor

nea/

Levi

stic

um co

mp.

(0

2.03

.199

1)C

ornu

Cap

rae

ibec

isCa

pra

ibex

L.

Hor

n fr

om th

e ib

ex

IVA

A st

atem

ent 2

013


• Appendix 2.3

134

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Cor

nu C

ervi

Cerv

us el

aphu

s L.

Ant

lers

from

the

deer

Li

ste

HA

S (1

0.20

12)

Cor

pora

qua

drig

emin

a*Bo

s tau

rus L

.Pa

rts o

f the

Lam

ina

tect

i with

the

Cor

pora

qu

adrig

emin

a fr

om th

e ca

lf A

rnic

a/Ep

iphy

sis/P

lum

-bu

m m

ellit

um co

mp.

(0

3.07

.199

2)C

orpu

s am

ygda

loi-

deum

*Bo

s tau

rus L

.Br

ain

mat

ter o

f the

regi

on o

f the

Cor

pus

amyg

dalo

ideu

m fr

om th

e ca

lfVa

dem

ecum

: C

orpu

s am

ygda

loid

eum

C

orpu

s lut

eum

Bos t

auru

s L.

Cor

pus l

uteu

m fr

om th

e ca

lf M

eliss

a/Ph

osph

orus

com

p.

(03.

07.1

992)

Cor

pus l

uteu

mSu

s scr

ofa

dom

estic

a L.

Cor

pus l

uteu

m fr

om th

e so

wM

eliss

a/Ph

osph

orus

com

p.

(03.

07.1

992)

Cor

pus s

tria

tum

*Bo

s tau

rus L

.C

orpu

s str

iatu

m fr

om th

e ca

lf Va

dem

ecum

[men

tione

d un

der:

Regi

o su

bsta

ntia

e ni

grae

]C

orpu

s vitr

eum

*Bo

s tau

rus L

.C

orpu

s vitr

eum

from

the

calf

Cor

pus v

itreu

m/H

orne

rz

com

p. (0

2.03

.199

1)C

orpu

s vitr

eum

Ory

ctol

agus

cuni

culu

s L.

Cor

pus v

itreu

m fr

om th

e ra

bbit

Cor

pus v

itreu

m/H

orne

rz

com

p. (0

2.03

.199

1)C

rota

lus h

orrid

usCr

otal

us h

orrid

us L

.Fr

eeze

drie

d po

ison

from

Cro

talu

s ho

rrid

us L

. H

AB

Der

Mer

kurs

tab

1993

; 46

(3):

288-

297

Cro

talu

s ter

ri�cu

sCr

otal

us d

uriss

us te

rri�

cus

LAU

REN

TI

Free

ze d

ried

poiso

n fr

om C

rota

lus d

uriss

us

terr

i�cu

s Lau

rent

i D

er M

erku

rsta

b 19

93;

46(3

): 28

8-29

7Cu

tis (f

eti)

Bos t

auru

s L.

�e

exte

rnal

skin

of a

3 to

9 m

onth

s old

bo

vine

foet

us

Cal

endu

la/T

ropa

eolu

m

com

p. (0

2.03

.199

1)Cu

tis (f

eti f

emin

i)Bo

s tau

rus L

.�

e ex

tern

al sk

in o

f a c

a. 5

mon

ths o

ld

fem

ale

bovi

ne fo

etus

Pr

unus

/Ros

mar

inus

com

p.

(02.

03.1

991)

Dac

tylo

pius

cocc

usse

e Co

ccus

cact

i D

ens

Bos t

auru

s L.

Teet

h fr

om th

e ca

lf IV

AA

stat

emen

t 201

3D

iaph

ragm

aBo

s tau

rus L

.M

uscu

lar a

nd te

ndin

ous p

arts

of t

he

diap

hrag

m fr

om th

e ca

lf Va

dem

ecum

[men

tione

d un

der:

Regi

o su

bsta

ntia

e ni

grae

]D

iaph

ragm

a pe

lvis

Bos t

auru

s L.

Part

s of t

he m

uscl

e an

d fa

scie

s clo

sing

the

pelv

is, in

clud

ing

conn

ectiv

e tis

sue

from

th

e ca

lf

Vade

mec

um: D

iaph

ragm

a pe

lvis

Die

ncep

halo

n*Bo

s tau

rus L

.D

ienc

epha

lon

from

the

calf

IVA

A st

atem

ent 2

013


• Ap

pend

ix 2

.3

135

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Disc

i int

erve

rteb

rale

s (c

ervi

cale

s)Bo

s tau

rus L

.Fi

broc

artil

age

of in

terv

erte

bral

disc

s of

cerv

ical

spin

e fr

om th

e ca

lf Va

dem

ecum

[men

tione

d un

der:

Disc

i int

erve

rte-

bral

es (f

eti)]

Disc

i int

erve

rteb

rale

s (c

ervi

cale

s, th

orac

ici e

t lu

mba

les)

Bos t

auru

s L.

Part

s of i

nter

vert

ebra

l disc

s of c

ervi

cal,

thor

acic

and

lum

bar s

pine

from

the

calf

Disc

i com

p. c

um

Arg

ento

(05.

12.1

989)

Disc

i int

erve

rteb

rale

s (fe

ti)Bo

s tau

rus L

.In

terv

erte

bral

disc

s of d

i�er

ent r

egio

ns o

f th

e sp

ine

from

a 3

to 9

mon

ths o

ld b

ovin

e fo

etus

Vade

mec

um:

Disc

i int

erve

rteb

rale

s (fe

ti)D

isci i

nter

vert

ebra

les

(lum

bale

s)Bo

s tau

rus L

.In

terv

erte

bral

disc

s of l

umba

r spi

ne fr

om

the

calf

Vade

mec

um [m

entio

ned

unde

r: D

isci i

nter

vert

e-br

ales

(fet

i)]D

uctu

s cho

ledo

chus

Sus s

crof

a

dom

estic

a L.

Duc

tus c

hole

doch

us fr

om th

e pi

g D

er M

erku

rsta

b:

Sond

erhe

� 19

99D

uctu

s def

eren

sBo

s tau

rus L

.D

uctu

s def

eren

s fro

m th

e ca

lf IV

AA

stat

emen

t 201

3D

uctu

s tho

raci

cus

Bos t

auru

s L.

Duc

tus t

hora

cicu

s fro

m th

e ca

lf Bo

rago

/Ren

es co

mp.

(1

2.09

.199

2)D

uode

num

Sus s

crof

a

dom

estic

a L.

Part

s of d

uode

num

from

the

pig

Vade

mec

um [m

entio

ned

unde

r: Pl

exus

gas

tric

us]

Dur

a m

ater

en

ceph

ali*

Bos t

auru

s L.

Dur

a m

ater

enc

epha

li fr

om th

e ca

lf IV

AA

stat

emen

t 201

3

Elap

sM

icrur

us co

ralli

nus

MER

REM

Poiso

n fr

om M

icru

rus c

oral

linus

Mer

rem

IVA

A st

atem

ent 2

013

Endo

card

ium

Bos t

auru

s L.

Endo

card

ium

from

the

calf

IVA

A st

atem

ent 2

013

Endo

met

rium

Bos t

auru

s L.

Endo

met

rium

from

the

cow

En

dom

etriu

m co

mp.

(2

5.10

.199

4)En

dom

etriu

mSu

s scr

ofa

do

mes

tica

L.En

dom

etriu

m fr

om th

e pi

gEn

dom

etriu

m co

mp.

(2

5.10

.199

4)Ep

idid

ymis

Bos t

auru

s L.

Le�

epid

idym

is fr

om th

e bu

ll IV

AA

stat

emen

t 201

3Ep

iphy

sis*

Bos t

auru

s L.

Part

s of t

he e

piph

ysis

from

the

calf

Epip

hysis

(12.

09.1

992)

Ep

iphy

sisO

ryct

olag

us cu

nicu

lus L

.Pa

rts o

f the

epi

phys

is fr

om th

e ra

bbit

Epip

hysis

(12.

09.1

992)

Er

ytro

cyte

sEq

uus p

rzew

alsk

ii f.

caba

llus

POLI

AKO

VEr

ythr

ocyt

es fr

om th

e bl

ood

of th

e ho

rse

IVA

A st

atem

ent 2

013


• Appendix 2.3

136

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Fasc

icul

us at

riove

n-tr

icul

aris

Bos t

auru

s L.

Part

s of t

he co

nduc

tion

syst

em o

f the

he

art,

His´

s bun

dle

and

Purk

inje

´s �

ber

from

the

calf

Vade

mec

um:

Fasc

icul

us at

riove

ntric

u-la

ris

Fasc

icul

us o

ptic

us*

Bos t

auru

s L.

Fasc

icul

us o

ptic

us fr

om th

e ca

lf Li

ste

HA

S (1

0.20

12)

Favu

sAp

is m

ellife

ra L

.ho

neyc

ombs

with

pol

len

IVA

A st

atem

ent 2

013

Fel p

iscis

Salm

o tr

utta

L.

Bile

from

pre

dato

ry �

sh, e

.g. t

rout

Der

Mer

kurs

tab

2004

; 57

(3):

224

Fel t

auri

Bos t

auru

s L.

Fres

h bi

le fr

om g

all b

ladd

er fr

om th

e ca

lf G

land

ulae

supr

aren

ales

co

mp.

(12.

09.1

992)

Fel

Ory

ctol

agus

cuni

culu

s L.

Bile

from

gal

l bla

dder

from

the

rabb

itG

land

ulae

su

prar

enal

es co

mp.

(1

2.09

.199

2)Fe

mur

Bos t

auru

s L.

Part

s of t

he d

iaph

ysis

of O

s fem

oris

from

th

e ca

lf Va

dem

ecum

: Fem

ur

Folli

culi

lym

phat

ici a

g-gr

egat

iSu

s scr

ofa

do

mes

tica

L.Pa

rts o

f Pey

ers’s

pat

ch o

f the

smal

l int

estin

e fr

om th

e pi

g IV

AA

stat

emen

t 201

3

Form

ica

Form

ica ru

fa L

., Fo

rmica

po

lyct

ena

FÖRS

TER

L.Li

ve w

orke

r ant

sH

AB

/ Ph.

Fr.

Form

ica

(07.

04.1

988)

Vade

mec

um: F

orm

ica

Form

ica

parv

aLa

sius n

iger

Live

wor

ker a

nts

List

e H

AS

(10.

2012

)Fu

nicu

lus u

mbi

lical

isBo

s tau

rus L

.Fu

nicu

lus u

mbi

lical

is fr

om a

bov

ine

foet

us

betw

een

the

third

and

nin

th m

onth

of

preg

nanc

y

Cal

endu

la/

Trop

aeol

um co

mp.

(0

2.03

.199

1)G

alea

apon

euro

tica

Bos t

auru

s L.

Part

s of t

he su

per�

cial

fasc

ia o

f the

fo

rehe

ad fr

om th

e ca

lf IV

AA

stat

emen

t 201

3

Gin

giva

Bos t

auru

s L.

Gin

giva

from

the

calf

Perio

dont

ium

/Sili

cea

com

p.

(12.

09.1

992)

Gla

ndul

a la

crim

alis

Bos t

auru

s L.

Lacr

imal

gla

nd fr

om th

e ca

lf Va

dem

ecum

: Gla

ndul

a la

crim

alis

Gla

ndul

a pa

rotis

Bos t

auru

s L.

Gla

ndul

ar ti

ssue

of t

he b

ody

of th

e pa

rotid

gl

and

from

the

calf

IVA

A st

atem

ent 2

013

Gla

ndul

a

supr

aren

alis

Bos t

auru

s L.

Supr

aren

al g

land

from

the

calf

Gla

ndul

a su

prar

enal

is (2

5.10

.199

4)G

land

ula

su

prar

enal

is (C

orte

x)

Bos t

auru

s L.

Supr

aren

al g

land

(Cor

tex)

from

the

calf

IVA

A st

atem

ent 2

013


• Ap

pend

ix 2

.3

137

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Gla

ndul

a su

prar

enal

is (M

edul

la)

Bos t

auru

s L.

Mar

row

of t

he su

prar

enal

gla

nd o

f bot

h ad

rena

l gla

nds f

rom

the

calf

IVA

A st

atem

ent 2

013

Gla

ndul

a su

prar

enal

is de

xtra

Bos t

auru

s L.

Righ

t sup

rare

nal g

land

from

the

calf

Cupr

um/G

land

ula

supr

are-

nalis

dex

tra

(02.

03.1

991)

Gla

ndul

a su

prar

enal

is sin

istra

Bos t

auru

s L.

Le�

supr

aren

al g

land

from

the

calf

Cupr

um/G

land

ula

supr

are-

nalis

sini

stra

(02.

03.1

991)

Gla

ndul

a �

ymus

see

�ym

us (G

land

ula)

G

land

ula

thyr

eoid

eaBo

s tau

rus L

.�

yroi

d gl

and

from

the

calf

Gla

ndul

a th

yreo

idea

(0

7.04

.198

8)G

land

ula

thyr

eoid

eaO

ryct

olag

us cu

nicu

lus L

.�

yroi

d gl

and

from

the

rabb

itG

land

ula

thyr

eoid

ea

(07.

04.1

988)

Gla

ndul

ae

para

thyr

eoid

eae

Bos t

auru

s L.

Para

thyr

oid

glan

d fr

om th

e ca

lf Pa

rath

yreo

idea

com

p.

(02.

03.1

991)

Gla

ndul

ae

para

thyr

eoid

eae

Sus s

crof

a do

mes

tica

L.Pa

rath

yroi

d gl

and

from

the

pig

Para

thyr

eoid

ea co

mp.

(0

2.03

.199

1)G

land

ulae

su

prar

enal

esse

e G

land

ula

supr

aren

alis

Glu

coge

num

Ory

ctol

agus

cuni

culu

s L.

Gly

coge

n fr

om th

e ra

bbit

liver

IV

AA

stat

emen

t 201

3G

yrus

cing

uli*

Bos t

auru

s L.

Gyr

us ci

ngul

i fro

m th

e ca

lf IV

AA

stat

emen

t 201

3H

epar

Bos t

auru

s L.

Pars

inte

rmed

ia o

f the

live

r fro

m th

e ca

lf H

epar

(25.

10.1

994)

Hep

arO

ryct

olag

us cu

nicu

lus L

.Li

ver f

rom

the

rabb

it IV

AA

stat

emen

t 201

3H

ippo

cam

pus*

Bos t

auru

s L.

Hip

poca

mpu

s fro

m th

e ca

lf Va

dem

ecum

: Hip

poca

m-

pus

Hiru

do e

x an

imal

eH

irudo

m

edici

nalis

L.

Leec

h im

med

iate

ly a

�er s

acri�

ce

Vesp

a cr

abro

com

p.

(02.

03.1

991)

Hyp

ophy

sis*

Bos t

auru

s L.

Hyp

ophy

sis fr

om th

e ca

lf H

ypop

hysis

(12.

09.1

992)

H

ypop

hysis

Ory

ctol

agus

cuni

culu

s L.

Hyp

ophy

sis fr

om th

e ra

bbit

Hyp

ophy

sis (1

2.09

.199

2)H

ypot

hala

mus

*Bo

s tau

rus L

.H

ypot

hala

mus

from

the

calf

Vade

mec

um:

Hyp

otha

lam

us


• Appendix 2.3

138

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Ieco

ris a

selli

ole

umG

adid

ae

Cod

live

r oil:

(typ

e A

or B

) Pur

i�ed

fatty

oi

l obt

aine

d fr

om th

e fr

esh

liver

s of G

adus

m

orhu

a L.

and

oth

er sp

ecie

s of G

adid

ae,

solid

subs

tanc

es b

eing

rem

oved

by

cool

ing

and

�lte

ring

Ph. E

ur.

Berb

eris/

Che

lidon

ium

co

mp.

(02.

03.1

991)

Ileum

Sus s

crof

a

dom

estic

a L.

Ileum

from

the

pig

Vade

mec

um

[men

tione

d un

der:

Nux

vo

mic

a/N

icot

iana

com

p.]

Iris

Bos t

auru

s L.

Iris

from

the

calf

Iris

bovi

s com

p.

(02.

03.1

991)

Jeco

ris o

leum

see

Ieco

ris a

selli

ole

umJe

junu

mSu

s scr

ofa

do

mes

tica

L.Je

junu

m fr

om th

e pi

g IV

AA

stat

emen

t 201

3

Kera

tinum

Equ

iEq

uus p

rzew

alsk

ii f.

caba

llus

POLI

AKO

VH

oof f

rom

the

hors

e IV

AA

stat

emen

t 201

3

Laby

rinth

us*

Bos t

auru

s L.

Coc

hlea

and

laby

rinth

from

the

calf

Arn

ica/

Epip

hysis

/Plu

m-

bum

mel

litum

com

p.

(03.

07.1

992)

Lac c

anin

umCa

nis l

upus

fam

iliar

is L.

Fr

esh

milk

from

the

fem

ale

dog

ABM

A-Va

dem

ecum

M

amm

a-A

rgen

tum

Sir-

imim

P. 1

69La

ches

isLa

ches

is m

elano

ceph

ala

SOLÒ

RZA

NO

& C

ERD

AS,

La

ches

is ste

noph

rys C

ope

or

Lach

esis

mut

a L.

Car

eful

ly d

ried

poiso

n fr

om L

ache

sis

mel

anoc

epha

la S

olòr

zano

& C

erda

s,

Lach

esis

sten

ophr

ys C

ope

or L

ache

sis

mut

a L.

HA

B La

ches

is (0

2.03

.199

1)Va

dem

ecum

: Lac

hesis

Lach

esis

lanc

eola

tus

Both

rops

jara

raca

WIE

D.

Poiso

n fr

om B

othr

ops j

arar

aca

Wie

d.

Der

Mer

kurs

tab

1993

; 46

(3):

288-

297

Lac v

acca

eBo

s tau

rus L

.Fr

esh

cow

’s m

ilk

IVA

A st

atem

ent 2

013

Lam

ina

qu

adrig

emin

a*Bo

s tau

rus L

.La

min

a qu

adrig

emin

a fr

om th

e ca

lfLa

min

a/Re

tina

com

p.

(25.

10.1

994)

Lath

rode

ctus

Lath

rode

ctus

mac

tans

Koc

hLi

ving

spid

er o

f Lat

hrod

ectu

s mac

tans

Ko

chA

BMA-

Vade

mec

um

Cor

-Ars

enic

um a

lbum

Si

rimim

P. 1

05La

pis c

ancr

iA

stacu

s asta

cus L

. �

e ga

stro

lithe

s fro

m th

e bo

dy c

avity

from

A

stac

us a

stac

us L

. or o

ther

cray

�sh

List

e H

AS

(10.

2012

)


• Ap

pend

ix 2

.3

139

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Lary

nxBo

s tau

rus L

.Pa

rts o

f the

lary

nx fr

om th

e ca

lfAp

is/La

rynx

com

p.

(25.

10.1

994)

Lens

crist

allin

aBo

s tau

rus L

.Le

ns cr

istal

lina

from

the

calf

Lens

crist

allin

a/V

is-cu

m co

mp.

cum

Sta

nno

(02.

03.1

991)

Lien

Bos t

auru

s L.

Sple

en fr

om th

e ca

lf Li

en co

mp.

(25.

10.1

994)

Liga

men

tum

long

itudi

-na

le a

nter

ius

Bos t

auru

s L.

Part

s of t

he L

igam

entu

m lo

ngitu

dina

le

ante

rius o

f tho

raci

c and

lum

bar r

egio

ns o

f th

e sp

ine

from

the

calf

IVA

A st

atem

ent 2

013

Liga

men

tum

long

itudi

-na

le p

oste

rius*

Bos t

auru

s L.

Liga

men

tum

long

itudi

nale

dor

sale

from

th

e ca

lf Va

dem

ecum

: Lig

a-m

entu

m lo

ngitu

dina

le

post

eriu

s Li

gam

entu

m v

ocal

eBo

s tau

rus L

.Pa

rts o

f the

voc

al ch

ords

incl

uded

the

mu-

cous

mem

bran

e of

the

lary

nx fr

om th

e ca

lf Va

dem

ecum

[m

entio

ned

unde

r: La

r-yn

x co

mp.

]Li

ngua

Bos t

auru

s L.

Part

s of t

he to

ngue

mus

cles

, muc

ous

mem

bran

e an

d pa

pilla

e fr

om th

e ca

lfIV

AA

stat

emen

t 201

3

Liqu

or

cere

bros

pina

lisBo

s tau

rus L

.C

ereb

rosp

inal

�ui

d fr

om th

e ca

lf IV

AA

stat

emen

t 201

3

Lobu

s fro

ntal

is*Bo

s tau

rus L

.Fr

onta

l lob

e of

cere

brum

from

the

calf

Glö

ckle

r, M

.: “A

nthr

opos

-op

hisc

he A

rzne

ither

apie”

(A

nthr

opos

ophi

c �er

apy

with

Med

icin

al P

rodu

cts)

, Pu

blish

er W

issen

scha

�li-

che

Verla

gsge

sells

cha�

, St

uttg

art 2

010

Lobu

s occ

ipita

lis*

Bos t

auru

s L.

Occ

ipita

l lob

e of

cere

brum

from

the

calf

Glö

ckle

r, M

.: “A

nthr

opos

-op

hisc

he A

rzne

ither

apie”

(A

nthr

opos

ophi

c �er

apy

with

Med

icin

al P

rodu

cts)

, Pu

blish

er W

issen

scha

�li-

che

Verla

gsge

sells

cha�

, St

uttg

art 2

010


• Appendix 2.3

140

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Lobu

s par

ieta

lis*

Bos t

auru

s L.

Parie

tal l

obe

of th

e ce

rebr

um fr

om th

e ca

lf G

löck

ler,

M.:

“Ant

hrop

os-

ophi

sche

Arz

neith

erap

ie”

(Ant

hrop

osop

hic �

erap

y w

ith M

edic

inal

Pro

duct

s),

Publ

isher

Wiss

ensc

ha�l

i-ch

e Ve

rlags

gese

llsch

a�,

Stut

tgar

t 201

0Lo

bus t

empo

ralis

*Bo

s tau

rus L

.Te

mpo

ral l

obe

from

the

calf

Glö

ckle

r, M

.: “A

nthr

opos

-op

hisc

he A

rzne

ither

apie”

(A

nthr

opos

ophi

c �er

apy

with

Med

icin

al P

rodu

cts)

, Pu

blish

er W

issen

scha

�li-

che

Verla

gsge

sells

cha�

, St

uttg

art 2

010

Mam

ma

Bos t

auru

s L.

Gla

ndul

ar ti

ssue

from

bov

ine

udde

r M

agne

sit/M

amm

a co

mp.

(1

2.09

.199

2)M

amm

a (d

extr

a)Bo

s tau

rus L

.G

land

ular

tiss

ue fr

om ri

ght p

art o

f bov

ine

udde

r Va

dem

ecum

: Mam

ma

Mam

ma

(sin

istra

)Bo

s tau

rus L

.G

land

ular

tiss

ue fr

om le

� pa

rt o

f bov

ine

udde

r Va

dem

ecum

: Mam

ma

Man

dibu

la (f

eti)

Bos t

auru

s L.

Man

dibl

e fr

om a

bov

ine

foet

us b

etw

een

3

and

9 m

onth

s Pe

riodo

ntiu

m/S

ilice

a co

mp.

(1

2.09

.199

2)M

arm

ot fa

tse

e M

arm

otta

e ol

eum

Mar

mot

tae

oleu

mM

arm

ota

spec

ies

Fat f

rom

bro

wn

adip

ose

tissu

e fr

om d

i�er

-en

t spe

cies

of m

arm

ota,

e.g.

Mar

mot

a m

ar-

mot

a L.

, Mar

mot

a bo

bak

sibiri

ca R

adde

, M

arm

ota

cam

tsch

atic

a Pa

llas

Sal M

aris

com

p.

(04.

06.1

986)

Max

illa

(feti)

Bos t

auru

s L.

Max

illa

from

a b

ovin

e fo

etus

bet

wee

n 3

and

9 m

onth

s Pe

riodo

ntiu

m/S

ilice

a co

mp.

(1

2.09

.199

2)M

edul

la o

blon

gata

*Bo

s tau

rus L

.M

edul

la o

blon

gata

from

the

calf

Arn

ica/

Epip

hysis

/Plu

m-

bum

mel

litum

com

p.

(03.

07.1

992)

Med

ulla

obl

onga

taO

ryct

olag

us cu

nicu

lus L

.M

edul

la o

blon

gata

from

the

rabb

itA

rnic

a/Ep

iphy

sis/P

lum

-bu

m m

ellit

um co

mp.

(0

3.07

.199

2)


• Ap

pend

ix 2

.3

141

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Med

ulla

oss

ium

(rub

ra)

Bos t

auru

s L.

Red

bone

mar

row

from

the

epip

hysis

of

tubu

lar b

ones

from

the

calf

Med

ulla

oss

ium

(2

5.10

.199

4)M

edul

la o

ssiu

m (r

ubra

)O

ryct

olag

us cu

nicu

lus L

.Re

d bo

ne m

arro

w fr

om th

e ep

iphy

sis o

f tu

bula

r bon

es fr

om th

e ra

bbit

Med

ulla

oss

ium

(2

5.10

.199

4)M

edul

la sp

inal

is to

ta*

Bos t

auru

s L.

Med

ulla

spin

alis

of d

i�er

ent s

ectio

ns fr

om

the

calf

Vade

mec

um: M

edul

la

spin

alis

tota

M

elAp

is m

ellife

ra L

.H

oney

Ph

. Eur

.A

escu

lus/

Cer

a co

mp.

(0

2.03

.199

1)M

embr

ana

sinus

fron

-ta

lisBo

s tau

rus L

.M

ucos

a of

Sin

us fr

onta

lis fr

om th

e ca

lf Li

ste

HA

S (1

0.20

12)

Mem

bran

a sin

us m

axil-

laris

Bos t

auru

s L.

Muc

osa

of S

inus

max

illar

is fr

om th

e ca

lf G

löck

ler,

M.:

“Ant

hrop

os-

ophi

sche

Arz

neith

erap

ie”

(Ant

hrop

osop

hic �

erap

y w

ith M

edic

inal

Pro

duct

s),

Publ

isher

Wiss

ensc

ha�l

i-ch

e Ve

rlags

gese

llsch

a�,

Stut

tgar

tM

embr

ana

sinus

par

a-na

salis

Bos t

auru

s L.

Muc

osa

of si

nus p

aran

asal

es fr

om th

e ca

lf H

epar

sulfu

ris co

mp.

(0

5.12

.198

9)M

embr

ana

syno

vial

isBo

s tau

rus L

.In

ner l

ayer

of t

he jo

int c

apsu

le o

f di�

eren

t jo

ints

from

the

calf

Vade

mec

um [m

entio

ned

unde

r: Sa

lix/R

hus c

omp.

]M

enisc

us a

rtic

ular

isBo

s tau

rus L

.M

enisc

us a

rtic

ular

is of

the

knee

from

cal

fM

enisc

us G

enus

/Sta

nnum

(2

5.10

.199

4)

Der

Mer

kurs

tab:

Son

der-

he�

1999

Men

iscus

gen

usBo

s tau

rus L

.M

enisc

us o

f the

kne

e fr

om th

e ca

lfM

andr

agor

a co

mp.

(0

7.04

.198

8)M

ephi

tis p

utor

ius

Mep

hitis

m

ephi

tis S

CH

REB.

Li

quid

secr

etio

n of

ana

l gla

nds f

rom

Me-

phiti

s mep

hitis

Sch

reb.

IV

AA

stat

emen

t 201

3

Mes

ence

phal

on*

Bos t

auru

s L.

Mes

ence

phal

on fr

om th

e ca

lf Va

dem

ecum

[men

tione

d un

der:

Regi

o su

bsta

ntia

e ni

grae

]


• Appendix 2.3

142

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Mes

ench

ymBo

s tau

rus L

.Em

bryo

nal c

onne

ctiv

e tis

sue

and

tissu

e pa

rts o

f the

adu

lt an

imal

. Foe

tal t

issue

s de

velo

ped

from

mes

ench

yma

with

a h

igh

mes

ench

ymal

func

tion:

ute

rus o

f the

adu

lt an

imal

; foe

tal s

lack

conn

ectiv

e tis

sue

(e.g

. fr

om a

xilla

), th

ymus

, hea

rt ti

ssue

(with

out

valv

es),

red

bone

mar

row

with

retic

ular

co

nnec

tive

tissu

e an

d sp

ongi

ous b

ones

, nu

cleu

s pul

posu

s int

erve

rteb

ralis

, mes

en-

teriu

m

Mes

ench

ym (2

5.10

.199

4)

Mes

ench

ymSu

s scr

ofa

dom

estic

a L.

List

e H

AS

(10.

2012

)M

osch

usM

osch

us

mos

chife

rus L

. Se

cret

ion

of b

ursa

from

mal

e M

osch

us

mos

chife

rus L

. Ph

. Fr.

IVA

A st

atem

ent 2

013

Muc

osa

bucc

alis

Bos t

auru

s L.

Bucc

al m

ucos

a fr

om th

e ca

lfA

BMA-

Vade

mec

um

Cyd

onia

-Sili

cea

Sirim

im

P. 1

17M

uscu

liBo

s tau

rus L

.Bo

vine

glu

teal

mus

cles

and

bic

eps m

uscl

e of

the

arm

(age

1,5

-4 y

ears

)A

BMA-

Vade

mec

um:

Mus

culi-

Auru

m S

irim

im

P. 1

78M

uscu

li gl

utae

iBo

s tau

rus L

.G

lute

al m

uscl

es fr

om th

e ca

lf IV

AA

stat

emen

t 201

3M

uscu

lus d

elto

ideu

s-Ko

mpl

exBo

s tau

rus L

.Pa

rts o

f the

Mus

culu

s del

toid

eus-

com

plex

, M

uscu

lus s

upra

spin

am, M

uscu

lus i

nfra

sp

inam

, Mus

culu

s del

toid

eus,

Mus

culu

s bi

ceps

bra

chii

and

Mus

culu

s tric

eps b

ra-

chii

from

the

calf

Der

Mer

kurs

tab:

Son

der-

he�

1999

Mus

culu

s rec

tus a

b-do

min

isBo

s tau

rus L

.M

uscu

lus r

ectu

s abd

omin

is fr

om th

e ca

lf Va

dem

ecum

: Mus

culu

s re

ctus

abd

omin

isM

uscu

lus s

oleu

s-Ko

m-

plex

Bos t

auru

s L.

Part

s of t

he M

uscu

lus s

oleu

s-Ko

mpl

ex,

Mus

culu

s sol

eus,

Mus

culu

s �bu

laris

(p

eron

aeus

) lon

gus,

Mus

culu

s gas

troc

ne-

miu

s fro

m th

e ca

lf

IVA

A st

atem

ent 2

013

Myg

ale

avic

ular

isse

e Ar

anea

avi

cula

ris

IVA

A st

atem

ent 2

013

Myg

ale

Seve

ral s

peci

es o

f the

Myg

ale

sp, �

erap

hros

a sp

, La

siodo

ra sp

Livi

ng sp

ider

ABM

A-Va

dem

ecum

H

epar

-Plu

mbu

m S

irim

im

P. 1

48


• Ap

pend

ix 2

.3

143

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Myo

card

ium

Bos t

auru

s L.

Myo

card

ium

from

the

calf

Prim

ula

com

p. (0

2.03

.199

1)N

aja

trip

udia

nsN

aja

naja

L.

Car

eful

ly d

ried

poiso

n fr

om N

aja

naja

L.

HA

B IV

AA

stat

emen

t 201

3N

ervi

inte

rcos

tale

sBo

s tau

rus L

.In

terc

osta

l Ner

ves f

rom

the

calf

Der

Mer

kurs

tab:

Son

der-

he�

1999

Ner

vus a

bduc

ens*

Bos t

auru

s L.

Ner

vus a

bduc

ens f

rom

the

calf

IVA

A st

atem

ent 2

013

Ner

vus a

cces

soriu

sBo

s tau

rus L

.N

ervu

s acc

esso

rius f

rom

the

calf

IVA

A st

atem

ent 2

013

Ner

vus f

acia

lis*

Bos t

auru

s L.

Ner

vus f

acia

lis fr

om th

e ca

lf D

er M

erku

rsta

b: S

onde

r-he

� 19

99N

ervu

s fem

oral

isBo

s tau

rus L

.N

ervu

s fem

oral

is fr

om th

e ca

lf IV

AA

stat

emen

t 201

3N

ervu

s glo

ssop

hary

n-ge

usBo

s tau

rus L

.N

ervu

s glo

ssop

hary

ngeu

s fro

m th

e ca

lf G

löck

ler,

M.:

“Ant

hrop

os-

ophi

sche

Arz

neith

erap

ie”

(Ant

hrop

osop

hic �

erap

y w

ith M

edic

inal

Pro

duct

s),

Publ

isher

Wiss

ensc

ha�l

i-ch

e Ve

rlags

gese

llsch

a�,

Stut

tgar

t N

ervu

s hyp

oglo

ssus

Bos t

auru

s L.

Ner

vus h

ypog

loss

us fr

om th

e ca

lf IV

AA

stat

emen

t 201

3N

ervu

s isc

hiad

icus

Bos t

auru

s L.

Ner

vus i

schi

adic

us fr

om th

e ca

lf N

ervu

s isc

hiad

icus

(2

5.10

.199

4)N

ervu

s isc

hiad

icus

Ory

ctol

agus

cuni

culu

s L.

Ner

vus i

schi

adic

us fr

om th

e ra

bbit

Ner

vus i

schi

adic

us

(25.

10.1

994)

Ner

vus l

aryn

geus

recu

r-re

nsBo

s tau

rus L

.N

ervu

s lar

ynge

us re

curr

ens f

rom

the

calf

Apis/

Lary

nx co

mp.

(2

5.10

.199

4)N

ervu

s lar

ynge

us

supe

rior

Bos t

auru

s L.

Ner

vus l

aryn

geus

supe

rior f

rom

the

calf

Apis/

Lary

nx co

mp.

(2

5.10

.199

4)N

ervu

s med

ianu

sBo

s tau

rus L

.N

ervu

s med

ianu

s fro

m th

e ca

lf D

er M

erku

rsta

b: S

onde

r-he

� 19

99N

ervu

s ocu

lom

otor

ius*

Bos t

auru

s L.

Ner

vus o

culo

mot

oriu

s fro

m th

e ca

lf N

ervu

s opt

icus

com

p.

(03.

07.1

992)

Ner

vus o

phta

lmic

usBo

s tau

rus L

.N

ervu

s oph

talm

icus

from

the

calf

Iris

bovi

s com

p.

(02.

03.1

991)

Ner

vus o

ptic

us*

Bos t

auru

s L.

Ner

vus o

ptic

us fr

om th

e ca

lf N

ervu

s opt

icus

com

p.

(03.

07.1

992)


• Appendix 2.3

144

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Ner

vus o

ptic

usO

ryct

olag

us cu

nicu

lus L

.N

ervu

s opt

icus

from

the

rabb

itN

ervu

s opt

icus

com

p.

(03.

07.1

992)

Ner

vus p

eron

aeus

Bos t

auru

s L.

Ner

vus p

eron

aeus

(�bu

laris

) fro

m th

e ca

lf D

er M

erku

rsta

b: S

onde

r-he

� 19

99N

ervu

s phr

enic

usBo

s tau

rus L

.N

ervu

s phr

enic

us fr

om th

e ca

lf Va

dem

ecum

: Ner

vus

phre

nicu

s N

ervu

s pud

endu

sBo

s tau

rus L

.N

ervu

s pud

endu

s fro

m th

e ca

lf IV

AA

stat

emen

t 201

3N

ervu

s rad

ialis

Bos t

auru

s L.

Ner

vus r

adia

lis fr

om th

e ca

lf IV

AA

stat

emen

t 201

3N

ervu

s sta

toac

ustic

us*

Bos t

auru

s L.

Ner

vus s

tato

acus

ticus

from

the

calf

Arn

ica/

Epip

hysis

/Plu

m-

bum

mel

litum

com

p.

(03.

07.1

992)

Ner

vus s

tato

acus

ticus

Ory

ctol

agus

cuni

culu

s L.

Ner

vus s

tato

acus

ticus

from

the

rabb

itA

rnic

a/Ep

iphy

sis/P

lum

-bu

m m

ellit

um co

mp.

(0

3.07

.199

2)N

ervu

s tib

ialis

Bos t

auru

s L.

Ner

vus t

ibia

lis fr

om th

e ca

lf IV

AA

stat

emen

t 201

3N

ervu

s trig

emin

us*

Bos t

auru

s L.

Ner

vus t

rigem

inus

from

the

calf

Ner

vus t

rigem

inus

(2

5.10

.199

4)N

ervu

s trig

emin

usO

ryct

olag

us cu

nicu

lus L

.N

ervu

s trig

emin

us fr

om th

e ra

bbit

Ner

vus t

rigem

inus

(2

5.10

.199

4)N

ervu

s tro

chle

aris*

Bos t

auru

s L.

Ner

vus t

roch

lear

is fr

om th

e ca

lf D

er M

erku

rsta

b 20

05;

58(4

): 31

0-31

5N

ervu

s uln

aris

Bos t

auru

s L.

Ner

vus u

lnar

is fr

om th

e ca

lf IV

AA

stat

emen

t 201

3N

ervu

s vag

usBo

s tau

rus L

.N

ervu

s vag

us fr

om th

e ca

lf Ap

is/La

rynx

com

p.

(25.

10.1

994)

Ner

vus v

agus

Ory

ctol

agus

cuni

culu

s L.

Ner

vus v

agus

from

the

rabb

itAp

is/La

rynx

com

p.

(25.

10.1

994)

Nod

i lym

phat

ici

Bos t

auru

s L.

Part

s of l

ymph

nod

e tis

sue

from

di�

eren

t pa

rts o

f the

bod

y fr

om th

e ca

lfD

er M

erku

rsta

b: S

onde

r-he

� 19

99N

ucle

us ru

ber*

Bos t

auru

s L.

Brai

n su

bsta

nce

from

the

Nuc

leus

rube

r fr

om th

e ca

lf D

er M

erku

rsta

b 20

05;

58(4

): 31

0-31

5O

esop

hagu

sSu

s scr

ofa

dom

estic

a L.

Oes

opha

gus f

rom

the

pig

IVA

A st

atem

ent 2

013

Oss

aSu

s scr

ofa

dom

estic

a L.

Bone

s fro

m th

e pi

g Li

ste

HA

S (1

0.20

12)


• Ap

pend

ix 2

.3

145

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Oss

aAv

es v

aria

e, e.g

. Pha

sianu

s co

lchicu

s L.

Cle

aned

and

mill

ed b

ones

from

bird

s, e.g

. Ph

asia

nus c

olch

icus

L.

List

e H

AS

(10.

2012

)

Oss

a lo

nga

Bos t

auru

s L.

Oss

a lo

nga

from

the

calf

IVA

A st

atem

ent 2

013

Oss

icul

a au

ditu

s*Bo

s tau

rus L

.Au

dito

ry b

ones

from

the

calf

IVA

A st

atem

ent 2

013

Ova

riase

e O

variu

mO

variu

mBo

s tau

rus L

.O

vary

from

the

cow

O

variu

m (2

8. S

erie

) (D

AZ

Nr.

29 v

om 2

1.07

.199

4)Pa

ncre

asBo

s tau

rus L

.Pa

ncre

as fr

om th

e ca

lf Pa

nkre

as (0

3.07

.199

2)Pa

ncre

asO

ryct

olag

us cu

nicu

lus L

.Pa

ncre

as fr

om th

e ra

bbit

Pank

reas

(03.

07.1

992)

Panc

reas

Sus s

crof

a do

mes

tica

L.Pa

ncre

as fr

om th

e pi

g Pa

nkre

as (0

3.07

.199

2)Pa

pilla

e du

oden

iSu

s scr

ofa

dom

estic

a L.

Papi

lla d

uode

ni re

gion

of t

he sm

all

inte

stin

e fr

om th

e pi

g IV

AA

stat

emen

t 201

3

Para

met

rium

Bos t

auru

s L.

Tiss

ue fr

om th

e br

oad

ligam

ent o

f the

ut

erus

from

the

cow

Ec

hina

cea/

Para

met

rium

co

mp.

(25.

10.1

994)

Para

met

rium

de

xtru

mBo

s tau

rus L

.Ti

ssue

from

the

right

bro

ad li

gam

ent o

f th

e ut

erus

from

the

cow

Der

Mer

kurs

tab:

Son

der-

he�

1999

Pars

feta

lis (p

lace

nta)

Bos t

auru

s L.

Alla

ntoc

horio

n fr

om th

e bo

vine

foet

us

Prun

us/R

osm

arin

us co

mp.

(0

2.03

.199

1)Pa

rs p

allid

a*Bo

s tau

rus L

.Pa

rts o

f th

e ba

se o

f the

bra

in fr

om th

e ca

lfIV

AA

stat

emen

t 201

3Pa

tella

Bos t

auru

s L.

Pate

lla fr

om th

e ca

lf IV

AA

stat

emen

t 201

3Pe

lvis

rena

lis (e

t Ure

ter)

Bos t

auru

s L.

Part

s of t

he P

elvi

s ren

alis

and

Ure

ter f

rom

th

e ca

lf IV

AA

stat

emen

t 201

3

Peni

sBo

s tau

rus L

.Pe

nis f

rom

the

bull

IVA

A st

atem

ent 2

013

Peric

ardi

umBo

s tau

rus L

.Pe

ricar

dium

from

the

calf

Glö

ckle

r, M

.: “A

nthr

opos

-op

hisc

he A

rzne

ither

apie”

(A

nthr

opos

ophi

c �er

apy

with

Med

icin

al P

rodu

cts)

, Pu

blish

er W

issen

scha

�li-

che

Verla

gsge

sells

cha�

, St

uttg

art 2

010

Perio

dont

ium

Bos t

auru

s L.

Part

s of t

he a

lveo

lar a

nd d

enta

ls re

gion

s fr

om th

e ca

lf Pe

riodo

ntiu

m/S

ilice

a co

mp.

(1

2.09

.199

2)


• Appendix 2.3

146

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Perio

steu

mBo

s tau

rus L

.Pe

riost

eum

from

the

calf

Alli

um ce

pa/T

endo

com

p.

(12.

09.1

992)

Perio

steu

mO

ryct

olag

us cu

nicu

lus L

.Pe

riost

eum

from

the

rabb

itA

llium

cepa

/Ten

do co

mp.

(1

2.09

.199

2)Pe

riton

aeum

Bos t

auru

s L.

Perit

onae

um fr

om th

e ca

lf Br

yoni

a/V

iscum

com

p.

(25.

10.1

994)

Perit

onae

umO

ryct

olag

us cu

nicu

lus L

.Pe

riton

aeum

from

the

rabb

itBr

yoni

a/V

iscum

com

p.

(25.

10.1

994)

Phar

ynx

Bos t

auru

s L.

Part

s fro

m th

e Ph

aryn

x di

gest

oriu

m a

nd

Phar

ynx

resp

irato

rius f

rom

the

calf

Vade

mec

um: P

hary

nx

Phys

eter

cat

odon

see

Ambr

a gr

isea

Phys

eter

m

acro

ceph

alus

see

Ambr

a gr

isea

Pia

mat

er e

ncep

hali*

Bos t

auru

s L.

Pia

mat

er e

ncep

hali

from

the

calf

IVA

A st

atem

ent 2

013

Plac

enta

Bos t

auru

s L.

Plac

ento

mas

from

the

preg

nant

cow

Pl

acen

ta/T

ropa

eolu

m

(02.

03.1

991)

Glö

ckle

r, M

.: “A

nthr

opos

-op

hisc

he A

rzne

ither

apie”

(A

nthr

opos

ophi

c �er

apy

with

Med

icin

al P

rodu

cts)

, Pu

blish

er W

issen

scha

�li-

che

Verla

gsge

sells

cha�

, St

uttg

art

Pleu

raBo

s tau

rus L

.Pl

eura

par

ieta

lis fr

om th

e ca

lf D

er M

erku

rsta

b: S

onde

r-he

� 19

99Pl

exus

bra

chia

lisBo

s tau

rus L

.Pl

exus

bra

chia

lis fr

om th

e ca

lf Va

dem

ecum

[men

tione

d un

der:

Disc

i/Rhu

s tox

ico-

dend

ron

com

p.]

Plex

us c

ardi

acus

Bos t

auru

s L.

Plex

us c

ardi

acus

from

the

calf

Vade

mec

um: P

lexu

s ca

rdia

cus

Plex

us co

elia

cus

Bos t

auru

s L.

Plex

us co

elia

cus f

rom

the

calf

Vade

mec

um: P

lexu

s co

elia

cus

Plex

us g

astr

icus

Bos t

auru

s L.

Plex

us g

astr

icus

from

the

calf

Vade

mec

um: P

lexu

s ga

stric

us

Plex

us h

aem

orrh

oida

lisBo

s tau

rus L

.Ve

nous

net

wor

k in

the

regi

on o

f the

re

ctum

from

the

calf

Vade

mec

um: P

lexu

s ha

emor

rhoi

dalis


• Ap

pend

ix 2

.3

147

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Plex

us lu

mba

lisBo

s tau

rus L

.Pl

exus

lum

balis

from

the

calf

IVA

A st

atem

ent 2

013

Plex

us p

elvi

nus

Bos t

auru

s L.

Plex

us p

elvi

nus f

rom

the

calf

Der

Mer

kurs

tab:

Son

der-

he�

1999

Plex

us p

ulm

onal

is (N

er-

vus v

agus

)Bo

s tau

rus L

.Pl

exus

pul

mon

alis

from

the

calf

Vade

mec

um: P

lexu

s pul

-m

onal

is (N

ervu

s vag

us)

Plex

us re

ctal

isse

e Pl

exus

hae

mor

rhoi

dalis

IV

AA

stat

emen

t 201

3Pl

exus

sacr

alis

Bos t

auru

s L.

Plex

us sa

cral

is fr

om th

e ca

lf D

er M

erku

rsta

b: S

onde

r-he

� 19

99Po

ns*

Bos t

auru

s L.

Pons

from

the

calf

Der

Mer

kurs

tab:

Son

der-

he�

1999

Port

io v

agin

alis

Bos t

auru

s L.

Port

io v

agin

alis

from

the

cow

IV

AA

stat

emen

t 201

3Pr

opol

isAp

is m

ellife

ra L

.Pr

opol

is Ph

. Fr.

Der

Mer

kurs

tab

2011

; 64

(4):

338

Pros

tata

Bos t

auru

s L.

Pros

tata

from

the

bull

Berb

eris/

Pros

tata

com

p.

(12.

09.1

992)

Pude

ndum

fe

min

ium

Bos t

auru

s L.

Labi

a vu

lvae

, Klit

oris

and

Gla

ndul

a

vest

ibul

aris

maj

or fr

om th

e co

w

Prun

us/R

osm

arin

us co

mp.

(0

2.03

.199

1)Pu

lmo

Bos t

auru

s L.

Lung

tiss

ue fr

om th

e ca

lf Fe

rrum

/Pul

mo

(12.

09.1

992)

Pulm

oO

ryct

olag

us cu

nicu

lus L

.Lu

ng fr

om th

e ra

bbit

Ferr

um/P

ulm

o (1

2.09

.199

2)Pu

lpa

dent

isBo

s tau

rus L

.Pu

lpa

dent

is fr

om th

e ca

lf Va

dem

ecum

: Pul

pa d

entis

Py

loru

sSu

s scr

ofa

dom

estic

a L.

Pylo

rus f

rom

the

pig

Der

Mer

kurs

tab:

Son

der-

he�

1999

Rect

umSu

s scr

ofa

dom

estic

a L.

Rect

um fr

om th

e pi

g D

er M

erku

rsta

b: S

onde

r-he

� 19

99Re

gio

subs

tant

iae

nigr

ae*

Bos t

auru

s L.

Tiss

ue fr

om th

e Su

bsta

ntia

nig

ra fr

om th

e ca

lf Va

dem

ecum

: Reg

io su

b-st

antia

e ni

grae

Rene

sBo

s tau

rus L

.K

idne

y fr

om th

e ca

lfRe

n (D

AZ

Nr.

29,

21.0

7.19

94)

Rene

sO

ryct

olag

us cu

nicu

lus L

.K

idne

y fr

om th

e ra

bbit

Ren

(DA

Z N

r. 29

, 21

.07.

1994

)


• Appendix 2.3

148

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Rene

s, re

gio

pyel

ore-

nalis

Bos t

auru

s L.

Part

s of t

issue

from

the

Pelv

is re

nalis

and

M

edul

la re

nalis

from

the

calf

IVA

A st

atem

ent 2

013

Retic

uloe

ndot

helia

l Sy

stem

Bos t

auru

s L.

Part

s fro

m th

e th

ymus

gla

nd, l

ymh

node

s, bo

ne m

arro

w, li

ver a

nd sp

leen

from

the

calf

Vade

mec

um [m

entio

ned

unde

r: Le

vico

com

p.]

Retin

a

(et C

horio

idea

)*Bo

s tau

rus L

.Pa

rts o

f the

Ret

ina

and

the

Cho

rioid

ea

from

the

calf

Retin

a (2

8. S

erie

) (D

AZ

Nr.

29 v

om 2

1.07

.199

4)Sc

lera

*Bo

s tau

rus L

.Sc

lera

from

the

calf

IVA

A st

atem

ent 2

013

Scol

open

dra

Seve

ral s

pecie

s of S

colo

pen-

dra

fam

ilyLi

ving

cent

iped

e of

Sco

lope

ndrid

eae

fa

mily

ABM

A-Va

dem

ecum

Si

nus f

acia

lis-M

ercu

rius

Sirim

im P

. 238

Sepi

a o�

cina

lis e

vol

u-m

ine

burs

ae re

c.Se

pia

o�cin

alis

L.

Fres

h se

cret

ion

from

ink

glan

d fr

om S

epia

o�

cina

lis L

.Be

rber

is/Se

pia

com

p.

(25.

10.1

994)

Sepi

a gr

uner

isSe

pia

o�cin

alis

L.

Drie

d se

cret

ion

from

ink

glan

d fr

om S

epia

o�

cina

lis L

. H

AB

Der

Mer

kurs

tab

1997

; 52

(1):

51Se

pia

o�ci

nalis

Sepi

a o�

cinal

is L.

D

ried

ink

bag

from

Sep

ia o

�ci

nalis

L.

Ph. F

r. D

er M

erku

rsta

b 19

97;

52(1

): 51

Sinu

s cav

erno

sus-

Kom

-pl

ex*

Bos t

auru

s L.

Part

s of t

he si

nus c

aver

nosu

s-Ko

mpl

ex;

Sinu

s cav

erno

sus,

Ner

vus o

ptic

us, N

ervu

s oc

ulom

otor

ius,

Ner

vus t

roch

lear

is, N

ervu

s tr

igem

inus

and

Ner

vus a

bduc

ens f

rom

the

calf

IVA

A st

atem

ent 2

013

Spon

gia

tost

aEu

spon

gia

o�

cinal

is L.

To

aste

d Eu

spon

gia

o�ci

nalis

L.

HA

B / P

h. F

r. Sp

ongi

a (0

2.03

.199

1)Va

dem

ecum

: Spo

ngia

Sym

path

icus

see

Trun

cus

sym

path

icus

Tara

ntul

a hi

span

ica

Lyco

sa h

ispan

icaW

alck

enae

r�

e w

hole

spid

er L

ycos

a ta

rant

ula

L.,

A

lloco

sa fa

sciiv

entr

is D

uf.,

or H

ogna

hi

span

ica

Wal

cken

aer

IVA

A st

atem

ent 2

013

Tend

oBo

s tau

rus L

.Te

ndo

from

the

calf

Alli

um ce

pa/T

endo

com

p.

(12.

09.1

992)

Test

a ov

iG

allu

s gal

lus d

omes

ticus

L.

Shel

l of h

en’s

eggs

Au

rum

/Pul

satil

la/

Spon

gia

com

p. (0

3.07

.199

2)


• Ap

pend

ix 2

.3

149

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Test

esBo

s tau

rus L

.Te

stes

from

the

bull

Test

es co

mp.

(2

8. S

erie

) (D

AZ

Nr.

29

vom

21.

07.1

994)

Test

esO

ryct

olag

us cu

nicu

lus L

.Te

stes

from

the

(mal

e) ra

bbit

Test

es co

mp.

(2

8. S

erie

) (D

AZ

Nr.

29

vom

21.

07.1

994)

Text

us co

nnec

tivus

Bos t

auru

s L.

Subc

utan

eous

and

inte

rmus

cula

r con

nec-

tive

tissu

e, fa

scia

, lig

amen

ts, t

endo

ns, a

s w

ell a

s mes

ente

rium

from

the

calf

Bora

go/R

enes

com

p.

(12.

09.1

992)

�al

amus

*Bo

s tau

rus L

.�

alam

us fr

om th

e ca

lf A

rnic

a/H

ypop

hysis

/Pl

umbu

m m

ellit

um co

mp.

(0

3.07

.199

2)�

alam

usO

ryct

olag

us cu

nicu

lus L

.�

alam

us fr

om th

e ra

bbit

Arn

ica/

Hyp

ophy

sis/

Plum

bum

mel

litum

com

p.

(03.

07.1

992)

�ro

mbo

cyte

sEq

uus

prze

wal

skii

f. ca

ballu

s PO

LIA

KOV

�ro

mbo

cyte

s fro

m th

e bl

ood

of th

e ho

rse

IVA

A st

atem

ent 2

013

�ym

us (G

land

ula)

Bos t

auru

s L.

�ym

us fr

om th

e ca

lf G

land

ula

�ym

us (2

5.

Serie

) (D

AZ

Nr.

29 v

om

21.0

7.19

94)

Tons

illa

phar

ynge

aBo

s tau

rus L

.To

nsill

a ph

aryn

gea

from

the

calf

IVA

A st

atem

ent 2

013

Tons

illae

pal

atin

aeBo

s tau

rus L

.To

nsill

a pa

latin

ae fr

om th

e ca

lf C

alen

dula

/Ech

inac

ea co

mp.

(0

2.03

.199

1)

Trab

ecul

um*

Bos t

auru

s L.

Trab

ecul

um fr

om th

e ca

lf Tr

abec

ulum

com

p.

(03.

07.1

992)

List

e H

AS

(10.

2012

)

Trac

hea

Bos t

auru

s L.

Trac

hea

from

the

calf

IVA

A st

atem

ent 2

013

Trac

tus d

iges

tivus

Bos t

auru

s L.

Equa

l par

ts o

f the

com

plet

e di

gest

ive

sy

stem

from

the

bovi

ne fo

etus

ABM

A-Va

dem

ecum

: Tr

actu

s dig

estiv

us-C

u-pr

um

Sirim

im P

. 257


• Appendix 2.3

150

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Trig

onum

ves

icae

et

Mus

culu

s sph

inct

erBo

s tau

rus L

.Ti

ssue

of t

he v

esic

a fr

om th

e re

gion

of t

he

Trig

onum

ves

icae

and

mus

cula

r tiss

ue

from

the

sphi

ncte

r of t

he v

esic

a fr

om th

e ca

lf

Der

Mer

kurs

tab:

Son

der-

he�

1999

Trun

cus c

ereb

ri*Bo

s tau

rus L

.Pa

rts f

rom

Hyp

otha

lam

us, �

alam

us,

Cor

pora

qua

drig

emin

a, P

ons,

Med

ulla

ob

long

ata

and

Cer

ebel

lum

from

the

calf

Hirn

stam

m/T

ritic

um (2

8.

Serie

) (D

AZ

Nr.

29 v

om

21.0

7.19

94)

Trun

cus c

oelia

cus

Bos t

auru

s L.

Art

eria

coel

iaca

(Tru

ncus

coel

iacu

s) fr

om

the

calf

IVA

A st

atem

ent 2

013

Trun

cus e

ncep

hali

Bos t

auru

s L.

Brai

n st

em fr

om th

e ca

lf IV

AA

stat

emen

t 201

3Tr

uncu

s enc

epha

liBo

s tau

rus L

.H

ypot

hala

mus

, �al

amus

, Cor

pora

qu

adrig

emin

a, P

ons,

Med

ulla

obl

onga

ta

from

the

calf

IVA

A st

atem

ent 2

013

Trun

cus s

ympa

thic

usBo

s tau

rus L

.Tr

uncu

s sym

path

icus

from

the

calf

Vade

mec

um: S

ympa

thi-

cus

Tuba

audi

tiva*

Bos t

auru

s L.

Tuba

audi

tiva

from

the

calf

Vade

mec

um [m

entio

ned

unde

r: C

avum

tym

pani

]Tu

ba u

terin

aBo

s tau

rus L

.Tu

ba u

terin

a fr

om th

e co

w

Echi

nace

a/

Para

met

rium

com

p.

(25.

10.1

994)

Tuba

ute

rina

Ory

ctol

agus

cuni

culu

s L.

Tuba

ute

rina

from

the

(fem

ale)

rabb

itEc

hina

cea/

Pa

ram

etriu

m co

mp.

(2

5.10

.199

4)Tu

nica

muc

osa

in

test

ini t

enui

sSu

s scr

ofa

do

mes

tica

L.M

ucos

a fr

om th

e di

�ere

nt re

gion

s of t

he

smal

l int

estin

e fr

om th

e pi

g IV

AA

stat

emen

t 201

3

Tuni

ca m

ucos

a na

siBo

s tau

rus L

.Tu

nica

muc

osa

nasi

from

the

calf

Bron

chi/P

lant

ago

com

p.

(12.

09.1

992)

Tu

nica

muc

osa

rect

iSu

s scr

ofa

do

mes

tica

L.Tu

nica

muc

osa

rect

i fro

m th

e pi

g IV

AA

stat

emen

t 201

3

Tuni

ca m

ucos

a ve

n-tr

icul

iSu

s scr

ofa

do

mes

tica

L.M

ucos

a fr

om th

e di

�ere

nt re

gion

s of t

he

stom

ach

from

the

pig

IVA

A st

atem

ent 2

013

Ure

ter

Bos t

auru

s L.

Ure

ter f

rom

the

calf

IVA

A st

atem

ent 2

013

Ure

thra

fem

inin

aBo

s tau

rus L

.U

reth

ra fr

om th

e fe

mal

e ca

lf D

er M

erku

rsta

b: S

onde

r-he

� 19

99


• Ap

pend

ix 2

.3

151

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Ure

thra

mas

culin

aBo

s tau

rus L

.U

reth

ra fr

om th

e m

ale

calf

Der

Mer

kurs

tab:

Son

der-

he�

1999

Ute

rus

Bos t

auru

s L.

Ute

rus f

rom

the

cow

Be

rber

is/U

teru

s com

p.

(12.

09.1

992)

Ute

rus

Ory

ctol

agus

cuni

culu

s L.

Ute

rus f

rom

the

(fem

ale)

rabb

itBe

rber

is/U

teru

s com

p.

(12.

09.1

992)

Ute

rus

Sus s

crof

a do

mes

tica

L.U

teru

s fro

m th

e pi

gBe

rber

is/U

teru

s com

p.

(12.

09.1

992)

Uve

a*Bo

s tau

rus L

.U

vea

from

the

calf

List

e H

AS

(10.

2010

: Uve

a co

mp.

)Va

gina

Bos t

auru

s L.

Vagi

na fr

om th

e co

w

IVA

A st

atem

ent 2

013

Vagi

nae

syno

vial

es

tend

inum

Bos t

auru

s L.

Tend

on sh

eath

s fro

m th

e ca

lf A

llium

cepa

/Ten

do co

mp.

(1

2.09

.199

2)Va

lva

trun

ci p

ulm

onal

isBo

s tau

rus L

.Va

lva

trun

ci p

ulm

onal

is fr

om th

e ca

lf IV

AA

stat

emen

t 201

3Va

lvul

a ao

rtae

Bos t

auru

s L.

Valv

a ao

rtae

from

the

calf

IVA

A st

atem

ent 2

013

Valv

ula

mitr

alis

Bos t

auru

s L.

Valv

a m

itral

is fr

om th

e ca

lf IV

AA

stat

emen

t 201

3Va

lvul

a tr

icus

pida

lisBo

s tau

rus L

.Va

lva

tric

uspi

dalis

from

the

calf

Der

Mer

kurs

tab:

Son

der-

he�

1999

Vena

cav

aBo

s tau

rus L

.Pa

rts o

f the

Ven

a ca

va cr

ania

lis a

nd V

ena

cava

cau

dalis

from

the

calf

IVA

A st

atem

ent 2

013

Vena

fem

oral

isBo

s tau

rus L

.Ve

na fe

mor

alis

from

the

calf

Der

Mer

kurs

tab:

Son

der-

he�

1999

Vena

por

tae

Bos t

auru

s L.

Vena

por

tae

from

the

calf

IVA

A st

atem

ent 2

013

Vena

saph

ena

mag

naBo

s tau

rus L

.Ve

na sa

phen

a m

agna

from

the

calf

Vade

mec

um: V

ena

sa-

phen

a m

agna

Ve

na ti

bial

isBo

s tau

rus L

.Ve

na ti

bial

is fr

om th

e ca

lf IV

AA

stat

emen

t 201

3Ve

ntric

ulus

Sus s

crof

a do

mes

tica

L.Ve

ntric

ulus

from

the

pig

Vade

mec

um: V

entr

icul

us

Vert

ebra

cerv

ical

is*Bo

s tau

rus L

.Ve

rteb

ra ce

rvic

alis

from

the

calf

IVA

A st

atem

ent 2

013

Vert

ebra

cocc

ygea

Bos t

auru

s L.

Vert

ebra

cocc

ygea

from

the

calf

IVA

A st

atem

ent 2

013

Vert

ebra

lum

balis

*Bo

s tau

rus L

.Ve

rteb

ra lu

mba

lis fr

om th

e ca

lf IV

AA

stat

emen

t 201

3Ve

sica

felle

aBo

s tau

rus L

.Ve

sica

felle

a fr

om th

e ca

lf Fe

rrum

/Ves

ica

felle

a (2

5.10

.199

4)


• Appendix 2.3

152

Scie

nti�

c nam

e Sc

ient

i�c n

ame o

f the

anim

alAb

brev

iate

d de

�niti

onRe

fere

nce t

o St

anda

rdEx

empl

ary r

efer

ence

for u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Vesic

a ur

inar

iaBo

s tau

rus L

.Ve

sica

urin

aria

from

the

calf

Can

thar

is co

mp.

(0

1.07

.199

2)Ve

sica

urin

aria

Ory

ctol

agus

cuni

culu

s L.

Vesic

a ur

inar

ia fr

om th

e ra

bbit

Can

thar

is co

mp.

(0

1.07

.199

2)Ve

spa

crab

roVe

spa

crab

ro L

. Li

ve h

orne

tsH

AB

Vesp

a cr

abro

(25.

10.1

994)

Vade

mec

um: V

espa

cr

abro

Ve

spa

vulg

aris

Vesp

ula

germ

anica

Fab

ri-ci

us, V

espu

la v

ulga

ris L

. and

/or

Dol

ichov

espu

la sa

xoni

a Fa

bric

ius

Live

wor

ker w

asps

Li

ste

HA

S (1

0.20

12)

Vip

era

beru

sVi

pera

ber

us L

. Fr

eeze

drie

d ve

nom

of V

iper

a be

rus L

. N

aja

com

p. (2

5.10

.199

4)


153

APPENDIX 2.4

Starting materials that can be described chemically Additional Information, see p. 22

• Ap

pend

ix 2

.4


• Appendix 2.4

154

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Aci

dum

ars

enic

osum

see

Ars

enii

trio

xidu

m ap

hA

cidu

m b

enzo

icum

Aci

dum

ben

zoic

um, B

enzo

icum

ac

idum

pph

Benz

oic a

cid

Ph.E

ur.

(HA

B, P

h.fr.

)A

cidu

m b

enzo

icum

e re

sina

Benz

oic a

cid

from

Sia

m

benz

oin

HA

B

Aci

dum

citr

icum

anh

ydric

umA

cidu

m ci

tric

umC

itric

aci

d, a

nhyd

rous

Ph.E

ur. (

HA

B)A

cidu

m ci

tric

um m

onoh

ydric

umC

itric

aci

d m

onoh

ydra

tePh

.Eur

. Be

rber

is/Si

licea

com

p. (0

2.03

.199

1)A

cidu

m F

orm

icae

see

Appe

ndix

2.3

Aci

dum

form

icic

umFo

rmic

aci

dH

AB

Aci

dum

hex

achl

orop

latin

icum

Hex

achl

orop

latin

ic a

cid

HA

BPa

ncre

as/P

latin

um ch

lora

tum

com

p.

(02.

03.1

991)

Aci

dum

hyd

roch

lorid

um d

ilutu

mA

cidu

m h

ydro

chlo

ricum

Hyd

roch

loric

aci

d, d

ilute

(1

0%)

Ph.E

ur. (

HA

B)A

cidu

m h

ydro

chlo

ricum

com

p.

(02.

09.1

987)

Aci

dum

lact

icum

Aci

dum

lact

icum

Lact

ic a

cid

Ph.E

ur.

Maj

oran

a/�

uja

com

p. (0

2.03

.199

1)A

cidu

m n

itric

umA

cidu

m n

itric

um, N

itric

um

acid

um p

phN

itric

aci

dPh

.Eur

. (H

AB,

Ph.

fr.)

Mix

tura

Sta

nni c

omp.

(05.

12.1

989)

Aci

dum

pho

spho

ricum

dilu

tum

Aci

dum

pho

spho

ricum

Phos

phor

ic a

cid,

di

lute

(10%

)Ph

.Eur

. H

AB

Apis

regi

na/A

urum

com

p. (0

2.03

.199

1)

Aci

dum

pho

spho

ricum

conc

en-

trat

umA

cidu

m p

hosp

horic

um co

ncen

tra-

tum

, Pho

spho

ricum

aci

dum

pph

Phos

phor

ic a

cid,

co

ncen

trat

edPh

.Eur

. (P

h.fr.

)Ap

is re

gina

/Aur

um co

mp.

(02.

03.1

991)

Aci

dum

silic

icum

Aci

dum

silic

icum

Prec

ipita

ted

silic

on d

ioxi

deD

AB

Aci

dum

sulfu

ricum

Aci

dum

sulfu

ricum

, Sul

furic

um

acid

um p

phSu

lfuric

aci

dPh

.Eur

. (H

AB,

Ph

.fr.)

Aci

dum

tart

aric

umA

cidu

m ta

rtar

icum

Tart

aric

aci

dPh

.Eur

.A

escu

linum

Aes

culin

DA

B / H

AB

Echi

nace

a/Pr

unus

com

p. (0

4.06

.198

6)A

ethi

ops a

ntim

onia

lisse

e H

ydra

rgyr

um

stib

iato

-sul

fura

tum

Aet

hiop

s ant

imon

ialis

(02.

09.1

987)

Alu

men

Alu

men

Alu

mPh

.Eur

.M

ixtu

ra S

tann

i com

p. (0

5.12

.198

9)A

lum

en ch

rom

icum

Pota

ssiu

m ch

rom

ium

(III

) su

lfate

dod

ecah

ydra

teA

lum

iniu

m-k

aliu

m-s

ulfu

ricum

see

Alu

men

Ph.E

ur.


• Ap

pend

ix 2

.4

155

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Am

mon

iae

solu

tio co

ncen

trat

aA

mm

onia

solu

tion,

co

ncen

trat

edPh

.Eur

.

Am

mon

ium

car

boni

cum

Mix

ture

of a

mm

oniu

m

hydr

ogen

car

bona

te a

nd

amm

oniu

m c

arba

mat

e of

va

ryin

g pr

opor

tions

HA

BEc

hina

cea

com

p. (0

4.06

.198

6)

Ant

imon

ium

tart

aric

umse

e K

aliu

m st

ibyl

tart

aric

umA

rgen

ti ca

rbon

asA

rgen

tum

car

boni

cum

Silv

er ca

rbon

ate,

99-1

00,5

%

Ag 2

CO

3 (s

ee A

ppen

dix

2.5,

e.g.

V

iscum

Mal

i cum

Arg

ento

)A

rgen

tum

met

allic

um,

Arg

entu

m m

etal

licum

pph

Met

allic

silv

erH

AB,

Ph.

fr.A

rgen

tum

met

allic

um (0

4.06

.198

6)

Arg

enti

nitr

asA

rgen

tum

nitr

icum

, A

rgen

tum

nitr

icum

pph

Silv

er n

itrat

ePh

.Eur

. (H

AB,

Ph.

fr.)

Arg

entu

m n

itric

um (0

4.06

.198

6)

Ars

enii

trio

xidu

m ap

hA

rsen

icum

alb

umA

rsen

ious

trio

xide

�p

Ph.E

ur.

Ars

enic

um a

lbum

(02.

09.1

987)

Auru

m ch

lora

tum

Hyd

roge

n te

trac

hlor

oaur

ate(

III)

tr

ihyd

rate

HA

BAp

is re

gina

/Aur

um co

mp.

(02.

03.1

991)

Auru

m ch

lora

tum

nat

rona

tum

see

Nat

rium

te

trac

hlor

oaur

atum

Auru

m m

etal

licum

, Au

rum

met

allic

um p

phM

etal

lic g

old

HA

B, P

h.fr.

Auru

m m

etal

licum

(04.

06.1

986)

Auru

m m

etal

licum

folia

tum

Gol

d le

afAu

rum

nat

ural

ese

e Ap

pend

ix 2

.1Au

rum

mur

iatic

um n

atro

natu

mse

e N

atriu

m

tetr

achl

oroa

urat

umAu

rum

sulfu

ratu

mM

ixtu

re o

f gol

d(I)

- and

go

ld(I

II) s

ul�d

eBa

rium

citr

icum

Bariu

m ci

trat

e he

xahy

drat

eBa

rium

/Pan

crea

s com

p. (0

2.03

.199

1)Ba

rii io

didu

mBa

rium

ioda

tum

Bariu

m io

dide

m

onoh

ydra

teH

AB

Benz

oicu

m a

cidu

m p

phse

e A

cidu

m b

enzo

icum


• Appendix 2.4

156

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Bism

utum

met

allic

umM

etal

lic b

ismut

hH

AB

Bism

utum

/Stib

ium

(12.

09.1

992)

Bism

uthu

m p

phse

e Bi

smut

um su

bnitr

as

pond

eros

usBi

smut

um su

bnitr

as p

onde

rosu

sBi

smut

um su

bnitr

icum

, Bi

smut

hum

pph

Bism

uth

subn

itrat

e, he

avy

Ph.E

ur.

(HA

B, P

h.fr.

)C

arbo

San

guin

is co

mp.

(25.

10.1

994)

Bora

xN

atriu

m te

trab

orac

ium

, Bo

rax

pph

Diso

dium

tetr

abor

ate

deca

hydr

ate

Ph.E

ur.

(HA

B, P

h.fr.

)C

alca

rea

form

icic

a

(Cal

cium

form

icic

um)

Cal

cium

form

ate,

obta

ined

fr

om C

onch

ae a

nd A

cidu

m

Form

icae

(s

ee A

ppen

dix

2.3)

Viti

s com

p. (0

4.06

.198

6)

Cal

care

a ph

osph

oric

a pp

hse

e C

alci

i hyd

roge

noph

os-

phas

dih

ydric

usC

alci

i hyd

roxi

dum

Cal

cii h

ydro

xidu

mC

alci

um h

ydro

xide

Ph.E

ur.

Cal

cii o

xidu

mFr

eshl

y bu

rnt l

ime

or

mar

ble

Cal

cii c

arbo

nas

Cal

cium

car

boni

cum

Cal

cium

car

bona

tePh

.Eur

.C

alci

i hyd

roge

noph

osph

as d

ihy-

dric

usC

alci

um p

hosp

horic

um,

Cal

care

a ph

osph

oric

a pp

hC

alci

um h

ydro

gen

ph

osph

ate

dihy

drat

ePh

.Eur

. (H

AB,

Ph.

fr.)

Cal

cium

stib

iato

-sul

fura

tum

A m

ixtu

re, p

repa

red

by

mel

ting

stib

ium

sulfu

ratu

m

nigr

um, s

ulfu

r and

conc

hae

toge

ther

HA

B

Cal

cii s

ulfa

s dih

ydric

usC

alci

um su

lfuric

um,

Cal

care

a su

lfuric

a pp

hC

alci

um su

lfate

dih

ydra

tePh

.Eur

. (H

AB,

Ph.

fr.)

d-C

amph

ora

Cam

phor

a, C

amph

ora

pph

D-C

amph

orPh

.Eur

. (H

AB,

Ph.

fr.)

Cam

phor

a (0

4.06

.198

6)

Cer

ussa

see

Plum

bum

car

boni

cum

Chi

nini

sulfa

sC

hini

num

sulfu

ricum

Qui

nine

sulfa

tePh

.Eur

. (H

AB,

Ph.

fr.)

Chl

orop

hyllu

m�

e gr

een

plan

t pig

men

t (G

reen

of l

eave

s).

Arg

entu

m/Q

uerc

us co

mp.

(04.

06.1

986)


• Ap

pend

ix 2

.4

157

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Cin

naba

risse

e H

ydra

rgyr

um su

lfura

-tu

m ru

brum

or C

inna

bar

in A

ppen

dix

2.1

Cob

altu

m m

etal

licum

Met

allic

coba

ltH

AB

Cob

altu

m m

etal

licum

(12.

09.1

992)

Cre

osot

umse

e K

reos

otum

Cop

per t

etra

mm

ine

sulp

hate

m

onoh

ydra

tePr

epar

ed fr

om co

pper

(II)

su

lfate

pen

tahy

drat

e an

d co

ncen

trat

ed a

mm

onia

so

lutio

n. S

ee A

ppen

dix

2.6

Cupr

um-R

en

Cupr

um-R

en-G

land

ula

supr

aren

alis

(12.

09.1

992)

Cupr

o-St

ibiu

mA

lloy

of 1

par

t of c

oppe

r an

d 1

part

of a

ntim

ony

Cupr

i ace

tas m

onoh

ydric

us ap

hCu

prum

ace

ticum

Cop

per(

II) a

ceta

te

mon

ohyd

rate

�p

Ph.E

ur.

(HA

B)Cu

prum

ace

ticum

(04.

06.1

986)

Cupr

um ci

tric

umC

oppe

r(II

) citr

ate

2,5

Hyd

rate

Cupr

um ap

hCu

prum

met

allic

umC

oppe

r �p

Ph.E

ur. (

HA

B)Cu

prum

met

allic

um (0

4.06

.198

6)Cu

prum

oxy

dula

tum

rubr

umC

oppe

r(I)

oxi

deCu

prum

oxy

dula

tum

rubr

um

(02.

03.1

990)

Cupr

i sul

fas p

enta

hydr

icus

Cupr

um su

lfuric

umC

oppe

r(II

) sul

fate

pe

ntah

ydra

tePh

.Eur

. (H

AB)

Cupr

um su

lfuric

um (0

2.03

.199

0)

Din

atrii

pho

spha

s dod

ecah

ydri-

cus

Nat

rium

pho

spho

ricum

, N

atru

m p

hosp

horic

um p

phD

isodi

um p

hosp

hate

do

deca

hydr

ate

Ph.E

ur.

(HA

B, P

h.fr.

)Ro

bini

a co

mp.

(12.

09.1

992)

Ferr

um ci

tric

umIr

on(I

II) c

itrat

e, co

ntai

ning

no

t les

s tha

n 18

.0 a

nd n

ot

mor

e th

an 2

0.0

per c

ent o

f Fe

(Ar 5

5.85

)Fe

rrum

glu

coni

cum

Iron

(II)

glu

cona

te

(Fer

rous

glu

cona

te)

Ferr

um/A

cidu

m ch

olal

icum

(25.

10.1

994)

Ferr

um h

ydro

xyda

tum

see

Appe

ndix

2.6

(F

erru

m h

ydro

xyda

tum

)Fe

rrum

aph

Ferr

um m

etal

licum

Iron

�p

(obt

aine

d by

re

duct

ion

or su

blim

atio

n)

Ph.E

ur. (

HA

B)Fe

rrum

met

allic

um (0

4.06

.198

6)


• Appendix 2.4

158

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Ferr

um m

etal

licum

redu

ctum

Iron

obt

aine

d by

redu

ctio

n of

the

min

eral

side

rite

(HA

B)

Ferr

um p

hosp

horic

um,

Ferr

um p

hosp

horic

um p

ph

(Fer

rosi

phos

phas

aph)

Hyd

rate

d iro

n(II

I)

phos

phat

eH

AB,

Ph.

fr.Fe

rrum

pho

spho

ricum

(04.

06.1

986)

Ferr

um se

squi

chlo

ratu

m so

lutu

m,

Ferr

um se

squi

chlo

ratu

mA

queo

us so

lutio

n of

iro

n(II

I) ch

lorid

e

hexa

hydr

ate

HA

BFe

rrum

pra

epar

atum

com

p. (D

AZ

Nr.

29,

21.0

7.19

94)

Ferr

osi s

ulfa

s des

icca

tus

Ferr

um su

lfuric

umFe

rrou

s sul

fate

, drie

dPh

.Eur

. (H

AB)

Ferr

osi s

ulfa

s hep

tahy

dric

usFe

rrou

s sul

fate

he

ptah

ydra

te

Ph.E

ur.

Ferr

um/Q

uarz

(04.

06.1

986)

Ferr

um u

stum

Com

plex

Iron

(II,

III)

oxi

de

– ob

tain

ed b

y gl

owin

g an

d fo

rgin

g m

etal

lic ir

on –

con-

tain

ing

not l

ess t

han

71.0

an

d no

t mor

e th

an 7

5.0

per

cent

of F

e (A

r 55.

85)

Ferr

um u

stum

com

p. (0

4.06

.198

6)

Ferr

um(I

II)-

kaliu

m-t

arta

ricum

Iron

(III

) pot

assiu

m ta

rtra

te

dehy

drat

e (F

erric

pot

as-

sium

tart

rate

)

Solu

tio F

erri

com

p. (2

5.10

.199

4)

Glo

noin

umse

e N

itrog

lyce

rinum

Hyd

rarg

yri d

ichl

orid

umH

ydra

rgyr

um b

ichl

orat

um,

Mer

curic

chlo

ride

Ph.E

ur. (

HA

B)H

ydra

rgyr

um b

icya

natu

mM

ercu

ry(I

I) c

yani

deH

AB

Mer

curiu

s cya

natu

s (02

.09.

1987

)H

ydra

rgyr

um b

iioda

tum

Mer

cury

(II)

iodi

deH

AB

Trab

ecul

um co

mp.

(03.

07.1

992)

Hyd

rarg

yrum

chlo

ratu

mM

ercu

rius d

ulci

s pph

Mer

cury

(I) c

hlor

ide

HA

B, P

h.fr.

Mer

curiu

s dul

cis (

05.1

2.19

89)

Hyd

rarg

yrum

met

allic

um, M

ercu

-riu

s viv

is, M

ercu

rius v

ivus

pph

Met

allic

mer

cury

HA

B, P

h.fr.

Mer

curiu

s viv

us (0

2.09

.198

7)

Hyd

rarg

yrum

nitr

icum

ox

ydul

atum

Mer

cury

(I) n

itrat

e

dihy

drat

eH

AB

Hyd

rarg

yrum

stib

iato

-sul

fura

tum

HA

B


• Ap

pend

ix 2

.4

159

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Hyd

rarg

yri s

ulfa

sM

ercu

ry(I

I) su

lfate

, 99

–100

,5%

HgS

O4,

(see

Ap

ppen

dix

2.5,

e.g.

Visc

um

Mal

i cum

Hyd

rarg

yro)

Hyd

rarg

yrum

sulfu

ratu

m n

igru

mBl

ack

Mer

cury

(II)

sul�

de

HA

BA

ethi

ops a

ntim

onia

lis (0

2.09

.198

7)H

ydra

rgyr

i sul

�dum

aph

Hyd

rarg

yrum

sulfu

ratu

m ru

brum

, C

inna

baris

, Cin

naba

ris p

phRe

d M

ercu

ry(I

I) su

l�de

Ph.E

ur.

(HA

B, P

h.fr.

)Ec

hina

cea/

Prun

us co

mp.

(04.

06.1

986)

Iodu

mJo

dum

, Iod

um p

phIo

dine

Ph.E

ur.

(HA

B, P

h.fr.

)Jo

dum

(07.

04.1

988)

Kal

ium

ars

enic

osum

pph

Pota

ssiu

m a

rsen

ite, K

As0

2Ph

.fr.

Kal

ii bi

chro

mas

aph

Kal

ium

bic

hrom

icum

Pota

ssiu

m d

ichr

omat

e �

pPh

.Eur

. (H

AB)

Kal

ium

bic

hrom

icum

(07.

04.1

988)

Kal

ii ca

rbon

asK

aliu

m c

arbo

nicu

m,

Kal

ium

car

boni

cum

pph

Pota

ssiu

m c

arbo

nate

Ph.E

ur.

(HA

B, P

h.fr.

)K

aliu

m c

arbo

nicu

m (1

2.09

.199

2)

Kal

ium

car

boni

cum

e ci

nere

Fag

iPo

tass

ium

car

bona

te,

prep

ared

from

the

ash

of b

eech

woo

d (F

agus

sil

vatic

a)

Agr

opyr

on co

mp.

(07.

04.1

988)

Kal

ii ch

lorid

umK

aliu

m ch

lora

tum

, K

aliu

m m

uria

ticum

pph

Pota

ssiu

m ch

lorid

ePh

.Eur

. (H

AB,

Ph.

fr.)

Kal

ium

-Eise

n-Ta

rtra

tse

e Fe

rrum

(III

)-ka

lium

-ta

rtar

icum

Kal

ii hy

drog

enot

artr

asPo

tass

ium

hyd

roge

n ta

rtra

tePh

.Eur

.

Kal

ii io

didu

mK

aliu

m io

datu

m,

Kal

ium

ioda

tum

pph

Pota

ssiu

m io

dide

Ph.E

ur.

(HA

B, P

h.fr.

)K

alii

nitr

asK

aliu

m n

itric

um,

Kal

ium

nitr

icum

pph

Pota

ssiu

m n

itrat

ePh

.Eur

. (H

AB,

Ph.

fr.)

Kal

ii di

hydr

ogen

opho

spha

sK

aliu

m p

hosp

horic

um,

Kal

ium

pho

spho

ricum

pph

Pota

ssiu

m d

ihyd

roge

n ph

osph

ate

Ph.E

ur.

(HA

B, P

h.fr.

)Be

rber

is/H

yper

icum

com

p. (2

5.10

.199

4)

Kal

ium

stib

ylta

rtar

icum

Pota

ssiu

m d

i-µ-

tart

rato

bis[

antim

onat

e(II

I)]

trih

ydra

te

HA

BTa

rtar

us st

ibia

tus (

02.0

9.19

87)


• Appendix 2.4

160

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Kal

ium

sulfu

ratu

m,

Hep

ar su

lfuris

kal

inum

C

rude

pot

ash,

cont

ain-

ing

a m

ixtu

re o

f mai

nly

pota

ssiu

m tr

isul�

de a

nd

pota

ssiu

m m

etab

isul�

te

(dip

otas

sium

pyr

osul

�te)

(HA

B 19

34, D

AB

6, P

h. H

elv.

VI)

)K

aliu

m su

lfura

tum

(02.

03.1

991)

Kal

ii su

lfas

Kal

ium

sulfu

ricum

, K

aliu

m su

lfuric

um p

phPo

tass

ium

sulfa

tePh

.Eur

. (H

AB,

Ph.

fr.)

Kal

ium

/Teu

criu

m co

mp.

(25.

10.1

994)

Kre

osot

umH

AB

Kre

osot

um (0

5.12

.198

9)Li

quor

nat

rii si

licic

ise

e N

atrii

silic

ici,

Liqu

orLi

thii

carb

onas

Lith

ium

car

boni

cum

, Li

thiu

m c

arbo

nicu

m p

phLi

thiu

m c

arbo

nate

Ph

.Eur

. (H

AB,

Ph.

fr.)

Mag

nesii

chlo

ridum

hex

ahyd

ri-cu

sM

agne

sium

chlo

ratu

m,

Mag

nesia

mur

iatic

a pp

hM

agne

sium

chlo

ride

he

xahy

drat

ePh

.Eur

. (H

AB,

Ph.

fr.)

Mag

nesiu

m h

ydro

xyda

tum

Mag

nesiu

m h

ydro

xide

(s

ee a

lso A

ppen

dix

2.6

e.g.

Hep

ar-M

agne

sium

)

Ph.E

ur.

Hep

ar-M

agne

sium

(03.

07.1

992)

Mag

nesiu

m m

etal

licum

Met

allic

mag

nesiu

mH

AB

Mag

nesii

hyd

roge

noph

osph

as

trih

ydric

usM

agne

sium

pho

spho

ricum

, M

agne

sia p

hosp

horic

a pp

hM

agne

sium

hyd

roge

n ph

osph

ate

trih

ydra

tePh

.Eur

. (H

AB,

Ph.

fr.)

Mag

nesiu

m p

hosp

horic

um (1

2.09

.199

2)

Mag

nesiu

m p

hosp

horic

um

acid

um 2

0%A

queo

us so

lutio

n of

mag

-ne

sium

dih

ydro

gen

phos

-ph

ate

(20

per c

ent m

/m)

Mag

nesiu

m p

hosp

horic

um a

cidu

m

(12.

09.1

992)

Mag

nesii

sulfa

s hep

tahy

dric

usM

agne

sium

sulfu

ricum

, M

agne

sia su

lfuric

a pp

hM

agne

sium

sulfa

te

hept

ahyd

rate

Ph.E

ur.

Mag

nesiu

m su

lfuric

um/O

varia

com

p.

(25.

10.1

994)

Mer

curiu

s aur

atus

Gol

d-m

ercu

ry a

lloy,

cont

aini

ng at

leas

t 32.

0 an

d no

t mor

e th

an 3

5.0

per

cent

Au

(Ar 1

96,9

7) a

nd

at le

ast 6

5.0

and

not m

ore

than

68.

0 pe

r cen

t Hg

(Ar

200,

59)

Mer

curiu

s bijo

datu

sse

e H

ydra

rgyr

um

biio

datu

mM

ercu

rius c

yana

tus

see

Hyd

rarg

yrum

bi

cyan

atum


• Ap

pend

ix 2

.4

161

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Mer

curiu

s dul

cis

see

Hyd

rarg

yrum

ch

lora

tum

Mer

curiu

s sol

ubili

s Hah

nem

anni

HA

BEc

hina

cea/

Mer

curiu

s com

p. (0

3.07

.199

2)M

ercu

rius s

ublim

atus

corr

osiv

usse

e H

ydra

rgyr

i di

chlo

ridum

Mer

curiu

s viv

usse

e H

ydra

rgyr

um

met

allic

umM

iniu

mM

iniu

m [L

ead(

II,IV

) ox

ide]

HA

BM

iniu

m (0

3.07

.199

2)

Nat

rii c

arbo

nas d

ecah

ydric

usSo

dium

car

bona

te

deca

hydr

ate

Ph.E

ur.

Nat

rii c

arbo

nas m

onoh

ydric

usN

atriu

m c

arbo

nicu

m,

Nat

rum

car

boni

cum

pph

Sodi

um c

arbo

nate

m

onoh

ydra

tePh

.Eur

. (H

AB,

Ph.

fr.)

Frag

aria

/Urt

ica

com

p. (0

3.07

.199

2)

Nat

rii ch

lorid

umN

atriu

m ch

lora

tum

, N

atru

m m

uria

ticum

pph

Sodi

um ch

lorid

ePh

.Eur

. (H

AB,

Ph.

fr.)

Nat

rium

pho

spho

ricum

, N

atru

m p

hosp

horic

um p

phse

e D

inat

rii p

hosp

has

dode

cahy

dric

usN

atrii

silic

ici,

Liqu

orLi

quor

nat

rii si

licic

iA

queo

us so

lutio

n of

so

dium

pol

ysili

cate

with

7,

5 –

8,5%

sodi

um o

xide

(N

a 2O

) and

25,

5 –

28,5

%

silic

icum

dio

xide

(SiO

2).

(See

also

App

endi

x 2.

6 e.g

. U

vea

com

p.)

DA

B 6

Berb

eris/

Silic

ea co

mp.

(02.

03.1

991)

Nat

rii su

lfas a

nhyd

ricus

Nat

rium

sulfu

ricum

, N

atru

m su

lfuric

um p

phA

nhyd

rous

sodi

um su

lfate

Ph.E

ur.

(HA

B, P

h.fr.

)Ly

copo

dium

com

p. (1

2.09

.199

2)

Nat

rium

tetr

abor

aciu

mse

e Bo

rax

Ph.E

ur.

Nat

rii te

trac

hlor

oaur

as

dihy

dric

us ap

hN

atriu

m te

trac

hlor

oaur

atum

Sodi

um te

trac

hlor

oaur

ate

dihy

drat

e �

pPh

.Eur

. (H

AB)

Nitr

icum

aci

dum

pph

see

Aci

dum

nitr

icum

Nitr

ogly

cerin

umG

lono

inum

, Glo

noin

um p

phSo

lutio

n of

gly

cero

l trin

i-tr

ate

(1 p

er ce

nt) i

n Et

hano

l 96

per

cent

HA

B, P

h.fr.

Glo

noin

um (0

7.04

.198

8)


• Appendix 2.4

162

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Petr

oleu

m re

cti�

catu

m,

Petr

oleu

m p

phPe

trol

eum

spiri

t boi

ling

betw

een

180

and

220

°C

obta

ined

by

rect

i�ca

tion

of

crud

e oi

l

HA

B, P

h.fr.

Petr

oleu

m (0

5.12

.198

9)

Phos

phor

icum

aci

dum

pph

see

Aci

dum

pho

spho

ricum

co

ncen

trat

umPh

osph

orus

Yello

w p

hosp

horu

sH

AB

Phos

phor

us (0

4.06

.198

6)Ph

osph

orus

rube

rRe

d am

orph

ous p

hosp

horu

sPh

osph

orus

met

allic

us (n

iger

)Bl

ack

met

allic

pho

spho

rus

Plat

inum

chlo

ratu

mse

e A

cidu

m

hexa

chlo

ropl

atin

icum

Plat

inum

met

allic

umM

etal

lic p

latin

HA

BPl

umbu

m a

cetic

umLe

ad(I

I) a

ceta

te tr

ihyd

rate

HA

BPl

umbu

m jo

datu

mLe

ad(I

I) io

dide

Plum

bum

met

allic

umM

etal

lic le

adH

AB

Plum

bum

met

allic

um (0

2.09

.198

7)Pl

umbu

m si

licic

umLe

ad(I

I) m

eta

silic

ate,

ob-

tain

ed b

y sm

eltin

g ce

russ

ite

and

quar

tz.

Plum

bum

silic

icum

(DA

Z N

r. 29

, 21

.07.

1994

)

Plum

bi c

arbo

nas

Plum

bum

car

boni

cum

Basic

lead

(II)

car

bona

teC

inis

Cap

sella

e co

mp.

(03.

07.1

992)

Sacc

haru

mSa

ccha

rum

Sac

char

iSu

cros

e ob

tain

ed fr

om th

e st

ems o

f Sac

char

um o

�ci

-na

rum

L.

Ph.E

ur.

Arg

entu

m/R

ohrz

ucke

r (05

.12.

1989

)

Silic

ease

e A

cidu

m si

licic

umSi

licea

collo

idal

isC

ollo

idal

silic

a, d

irect

ly

obta

ined

in th

e m

anuf

ac-

ture

of t

he �

nish

ed p

rodu

ct

by re

actio

n of

adj

uste

d am

ount

s of a

queo

us so

lu-

tions

of s

odiu

m si

licat

e an

d ci

tric

aci

d m

onoh

ydra

te.

Berb

eris/

Silic

ea co

mp.

(02.

03.1

991)

Stan

nosi

chlo

ridum

dih

ydric

umSt

anno

us ch

lorid

e di

hy-

drat

ePh

.Eur

.


• Ap

pend

ix 2

.4

163

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Stan

num

hyd

roxy

datu

mTi

n(II

) hyd

roxi

de (s

ee a

lso

Appe

ndix

2.6

e.g.

Hep

ar-

Stan

num

)St

annu

m m

etal

licum

Met

allic

tin

HA

BSt

annu

m m

etal

licum

(04.

06.1

986)

Stan

num

silic

icum

Tran

sluce

nt m

elt f

rom

silic

a hy

drox

ide

and

tin(I

I,IV

) hy

drox

ide

Stib

ium

ars

enic

osum

Mix

ture

of e

qual

par

ts o

f an

tym

ony(

V)o

xide

and

ar

seni

c(II

I)ox

ide

HA

BSt

ibiu

m a

rsen

icos

um (0

2.09

.198

7)

Stib

ium

met

allic

umM

etal

lic a

ntim

ony

HA

BSt

ibiu

m m

etal

licum

(04.

06.1

986)

Stib

ium

sulfu

ratu

m au

rant

iacu

mM

ixtu

re o

f ant

imon

y(V

) su

l�de

and

sulfu

rH

AB

Stib

ium

sulfu

ratu

m au

rant

iacu

m (D

AZ

Nr.

29, 2

1.07

.199

4)St

ibiu

m su

lfura

tum

nig

rum

, A

ntim

oniu

m cr

udum

pph

Blac

k A

ntim

ony(

III)

sul�

deH

AB,

Ph.

fr.A

ethi

ops a

ntim

onia

lis (0

2.09

.198

7)

Sulfu

r aph

Sulfu

rsu

lfur �

p (s

ublim

ed su

lfur)

Ph.E

ur. (

HA

B)Su

lfur (

04.0

6.19

86)

Sulfu

r iod

idum

Sulfu

r iod

atum

Mix

ture

of 4

par

ts o

f io

dine

and

1 p

art o

f sul

fur

care

fully

mel

ted

toge

ther

(c

onta

ins 7

0–80

% I)

HA

B

Sulfu

r iod

idum

aph

Iode

et s

oufr

e (m

élan

ge d

’) pp

hM

ixtu

re o

f 4 p

arts

of

iodi

ne a

nd 1

par

t of s

ulfu

r ca

refu

lly m

elte

d to

geth

er

(con

tain

s 75–

82%

I)

Ph.fr

.

Sulfu

ricum

aci

dum

pph

see

Aci

dum

sulfu

ricum

Sulfu

r sel

enos

umM

ixtu

re o

btai

ned

by

mel

ting

1 pa

rt o

f sel

en

with

99

part

s of s

ulfu

r.Ta

rtar

us d

epur

atus

Puri�

ed ta

rtar

, mai

nly

cons

istin

g of

pot

assiu

m

hydr

ogen

tart

rate

Ta

rtar

us st

ibia

tus

see

Kal

ium

stib

ylta

rtar

icum

Tetr

amm

ine

copp

er(I

I) su

lfate

see

Cop

per t

etra

mm

ine

sulfa

te m

onoh

ydra

te


164

• Appendix 2.4

Latin

nam

e:

Ph.E

ur.,

HAB

or P

h.fr.

Trad

ition

al n

ame:

H

AB an

d/or

Ph.

fr.Ab

brev

iate

d de

�niti

on

Engl

ish N

ame P

h.Eu

r. if

appl

icab

le

Refe

renc

e to

stan

dard

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

(dat

e)O

ther

Zinc

um is

oval

eria

nicu

m,

Zinc

um v

aler

iani

cum

Zinc

isov

aler

ate

dihy

drat

eH

AB

Zinc

um v

aler

iani

cum

(02.

09.1

987)

Zinc

um m

etal

licum

, Zi

ncum

met

allic

um p

phM

etal

lic zi

ncH

AB,

Ph.

fr.

Zinc

um v

aler

iani

cum

see

Zinc

um

isova

leria

nicu

m


165

APPENDIX 2.5

Starting material that have undergone special treatment Additional Information, see p. 22

• Ap

pend

ix 2

.5


• Appendix 2.5

166

Nam

e of t

he su

bsta

nce

Abbr

evia

ted

de�n

ition

Refe

renc

e to

stan

dard

(fo

r the

pla

nt)

Exem

plar

y ref

eren

ce fo

r use

in

anth

ropo

soph

ic m

edic

ine

Com

miss

ion

C

mon

ogra

ph (d

ate)

Oth

er

Aco

nitu

m n

apel

lus

Plum

bo c

ultu

mW

hole

fres

h pl

ants

of A

coni

tum

nap

ellu

s L.,

colle

cted

at th

e st

art o

f �ow

erin

g,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

lead

cont

aini

ng su

bsta

nce

for t

he tr

eatm

ent o

f the

soil

for t

he 1

st li

fe c

ycle

).

(HA

B)A

coni

tum

nap

el-

lus P

lum

bo c

ultu

m

(12.

09.1

992)

Atro

pa b

ella

donn

a Cu

pro

culta

Who

le fr

esh

plan

ts o

f Atr

opa

bella

-don

na L

., w

ithou

t woo

dy lo

wer

stem

sect

ions

, co

llect

ed at

the

end

of �

ower

ing,

cul

tivat

ed a

ccor

ding

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

copp

er co

ntai

ning

subs

tanc

e fo

r the

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

Bryo

phyl

lum

pin

natu

m

Arg

ento

cul

taFr

esh

leav

es o

f Bry

ophy

llum

pin

natu

m (L

am.)

Oke

n [S

yn. K

alan

choe

pin

nata

(Lam

.) Pe

rs.],

har

vest

ed in

the

�rst

yea

r of g

row

th, c

ultiv

ated

acc

ordi

ng to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d sil

ver c

onta

inin

g su

bsta

nce

for t

he tr

eatm

ent o

f the

soil

for t

he 1

st li

fe

cycl

e).

(HA

B)Br

yoph

yllu

m A

rgen

to

cultu

m (0

3.07

.199

2)

Bryo

phyl

lum

pin

natu

m

Mer

curio

cul

taFr

esh

leav

es o

f Bry

ophy

llum

pin

natu

m (L

am.)

Oke

n [S

yn. K

alan

choe

pin

nata

(Lam

.) Pe

rs.],

har

vest

ed in

the

�rst

yea

r of g

row

th, c

ultiv

ated

acc

ordi

ng to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d m

ercu

ry co

ntai

ning

subs

tanc

e fo

r the

trea

tmen

t of t

he so

il fo

r the

1st

lif

e cy

cle)

.

(HA

B)Br

yoph

yllu

m M

ercu

rio

cultu

m (1

2.09

.199

2)

Cha

mom

illa

recu

tita

Cupr

o cu

ltaFr

esh

unde

rgro

und

part

s of C

ham

omill

a re

cutit

a (L

.) Ra

usch

ert,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

copp

er co

ntai

ning

subs

tanc

e fo

r the

trea

tmen

t of

the

soil

for t

he 1

st li

fe c

ycle

).

Cha

mom

illa

Cupr

o

culta

, Rad

ix

(03.

07.1

992)

Che

lidon

ium

maj

us

Ferr

o cu

ltum

Fres

h rh

izom

e an

d ad

here

nt ro

ots o

f Che

lidon

ium

maj

us L

., co

llect

ed d

urin

g la

te

autu

mn

or o

n th

e ap

pear

ance

of t

he �

rst s

hoot

s, cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d iro

n co

ntai

ning

subs

tanc

e fo

r the

trea

tmen

t of t

he so

il fo

r the

1s

t life

cyc

le).

(HA

B)C

helid

oniu

m F

erro

cu

ltum

(03.

07.1

992)

Cic

horiu

m in

tybu

s Pl

umbo

cul

tum

Who

le fr

esh

�ow

erin

g pl

ants

of C

icho

rium

inty

bus L

. (va

r. in

tybu

s and

/or v

ar. s

ati-

vum

DC

), cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d le

ad co

ntai

ning

su

bsta

nce

for t

he tr

eatm

ent o

f the

soil

for t

he 1

st li

fe c

ycle

).

(HA

B)C

icho

rium

Plu

mbo

cu

ltum

(03.

07.1

992)

Cic

horiu

m in

tybu

s St

anno

cul

tum

Who

le fr

esh

�ow

erin

g pl

ants

of C

icho

rium

inty

bus L

. (va

r. in

tybu

s and

/or v

ar. s

ati-

vum

DC

), cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d tin

cont

aini

ng

subs

tanc

e fo

r the

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

(HA

B)C

icho

rium

Sta

nno

cultu

m (P

harm

.Ind.

11,

19

90)

Cic

horiu

m in

tybu

s St

anno

cul

tum

, Rad

ixFr

esh

root

of C

icho

rium

inty

bus L

. (va

r. in

tybu

s and

/or v

ar. s

ativ

um D

C),

colle

cted

at

�ow

erin

g tim

e, cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d tin

con-

tain

ing

subs

tanc

e fo

r the

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

Cic

horiu

m S

tann

o cu

ltum

(Pha

rm.In

d. 1

1,

1990

)C

inis

Urt

icae

Fer

ro

culta

eD

ried

and

ashe

d ae

rial p

arts

of U

rtic

a di

oica

L.,

colle

cted

at �

ower

ing

time,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

iron

cont

aini

ng su

bsta

nce

for t

he

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

(Urt

ica

dioi

ca F

erro

cu

lta (0

3.07

.199

2))

Equi

setu

m a

rven

se

Silic

ea c

ultu

mFr

esh

gree

n st

erile

aer

ial p

arts

of E

quise

tum

arv

ense

L.,

culti

vate

d ac

cord

ing

to A

PC

Met

hod

1.1.

2 (u

sing

a di

lute

d sil

icat

e co

ntai

ning

subs

tanc

e fo

r the

trea

tmen

t of t

he

soil

for t

he 1

st li

fe c

ycle

).

(HA

B: E

quise

tum

ar

vens

e Rh

)Eq

uise

tum

arv

ense

Si

licea

cul

tum

(1

2.09

.199

2)


• Ap

pend

ix 2

.5

167

Nam

e of t

he su

bsta

nce

Abbr

evia

ted

de�n

ition

Refe

renc

e to

stan

dard

(fo

r the

pla

nt)

Exem

plar

y ref

eren

ce fo

r use

in

anth

ropo

soph

ic m

edic

ine

Com

miss

ion

C

mon

ogra

ph (d

ate)

Oth

er

Hyp

eric

um p

erfo

ratu

m

Auro

cul

tum

Fres

h ae

rial p

arts

of H

yper

icum

per

fora

tum

L.,

colle

cted

at �

ower

ing

time,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

gold

cont

aini

ng su

bsta

nce

for t

he

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

(HA

B)H

yper

icum

Aur

o

cultu

m (0

3.07

.199

2)

Kal

anch

oe p

inna

tum

A

rgen

to c

ulta

see

Bryo

phyl

lum

pin

natu

m A

rgen

to c

ulta

Kal

anch

oe p

inna

tum

M

ercu

rio c

ulta

see

Bryo

phyl

lum

pin

natu

m M

ercu

rio c

ulta

Mel

issa

o�ci

nalis

Cu-

pro

culta

Fres

h ae

rial p

arts

of M

eliss

a o�

cina

lis L

., cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d co

pper

cont

aini

ng su

bsta

nce

for t

he tr

eatm

ent o

f the

soil

for t

he 1

st

life

cycl

e).

(HA

B)M

eliss

a Cu

pro

culta

(2

5.10

.199

4)

Nas

turt

ium

o�

cina

le

Mer

curio

cul

tum

Fres

h ae

rial p

arts

of N

astu

rtiu

m o

�ci

nale

R. B

r., co

llect

ed at

�ow

erin

g tim

e, cu

lti-

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

mer

cury

cont

aini

ng su

bsta

nce

for t

he tr

eatm

ent o

f the

soil

for t

he 1

st li

fe c

ycle

).

(HA

B)N

astu

rtiu

m M

ercu

rio

cultu

m (2

5.10

.199

4)

Nic

otia

na ta

bacu

m

Cupr

o cu

ltaFr

esh

leave

s of N

icotia

na ta

bacu

m L

., cul

tivat

ed ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

copp

er co

ntai

ning

subs

tanc

e for

the t

reat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.(H

AB)

Taba

cum

Cup

ro

cultu

m (1

2.09

.199

2)O

enot

hera

Arg

ento

cu

ltaFr

esh

aeria

l par

ts o

f Oen

othe

ra b

ienn

is L.

, col

lect

ed at

�ow

erin

g tim

e, cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d sil

ver c

onta

inin

g su

bsta

nce

for t

he

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

(HA

B 19

24)

Vade

mec

um:

Oen

othe

ra

Arg

ento

cul

taPr

imul

a ve

ris A

uro

culta

Fres

h �o

wer

s of P

rimul

a ve

ris L

., cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d go

ld co

ntai

ning

subs

tanc

e fo

r the

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

Prim

ula

Auro

cul

ta

(25.

10.1

994)

Tara

xacu

m o

�ci

nale

St

anno

cul

tum

Who

le fr

esh

�ow

erin

g pl

ants

of T

arax

acum

o�

cina

le a

gg. F

.H. W

igg.

, cul

tivat

ed

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d tin

cont

aini

ng su

bsta

nce

for t

he

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

(HA

B)Ta

raxa

cum

Sta

nno

cultu

m (2

5.10

.199

4)

�uj

a oc

cide

ntal

is A

rgen

to c

ulta

Fres

h, le

afy,

one-

year

-old

twig

s of �

uja

occi

dent

alis

L., c

ultiv

ated

acc

ordi

ng to

APC

M

etho

d 1.

1.1

(usin

g a

dilu

ted

silve

r con

tain

ing

subs

tanc

e fo

r the

trea

tmen

t of t

he so

il fo

r the

1st

life

cyc

le).

(HA

B)�

uja

occi

dent

alis

A

rgen

to c

ulta

(1

2.09

.199

2)U

rtic

a di

oica

Fer

ro

culta

Fres

h ae

rial p

arts

of U

rtic

a di

oica

L, c

olle

cted

at �

ower

ing

time,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

iron

cont

aini

ng su

bsta

nce

for t

he tr

eatm

ent o

f th

e so

il fo

r the

1st

life

cyc

le).

Urt

ica

dioi

ca F

erro

cu

lta (0

3.07

.199

2)

Urt

ica

dioi

ca F

erro

cu

lta, C

inis

see

Cin

is U

rtic

ae F

erro

cul

tae

Urt

ica

dioi

ca F

erro

cu

lta, R

adix

Fres

h un

derg

roun

d pa

rts o

f Urt

ica

dioi

ca L

., co

llect

ed at

�ow

erin

g tim

e, cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d iro

n co

ntai

ning

subs

tanc

e fo

r the

tr

eatm

ent o

f the

soil

for t

he 1

st li

fe c

ycle

).

Urt

ica

dioi

ca F

erro

cu

lta (0

3.07

.199

2)


168

• Appendix 2.6


169

APPENDIX 2.6

List of compositions Additional Information, see p. 22

• Ap

pend

ix 2

.6


• Appendix 2.6

170

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Alk

ali c

omp.

Com

mip

hora

Jacq

. sp

ecie

s (M

yrrh

) /

Kal

ium

car

boni

cum

/ Q

uarz

/ Tr

ona

�e

min

eral

com

posit

ion

acco

rdin

g to

the

mod

el o

f Cic

horiu

m in

tybu

s, Pl

anta

to

ta, A

lkal

i com

p. is

mad

e fr

om: P

otas

sium

car

bona

te /

Tron

a / Q

uart

z and

Myr

rh.

Pota

ssiu

m c

arbo

nate

, Tro

na a

nd q

uart

z are

inte

nsiv

ely

tritu

rate

d an

d m

ixed

with

an

orga

nic b

inde

r (M

yrrh

).

Vade

mec

um:

Alk

ali c

omp.

Ani

s-Py

ritPi

mpi

nella

ani

sum

L.

/ Py

rite

/ Sac

-ch

arum

(Sac

char

um

o�ci

naru

m L

.)

1 g

Ani

s-Py

rit is

pre

pare

d fr

om: P

impi

nella

ani

sum

, Fru

ctus

0.3

3 g

/ pyr

ite 0

.33

g / s

acch

arum

0.3

3 g.

War

med

pyr

ite p

owde

r and

mel

ted

sucr

ose

(can

e su

gar)

are

th

orou

ghly

mix

ed, t

he p

owde

red

anise

ed a

dded

, with

�na

l tho

roug

h m

ixin

g. �

is fo

rmul

atio

n is

dilu

ted

with

an

equa

l am

ount

of l

acto

se m

onoh

ydra

te, g

rinde

d an

d sie

ved.

�e

resu

lting

pre

para

tion

is na

med

Ani

s-Py

rit 5

0%. �

e po

tenc

y A

nis-

Pyrit

D

1 is

prep

ared

from

2 p

arts

Ani

s-Py

rit 5

0% a

nd 8

par

ts la

ctos

e m

onoh

ydra

te.

Ani

s-Py

rit (0

4.06

.198

6)

Apis

cum

Lev

istic

oAp

is m

elli�

ca L

. /

Levi

stic

um o

�ci

nale

W

. D. J

. Koc

h

1 g

Apis

cum

Lev

istic

o Ø

(= D

1) is

pre

pare

d fr

om 0

.1 g

Api

s mel

li�ca

/ 0.

1 g

aque

-ou

s ext

ract

of L

evist

icum

, Rad

ix (d

rug

to e

xtra

ct =

4:1

). �

e be

es a

re k

illed

, com

-m

inut

ed a

nd m

ixed

with

a fr

eshl

y pr

epar

ed a

queo

us e

xtra

ct o

f Lev

istic

um, R

adix

(d

rug

to e

xtra

ct =

4:1

) and

gly

cero

l 85%

. �e

liqui

d is

furt

her p

roce

ssed

imm

edi-

atel

y.

Apis

cum

Lev

istic

o (1

2.09

.199

2)

Arg

entu

m-C

orpu

s vi

treu

mA

rgen

tum

met

al-

licum

/ C

orpu

s vi

treu

m (B

os ta

urus

L.

or O

ryct

olag

us

cuni

culu

s L.)

Fres

h ey

e ba

ll (C

orpu

s vitr

eum

) is c

lean

ed a

nd m

ixed

with

a so

lutio

n pr

epar

ed

of si

lver

nitr

ate,

conc

entr

ated

am

mon

ia so

lutio

n an

d pu

ri�ed

wat

er a

nd m

ixed

. A

�er a

dditi

on o

f a so

lutio

n of

glu

cose

mon

ohyd

rate

in p

uri�

ed w

ater

the

mix

ture

is

gent

ly w

arm

ed so

that

the

silve

r nitr

ate

is re

duce

d to

the

met

al. A

�er �

lterin

g,

the

resid

ue is

drie

d w

ith la

ctos

e m

onoh

ydra

te, b

eing

adj

uste

d to

giv

e a

�nal

silv

er

cont

ent o

f 1%

.

Arg

entu

m-C

orpu

s vit-

reum

(12.

09.1

992)

Arn

ica-

Cer

ebru

mA

rnic

a m

onta

na L

. /

Cer

ebru

m, C

er-

ebel

lum

, Tru

ncus

ce

rebr

i (Bo

s tau

rus

L. o

r Ory

ctol

agus

cu

nicu

lus L

.)

1 g

Arn

ica-

Cer

ebru

m D

1 co

ntai

ns: A

rnic

a, P

lant

a to

ta, p

ress

ed ju

ice

0.05

g/

Cer

ebru

m 0

.05

g (C

ereb

rum

= C

ereb

rum

, Cer

ebel

lum

, bra

in st

em =

2+1

+1).

�e

clea

ned

ingr

edie

nts o

f Cer

ebru

m a

re m

ixed

with

the

fres

h pr

esse

d pl

ant j

uice

of

Arn

ica

mon

tana

and

inte

nsiv

ely

tritu

rate

d. W

ater

for i

njec

tions

is a

dded

and

the

mix

ture

pot

entis

ed to

mak

e th

e D

1 po

tenc

y. �

e D

1 po

tenc

y is

furt

her p

roce

ssed

im

med

iate

ly.

Arn

ica-

Cer

ebru

m

(12.

09.1

992)

Cal

cium

silic

icum

co

mp.

Arn

ica

mon

tana

L.

/ Cal

cii o

xidu

m /

Cam

phor

a / K

alii

carb

onas

/ Q

uarz

/ Q

uerc

us ro

bur L

. an

d Q

uerc

us p

etra

ea

(Mat

t.) L

iebl

. /

Triti

cum

aes

tivum

L.

em

end

Fior

i et

Paol

.

�e

min

eral

com

posit

ion

acco

rdin

g to

the

mod

el o

f Arn

ica

mon

tana

, Rad

ix,

Cal

cium

silic

icum

com

p. is

pre

pare

d fr

om: S

ilica

te m

elt (

obta

ined

from

qua

rtz /

po

tass

ium

car

bona

te /

calc

ium

oxi

de) /

arn

ica

late

x / d

ried

wat

er-e

xtra

ct o

f Que

r-cu

s, C

orte

x / c

amph

or /

esse

ntia

l oil

from

Arn

ica

mon

tana

, Rad

ix /

fres

h w

heat

gl

uten

. �e

silic

ate

mel

t is a

dded

to a

mix

ture

of t

he A

rnic

a la

tex

and

drie

d ex

trac

t of

Que

rcus

, Cor

tex

and

tritu

rate

d. F

inal

ly th

e ca

mph

or a

nd th

erea

�er t

he e

ssen

tial

oil o

f Arn

ica

are

adde

d. �

e m

ixtu

re is

tritu

rate

d w

ell,

fres

h w

heat

glu

ten

adde

d an

d th

e w

hole

kne

aded

to m

ake

a pa

ste.

�is

is th

en d

ried,

pow

dere

d an

d di

lute

d w

ith

lact

ose

mon

ohyd

rate

. Pot

entis

atio

n ac

cord

ing

to P

h.Eu

r. 4.

1.1.

Vade

mec

um:

Cal

cium

silic

icum

co

mp.


171

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Car

bo B

etul

ae c

um

Met

hano

Betu

la p

endu

la R

oth

/ Met

hane

Car

bo B

etul

ae (c

harc

oal f

rom

the

birc

h) sa

tura

ted

with

met

hane

R1

(Ph.

Eur.)

is

used

: Pow

dere

d C

arbo

Bet

ulae

is h

eate

d un

der v

acuu

m. A

�er h

eatin

g an

d du

ring

cool

ing

Car

bo B

etul

ae is

satu

rate

d w

ith m

etha

ne.

Car

bo B

etul

ae c

um

Met

hano

(25.

10.1

994)

Che

lidon

ium

/ Cur

cum

a pr

aep.

Che

lidon

ium

maj

us

L. /

Curc

uma

xan-

thor

rhiz

a Ro

xb.

Che

lidon

ium

Ø (P

h.Eu

r. 1.

1.5)

Cur

cum

a xa

ntho

rrhi

za, R

hizo

ma

Ø (H

AB

19f w

ith

62%

Eth

anol

) are

mix

ed b

y dr

oppi

ng 1

par

t of t

he �

rst i

nto

1 pa

rt o

f the

rota

ting

seco

nd m

othe

r tin

ctur

e.

Che

lidon

ium

/ Cur

cum

a (0

4.06

.198

6)

Chi

netu

m a

rsen

icos

umC

inch

ona

pube

scen

s Va

hlA

rsen

ic a

cid-

boun

d al

kalo

id co

mpl

ex o

btai

ned

from

the

bark

of C

inch

ona

pube

s-ce

ns V

ahl

Chi

netu

m a

rsen

icos

um

(03.

07.1

992)

Cin

is e

fruc

tibus

Ave

nae

sativ

ae c

um M

agne

sio

phos

phor

ico

(1:1

)

Aven

a sa

tiva

L. /

Mag

nesiu

m p

hos-

phor

icum

1. C

inis

e fr

uctib

us A

vena

e sa

tivae

(ash

of t

he fr

uit o

f Ave

na sa

tiva,

oat

s): O

ats a

re

moi

sten

ed w

ith w

ater

to st

art g

erm

inat

ion,

drie

d an

d as

hed.

2.

Ash

of o

ats w

ith m

agne

sium

hyd

roge

n ph

osph

ate:

Equ

al p

arts

of a

sh o

f oat

s and

m

agne

sium

hyd

roge

n ph

osph

ate

are

mix

ed to

geth

er.

3. P

oten

tisat

ion

acco

rdin

g to

Ph.

Eur.

4.1.

1.

Mag

nesiu

m p

hosp

hori-

cum

cum

cine

re A

vena

e (0

2.03

.199

1)

Cin

is C

apse

llae

com

p.

APC

Art

emisi

a ab

sin-

thiu

m L

. / C

apse

lla

burs

a-pa

stor

is (L

.) M

ed. /

Cup

ri su

lfas

pent

ahyd

ricus

/ Fe

rros

i sul

fas d

esic

-ca

tus /

Hal

ite /

Kal

ii ca

rbon

as/ P

lan-

tago

lanc

eola

ta L

. /

Plum

bum

subc

ar-

boni

cum

(Cer

ussa

) / R

osa

cent

ifolia

L.

/ Cre

mor

Tar

tari

(Cre

am o

f Tar

tar)

�e

drie

d pl

ant m

ater

ial i

s inc

iner

ated

. �e

wat

er so

lubl

e as

h sa

lts o

btai

ned

ther

e-fr

om, p

otas

sium

car

bona

te (o

btai

ned

from

Cre

am o

f Tar

tar)

and

hal

ite a

re m

ixed

an

d ad

ded

to th

e po

wde

r-m

ixtu

re o

f cop

per s

ulfa

te a

nd fe

rrou

s sul

fate

. �is

com

-bi

ned

pow

der i

s gro

und

until

the

colo

ur ch

ange

s to

redd

ish b

row

n. In

the

next

step

w

ine

vine

gar,

in w

hich

fres

h ro

se p

etal

s hav

e be

en so

aked

, is a

dded

and

the

mix

ture

is

heat

ed a

nd m

ixed

whi

le th

e co

lour

turn

s to

pist

achi

o gr

een.

Whe

n th

e pa

sty

mas

s ge

ts m

ore

solid

, cer

ussa

is a

dded

and

hea

ting

is co

ntin

ued

until

the

mix

ture

is so

lid

and

dry.

A�e

r coo

ling

the

subs

tanc

e ob

tain

ed is

pow

dere

d.

For e

xter

nal u

se (e

.g. o

intm

ent,

gel)

an a

queo

us so

lutio

n of

the

wat

er so

lubl

e sa

lts is

us

ed a

s act

ive

subs

tanc

e: 9

par

ts o

f pur

i�ed

wat

er a

re a

dded

to 1

par

t of C

inis

Cap

-se

llae

com

p. A

PC, t

he m

ixtu

re is

agi

tate

d in

a cl

osed

cont

aine

r and

allo

wed

to st

and

at ro

om te

mpe

ratu

re fo

r at l

east

20

hour

s. �

e su

pern

atan

t is �

ltere

d. �

e re

sulti

ng

Cin

is C

apse

llae

com

p. a

queo

us so

lutio

n 10

% is

clea

r and

viri

dian

gre

en (t

urqu

oise

bl

ue to

em

eral

d gr

een)

in co

lour

and

has

to b

e pr

oces

sed

imm

edia

tely.

1

part

Cin

is C

apse

llae

com

p. a

queo

us so

lutio

n 10

% co

rres

pond

s to

0.1

part

s of

Cin

is C

apse

llae

com

p. A

PC.

Vade

mec

um 2

013:

C

inis

Cap

sella

e co

mp.

Ciss

us-O

ssa

Aves

var

iae,

e.g.

Phas

ianu

s col

chic

us

L. (O

ssae

) / C

issus

go

ngyl

odes

(Bak

.) Bu

rch.

1 g

Ciss

us-O

ssa

is pr

epar

ed fr

om: E

than

olic

ext

ract

from

: Ciss

us g

ongy

lode

s, ae

rial

root

1.5

g/ O

ssa

0.5

g. �

e bo

nes o

f par

trid

ge o

r phe

asan

t are

clea

ned,

boi

led,

drie

d,

pow

dere

d an

d m

ixed

with

equ

al p

arts

of l

acto

se m

onoh

ydra

te. T

o th

is m

ixtu

re a

dd

the

mot

her t

inct

ure

of C

issus

gon

gylo

des,

aeria

l roo

ts d

ried

(Ph.

Eur.

Met

hod

1.1.

7).

Ciss

us-O

ssa

(03.

07.1

992)

• Ap

pend

ix 2

.6


172

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Com

posit

io C

icho

riiSe

e Com

posit

io M

iner

alis

cum

Myr

rha

Com

posit

io M

iner

alis

cum

Myr

rha

APC

Qua

rz /

Kal

ii ca

r-bo

nas /

Com

mip

h-or

a Ja

cob

spec

ies

(myr

rh) /

Aci

dum

ph

osph

oric

um /

Hal

it / F

ruct

osum

/ La

ctos

um m

onoh

y-dr

icum

�e

min

eral

com

posit

ion

acco

rdin

g to

the

mod

el o

f Cic

horiu

m in

tybu

s, Pl

anta

tota

, C

ompo

sitio

Cic

horii

, is p

repa

red

by m

eltin

g qu

artz

with

pot

assiu

m c

arbo

nate

. A�e

r co

olin

g, th

e pro

duct

is d

issol

ved

in w

ater

and

add

ed to

pow

dere

d m

yrrh

, sw

olle

n by

ad

ding

Spi

ritus

vin

i and

wat

er. �

en p

hosp

horic

aci

d is

adde

d, le

adin

g to

pre

cipi

ta-

tion

of si

licic

aci

d. �

e m

ixtu

re is

drie

d, si

eved

and

mix

ed w

ith h

alite

. A co

ncen

trat

-ed

aqu

eous

solu

tion

of c

aram

el o

f fru

ctos

e an

d th

en la

ctos

e m

onoh

ydra

te is

add

ed.

A�e

r dry

ing,

the

who

le m

ixtu

re is

grin

ded

to a

uni

form

pow

der.

Com

posit

io M

iner

alis

cum

Sac

char

o A

PCK

alii

carb

onas

/ Q

uarz

/ Tr

ona/

Sac-

char

um

�e

min

eral

com

posit

ion

acco

rdin

g to

the

mod

el o

f Cha

mom

illa

(Mat

ricar

ia

recu

tita

L.) R

adix

, Com

posit

io M

iner

alis

cum

Sac

char

o is

prep

ared

from

: Pot

as-

sium

car

bona

te/q

uart

z/tr

ona.

Pot

assiu

m c

arbo

nate

and

qua

rtz a

re m

elte

d to

geth

er.

�e

mel

t is d

issol

ved

in w

ater

to p

rodu

ce a

clea

r sol

utio

n, a

nd si

mul

tane

ously

with

a

solu

tion

of su

cros

e ad

ded

to a

solu

tion

of p

otas

sium

car

bona

te a

nd tr

ona.

�is

mix

ture

is im

med

iate

ly p

oten

tised

with

eth

anol

15%

to D

1.

Der

Mer

kurs

tab

2012

; 65(

1): 4

6-53

Cor

pus v

itreu

m-S

tan-

num

Cor

pus v

itreu

m

(Bos

taur

us L

. or

Ory

ctol

agus

cun

icu-

lus L

.) / S

tann

um

hydr

oxat

um

1 g

Cor

pus v

itreu

m-S

tann

um D

1 co

ntai

ns: C

orpu

s vitr

eum

0.0

8 g

/ sta

nnum

hy-

drox

ydat

um 0

.02

g. A

solu

tion

of ti

n (I

I) ch

lorid

e in

pur

i�ed

wat

er is

mix

ed w

ith a

so

lutio

n of

sodi

um c

arbo

nate

in p

uri�

ed w

ater

. �e

resu

lting

pre

cipi

tate

(sta

nnum

hy

drox

atum

) is a

dded

to fr

esh,

min

ced

corp

us v

itreu

m a

nd th

orou

ghly

mix

ed. �

e m

ixtu

re is

dilu

ted

in th

e pr

opor

tion

1:10

with

wat

er fo

r inj

ectio

ns to

mak

e th

e D

1 po

tenc

y. �

e D

1 po

tenc

y is

furt

her p

roce

ssed

imm

edia

tely.

Cor

pus v

itreu

m-S

tann

um

(12.

09.1

992)

Cupr

um-R

en-G

land

ula

supr

aren

alis

Gla

ndul

a su

prar

e-na

lis /

Rene

s (Bo

s ta

urus

L. o

r Ory

c-to

lagu

s cun

icul

us

L.) /

Tet

ram

min

e co

pper

(II)

sulfa

te

1 g

Cupr

um-R

en (=

D1)

cont

ains

: Gla

ndul

a su

prar

enal

is 0.

023

g / r

en 0

.060

g /

tetr

amm

ine

copp

er(I

I)su

lfate

0.0

17 g

. �e

fres

h, cl

eane

d an

imal

ingr

edie

nt is

mix

ed

with

a sm

all a

mou

nt o

f wat

er fo

r inj

ectio

ns a

nd te

tram

min

e co

pper

(II)

sulfa

te, a

nd

tritu

rate

d to

geth

er. A

�erw

ards

the

rest

of t

he w

ater

for i

njec

tions

is a

dded

to m

ake

the

D1

pote

ncy,

and

the

solu

tion

is po

tent

ised.

�e

D1

pote

ncy

is fu

rthe

r pro

cess

ed

imm

edia

tely.

Cupr

um-R

en-G

land

ula

supr

aren

alis

(12.

09.1

992)

Equi

setu

m c

um S

ulfu

re

tost

umEq

uise

tum

arv

ense

L.

/ Su

lfur

Equi

setu

m c

um S

ulfu

re to

stum

is p

repa

red

from

Equ

isetu

m a

rven

se, H

erba

and

su

lfur.

99 p

arts

Equ

isetu

m a

rven

se, H

erba

(drie

d, h

erba

l dru

g, co

mm

inut

ed to

a

part

icle

size

≤ 4

mm

) are

mix

ed w

ith o

ne p

art s

ulfu

r (pa

rtic

le si

ze ≤

0,0

63 m

m) a

nd

then

toas

ted

acco

rdin

g to

APC

4.1

. Hea

ting

time:

abo

ut 5

–15

min

utes

.

Equi

setu

m c

um S

ulfu

re

tost

um (0

5.12

.198

9)

Equi

setu

m li

mos

um-

Rube

llit

Equi

setu

m li

mos

um

L. (E

quise

tum

�u-

viat

ile L

.) /

Rube

llit

Fres

h ha

rves

ted

shoo

ts o

f Equ

isetu

m li

mos

um L

. (Eq

uise

tum

�uv

iatil

e L.

) are

put

in

to a

n aq

ueou

s dilu

tion

of R

ubel

lit D

6 du

ring

the

day

and

unde

r pre

senc

e of

day

lig

ht. I

n th

e ev

enin

g th

e sh

oots

are

take

n ou

t, co

mm

inut

ed a

nd e

xpre

ssed

. �e

expr

esse

d ju

ice

is m

ixed

with

an

equa

l mas

s of e

than

ol 9

6%. F

ilter

a�e

r 5 to

10

days

. �

e �l

trat

e is

Equi

setu

m li

mos

um-R

ubel

lit Ø

.

Sold

ner G

, Ste

ll-m

ann

HM

. Ind

ivi-

duel

le P

ädia

trie

, 4.

Au�a

ge, W

issen

-sc

ha�l

. Ver

l. G

es.,

Stut

tgar

t, 20

11, p

. 74

3

• Appendix 2.6


• Ap

pend

ix 2

.6

173

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Ferr

um h

ydro

xyda

tum

Ferr

um ap

h / V

itis

vini

fera

L.

Ferr

um h

ydro

xyda

tum

is p

repa

red

from

Fer

rum

met

allic

um re

duct

um a

nd re

d w

ine

vine

gar.

Iron

that

pre

viou

sly h

as b

een

obta

ined

from

side

rite

by re

duct

ion

is co

vere

d w

ith re

d w

ine

vine

gar a

nd li

ghtly

war

med

for a

bout

14

days

. �en

the

solu

tion

is �l

tere

d, a

nd th

e re

sidue

was

hed

with

wat

er a

nd le

� to

reac

t with

air.

�

is ox

idat

ion

rele

ases

hea

t, w

here

fore

the

prep

arat

ion

has t

o be

kep

t moi

st. �

e ox

idise

d iro

n is

redu

ced

to p

owde

r.

Ferr

um h

ydro

xyda

tum

(0

2.03

.199

1)

Ferr

um p

omat

umFe

rrum

aph

/ Mal

us

dom

estic

a Bo

rkh.

1 g

of th

e D

1 co

ntai

ns: F

e 5

mg.

Sou

r app

les a

re p

ress

ed; t

he ju

ice

is m

ixed

with

Fer

-ru

m m

etal

licum

. �e

mix

ture

is le

� fo

r sev

eral

day

s and

then

war

med

to a

bout

50

°C. A

�erw

ards

the

solu

tion

is �l

tere

d an

d m

ixed

with

eth

anol

96%

.Fe

rrum

-Qua

rzFe

rros

i sul

fas d

esic

-ca

tus /

Mel

, Qua

rz

/ Vin

um (V

itis

vini

fera

L.)

A m

ixtu

re o

f fer

rous

sulfa

te, h

oney

, whi

te w

ine,

and

calc

inat

ed q

uart

z is p

repa

red

�is

mix

ture

is h

eate

d an

d dr

ied

unde

r vac

uum

.Fe

rrum

/ Q

uarz

(0

4.06

.198

6)

Ferr

um ro

satu

mFe

rrum

side

reum

/ Ro

sa ce

ntifo

lia L

.Fe

rrum

rosa

tum

is p

repa

red

from

Ros

a ce

ntifo

lia a

nd F

erru

m si

dere

um D

1. F

resh

ro

se p

etal

s are

tritu

rate

d w

ith 1

% F

erru

m si

dere

um D

1 an

d th

e am

ount

of w

ater

, ca

lcul

ated

acc

ordi

ng to

Ph.

Eur.

1.1.

6, a

nd th

en a

llow

ed to

stan

d fo

r 2-4

day

s at

15-2

00C

. �en

the

calc

ulat

ed a

mou

nt o

f eth

anol

96%

is a

dded

and

the

prep

arat

ion

cont

inue

d ac

cord

ing

to P

h.Eu

r. 1.

1.6.

�e

com

posit

ion

can

be p

oten

tised

.

Ferr

um ro

satu

m/G

raph

-ite

s (03

.07.

1992

)

Hel

lebo

rus n

iger

H

elle

boru

s nig

er L

. A

queo

us e

xtra

ct p

repa

red

from

the

fres

h pl

ant p

arts

of H

elle

boru

s nig

er L

. (Fl

os

rec.

and

Plan

ta to

ta re

c.), a

ccor

ding

to A

PC 7

.5.

Hel

lebo

rus n

iger

(0

4.06

.198

6)

Hel

lebo

rus f

oetid

us

Hel

lebo

rus f

oetid

us

L.

Aqu

eous

ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t par

ts o

f Hel

lebo

rus f

oetid

us L

. (Fl

os

rec.

and

Foliu

m e

t Rad

ix re

c.) a

ccor

ding

to A

PC 7

.5.

Hep

ar-M

agne

sium

Hep

ar (B

os ta

urus

L.

or O

ryct

olag

us

cuni

culu

s L.)

/ Mag

-ne

sium

hyd

roxy

da-

tum

1 g

Hep

ar-M

agne

sium

D1

cont

ains

: Hep

ar 0

.06

g / m

agne

sium

hyd

roxy

datu

m 0

.04

g. A

solu

tion

of m

agne

sium

chlo

ride

in w

ater

is m

ixed

with

a so

lutio

n of

sodi

um

hydr

oxid

e in

wat

er. �

e re

sulti

ng p

reci

pita

te (M

agne

sium

hyd

roxy

datu

m) i

s was

hed

seve

ral t

imes

with

wat

er a

nd th

an m

ixed

with

chop

ped

piec

es o

f liv

er a

nd th

en

toge

ther

with

hon

ey, i

t is �

nely

tritu

rate

d. �

e m

ixtu

re is

mix

ed w

ith w

ater

for i

n-je

ctio

ns (P

h.Eu

r. 3.

1.2)

or g

lyce

rol 8

5% (P

h.Eu

r. 2.

1.1)

, and

pot

entis

ed to

mak

e th

e D

1 po

tenc

y. �

is D

1 po

tenc

y is

proc

esse

d im

med

iate

ly.

Hep

ar-M

agne

sium

(0

3.02

.199

2)

Hep

ar-S

tann

umH

epar

(Bos

taur

us

L. o

r Ory

ctol

agus

cu

nicu

lus L

.) / S

tan-

num

hyd

roxy

datu

m

1 g

Hep

ar-S

tann

um co

ntai

ns: H

epar

0.0

8 g

/ Sta

nnum

hyd

roxy

datu

m 0

.02

g. A

so

lutio

n of

tin

(II)

chlo

ride

in w

ater

is m

ixed

with

a so

lutio

n of

sodi

um c

arbo

nate

in

wat

er. �

e re

sulti

ng p

reci

pita

te (S

tann

um h

ydro

xyat

um) i

s was

hed

with

wat

er.

�e

resu

lting

Sta

nnum

hyd

roxy

atum

is m

ixed

with

chop

ped

piec

es o

f liv

er a

nd th

en

thor

ough

ly tr

itura

ted

with

hon

ey. �

e m

ixtu

re is

mix

ed w

ith w

ater

for i

njec

tions

(P

h. E

ur. 3

.1.2

) or g

lyce

rol 8

5% (P

h. E

ur. 2

.1.1

), an

d po

tent

ised

to m

ake

the

D1

pote

ncy.

�is

D1

pote

ncy

is pr

oces

sed

imm

edia

tely.

Hep

ar-S

tann

um

(02.

03.1

991)


174

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Hep

ar su

lfuris

Ost

rea

edul

is L.

/ Su

lfur

HA

BH

epar

sulfu

ris co

mp.

(0

5.12

.198

9)K

aliu

m a

cetic

um co

mp.

Ant

imon

ite /

Cor

al-

lium

rubr

um L

. /

Cro

cus s

ativ

us L

. / K

alii

carb

onas

/ A

cetu

m V

ini d

estil

-la

tum

(Viti

s vin

ifera

L.

) / S

pirit

us e

Vin

o (V

itis v

inife

ra L

.)

Kal

ium

ace

ticum

com

p. is

pre

pare

d fr

om:

Pota

ssiu

m c

arbo

nate

/ di

still

ed re

d w

ine

vine

gar /

ant

imon

ite /

Cro

cus s

ativ

us ti

nc-

ture

(veh

icle

: spi

ritus

e v

ino)

/ sp

iritu

s e v

ino

/ Cor

alliu

m ru

brum

. Po

tass

ium

car

bona

te/d

istill

ed re

d w

ine

vine

gar/

antim

onite

/ Cro

cus s

ativ

us ti

nc-

ture

/Cor

alliu

m ru

brum

and

spiri

tus e

vin

o ar

e st

epw

ise co

mbi

ned

and

repe

ated

ly

dist

illed

. �e

resu

ltant

drie

d re

sidue

is u

sed.

Kal

ium

ace

ticum

com

p.

(03.

07.1

992)

Kal

ium

sulfu

ricum

co

mp.

Kal

ii su

lfas /

Nat

rii

sulfa

s / L

inum

usit

a-tis

simum

L.

�e

min

eral

com

posit

ion

acco

rdin

g to

the

mod

el o

f Ana

galli

s arv

ensis

, Her

ba,

Kal

ium

sulfu

ricum

com

p. is

pre

pare

d by

mix

ing

Kal

ii su

lfas a

nd N

atrii

sulfa

s and

m

akin

g a

past

e by

grin

ding

with

muc

ilage

of l

inse

ed. �

e m

ixtu

re is

drie

d, g

rinde

d,

sieve

d; a

nd �

nally

dilu

ted

with

lact

ose

mon

ohyd

rate

.

Vade

mec

um:

Kal

ium

sulfu

ricum

co

mp.

Lapi

s Can

cri p

raep

a-ra

tus

Ast

acus

ast

acus

L. /

Fl

int /

Viti

s vin

ifera

L.

Lapi

s Can

cri p

raep

arat

us is

pre

pare

d by

trea

ting

a m

ixtu

re o

f equ

al p

arts

of p

ow-

dere

d �i

nt a

nd L

apis

Can

cri w

ith d

istill

ed re

d w

ine

vine

gar.

�e

mix

ture

is �

ltere

d an

d th

e �l

trat

e di

lute

d to

10%

dry

resid

ue.

Lapi

s Can

cri -

Flin

tste

inA

stac

us a

stac

us L

. /

Flin

t / V

itis v

inife

ra

L.

1 g

Lapi

s Can

cri -

Flin

tste

in co

ntai

ns: L

apis

Can

cri 0

.5 g

/�in

t 0.5

g: F

inel

y po

wde

red

Lapi

s Can

cri a

nd �

int a

re th

orou

ghly

mix

ed w

ith sp

irito

e v

ino

and

the

slurr

y tr

eate

d w

ith w

ater

. �e

resu

ltant

dry

resid

ue is

the

subs

tanc

e.

Lapi

s Can

cri /

Flin

tste

in

(07.

04.1

988)

Mix

tura

Sta

nni c

omp.

Alu

men

/ Cu

prum

m

etal

licum

/ St

an-

num

met

allic

um /

Aci

dum

nitr

icum

(6

5 pe

r cen

tum

);

1 g

susp

ensio

n is

prep

ared

from

: 1 m

g A

lum

en /

0,00

2 m

g Cu

prum

met

allic

um /

2 m

g St

annu

m m

etal

licum

10,

4 m

g A

cidu

m n

itric

um (6

5 pe

r cen

tum

).D

er M

erku

rsta

b 20

11; 6

4(4)

: 332

-33

7

Myr

rha

com

p.Au

rum

met

allic

um

/ Bos

wel

lia sp

ecie

s /

Com

mip

hora

Jacq

. Sp

ecie

s / S

acch

arum

(S

acch

arum

o�

ci-

naru

m L

.)

1 g

Myr

rha

com

p. D

1 is

prep

ared

from

: Myr

rha

0.1

g / A

urum

met

allic

um fo

liatu

m

(gol

d le

af) 0

.001

g a

nd O

liban

um 0

.1g.

Myr

rha

and

gold

leaf

are

bou

nd to

geth

er

with

the

aid

of m

oder

ate

heat

; inc

ense

smok

e (f

rom

Olib

anum

) is p

asse

d th

roug

h th

e m

ixtu

re. �

is co

mpo

sitio

n is

stirr

ed in

to m

olte

n su

cros

e (c

ane

suga

r). A

�er

cool

ing

it is

tritu

rate

d fo

r one

hou

r by

hand

, res

ultin

g th

e po

tenc

y D

1.

Vade

mec

um: M

yr-

rha

com

p.

Ono

pord

on co

mp.

Hyo

scya

mus

nig

er

L. /

Ono

pord

um

acan

thiu

m L

. /

Prim

ula

veris

L.

A co

mbi

natio

n of

Ono

pord

um a

cant

hium

, Flo

s rec

., et

hano

l. D

iges

tio (1

:3.1

) with

0.

1-1%

Hyo

scya

mus

nig

er, H

erba

rec.

Ø a

nd P

rimul

a ve

ris, F

los r

ec.,

etha

nol.

Di-

gest

io (1

:3.1

) with

0.1

-1%

Hyo

scya

mus

nig

er, H

erba

rec.

Ø

Ono

pord

on co

mp.

(0

4.06

.198

6)

• Appendix 2.6


175

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Ono

pord

on co

mp.

pr

aepa

ratu

mO

nopo

rdum

aca

n-th

ium

L. /

Hyo

-sc

yam

us n

iger

L. /

Pr

imul

a ve

ris L

.

Ono

pord

um a

cant

hium

, Flo

s rec

., et

hano

l. D

iges

tio (1

:3.1

) with

1%

Hyo

scya

mus

ni

ger,

Her

ba re

c. Ø

is d

ilute

d w

ith w

ater

(a).

Prim

ula

veris

, Flo

s rec

., et

hano

l. D

i-ge

stio

(1:3

.1) i

s dilu

ted

with

wat

er (b

). In

a sp

ecia

l equ

ipm

ent 1

par

t of t

he se

cond

m

ixtu

re (b

) is d

ropp

ed i

nto

1 pa

rt o

f the

rota

ting

mix

ture

a.

Ono

pord

on co

mp.

(0

4.06

.198

6)

Ono

pord

um a

cant

hium

, Fl

os re

c., e

than

ol.

Dig

estio

(1:3

.1) w

ith

0.1-

1% H

yosc

yam

us

nige

r, H

erba

rec.

Ø

Ono

pord

um a

can-

thiu

m L

. / H

yosc

ya-

mus

nig

er L

.

Dig

estio

pre

pare

d fr

om 1

par

t of t

he fr

esh

�ow

erhe

ads o

f Ono

pord

um a

cant

hium

L.

and

3.1

par

ts o

f eth

anol

of s

uita

ble

conc

entr

atio

n or

wat

er fo

r inj

ectio

ns a

nd th

e ad

ditio

n of

0.0

04 to

0.0

4 pa

rts (

corr

espo

ndin

g to

0.1

to 1

%) o

f Hyo

scya

mus

nig

er

L., H

erba

, mot

her t

inct

ure

( Ph.

Eur.

1.1.

3).

Ono

pord

on co

mp.

(0

4.06

.198

6)

Peat

mos

s ext

ract

com

-po

sitio

n I (

light

)So

lum

ulig

inos

um /

Aes

culu

s hip

poca

s-ta

num

L. /

Equ

ise-

tum

arv

ense

L.

98 p

arts

of p

eat m

oss e

xtra

ct in

ana

logy

to to

HA

B M

etho

d 12

c (us

ing

puri�

ed

wat

er o

nly)

, are

mix

ed w

ith e

ach

1 pa

rt o

f Aes

culu

s hip

poca

stan

um e

sem

ine

ac-

cord

ing

to H

AB

Met

hod

12m

and

Equ

isetu

m a

rven

se e

x he

rba

acco

rdin

g to

HA

B M

etho

d 12

c. �

e su

pern

atan

t liq

uid

is de

cant

ed a

nd �

ltere

d a�

er 1

0 - 1

2 w

eeks

yi

eldi

ng at

leas

t 75%

Pea

t mos

s ext

ract

com

posit

ion

I.

Solu

m u

ligin

osum

com

p.

(02.

03.1

991)

Peat

mos

s ext

ract

com

-po

sitio

n II

(dar

k)So

lum

ulig

inos

um /

Aes

culu

s hip

poca

s-ta

num

L. /

Equ

ise-

tum

arv

ense

L.

�e

rest

le�

from

the

deca

ntin

g fo

r pre

parin

g Pe

at m

oss e

xtra

ct co

mpo

sitio

n I,

(max

. 25%

) is P

eat m

oss e

xtra

ct co

mpo

sitio

n II

Solu

m u

ligin

osum

com

p.

(02.

03.1

991)

Plan

tago

lanc

eola

ta,

Foliu

m re

c., et

hano

l. D

i-ge

stio

(1:3

.1) w

ith 1

-2%

H

yosc

yam

us n

iger

, H

erba

rec.

Ø

Plan

tago

lanc

eola

ta

L. /

Hyo

scya

mus

ni

ger L

.

Dig

estio

pre

pare

d fr

om 1

par

t of t

he fr

esh

leav

es o

f Pla

ntag

o la

nceo

lata

L. a

nd 3

.1

part

s of e

than

ol o

f sui

tabl

e co

ncen

trat

ion

or w

ater

for i

njec

tions

and

the

addi

tion

of 0

.04

to 0

.08

part

s (co

rres

pond

ing

to 1

to 2

%) o

f Hyo

scya

mus

nig

er L

., H

erba

, m

othe

r tin

ctur

e (P

h. E

ur. 1

.1.3

).

Plan

tago

- Pr

imul

a cu

m

Hyo

scya

mo

(02.

09.1

987)

Plum

bum

mel

litum

Plum

bum

met

al-

licum

/ M

el /

Sac-

char

um (S

acch

arum

o�

cina

rum

L.)

Plum

bum

mel

litum

is p

repa

red

from

lead

, hon

ey a

nd c

ane

suga

r. D

epre

ssio

ns a

re

intr

oduc

ed in

to a

shee

t of l

ead,

this

is �l

led

with

hon

ey, a

nd th

e w

hole

cove

red

with

m

olte

n le

ad. A

�er c

oolin

g it

is gr

ated

, mel

ted

agai

n an

d th

en la

id o

ut a

s a sh

eet.

New

dep

ress

ions

are

intr

oduc

ed o

nce

mor

e. �

ese

are

�lle

d th

is tim

e w

ith m

olte

n su

cros

e (c

ane

suga

r) a

nd co

vere

d w

ith m

olte

n le

ad fr

om th

e �r

st le

ad-h

oney

-she

et.

A�e

r coo

ling

it is

�nel

y gr

ated

and

the

D1

pote

ncy

is pr

epar

ed b

y tr

itura

tion

with

la

ctos

e m

onoh

ydra

te. D

urin

g th

e gr

indi

ng a

nd tr

itura

tion

proc

ess t

he p

owde

r mus

t be

siev

ed.

Plum

bum

mel

litum

(0

4.06

.198

6)

Prim

ula

veris

, Flo

s rec

., et

hano

l. D

iges

tio (1

:3.1

) w

ith 0

.1-1

% H

yosc

ya-

mus

nig

er, H

erba

rec.

Ø

Prim

ula

veris

L. /

H

yosc

yam

us n

iger

L.

A d

iges

tio p

repa

red

from

1 p

art o

f the

fres

h �o

wer

s of P

rimul

a ve

ris L

. and

3.1

par

ts

of e

than

ol o

f sui

tabl

e co

ncen

trat

ion

or w

ater

for i

njec

tions

and

the

addi

tion

of 0

.004

to

0.0

4 pa

rts (

corr

espo

ndin

g to

0.1

to 1

%) o

f Hyo

scya

mus

nig

er L

., H

erba

, mot

her

tinct

ure

(Ph.

Eur

. 1.1

.3).

Ono

pord

on co

mp.

(04.

06.1

986)

• Ap

pend

ix 2

.6


176

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Prim

ula

veris

, Flo

s rec

., et

hano

l. D

iges

tio (1

: 12

.35)

with

0.6

%

Hyo

scya

mus

nig

er,

Her

ba re

c. Ø

Prim

ula

veris

L. /

H

yosc

yam

us n

iger

L.

Prep

ared

by

dige

stio

acc

ordi

ng to

APC

3.8

.1 fr

om 1

par

t of t

he fr

esh

�ow

ers o

f Pr

imul

a ve

ris L

. and

12.

35 p

arts

of e

than

ol o

f sui

tabl

e co

ncen

trat

ion

and

the

addi

-tio

n of

0.0

8 pa

rts (

corr

espo

ndin

g to

0.6

%) o

f Hyo

scya

mus

nig

er L

., H

erba

, mot

her

tinct

ure

(Ph.

Eur

. 1.1

.3).

Prun

usei

sen

Prun

us sp

inos

a e

�orib

us e

t sum

-m

itatib

us fe

rm c

um

Ferr

o

Prep

ared

acc

ordi

ng to

HA

B m

etho

d 37

aPr

unus

spin

osa

cum

Fe

rro

(25.

10.1

994)

Qua

rz c

um F

erro

sul-

furic

oFe

rros

i sul

fas /

Q

uarz

/ M

el /

Viti

s vi

nife

ra L

.

5 pa

rts o

f qua

rtz a

re in

cine

rate

d to

red

heat

at 8

00 °C

and

a�e

rwar

ds c

ut in

to sm

all

piec

es. �

e qu

artz

is tr

itura

ted

with

9.1

5 pa

rts o

f fer

rous

sulfa

te. 2

0 pa

rts o

f whi

te

win

e ar

e he

ated

to b

oilin

g, a

nd a

�er c

oolin

g to

35

°C, m

ade

into

a p

aste

with

the

quar

tz a

nd fe

rrou

s sul

fate

mix

ture

. 10

part

s of h

oney

and

20

part

s of l

acto

se m

ono-

hydr

ate

are

adde

d an

d th

ey a

re m

ixed

wel

l tog

ethe

r. �

e m

ixtu

re is

pla

ced

unde

r va

cuum

and

drie

d at

a su

itabl

e m

inim

um te

mpe

ratu

re. W

hile

still

war

m, t

he to

ugh

britt

le su

bsta

nce

is tr

itura

ted

with

eno

ugh

lact

ose

mon

ohyd

rate

to m

ake

100

part

s (m

othe

r sub

stan

ce=D

1).

Que

rcus

robu

r/pe

trae

e

cort

ice

cum

Cal

cio

carb

onic

o

Que

rcus

robu

r L.,

Que

rcus

pet

raea

(M

att.)

Lie

bl.

1. C

alci

um c

arbo

nicu

m e

cine

re Q

uerc

us: o

ak b

ark

is in

cine

rate

d. �

e as

h is

susp

ende

d 1

part

in 1

0 pa

rts o

f pur

i�ed

wat

er. C

arbo

n di

oxid

e is

indu

ced

for 5

to

10 m

inut

es a

nd th

en w

arm

ed u

ntil

bubb

ling

star

ts (7

5-85

°C).

�is

tem

pera

ture

is

kept

unt

il bu

bblin

g en

ds. �

e co

oled

susp

ensio

n is

�lte

red

and

the

resid

ue d

ried

= C

alci

um c

arbo

nicu

m e

cine

re Q

uerc

us.

2. C

alci

um c

arbo

nicu

m e

cine

re Q

uerc

us so

lutu

m: 0

.1 p

art o

f Cal

cium

car

boni

cum

e

cine

re Q

uerc

us is

mix

ed w

ith 6

100

part

s of p

uri�

ed w

ater

or w

ater

for i

njec

tions

an

d bo

iled

for 5

min

utes

. �e

cool

ed so

lutio

n is

�lte

red

(for s

olut

ions

for i

njec

tion

it is

deca

nted

and

�lte

red)

. �e

resu

lt is

a sa

tura

ted

aque

ous s

olut

ion

of C

alci

um

carb

onic

um e

cine

re Q

uerc

us =

Cal

cium

car

boni

cum

e ci

nere

Que

rcus

solu

tum

. 2.

1. C

alci

um c

arbo

nicu

m e

cine

re Q

uerc

us so

lutu

m sa

ccha

ratu

m: s

yrup

pre

pare

d w

ith su

cros

e an

d C

alci

um c

arbo

nicu

m e

cine

re Q

uerc

us so

lutu

m (6

4:36

). 3.

Que

rcus

robu

r/pe

trae

e co

rtic

e cu

m C

alci

o ca

rbon

ico

solu

tion

= D

5: A

dec

oc-

tion

of o

ak b

ark

acco

rdin

g to

HA

B M

etho

d 23

a (Ø

=D1)

is p

oten

tised

to D

5 w

ith

Cal

cium

car

boni

cum

e ci

nere

Que

rcus

solu

tum

as a

veh

icle

. Ap

pend

ix: a

ccor

ding

to th

e do

sage

form

to b

e pr

oduc

ed e

ither

pot

entis

e fu

rthe

r w

ith C

alci

um c

arbo

nicu

m e

cine

re Q

uerc

us so

lutu

m (e

.g. s

olut

ion

for i

njec

tion)

or

with

Cal

cium

car

boni

cum

e ci

nere

Que

rcus

solu

tum

sacc

hara

tum

(Glo

buli

vela

ti).

Cal

cium

car

boni

cum

cu

m Q

uerc

u (0

2.03

.199

1)

Rose

neise

nRo

sa e

�or

ibus

ferm

cu

m F

erro

Prep

ared

acc

ordi

ng to

HA

B m

etho

d 37

aFe

rrum

rosa

tum

/Gra

ph-

ites (

03.0

7.19

92)

• Appendix 2.6


177

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Sile

x –

Lapi

s can

cri

solu

tus

Sile

x (F

lint)

/ Kal

ii ni

tras

/ La

pis c

ancr

i / A

cetu

m V

ini d

est.

(Viti

s vin

ifera

L.)

Cal

cium

silic

ate

is pr

ecip

itate

d by

add

ing

an a

queo

us so

lutio

n of

pot

assiu

m si

licat

e (p

repa

red

from

�in

t and

pot

assiu

m n

itrat

e) to

an

aque

ous s

olut

ion

of c

alci

um

acet

ate

(pre

pare

d fr

om L

apis

Can

cri a

nd d

istill

ed re

d w

ine

vine

gar i

n se

vera

l ste

ps)

and

diss

olve

d in

dist

illed

red

win

e vi

nega

r to

give

a cl

ear s

olut

ion.

�e

solu

tion

is di

lute

d w

ith w

ater

to 1

.0%

and

then

succ

usse

d to

resu

lt th

e po

tenc

y D

2.

Vade

mec

um 2

013:

Si

lex-

Lapi

s Can

cri

solu

tus

Solu

tio a

lkal

ina

Leaf

y pl

ants

/ C

ream

of

Tar

tar

An

aque

ous s

olut

ion

prep

ared

from

the

ash

of a

spec

ial c

ompo

st. C

ompo

st p

rodu

c-tio

n pr

ocee

ds at

abo

ut 3

70C

with

gre

en p

arts

of p

lant

s, so

il an

d a

prep

arat

ion

from

ta

rtar

.

Solu

tio a

lkal

ina

(25.

10.1

994)

Solu

tio F

erri

com

p.K

alii

carb

onas

/ Fe

rrum

(III

)-K

alii-

tart

aric

um /

Sulfu

r / T

rona

/ A

cidu

m

tart

aric

um

�e

min

eral

com

posit

ion

acco

rdin

g to

the

mod

el o

f Urt

ica

dioi

ca, P

lant

a to

ta, S

o-lu

tio F

erri

com

p. is

pre

pare

d fr

om: P

otas

sium

car

bona

te /

ferr

ic p

otas

sium

tart

rate

/ s

ulfu

r / tr

ona

/ aci

dum

tart

aric

um. P

otas

sium

car

bona

te, t

rona

and

sulfu

r are

m

elte

d to

geth

er. �

e re

sulti

ng m

elt i

s diss

olve

d in

wat

er a

nd a

ltern

atel

y he

ated

and

su

bjec

ted

to a

n in

tens

ive

air-

stre

am. A

�er t

his p

roce

dure

ferr

ic p

otas

sium

tart

rate

an

d ac

idum

tart

aric

um a

re a

dded

. �e

resu

lting

solu

tion

is ex

pose

d to

the

light

.

Solu

tio F

erri

com

p.(2

5.10

.199

4)

Solu

tio S

acch

ari c

omp.

Aci

dum

sulfu

ricum

/ B

etul

a pe

ndul

a Ro

th /

Kal

ii ca

rbo-

nas /

Fer

rum

(III

)-K

aliu

m-t

arta

ricum

/ M

el /

Qua

rtz /

Tro

na

�e

min

eral

com

posit

ion

acco

rdin

g to

the

mod

el o

f Cha

mom

illa

(Mat

ricar

ia re

cu-

tita

L.),

Radi

x, S

olut

io S

acch

ari c

omp.

is p

repa

red

from

: Car

bo B

etul

ae /

pota

ssiu

m

carb

onat

e / f

erric

pot

assiu

m ta

rtra

te /

hone

y / q

uart

z / tr

ona.

Pot

assiu

m c

arbo

n-at

e, qu

artz

and

Car

bo B

etul

ae a

re m

elte

d to

geth

er. �

e m

elt i

s diss

olve

d in

wat

er

to p

rodu

ce a

clea

r sol

utio

n, to

whi

ch a

solu

tion

of p

otas

sium

car

bona

te, t

rona

and

di

lute

d su

lfuric

aci

d is

adde

d. A

�er a

dditi

on o

f fur

ther

dilu

ted

sulfu

ric a

cid,

hon

ey

and

then

ferr

ic p

otas

sium

tart

rate

are

add

ed. �

e re

sulti

ng so

lutio

n is

expo

sed

to

the

light

.

Solu

tio S

acch

ari c

omp.

(25.

10.1

994)

Solu

tio S

ilice

ae co

mp.

Kal

ii ca

rbon

as /

Mar

ble

/ Qua

rz /

Sulfu

r / T

rona

�e

min

eral

com

posit

ion

acco

rdin

g to

the

mod

el o

f Equ

isetu

m a

rven

se, H

erba

, So

lutio

Sili

ceae

com

p. is

pre

pare

d fr

om: P

otas

sium

car

bona

te /

mar

ble

/ qua

rtz /

tr

ona

and

sulfu

r. Q

uart

z and

pot

assiu

m c

arbo

nate

are

mel

ted

toge

ther

and

diss

olve

d in

wat

er. I

n a

furt

her s

tep

mar

ble,

pota

ssiu

m c

arbo

nate

and

tron

a ar

e di

ssol

ved

in w

ater

by

add-

ing

vapo

ur fr

om b

urni

ng su

lfur t

o a

seco

nd so

lutio

n. B

oth

solu

tions

are

com

bine

d un

der c

ontin

uos v

apou

r fro

m b

urni

ng su

lfur.

Air

is pa

ssed

thro

ugh

the

resu

lting

so

lutio

n fo

r sev

eral

hou

rs.

Solu

tio S

ilice

a co

mp.

(25.

10.1

994)

Stan

num

mel

litum

Stan

num

met

al-

licum

/ M

el /

Sac-

char

um (S

acch

arum

o�

cina

rum

L.)

Stan

num

mel

litum

is p

repa

red

from

tin

with

hon

ey a

nd c

ane

suga

r. D

epre

ssio

ns

are

intr

oduc

ed in

to a

shee

t of t

in, t

his i

s �lle

d w

ith h

oney

, and

the

who

le co

vere

d w

ith m

olte

n tin

. A�e

r coo

ling

it is

grat

ed, m

elte

d ag

ain

and

then

laid

out

as a

shee

t. N

ew d

epre

ssio

ns a

re in

trod

uced

onc

e m

ore.

�es

e ar

e �l

led

this

time

with

mol

ten

sucr

ose

(can

e su

gar)

and

cove

red

with

mol

ten

tin. A

�er c

oolin

g it

is �n

ely

grat

ed

and

the

D1

pote

ncy

is pr

epar

ed b

y tr

itura

tion

with

lact

ose

mon

ohyd

rate

. Dur

ing

the

grin

ding

and

tritu

ratio

n pr

oces

s the

pow

der m

ust b

e sie

ved.

Der

Mer

kurs

tab

1992

; 45(

2):

108-

12

• Ap

pend

ix 2

.6


178

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Trab

ecul

um co

mp.

Aci

dum

form

icic

um

e fo

rmic

a / A

m-

mon

iae

solu

tio co

n-ce

ntra

ta 2

5% /

Cupr

i su

lfas p

enta

hydr

icus

/ H

ydra

rgyr

um

biio

datu

m /

Kal

ii io

-di

dum

/ Tr

abec

ulum

(B

os ta

urus

L.)

1 g

of T

rabe

culu

m co

mp.

(=D

1) is

pre

pare

d fr

om: 0

.1 g

Tra

becu

lum

/ 0.

1 g

acid

um

form

icic

um e

form

ica

(5%

) / 0

.005

g C

upri

sulfa

s / 0

.007

g A

mm

onia

e so

lutio

con-

cent

rata

/ 0.

03 g

Hyd

rarg

yrum

biio

datu

m /

0.02

25 g

Kal

ii io

didu

m.

Trab

ecul

um is

trea

ted

with

an

aque

ous s

olut

ion

of A

cidu

m fo

rmic

icum

e fo

rmic

a to

mak

e a

pulp

with

a sm

ooth

cons

isten

cy a

nd th

en m

ixed

with

an

amm

onia

cal

solu

tion

of co

pper

sulfa

te. �

en a

solu

tion

of m

ercu

ry (I

I) io

dide

and

pot

assiu

m

iodi

de a

nd �

nally

lact

ose

mon

ohyd

rate

is a

dded

. A�e

r dry

ing,

the

who

le m

ixtu

re is

ru

bbed

to a

uni

form

pow

der.

Trab

ecul

um co

mp.

(03.

07.1

992)

Uve

a co

mp.

Aci

dum

form

icic

um

e fo

rmic

a / A

cidu

m

asco

rbic

um /

Liqu

or n

atrii

silic

ici

/ Fer

rosi

sulfa

s /

Hyo

scya

mus

nig

er

L. /

Mag

nesiu

m

phos

phor

icum

ac

idum

/ U

vea

(Bos

ta

urus

L.)

1 g

Uve

a co

mp.

cont

ains

: Uve

a bo

vis 1

.00

g / M

agne

sium

pho

spho

ricum

aci

dum

0.

10 g

/ A

cidu

m a

scor

bicu

m 0

.10

g / F

erru

m su

lfuric

um 0

.33

g / L

iquo

r nat

rii si

-lic

ici 1

.00

g / H

yosc

yam

us n

iger

, Pla

nta

tota

Rh

Ø (H

AB,

Met

hod

21) 1

.00

g. U

vea

is tr

eate

d w

ith a

n aq

ueou

s sol

utio

n of

Aci

dum

form

icic

um e

form

ica

to m

ake

a pu

lp

with

a sm

ooth

cons

isten

cy a

nd th

en m

ixed

with

a so

lutio

n of

mag

nesiu

m p

hos-

phat

e di

hydr

ate

and

sodi

um si

licat

e. �

en a

n aq

ueou

s sol

utio

n of

ferr

ous s

ulfa

te

and

asco

rbic

aci

d ar

e ad

ded,

and

�na

lly H

yosc

yam

us, P

lant

a to

ta R

h Ø

is a

dded

. A

�er d

ryin

g, th

e su

bsta

nce

is po

wde

red.

Visc

um A

biet

is V

iscum

alb

um L

. A

queo

us e

xtra

ct p

repa

red

from

the

fres

h pl

ant o

f Visc

um a

lbum

ssp.

abi

etis

(Wi-

esb.

) Jan

ch. (

Hos

t tre

e: A

bies

alb

a M

ill.;

�r tr

ee),

prep

ared

acc

ordi

ng to

APC

7.2

.2.

Visc

um a

lbum

(04.

06.1

986)

Visc

um M

ali

Visc

um a

lbum

L.

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m

of V

iscum

alb

um ss

p. a

lbum

L. (

Hos

t tre

e: M

alus

dom

estic

a Bo

ekh.

; app

le tr

ee),

prep

ared

acc

ordi

ng to

APC

7.2

.3.

Visc

um M

ali

Visc

um a

lbum

L.

Aqu

eous

ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t of V

iscum

alb

um ss

p. a

lbum

L.

(Hos

t tre

e: M

alus

dom

estic

a Bo

ekh.

; app

le tr

ee),

prep

ared

acc

ordi

ng to

APC

7.2

.2.

Visc

um M

ali c

um

Arg

ento

Visc

um a

lbum

L. /

A

rgen

ti ca

rbon

asFe

rmen

ted

aque

ous e

xtra

ct p

repa

red

from

the

fres

h pl

ant e

xclu

ding

hau

stor

ium

of

Visc

um a

lbum

ssp.

alb

um L

. (H

ost t

ree:

Mal

us d

omes

tica

Boek

h.; a

pple

tree

) with

ad

ditio

n of

silv

er c

arbo

nate

(2x1

0-5 m

g pe

r 100

mg

fres

h pl

ant),

pre

pare

d ac

cord

ing

to A

PC 7

.2.4

.

Visc

um a

lbum

c. A

rg.

(DA

Z N

r. 29

, 21.

07.1

994)

Visc

um M

ali c

um

Cupr

oV

iscum

alb

um L

. / C

upri

carb

onas

(m

alac

hite

)

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m

of V

iscum

alb

um ss

p. a

lbum

L. (

Hos

t tre

e: M

alus

dom

estic

a Bo

ekh.

; app

le tr

ee)

with

add

ition

of c

oppe

r car

bona

te (m

alac

hite

) (2x

10-5

mg

per 1

00 m

g fr

esh

plan

t),

prep

ared

acc

ordi

ng to

APC

7.2

.4.

Visc

um a

lbum

c. C

u(D

AZ

Nr.

29, 2

1.07

.199

4)

Visc

um M

ali c

um

Hyd

rarg

yro

Visc

um a

lbum

L. /

H

ydra

rgyr

i sul

fas

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f V

iscum

alb

um ss

p. a

lbum

L. (

Hos

t tre

e: M

alus

dom

estic

a Bo

ekh.

; app

le tr

ee) w

ith

addi

tion

of m

ercu

ry su

lfate

(2x1

0-5 m

g pe

r 100

mg

fres

h pl

ant),

pre

pare

d ac

cord

ing

to A

PC 7

.2.4

.

Visc

um a

lbum

c. H

g(D

AZ

Nr.

29, 2

1.07

.199

4)

• Appendix 2.6


179

Nam

e of t

he su

bsta

nce

Scie

nti�

c nam

e of

ingr

edie

nts

Prep

arat

ion

met

hod

Exem

plar

y ref

eren

ce fo

r use

in an

thro

poso

phic

m

edic

ine

KC M

onog

raph

(dat

e)O

ther

Visc

um P

ini

Visc

um a

lbum

L.

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f V

iscum

alb

um ss

p. au

stria

cum

(Wie

sb.)

Vollm

ann

(Hos

t tre

e: P

inus

sylv

estr

is L.

; pi

ne),

prep

ared

acc

ordi

ng to

APC

7.2

.3.

Visc

um a

lbum

(04.

06.1

986)

Visc

um P

ini

Visc

um a

lbum

L.

Aqu

eous

ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t of V

iscum

alb

um ss

p. au

stria

cum

(W

iesb

.) Vo

llman

n (H

ost t

ree:

Pin

us sy

lves

tris

L.; p

ine)

, pre

pare

d ac

cord

ing

to A

PC

7.2.

2.V

iscum

Pin

i cum

A

rgen

toV

iscum

alb

um L

. /

Arg

enti

carb

onas

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m

of V

iscum

alb

um ss

p. au

stria

cum

(Wie

sb.)

Vollm

ann

(Hos

t tre

e: P

inus

sylv

estr

is L.

; pin

e) w

ith a

dditi

on o

f silv

er c

arbo

nate

(2x1

0-5 m

g pe

r 100

mg

fres

h pl

ant)

, pr

epar

ed a

ccor

ding

to A

PC 7

.2.4

.

Visc

um a

lbum

c. A

rg.

(DA

Z N

r. 29

, 21.

07.1

994)

Visc

um P

ini c

um C

upro

Visc

um a

lbum

L.

/ Cup

ri ca

rbon

as

(mal

achi

te)

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f V

iscum

alb

um ss

p. a

lbum

L. (

Hos

t tre

e: P

inus

sylv

estr

is L.

; pin

e) w

ith a

dditi

on o

f co

pper

car

bona

te (m

alac

hite

) (2x

10-5

mg

per 1

00 m

g fr

esh

plan

t), p

repa

red

acco

rd-

ing

to A

PC 7

.2.4

.

Visc

um a

lbum

c. C

u(D

AZ

Nr.

29, 2

1.07

.199

4)

Visc

um P

ini c

um

Hyd

rarg

yro

Visc

um a

lbum

L. /

H

ydra

rgyr

i sul

fas

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f V

iscum

alb

um ss

p. au

stria

cum

(Wie

sb.)

Vollm

ann

(Hos

t tre

e: P

inus

sylv

estr

is L.

; pi

ne) w

ith a

dditi

on o

f mer

cury

sulfa

te (1

0-5 m

g pe

r 100

mg

fres

h pl

ant),

pre

pare

d ac

cord

ing

to A

PC 7

.2.4

.

Visc

um a

lbum

c. H

g(D

AZ

Nr.

29, 2

1.07

.199

4)

Visc

um Q

uerc

iV

iscum

alb

um L

. Fe

rmen

ted

aque

ous e

xtra

ct p

repa

red

from

the

fres

h pl

ant e

xclu

ding

hau

stor

ium

of

Visc

um a

lbum

ssp.

alb

um L

. (H

ost t

ree:

Que

rcus

robu

r L.,

Que

rcus

pet

raea

(Mat

t.)

Lieb

l.; o

ak),

prep

ared

acc

ordi

ng to

APC

7.2

.3.

Visc

um a

lbum

(04.

06.1

986)

Visc

um Q

uerc

i cum

A

rgen

toV

iscum

alb

um L

. /

Arg

enti

carb

onas

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f V

iscum

alb

um ss

p. a

lbum

L. (

Hos

t tre

e: Q

uerc

us ro

bur L

., Q

uerc

us p

etra

ea (M

att.)

Li

ebl.;

oak

) with

add

ition

of s

ilver

car

bona

te (1

0-5 m

g pe

r 100

mg

fres

h pl

ant),

pr

epar

ed a

ccor

ding

to A

PC 7

.2.4

.

Visc

um a

lbum

c. A

rg.

(DA

Z N

r. 29

, 21.

07.1

994)

Visc

um Q

uerc

i cum

Cu

pro

Visc

um a

lbum

L.

/ Cup

ri ca

rbon

as

(mal

achi

te)

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f V

iscum

alb

um ss

p. a

lbum

L. (

Hos

t tre

e: Q

uerc

us ro

bur L

., Q

uerc

us p

etra

ea (M

att.)

Li

ebl.;

oak

) with

add

ition

of c

oppe

r car

bona

te (m

alac

hite

) (10

-5 m

g pe

r 100

mg

fres

h pl

ant),

pre

pare

d ac

cord

ing

to A

PC 7

.2.4

.

Visc

um a

lbum

c. C

u(D

AZ

Nr.

29, 2

1.07

.199

4)

Visc

um Q

uerc

i cum

H

ydra

rgyr

oV

iscum

alb

um L

. /

Hyd

rarg

yri s

ulfa

sFe

rmen

ted

aque

ous e

xtra

ct p

repa

red

from

the

fres

h pl

ant e

xclu

ding

hau

stor

ium

of

Visc

um a

lbum

ssp.

alb

um L

. (H

ost t

ree:

Que

rcus

robu

r L.,

Que

rcus

pet

raea

(Mat

t.)

Lieb

l.; o

ak) w

ith a

dditi

on o

f mer

cury

sulfa

te (1

0-5 m

g pe

r 100

mg

fres

h pl

ant),

pr

epar

ed a

ccor

ding

to A

PC 7

.2.4

.

Visc

um a

lbum

c. H

g(D

AZ

Nr.

29, 2

1.07

.199

4)

Visc

um U

lmi c

um

Hyd

rarg

yro

Visc

um a

lbum

L. /

H

ydra

rgyr

i sul

fas

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d fr

om th

e fr

esh

plan

t exc

ludi

ng h

aust

oriu

m o

f V

iscum

alb

um ss

p. a

lbum

L. (

Hos

t tre

e: U

lmus

cap

rinifo

lia G

led.

[Ulm

us c

ampe

s-tr

is L.

], U

lmus

gla

bra

Hud

s.; el

m) w

ith a

dditi

on o

f mer

cury

sulfa

te (1

0-5 m

g pe

r 100

m

g fr

esh

plan

t), p

repa

red

acco

rdin

g to

APC

7.2

.4.

Visc

um a

lbum

c. H

g(D

AZ

Nr.

29, 2

1.07

.199

4)

• Ap

pend

ix 2

.6


180

• Appendix II


181

APPENDIX II

Correlation table: Ph.Eur./HAB manufacturing methods used in anthroposophic pharmacy and corresponding manufacturing methods in the HPUS

• Ap

pend

ix II

• Appendix II


182

Ph. E

ur. /

HA

B m

etho

ds u

sed

in

anth

ropo

soph

ic p

harm

acy

Cor

resp

ondi

ng m

anuf

actu

ring

in th

e H

PUS

Ph. E

ur. M

etho

d 1.

1.1

(HA

B 1a

)Ph

. Eur

. Met

hod

1.1.

2 (H

AB

1b)

Cla

ss O

Ph. E

ur. M

etho

d 1.

1.3

(HA

B 2a

)Ph

. Eur

. Met

hod

1.1.

4 (H

AB

2b)

Cla

ss M

Ph. E

ur. M

etho

d 1.

1.5

(HA

B 3a

)Ph

. Eur

. Met

hod

1.1.

6 (H

AB

3b)

Ph. E

ur. M

etho

d 1.

1.7

(HA

B 3c

)

Cla

ss N

Ph. E

ur. M

etho

d 1.

1.8

(HA

B 4a

)C

lass

C

Ph. E

ur. M

etho

d 1.

1.9

(HA

B 4b

)C

lass

E

Ph. E

ur. M

etho

d 1.

1.10

(Ph.

fr.)

No

corr

espo

ndin

g H

PUS

met

hod

for a

ttenu

atio

ns, t

houg

h C

lass

C is

the

sam

e pr

oces

s for

the

first

step

1

Ph. E

ur. M

etho

d 1.

1.11

(Ph.

fr.)

No

corr

espo

ndin

g H

PUS

met

hod

for a

ttenu

atio

ns, t

houg

h C

lass

D is

the

sam

e pr

oces

s for

the

first

step

2

Ph. E

ur. M

etho

d 3.

1.1

(HA

B 5a

)C

lass

A o

r Cla

ss B

, dep

endi

ng o

n so

lubi

lity

Cha

ract

erist

ics o

f the

star

ting

mat

eria

l

Ph. E

ur. M

etho

d 3.

1.2

(HA

B 5b

)C

lass

A o

r Cla

ss B

, dep

endi

ng o

n so

lubi

lity

Cha

ract

erist

ics o

f the

star

ting

mat

eria

l

Ph. E

ur. M

etho

d 4.

1.1

(HA

B 6)

Cla

ss F

Ph. E

ur. M

etho

d 4.

1.2

(Ph.

fr.)

Cla

ss F

Ph. E

ur. M

etho

d 4.

2.1

(HA

B 7)

“Med

icat

ion:

Med

icat

ed P

owde

rs” a

pplie

s for

cent

esim

al, b

ut n

ot fo

r dec

imal

atte

nuat

ions

3

Ph. E

ur. M

etho

d 3.

2.1

(HA

B 8a

)Ph

. Eur

. Met

hod

3.2.

2 (H

AB

8b)

Cla

ss H

1 �

e Ph

. Eur

. Met

hod

1.1.

10 p

rodu

ces a

1:1

0 pr

epar

atio

n fr

om w

hich

the

D1

or C

1 is

mad

e. �

e H

PUS

Cla

ss C

also

pro

duce

s a 1

:10

prep

arat

ion.

But

this

is co

nsid

-er

ed th

e sa

me

as a

D1.

�us

, Ph.

Eur

. Met

hod

1.1.

10 D

1 =

HPU

S D

2. F

or th

is re

ason

, the

met

hods

do

not c

orre

spon

d.2

�e

Ph. E

ur. M

etho

d 1.

1.11

pro

duce

s a 1

:20

prep

arat

ion

from

whi

ch th

e D

1 or

C1

is m

ade.

�e

HPU

S C

lass

D a

lso p

rodu

ces a

1:2

0 pr

epar

atio

n. B

ut th

e C

lass

D

prep

arat

ion

is th

en at

tenu

ated

2 p

arts

+ 8

par

ts v

ehic

le to

pro

duce

the

D2.

�e

prep

arat

ion

by P

h. E

ur. M

etho

d 1.

1.11

is at

tenu

ated

1 p

art +

9 p

arts

veh

icle

to p

rodu

ce

the

D1.

For

this

reas

on, t

he m

etho

ds d

o no

t cor

resp

ond.

3 H

PUS

“Med

iate

d Po

wde

rs” a

re sp

eci�

ed to

be

mad

e fr

om 1

par

t liq

uid

prep

arat

ion

+ 10

0 pa

rts v

ehic

le.


• Ap

pend

ix II

183

Ph. E

ur. /

HA

B m

etho

ds u

sed

in

anth

ropo

soph

ic p

harm

acy

Cor

resp

ondi

ng m

anuf

actu

ring

in th

e H

PUS

HA

B M

etho

d 9

“Med

icat

ion:

Tab

lets”

HA

B M

etho

d 10

“Med

icat

ion:

Glo

bule

s”

HA

B M

etho

d 11

“For

ms o

f veh

icle

s for

disp

ensin

g”

HA

B M

etho

d 12

a“F

orm

s of v

ehic

les f

or d

ispen

sing”

HA

B M

etho

d 12

bC

lass

M

HA

B M

etho

d 13

“For

ms o

f veh

icle

s for

disp

ensin

g”

HA

B M

etho

d 14

“For

ms o

f veh

icle

s for

disp

ensin

g”

HA

B M

etho

d 15

“For

ms o

f veh

icle

s for

disp

ensin

g: O

phth

alm

ic S

olut

ions

”

HA

B M

etho

d 16

New

Sec

tion

39, a

nd “I

ntro

duct

ion

to th

e H

omoe

opat

hic P

harm

acop

oeia

of t

he U

nite

d St

ates

: St

atem

ent r

egar

ding

com

bina

tions

of h

omoe

opat

hic d

rugs

”H

AB

Met

hod

17“A

ttenu

atio

ns: F

ifty

Mill

esim

al S

cale

of A

ttenu

atio

n”

HA

B M

etho

d 18

a-b

Cla

ss M

, “Ti

nctu

res o

f bot

anic

al su

bsta

nces

: Inc

ubat

ion”

HA

B M

etho

ds 1

8c-e

Cla

ss N

, “Ti

nctu

res o

f bot

anic

al su

bsta

nces

: Inc

ubat

ion”

HA

B M

etho

ds 1

8fC

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: I

ncub

atio

n”

HA

B M

etho

ds 1

9a-b

Cla

ss M

, “Ti

nctu

res o

f bot

anic

al su

bsta

nces

: Dec

octio

n”

HA

B M

etho

ds 1

9c-e

Cla

ss N

, “Ti

nctu

res o

f bot

anic

al su

bsta

nces

: Dec

octio

n”

HA

B M

etho

d 19

fC

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: D

ecoc

tion”


• Appendix II

184

Ph. E

ur. /

HA

B m

etho

ds u

sed

in a

nthr

opos

ophi

c ph

arm

acy

Cor

resp

ondi

ng m

anuf

actu

ring

in th

e H

PUS

HA

B M

etho

d 20

Cla

ss C

, “Ti

nctu

res o

f bot

anic

al su

bsta

nces

: Inf

usio

n”

HA

B M

etho

d 21

Cla

ss O

, fer

men

ted

HA

B M

etho

d 22

Cla

ss P

HA

B M

etho

d 23

aC

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: D

ecoc

tion”

HA

B M

etho

d 23

bC

lass

N, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: D

ecoc

tion”

HA

B M

etho

d 24

aC

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: I

nfus

ion”

HA

B M

etho

ds 3

3C

lass

P

HA

B M

etho

ds 3

4C

lass

P

HA

B M

etho

ds 3

5C

lass

P

HA

B M

etho

ds 3

6C

lass

P

Ph. E

ur. M

etho

d 5.

1.1

(HA

B 40

a)Ph

. Eur

. Met

hod

5.1.

2 (H

AB

40b)

Ph. E

ur. M

etho

d 5.

1.3

(HA

B 40

c)

No

corr

espo

ndin

g m

etho

d

Ph. E

ur. M

etho

d 2.

1.1

(HA

B 42

a)Ph

. Eur

. Met

hod

2.1.

2 (H

AB

42b)

Cla

ss L

, Met

hod

II

Ph. E

ur. M

etho

d 2.

1.3

(Ph.

fr.)

No

corr

espo

ndin

g m

etho

d

Ph. E

ur. M

etho

d 2.

2.1

(HA

B 41

a)Ph

. Eur

. Met

hod

2.2.

2 (H

AB

41b)

Ph. E

ur. M

etho

d 2.

2.3

(HA

B 41

c)Ph

. Eur

. Met

hod

2.2.

4 (H

AB

41d)

Cla

ss L

, Met

hod

II (a

ltern

ate

met

hodo

logy

)

HA

B M

etho

ds 4

5“F

orm

s of

veh

icle

s for

disp

ensin

g: N

asal

Sol

utio

ns”

HA

B M

etho

ds 5

1C

lass

P


• Ap

pend

ix II

185

anthroposophic pharmaceutical codex apc · ˜e anthroposophic pharmaceutical codex, apc is now...

Documents